Comprehensive Overview of Bottom-Up Proteomics using Mass Spectrometry

Yuming Jiang; Devasahayam Arokia Balaya Rex; Dina Schuster; Benjamin A. Neely; Germán L. Rosano; Norbert Volkmar; Amanda Momenzadeh; Trenton M. Peters-Clarke; Susan B. Egbert; Simion Kreimer; Emma H. Doud; Oliver M. Crook; Amit Kumar Yadav; Muralidharan Vanuopadath; Martín L. Mayta; Anna G. Duboff; Nicholas M. Riley; Robert L. Moritz; Jesse G. Meyer

Proteomics is the large scale study of protein structure and function from biological systems through protein identification and quantification. “Shotgun proteomics” or “bottom-up proteomics” is the prevailing strategy, in which proteins are hydrolyzed into peptides that are analyzed by mass spectrometry. Proteomics studies can be applied to diverse studies ranging from simple protein identification to studies of proteoforms, protein-protein interactions, protein structural alterations, absolute and relative protein quantification, post-translational modifications, and protein stability. To enable this range of different experiments, there are diverse strategies for proteome analysis. The nuances of how proteomic workflows differ may be challenging to understand for new practitioners. Here, we provide a comprehensive overview of different proteomics methods to aid the novice and experienced researcher. We cover from biochemistry basics and protein extraction to biological interpretation and orthogonal validation. We expect this work to serve as a basic resource for new practitioners in the field of shotgun or bottom-up proteomics.

Introduction

Proteomics is the large-scale study of protein structure and function. Proteins are translated from messenger RNA (mRNA) transcripts that are transcribed from the complementary DNA-based genome. Although the genome encodes potential cellular functions and states, the study of proteins in all their forms is necessary to truly understand biology.

Currently, proteomics can be performed with various methods. Mass spectrometry has emerged within the past few decades as the premier tool for comprehensive proteome analysis. The ability of mass spectrometry (MS) to detect charged chemicals enables the identification of peptide sequences and modifications for diverse biological investigations. Alternative (commercial) methods based on affinity interactions of antibodies or DNA aptamers have been developed, namely Olink and SomaScan. There are also nascent methods that are either recently commercialized or still under development and not yet applicable to whole proteomes, such as motif scanning using antibodies, variants of N-terminal degradation, and nanopores [1,2,3,4]. Another approach uses parallel immobilization of peptides with total internal reflection microscopy and sequential Edman degradation [5]. However, by far the most common method for proteomics is based on mass spectrometry coupled to liquid chromatography (LC).

Modern proteomics had its roots in the early 1980s with the analysis of peptides by mass spectrometry and low efficiency ion sources, but started ramping up around the year 1990 with the introduction of soft ionization methods that enabled, for the first time, efficient transfer of large biomolecules into the gas phase without destroying them [6,7]. Shortly afterward, the first computer algorithm for matching peptides to a database was introduced [8]. Another major milestone that allowed identification of over 1,000 proteins were improvements to chromatography upstream of MS anlaysis [9]. As the volume of data exploded, methods for statistical analysis transitioned from the wild west of ad hoc empirical analysis to modern informatics based on statistical models [10] and false discovery rate [11].

Two strategies of mass spectrometry-based proteomics differ fundamentally by whether proteins are analyzed as a whole chain or cleaved into peptides before analysis: “top-down” versus “bottom-up”. Bottom-up proteomics (also refered to as shotgun proteomics) is defined by the intentional hydrolysis of proteins into peptide pieces using enzymes called proteases [12]. Therefore, bottom-up proteomics does not actually measure proteins, but instead infers protein presence and abundance from identified peptides [10]. Sometimes, proteins are inferred from only one peptide sequence representing a small fraction of the total protein sequence predicted from the genome. In contrast, top-down proteomics attempts to measure intact proteins [13,14,15,16]. The potential benefit of top-down proteomics is the ability to measure the many varied proteoforms [14,17,18]. However, due to myriad analytical challenges, the depth of protein coverage that is achievable by top-down proteomics is considerably less than that of bottom-up proteomics [19].

In this tutorial we focus on the bottom-up proteomics workflow. The most common version of this workflow is generally comprised of the following steps. First, proteins in a biological sample must be extracted. Usually this is achieved by mechanically lysing cells or tissue while denaturing and solubilizing the proteins and disrupting DNA to minimize interference in analysis procedures. Next, proteins are hydrolyzed into peptides, most often using the protease trypsin, which generates peptides with basic C-terminal amino acids (arginine and lysine) to aid in fragment ion series production during tandem mass spectrometry (MS/MS). Peptides can also be generated by chemical reactions that induce residue specific hydrolysis, such as cyanogen bromide that cleaves after methionine. Peptides from proteome hydrolysis must be purified; this is often accomplished with reversed-phase liquid chromatography (RPLC) cartridges or tips to remove interfering molecules in the sample such as salts and buffers. The peptides are then almost always separated by reversed-phase LC before they are ionized and introduced into a mass spectrometer, although recent reports also describe LC-free proteomics by direct infusion [20,21,22]. The mass spectrometer then collects precursor and fragment ion data from those peptides. Peptides must be identified from the tandem mass spectra, protein groups are inferred from a proteome database, and then quantitative values are assigned. Changes in protein abundances across conditions are determined with statistical tests, and results must be interpreted in the context of the relevant biology. Data interpretation is the rate limiting step; data collected in less than one week can take months or years to understand.

There are many variations to this workflow. The diversity of experimental goals that are achievable with proteomics technology drives an expansive array of workflows. Every choice is important as every choice will affect the results, from instrument procurement to choice of data processing software and everything in between. In this tutorial, we detail all the required steps to serve as a comprehensive overview for new proteomics practitioners. There are 16 sections in total:

Biochemistry Basics

Proteins

Proteins are large biomolecules or biopolymers made up of a backbone of amino acids which are linked by peptide bonds. They perform various functions in living organisms ranging from structural roles to functional involvement in cellular signaling and the catalysis of chemical reactions (enzymes). Proteins are made up of 20 different amino acids (not counting pyrrolysine, hydroxyproline, and selenocysteine, which only occur in specific organisms) and their sequence is encoded in their corresponding genes. The human genome encodes approximately 19,778 of the predicted canonical proteins coded in the human genome (see www.neXtProt.org) [23]. Each protein is present at a different abundance depending on the cell type or bodily fluid. Previous studies have shown that the concentration range of proteins can span at least seven orders of magnitude to up to 20,000,000 copies per cell, and that their distribution is tissue-specific [24,25]. Protein abundances can span more than ten orders of magnitude in human blood, while a few proteins make up most of the protein by weight in these fluids, making blood and plasma proteomics one of the most challenging matrices for mass spectrometry to analyze. Due to genetic variation, alternative splicing, and co- and post-translational modifications (PTMs), multiple different proteoforms can be produced from a single gene (Figure 1) [14,26].

PTMs

After protein biosynthesis, enzymatic and nonenzymatic processes change the protein sequence through proteolysis or covalent chemical modification of amino acid side chains. Post-translational modifications (PTMs) are important biological regulators contributing to the diversity and function of the cellular proteome. Proteins can be post-translationally modified through enzymatic and non-enzymatic reactions in vivo and in vitro [27]. PTMs can be reversible or irreversible, and they change protein function in multiple ways, for example by altering substrate–enzyme interactions, subcellular localization or protein-protein interactions [28,29].

More than 400 biological PTMs have been discovered in both prokaryotic and eukaryotic cells. There are many more chemical artifact PTMs that occur during sample preparation, such as carbamylation. These modifications are crucial in controlling protein functions and signal transduction pathways [30]. The most commonly studied and biologically relevant post-translational modifications include phosphorylation (Ser, Thr, Tyr, His), glycosylation (Arg, Asp, Cys, Ser, Thr, Tyr, Trp), disulfide bonds (Cys-Cys), ubiquitination (Lys, Cys, Ser, Thr, N-term), succinylation (Lys), methylation (Arg, Lys, His, Glu, Asn, Cys), oxidation (especially Met, Trp, His, Cys), acetylation (Lys, N-term), and lipidations [31].

Protein PTMs can alter its function, activity, structure, spatiotemporal status and interaction with proteins or small molecules. PTMs alter signal transduction pathways and gene expression control [32] regulation of apoptosis [33,34] by phosphorylation. Ubiquitination generally regulates protein degradation [35], SUMOylation regulates chromatin structure, DNA repair, transcription, and cell-cycle progression [36,37], and palmitoylation regulates the maintenance of the structural organization of exosome-like extracellular vesicle membranes by [38]. Glycosylation is a ubiquitous modification that regulates various T cell functions, such as cellular migration, T cell receptor signaling, cell survival, and apoptosis [39,40]. Deregulation of PTMs is linked to cellular stress and diseases [41].

Several non-MS methods exist to study PTMs, including in vitro PTM reaction tests with colorimetric assays, radioactive isotope-labeled substrates, western blot with PTM-specific antibodies and superbinders, and peptide and protein arrays [42,43,44]. While effective, these approaches have many limitations, such as inefficiency and difficulty in producing pan-specific antibodies. MS-based proteomics approaches are currently the predominant tool for identifying and quantifying changes in PTMs.

Protein Structure

Almost all proteins (except for intrinsically disordered proteins[45]) fold into three-dimensional (3D) structures either by themselves or assisted by molecular chaperones [46]. There are four levels relevant to the folding of any protein:

Of recent note, the development of AlphaFold, has enabled the high-accuracy three-dimensional structural prediction of all human proteins and for proteins of many other species, enabling a more thorough study of protein folding and is used to predict the relationship between fold and function [47,48].

Types of Experiments

A wide range of questions are addressable with proteomics technology, which translates to a wide range of variations of proteomics workflows. In some workflows, the identification of proteins in a given sample is desired. For other experiments, the quantification of as many proteins as possible is essential for the success of the study. Therefore, proteomic experiments can be both qualitative and quantitative. The following sections give an overview of several common proteomics experiments.

Protein abundance changes

A common experiment is a discovery-based, unbiased mapping of proteins along with detection of changes in their abundance across sample groups. This is achieved using methods such as label free quantification (LFQ) or tandem mass tags (TMT), which are described in more detail in subsequent sections. In these experiments, data should be collected from at least three biological replicates of each condition to estimate the variance of measuring each protein. Depending on the experiment design, different statistical tests are used to calculate changes in measured protein abundances between groups. If there are only two groups, the quantities might be compared with a t-test or with a Wilcoxon signed-rank test. The latter is a non-parametric version of the t-test. If there are more than two sample groups, then Analysis of Variance (ANOVA) is used instead. With either testing scheme, the p-values from the first set of tests must be corrected for multiple tests. A common method for p-value correction is the Benjamini-Hochberg method [49]. These types of experiments have revealed wide ranges of proteomic remodeling from various biological systems.

PTMs

Proteins may become decorated with various chemical modifications during or after translation [31], or through proteolytic cleavage such as N-terminal methionine removal [50]. Several proteomics methods are available to detect and quantify each specific type of modification. See also the section on Protein/Peptide Enrichment and Depletion. For a good online resource listing potential modifications, sites of attachment, and their mass differences, the website www.unimod.org is an excellent curated and freely accessible database.

Phosphoproteomics

Phosphoproteomics is the study of protein phosphorylation, wherein a phosphate group is covalently attached to a protein side-chain (most commonly serine, threonine, or tyrosine). Although western blotting can measure one phosphorylation site at a time, mass spectrometry-based proteomics can measure thousands of sites from a sample at the same time. After proteolysis of the proteome, phosphopeptides need to be enriched to be detected by mass spectrometry. Various methods of enrichment have been developed [51,52,53,54].
See the Peptide/Protein Enrichment and Depletion section for more details. A key challenge of phosphoproteomics is sensitivity. It is important to ensure that there is sufficient amount of protein before completing a phosphoproteomics project as typical enrichment workflows may extract only ~1% of the proteome. Many phosphoproteomics workflows start with at least 1 mg of total protein per sample. Newer, more sensitive instrumentation is enabling detection of protein phosphosites from much less material, down to the nanogram-level of peptide loading on the the LC-MS system. Despite advancement in phosphoproteomics technology, the following challenges still exist: limited sample amounts, highly complex samples, and wide dynamic range [55]. Additionally, phosphoproteomic analysis is often time-consuming and requires the use of expensive equipment such as enrichment kits.

Glycoproteomics

Glycosylation is gaining interest due to its ubiquity and emerging functional roles. Protein glycosylation sites can be N-linked (asparagine-linked) or O-linked (serine/threonine-linked). Understanding the function of protein glycosylation will help us understand numerous biological processes since this is a universal protein modification across all domains of life, especially at the cell surface [56,57,58,59].

Studies of phosphorylation and glycosylation share several experimental pipeline steps including sample preparation. Protein clean-up approaches for glycoproteomics may differ from other proteomics experiments because glycopeptides are more hydrophilic than most peptides. Some approaches mentioned in the literature include: filter-aided sample preparation (FASP), suspension traps (S-traps), and protein aggregation capture (PAC) [56,60,61,62,63,64,65]. Multiple proteases may be used to increase the sequence coverage and detect more modification sites, such as: trypsin, chymotrypsin, Pepsin, WaLP/MaLP [66], GluC, AspN, Pronase, Proteinase K, OgpA, StcEz, BT4244, AM0627, AM1514, AM0608, Pic, ZmpC, CpaA, IMPa, PNGase F, Endo F, Endo H, and OglyZOR [56]. Mass spectrometry has improved over the past decade, and now many strategies are available for glycoprotein structure elucidation and glycosylation site quantification [56]. See also the section on “AminoxyTMT Isobaric Mass Tags” as an example quantitative glycoproteomics method.

Structural techniques

Several proteomics methods have been developed to reveal protein structure information for simple and complex systems.

Cross-linking mass spectrometry (XL-MS)

XL-MS is an emerging technology in the field of proteomics. It can be used to determine changes in protein-protein interactions and/or protein structure. XL-MS covalently locks interacting proteins together to preserve interactions and proximity during MS analysis. XL-MS is different from traditional MS in that it requires the identification of chimeric MS/MS spectra from cross-linked peptides [67,68].

The common steps in a XL-MS workflow are as follows [69]:
1. Generate a system with protein-protein interactions of interest (in vitro or in vivo [70])
2. Add a cross-linking reagent to covalently connect adjacent protein regions (such as disuccinimidyl sulfoxide, DSSO) [68]
3. Proteolysis to produce peptides
4. MS/MS data collection
5. Identify cross-linked peptide pairs using special software (i.e. pLink [71], Kojak [72,73], xQuest [74], XlinkX [75])
6. Generate cross-link maps for structural modeling and visualization [76,77] (optional: 7. Use detected cross-links for protein-protein docking [78])

Hydrogen deuterium exchange mass spectrometry (HDX-MS)

HDX-MS works by detecting changes in peptide mass due to exchange of amide hydrogens of the protein backbone with deuterium from D₂O [79]. The exchange rate depends on the protein solvent accessible surface area, dynamics, and the properties of the amino acid sequence [79,80,81,82]. Although using D₂O to make deuterium-labeled samples is simple, HDX-MS requires several controls to ensure that experimental conditions capture the dynamics of interest [79,83,84,85]. If the peptide dissociation process is tuned appropriately, residue-level quantification of changes in solvent accessibility are possible within a measured peptide [86]. HDX can produce precise protein structure measurements with high reproducibility. Masson et al. gave recommendations on how to prep samples, conduct data analysis, and present findings in a detailed stepwise manner [79].

Radical Footprinting

This technique uses hydroxyl radical footprinting and MS to elucidate protein structures, assembly, and interactions within a large macromolecule [87,88]. In addition to proteomics applications, various approaches to make hydroxide radicals have also been applied for footprinting studies in nucleic acid/ligand interactions [89,90,91]. This chapter is very useful in learning more about this topic: [92].

There are several methods of producing radicals for protein footprinting:
1. Fenton and Fenton‐like Chemistry [87,93,94]
2. Electron-Pulse Radiolysis [87,95]
3. High‐Voltage Electrical Discharge [87,96]
4. Synchrotron X‐ray Radiolysis of Water [87,97]
5. Plasma Formation of OH Radicals [87,98]
6. Photolysis of Hydrogen Peroxide [87,99]

Fast photochemical oxidation of proteins (FPOP) [100]

FPOP is an example of a radical footprinting method. In FPOP, a laser-based hydroxyl radical protein footprinting MS method that relies on the irreversible labeling of solvent-exposed amino acid side chains by hydroxyl radicals in order to understand structure of proteins. A laser produces 248 nm light that causes hydrogen peroxide to break into a pair of hydroxyl radicals [99,101]. The flow rate of solution through the capillary and laser frequency are adjusted such that each protein molecule is irradiated only once. After they are irradiated, the sample is collected in a tube that contins catalase and free methionine in the buffer, quenching the H2O2 and hydroxyl radicals and preventing secondary modification of residues that become exposed due to unfolding after the initial labeling. Control samples are made by running the sample through the flow system without any irradiation. Another experimental control involves the addition of a radical scavenger to tune the extent of protein oxidation [102,103]. FPOP has wide application for proteins including measurements of fast protein folding and transient dynamics.

Protein Painting [104,105]

Protein painting uses “molecular paints” to noncovalently coat the solvent-accessible surface of proteins. These paint molecules will coat the protein surfaces but will not have access to the hydrophobic cores or protein-protein interface regions that solvents cannot access. If the “paint” covers free amines of lysine side chains, the painted parts will not be subjected to trypsin cleavage, while the unpainted areas will. After proteolysis, the peptides samples will be subjected to MS. A lack of proteolysis in a region is interpreted as solvent accessibility, which gives rough structural information about complex protein mixtures or even a whole proteome.

LiP-MS (Limited Proteolysis Mass Spectrometry) [106,107,107,108]

Limited proteolysis coupled to mass spectrometry (LiP-MS) is a method that tracks structural changes in complex proteomes in response to a variety of perturbations or stimuli. The underlying tenet of LiP-MS is that a stimuli-induced change in native protein structure (i.e. protein-protein interaction, introduction of a PTM, ligand/substrate binding, or changes in osmolarity or ambient temperature) can be detected by a change in accessibility of a broad-specificity protease (i.e. proteinase K) to the region(s) of the protein where the structural change occurs. For example, small molecule binding may render a disordered region protected from non-specific proteolysis by directly blocking access of the protease to the cleavage site. LiP-MS can therefore provide a somewhat unbiased view of structural changes at the proteome scale. Importantly, LiP-MS necessitates cell lysates or individual proteins be maintained in their native state prior to or during perturbation and protease treatment. LiP-MS can also be applied to membrane suspensions, to facilitate the study of membrane proteins without the need for purification or detergents [109].
For additional information about LiP-MS, please refer to the following article: [110]

Protein stability and small molecule binding

Cellular Thermal Shift Assay (CETSA) [111,112]

CETSA involves subjecting a protein sample to a thermal shift assay (TSA), in which the protein is exposed to a range of temperatures, and the resulting changes in protein stability by quantifying protein remaining in the soluble fraction. This is done in live cells immediately before lysis, or in non-denaturing lysates. The original paper reported this method using immunoaffinity approaches for detecting changes in soluble protein. The assay is capable of detecting shifts in the thermal equilibrium of cellular proteins in response to a variety of perturbations, but most commonly in response to in vitro drug treatments.

Thermal proteome profiling (TPP) [113,114,115,116]

Thermal proteome profiling (TPP) follows the same principle as CETSA, but has been extended to use an unbiased mass spectrometry readout of many proteins. By measuring changes in thermal stability of thousands of proteins, binding to an unknown or unexpected protein can be discovered. During a typical TPP experiment, a protein sample is first treated with a drug of interest to stabilize protein-ligand interactions. The sample is then divided into multiple aliquots, which are subjected to different temperatures to induce thermal denaturation. The resulting drug-induced changes in protein stability curves are detected using mass spectrometry. By comparing protein stability curves across the temperatures between treatment conditions, TPP can provide insight into the proteins that bind a ligand.

Protein-protein interactions (PPIs)

Affinity purification coupled to mass spectrometry (AP-MS) [117,118,119]

AP-MS is an approach that involves purification of a target protein or protein complex using a specific antibody followed by mass spectrometry analysis to identify the interacting proteins. In a typical AP-MS experiment, a protein or protein complex of interest is first tagged with a specific epitope or affinity tag, such as a FLAG or HA tag, which is used to selectively capture the target protein using an antibody. The protein complex is then purified from the sample using a series of wash steps, and the interacting proteins are identified using mass spectrometry. The success of AP-MS experiments depends on many factors, including the quality of the antibody or tag used for purification, the specificity and efficiency of the resin used for capture, and the sensitivity and resolution of the mass spectrometer. In addition, careful experimental design and data analysis are critical for accurately identifying and interpreting protein-protein interactions. AP-MS has been used to study a wide range of biological processes, including signal transduction pathways, protein complex dynamics, and protein post-translational modifications. AP-MS has been performed on a whole proteome scale as part of the BioPlex project [120,121,122]. Despite its widespread use, AP-MS has some limitations, including the potential for non-specific interactions, the difficulty in interpreting complex data sets, and the possibility of missing important interacting partners due to constraints in sensitivity or specificity. However, with continued advances in technology and data analysis methods, AP-MS is likely to remain a valuable tool for studying protein-protein interactions.

APEX peroxidase [123,124]

APEX-MS is a labeling technique that utilizes a peroxidase genetically fused to a protein of interest. When biotin-phenol is transiently added in the presence of hydrogen peroxide, nearby proteins are covalently biotinylated [125]. APEX thereby enables the discovery of interacting proteins in living cells. One of the major advantages of APEX is its ability to label proteins in their native environment, allowing for the identification of interactions that occur under physiological conditions. Despite its advantages, APEX has some limitations, including the potential for non-specific labeling, the difficulty in distinguishing between direct and indirect interactions, and the possibility of missing interactions that occur at low abundance or in regions of the cell that are not effectively labeled.

Proximity-dependent biotin identification (BioID) [126,127,128,129]

BioID is a proximity labeling technique that allows for the identification of protein-protein interactions. BioID involves the genetic tagging of a protein of interest with a promiscuous biotin ligase in live cells, which then biotinylates proteins in close proximity to the protein of interest. One of the advantages of BioID is its ability to label proteins in their native environment, allowing for the identification of interactions that occur under physiological conditions. BioID has been used to identify a wide range of protein interactions, including receptor-ligand interactions, signaling complexes, and protein localization. BioID is a slower reaction than APEX and therefore may pick up more transient interactions. BioID has the same limitations as APEX. For more information on BioID, please refer to [130].

Protein Extraction

Protein extraction from the sample of interest is the initial phase of any mass spectrometry-based proteomics experiment. Thought should be given to any planned downstream assays, specific needs of proteolysis (LiP-MS, PTM enrichments, enzymatic reactions, glycan purification or hydrogen-deuterium exchange experiments), long-term project goals (reproducibility, multiple sample types, low abundance samples), as well as to the initial experimental question (coverage of a specific protein, subcellular proteomics, global proteomics, protein-protein interactions or affinity enrichment of specific classes of modifications). The 2009 version of Methods in Enzymology: guide to Protein Purification [131] serves as a deep dive into how molecular biologists and biochemists traditionally carried out protein extraction. The Protein Protocols handbook [132] and the excellent review by Linn [133] are good sources of general proteomics protocols. Another excellent resource is the “Proteins and Proteomics: A Laboratory Manual” by Richard J. Simpson [134,134]. This manual is 926 pages packed full of bench tested protocols and procedures for carrying out protein centric studies. Any change in extraction conditions should be expected to create potential changes in downstream results. Be sure to plan and optimize the protein extraction step first and use a protocol that works for your needs. To reproduce the results of another study, one should begin with the same extraction protocols.

Buffer choice

General proteomics

A common question to proteomics core facilities is, “What is the best buffer for protein extraction?” Unfortunately, there is no one correct answer. For global proteomics experiments where maximizing the number of protein or peptide identifications is a goal, a buffer of neutral pH (50-100 mM phosphate buffered saline (PBS), tris(hydroxymethyl)aminomethane (Tris), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), ammonium bicarbonate, triethanolamine bicarbonate; pH 7.5-8.5) is used in conjunction with a chaotrope or surfactant to denature and solubilize proteins (e.g., 8 M urea, 6 M guanidine, 5% sodium dodecyl sulfate (SDS)) [135,136]. Often other salts like 50-150 mM sodium chloride (NaCl) are also added. Although there are a range of buffers that can be used to provide the correct working pH and ionic strength, not all buffers are compatible with downstream workflows and some buffers can induce modifications of proteins (e.g., ammonium bicarbonate promotes methionine oxidation and we generally suggest Tris-HCl instead to minimize oxidation. A great online resource to help calculate buffer compositions and pH values is the website by Robert Beynon at http://phbuffers.org. Complete and quick denaturation of proteins in the sample is required to limit changes to protein status by endogenous proteases, kinases, phosphatases, and other enzymes. If intact protein separations are planned (based on size or isoelectric point), choose a denaturant compatible with those methods, such as SDS [137]. Compatibility with the protease (typically trypsin) and peptide cleanup steps must be considered. Of note, detergents can be incompatible with LC-MS workflows as they can cause ion suppression and column clogging. It is therefore advisable to remove detergents using detergent-removal kits or precipitation techniques (i.e. deoxycholate precipitates at low pH and can easily be removed by filtration or centrifugation). For more information, see section “Removal of buffer/interfering small molecules”. Alternatively, mass-specrtrometry-compatible detergents may be used (i.e. n-dodecyl-beta-maltoside). Urea must be diluted to 2 M or less for trypsin and chymotrypsin digestions, while guanidine and SDS should be removed either through protein precipitation, through filter-assisted sample preparation (FASP), or similar solid phase digestion techniques. Some buffers can potentially introduce modifications to proteins such as carbamylation from urea at high temperatures [138].

Protein-protein interactions

Denaturing conditions will efficiently extract proteins, but will denature proteins and therefore disrupt most protein-protein interactions. If you are working on an immune- or affinity purification of a specific protein and expect to analyze enzymatic activity, structural features, and/or protein-protein interactions, a non-denaturing lysis buffer should be utilized [139,140]. Check the calculated isoelectric point (pI) and hydrophobicity (e.g., try the Expasy.org resource ProtParam) for a good idea of starting pH/conductivity, but a stability screen may be needed. In general, a good starting point for the buffer will still be close to neutral pH with 50-250 mM NaCl, but specific proteins may require pH as low as 2 or as high as 9 for stable extraction. A low percent of mass spectrometry compatible detergent may also be used, such as n-dodecyl-beta-maltoside. Newer mass spectrometry-compatible detergents are also useful for protein extraction and ease of downstream processing – including Rapigest® (Waters), N-octyl-β-glucopyranoside, MS-compatible degradable surfactant (MaSDeS) [141], Azo [142], PPS silent surfactant [143], sodium laurate [144], and sodium deoxycholate [145]. Avoid using tween-20, triton-X, NP-40, and polyethylene glycols (PEGs) as these compounds are challenging to remove after digestion [146].

Optional additives

For non-denaturing buffer conditions, which preserve tertiary and quaternary protein structures, additional additives may not be necessary for successful extraction and to prevent proteolysis or PTMs throughout the extraction process. Protease, phosphatase and deubiquitinase inhibitors are optional additives in less denaturing conditions or in experiments focused on specific PTMs. For a broad range of inhibitors, a premixed tablet can be added to the lysis buffer, such as Roche cOmplete Mini Protease Inhibitor Cocktail tablets. Protease inhibitors may impact desired proteolysis from the added protease, and will need to be diluted or removed prior to protease addition. To improve extraction of DNA- or RNA-binding proteins, adding a small amount of nuclease or benzonase is useful for degradation of any bound nucleic acids and results in a more consistent digestion [147].

Mechanical or Sonic Disruption

Cell lysis

One typical lysis buffer is 8 M urea in 100 mM Tris, pH 8.5; the pH is based on optimum trypsin activity [148] Small mammalian cell pellets and exosomes will lyse almost instantly upon addition denaturing buffer. If non-denaturing conditions are desired, osmotic swelling and subsequent shearing or sonication can be applied [149]. Efficiency of extraction and degradation of nucleic acids can be improved using various sonication methods: 1) probe sonicator with ice; 2) water bath sonicator with ice or cooling; 3) bioruptor® sonication device 4) Adaptive focused acoustics (AFA®) [150]. Key to these additional lysis techniques is to keep the temperature of the sample from rising significantly which can cause proteins to aggregate or degrade. Some cell types may require additional force for effective lysis (see below). For cells with cell walls (i.e. bacteria or yeast), lysozyme is often added in the lysis buffer. Any added protein will be present in downstream results, however, so excessive addition of lysozyme is to be avoided unless tagged protein purification will occur.

Tissue/other lysis

Although small pieces of soft tissue can often be successfully extracted with the probe and sonication methods described above, larger/harder tissues as well as plants/yeast/fungi are better extracted with some form of additional mechanical force. If proteins are to be extracted from a large amount of sample, such as soil, feces, or other diffuse input, one option is to use a dedicated blender and filter the sample, followed by centrifugation. If samples are smaller, such as tissue, tumors, etc., cryo-homogenization is recommended. The simplest form of this is grinding the sample with liquid nitrogen and a mortar and pestle. Tools such as bead beaters (i.e. FastPrep-24®) are also used, where the sample is placed in a tube with appropriately sized glass or ceramics beads and shaken rapidly. Cryo-mills are chambers where liquid nitrogen is applied around a vessel and large bead or beads. Cryo-fractionators homogenize samples in special bags that are frozen in liquid nitrogen and smashed with various degrees of force [151]. In addition, rapid bead beating mills such as the Bertin Precellys Evolution are both economical, effective and detergent compatible for many types of proteomics experiments at a scale of 96 samples per batch. After homogenization, samples can be sonicated by one of the methods above to fragment DNA and increase solubilization of proteins.

Measuring the efficiency of protein extraction

Following protein extraction, samples should be centrifuged (10-14,000 g for 10-30 min depending on sample type) to remove debris and any unlysed material prior to determining protein concentration. The amount of remaining insoluble material should be noted throughout an experiment as a large change may indicate protein extraction issues. Protein concentration can be calculated using a number of assays or tools [152,153]; generally absorbance measurements are facile, fast and affordable, such as Bradford or BCA assays. Protein can also be estimated by tryptophan fluorescence, which has the benefit of not consuming sample [154]. A nanodrop UV spectrophotometer may be used to measure absorbance at UV280. Consistency in this method is important as each method will have inherent bias and error [155,156]. Extraction buffer components will need to be compatible with any assay chosen; alternatively, buffer may be removed (see below) prior to protein concentration calculation.

Reduction and alkylation

Typically, disulfide bonds in proteins are reduced and alkylated prior to proteolysis in order to disrupt structures and simplify peptide analysis. This allows better access to all residues during proteolysis and removes the crosslinked peptides created by S-S inter peptide linkages. There are a variety of reagent options for these steps. For reduction, the typical agents used are 5-15 mM concentration of tris(2-carboxyethyl)phosphine hydrochloride (TCEP-HCl), dithiothreitol (DTT), or 2-beta-mercaptoethanol (2BME). TCEP-HCl is an efficient reducing agent, but it also significantly lowers sample pH, which can be abated by increasing sample buffer concentration or resuspending TCEP-HCl in an appropriate buffer system (i.e. 1M HEPES pH 7.5).
Following the reducing step, a slightly higher 10-20mM concentration of alkylating agent such as chloroacetamide/iodoacetamide or n-ethyl maleimide is used to cap the free thiols [157,158,159]. In order to monitor which cysteine residues are linked or modified in a protein, it is also possible to alkylate free cysteine residues with one reagent, reduce di-sulfide bonds (or other cysteine modifications) and alkylate with a different reagent [160,161,162]. Alkylation reactions are generally carried out in the dark at room temperature to avoid excessive off-target alkylation of other amino acids.

Removal of buffer/interfering small molecules

If extraction must take place in a buffer which is incompatible for efficient proteolysis (check the guidelines for the protease of choice), then protein cleanup should occur prior to digestion. This is generally performed through precipitation of proteins. The most common types are 1) acetone, 2) trichloroacetic acid (TCA), and 3) methanol/chloroform/water [163,164]. Proteins are generally insoluble in most pure organic solvents, so cold ethanol or methanol are sometimes used. Pellets should be washed with organic solvent for complete removal especially of detergents. Alternatively, solid phase based digestion methods such as S-trap [165], FASP [166,167], SP3 [168,169] and on column/bead such as protein aggregation capture (PAC) [170] can allow for proteins to be applied to a solid phase and buffers removed prior to proteolysis [171]. Specialty detergent removal columns exist (Pierce/Thermo Fisher Scientific) but add expense and time-consuming steps to the process. Relatively low concentrations of specific detergents, such as 1% deoxycholate (DOC), or chaotropes (i.e. 1M urea) are compatible with proteolysis by trypsin/Lys-C. Often proteolysis-compatible concentrations of these detergents and chaotropes are achieved by diluting the sample in appropriate buffer (i.e. 100 mM ammonium bicarbonate, pH 8.5) after cell or tissue lysis in a higher concentration. DOC can then be easily removed by precipitation or phase separation [172] following digestion by acidification of the sample to pH 2-3.
Any small-molecule removal protocol should be tested for efficiency prior to implementing in a workflow with many samples as avoiding detergent (or polymer) contamination in the LC/MS is very important.

Protein quantification

After proteins are isolated from the sample matrix, they are often quantified. Protein quantification is important to assess the yield of an extraction procedure, and to adjust the scale of the downstream processing steps to match the amount of protein. For example, when purifying peptides, the amount of sorbent should match the amount of material to be bound. Presently, there is a wide variety of techniques to quantitate the amount of protein present in a given sample. These methods can be broadly divided into three types as follows:

Colorimetry-based methods:

The method includes different assays like Coomassie Blue G-250 dye binding (the Bradford assay), the Folin-Lowry assay, the bicinchoninic acid (BCA) assay and the biuret assay [173]. The most commonly used method is the BCA assay. In the BCA method the peptide bonds of the protein reduce cupric ions [Cu2+] to cuprous ions [Cu+] at a rate which is proportional to the amount of protein present in the sample. Subsequently, the BCA reagent binds to the cuprous ions, leading to the formation of a complex which absorbs 562 nm wavelength light. This permits a direct correlation between sample protein concentration and absorbance [174,175]. The Bradford assay is another method for protein quantification also based on colorimetry principle. It relies on the interaction between the Coomassie brilliant blue dye and the protein based on hydrophobic and electrostatic interactions. Dye binding shifts the absorption maxima from 470 nm to 595 nm [176,177]. Similarly, the Folin- Lowry method is a two-step colorimetric assay. Step one is the biuret reaction wherein complexes of copper with the nitrogen in the protein molecule are formed. In the second step, the complexed tyrosine and tryptophan amino acids react with Folin–Ciocalteu phenol reagent generating an intense, blue-green color absorbing light at 650–750 nm [178].

Another simple but less reliable protein quantification method of UV-Vis Absorbance at 280 nm estimates the protein concentration by measuring the absorption of the aromatic residues; tyrosine, and tryptophan, at 280 nm [179].

Fluorescence-based methods:

Colorimetric assays are inexpensive and require common lab equipment, but colorimetric detection is less sensitive than fluorescence. Total protein in proteomic samples can be quantified using intrinsic fluorescence of tryptophan based on the assumption that approximately 1% of all amino acids in the proteome are tryptophan [180].

NanoOrange is an assay for the quantitative measurement of proteins in solution using the NanoOrange reagent, a merocyanine dye that produces a large increase in fluorescence quantum yield when it interacts with detergent-coated proteins. Fluorescence is measured using 485-nm excitation and 590-nm emission wavelengths. The NanoOrange assay can be performed using fluorescence microplate readers, fluorometers, and laser scanners that are standard in the laboratory [153].

3-(4-carboxybenzoyl)quinoline-2-carboxaldehyde (CBQCA) is a sensitive fluorogenic reagent for amine detection, which can be used for analyzing proteins in solution. As the number of accessible amines in a protein is modulated by its concentration, CBQCA has a greater sensitivity and dynamic range when measuring protein concentration [181].

Summary

Learning the fundamentals and mechanisms of how and why sample preparation steps are performed is vital because it enables flexibility to perform proteomics from a wide range of samples. For bottom-up proteomics, the overreaching goal is efficient and consistent extraction and digestion. A range of mechanical and non-mechanical extraction protocols have been developed and the choice of technique is generally dictated by sample type or assay requirements (i.e. native versus non-native extraction). Extraction can be aided by the addition of detergents and/or chaotropes to the sample, but care should be taken that these additives do not interfere with the sample digestion step or downstream mass-spectrometry analysis.

Proteolysis

Proteolysis is the defining step that differentiates bottom-up or shotgun proteomics from top-down proteomics. Hydrolysis of proteins is extremely important because it defines the population of potentially identifiable peptides. Generally, peptides between a length of 7-35 amino acids are considered useful for mass spectrometry analysis. Peptides that are too long are difficult to identify by tandem mass spectrometry or may be lost during sample preparation due to irreversible binding with solid-phase extraction sorbents. Peptides that are too short are also not useful because they may match to many proteins during protein inference. There are many choices of enzymes and chemicals that hydrolyze proteins into peptides. This section summarizes potential choices and their strengths and weaknesses.

Trypsin is the most common choice of protease for proteome hydrolysis [182]. Trypsin is favorable because of its specificity, availability, efficiency and low cost. Trypsin cleaves at the C-terminus of basic amino acids, Arg and Lys, if not immediately followed by proline. Many of the peptides generated from trypsin are short in length (less than ~ 20 amino acids), which is ideal for chromatographic separation, MS-based peptide fragmentation and identification by database search. The main drawback of trypsin is that majority (56%) of the tryptic peptides are ≤ 6 amino acids, and hence using trypsin alone limits the observable proteome [183,184,185]. This limits the number of identifiable protein isoforms and post-translational modifications.

Although trypsin is the most common protease used for proteomics, in theory it can only cover a fraction of the proteome predicted from the genome [186]. This is due to production of peptides that are too short to be unique, for example due to R and K immediately next to each other. Peptides below a certain length are likely to occur many times in the whole proteome, meaning that even if we identify them we cannot know their protein of origin. In protein regions devoid of R/K, trypsin may also result in very long peptides that are then lost due to irreversible binding to the solid phase extraction device, or that become difficult to identify due to complicated fragmentation patterns. Thus, parts of the true proteome sequences that are present are lost after trypsin digestion due to both production of very long and very short peptides.

Many alternative proteases are available with different specificities that complement trypsin to reveal different protein sequences [183,187], which can help distinguish protein isoforms [188] (Figure 2). The enzyme choice mostly depends on the application. In general, for a mere protein identification, trypsin is often chosen due to the aforementioned reasons. However, alternative enzymes can facilitate de novo assembly when the genomic data information is limited in the public database repositories [189,190,191,192,193]. Use of multiple proteases for proteome digestion also can improve the sensitivity and accuracy of protein quantification [194]. Moreover, by providing an increased peptide diversity, the use of multiple proteases can expand sequence coverage and increase the probability of finding peptides which are unique to single proteins [66,186,195]. A multi-protease approach can also improve the identification of N-Termini and signal peptides for small proteins [196]. Overall, integrating multiple-protease data can increase the number of proteins identified [197,198], increase the identified post-translational modifications [66,195,199] and decrease the ambiguity of the inferred protein groups [195].

Lysyl endopeptidase (Lys-C) obtained from Lysobacter enzymogenesis is a serine protease involved in cleaving carboxyl terminus of Lys [184,200]. Like trypsin, the optimum pH range required for its activity is from 7 to 9. A major advantage of Lys-C is its resistance to denaturing agents, including 8 M urea - a chaotrope commonly used to denature proteins prior to digestion [188]. Trypsin is less efficient at cleaving Lys than Arg, which could limit the quality of quantitation from tryptic peptides. Hence, to achieve complete protein digestion with minimal missed cleavages, Lys-C is often used simultaneously with trypsin digestion [201].

Alpha-lytic protease (aLP) is another protease secreted by the soil bacterial Lysobacter enzymogenesis [202]. Wild-type aLP (WaLP) and an active site mutant of aLP, M190A (MaLP), have been used to expand proteome coverage [66]. Based on observed peptide sequences from yeast proteome digestion, WaLP showed a specificity for small aliphatic amino acids like alanine, valine, and glycine, but also threonine and serine. MaLP showed specificity for slightly larger amino acids like methionine, phenylalanine, and surprisingly, a preference for leucine over isoleucine. The specificity of WaLP for threonine enabled the first method for mapping endogenous human SUMO sites [37].

Glutamyl peptidase I, commonly known as Glu-C or V8 protease, is a serine protease obtained from Staphyloccous aureus [203]. Glu-C cleaves at the C-terminus of glutamate, but also after aspartate [203,204].

Peptidyl-Asp metallopeptidase, commonly known as Asp-N, is a metalloprotease obtained from Pseudomonas fragi [205]. Asp-N catalyzes the hydrolysis of peptide bonds at the N-terminal of aspartate residues. The optimum activity of this enzyme occurs at a pH range between 4 and 9. As with any metalloprotease, chelators like EDTA should be avoided for digestion buffers when using Asp-N. Studies also suggest that Asp-N cleaves at the amino terminus of glutamate when a detergent is present in the proteolysis buffer [205]. Asp-N often leaves many missed cleavages [188].

Chymotrypsin or chymotrypsinogen A is a serine protease obtained from porcine or bovine pancreas with an optimum pH range from 7.8 to 8.0 [206]. It cleaves at the C-terminus of hydrophobic amino acids Phe, Trp, Tyr and barely Met and Leu residues. Since the transmembrane region of membrane proteins commonly lacks tryptic cleavage sites, this enzyme works well with membrane proteins having more hydrophobic residues [188,207,208]. The chymotryptic peptides generated after proteolysis will cover the proteome space orthogonal to that of tryptic peptides both in a quantitative and qualitative manner [208,209,210]

Clostripain, commonly known as Arg-C, is a cysteine protease obtained from Clostridium histolyticum [211]. It hydrolyses mostly the C-terminal Arg residues and sometimes Lys residues, but with less efficiency. The peptides generated are generally longer than that of tryptic peptides. Arg-C is often used with other proteases for improving qualitative proteome data and also for investigating PTMs [184].

LysargiNase, also known as Ulilysin, is a recently discovered protease belonging to the metalloprotease family. It is a thermophilic protease derived from Methanosarcina acetivorans that specifically cleaves at the N-terminus of Lys and Arg residues [212]. Hence, it enabled discovery of C-terminal peptides that were not observed using trypsin. In addition, it can also cleave modified amino acids such as methylated or dimethylated Arg and Lys [212].

Peptidyl-Lys metalloendopeptidase, or Lys-N, is an metalloprotease obtained from Grifola frondosa [213]. It cleaves N-terminally of Lys and has an optimal activity at pH 9.0. Unlike trypsin, Lys-N is more resistant to denaturing agents and can be heated up to 70°C [184]. Peptides generated from Lys-N digestion produce more c-type ions using ETD fragmentation [214]. Hence this can be used for analysing PTMs, identification of C-terminal peptides and also for de novo sequencing strategies [214,215].

Pepsin A, commonly known as pepsin, is an aspartic protease obtained from bovine or porcine pancreas [216]. Pepsin was one of several proteins crystalized by John Northrop, who shared the 1946 Nobel prize in chemistry for this work [217,218,219,220]. Pepsin works at an optimum pH range from 1 to 4 and specifically cleaves Trp, Phe, Tyr and Leu [184]. Since it possess high enzyme activity and broad specificity at lower pH, it is preferred over other proteases for MS-based disulphide mapping [221,222]. Pepsin is also used extensively for structural mass spectrometry studies with hydrogen-deuterium exchange (HDX) because the rate of back exchange of the amide deuteron is minimized at low pH [223,224].

Proteinase K was first isolated from the mold Tritirachium album Limber [225]. The epithet ‘K’ is derived from its ability to efficiently hydrolyze keratin [225]. It is a member of the subtilisin family of proteases and is relatively unspecific with a preference for proteolysis at hydrophobic and aromatic amino acid residues [226]. The optimal enzyme activity is between pH 7.5 and 12. Proteinase K is used at low concentrations for limited proteolysis (LiP) and the detection of protein structural changes in the eponymous technique LiP-MS [227].

Although different specificity is useful in theory to enable improved proteome sequence coverage, there are practical challenges because most standard workflows are optimized for tryptic peptides. For example, peptides that lack a c-terminal positive charge due to arginine or lysine side chains can have a less pronounced y-ion series. This can lead to lower scoring peptide-spectra matches because some peptide identification algorithms preferentially score y ions higher.

Peptide quantitation assays

After peptide production from proteomes, it may be desirable to quantify the peptide yeild. Quantitation of peptide assays is not as easy as protein lysate assays. BCA protein assays perform poorly with peptide solutions and report erroneous values. A simplistic measurement is to use a nanodrop device, but absorbance measurements from a drop of solution does not report accurate values either. A more standardized and reliable approach is to Fluorescamine based assay for peptide solutions for higher accuracy [228,229]. This assay is based on the reaction between a labeling reagent and the N-terminal primary amine in the peptide(s); therefore, samples must be free of amine-containing buffers (e.g., Tris-based buffer and/or amino acids). This procedure has performance similar to the Pierce Quantitative Fluorometric Peptide Assay (Cat 23290).

Fluorescamine peptide digest assay (based on Udenfriend and Bantan-Polak papers cited above).

This assay is scaled to small volume reactions. Use a black flat-bottom 384 well plate such as Corning 384-Well Solid Black (Cat No. 3577). Warm solubilized fluorescamine reagent to room temperature out of light. • Dilute peptide digest standard from 1mg/ml down to 7.8ug/mL in same buffer as sample as 8 serial dilutions. • Include buffer blank of the sample buffer. • Dispense 35 uL of Fluorometric Peptide Assay Buffer (0.1M Sodium borate pH 8.0) to each well. • Dispense 5 uL of sample or 5 uL of peptide standards into designated wells. • Dispense 10 uL of Fluorescamine reagent, mix 3x by pipetting up/down. • Incubate 5 minutes at room temperature. • Measure fluorescence using filters at Excitation 390nm, Emission 475 nm on a BioTek Synergy plate reader. • Excitation 360/40nm, Emission 460/40nm (fixed values) • Gain: scale to high wells (select highest-concentration standards) • Mirror: Top 400nm, Read Height: 7mm • Calculate peptide concentrations using template with quadratic curve fitting and determine yield.

Reagents: Fluorometric Peptide Assay Buffer: 0.1M sodium borate in Milli-Q H2O, adjust to pH 8.0 with HCl

Making the Fluorescamine Reagent from Fluorescamine, pure, Thermo Scientific Chemicals 191675000 (100mg/100mL fluorescamine in 100% HPLC grade Acetonitrile). o i.e., weigh out 25mg fluorescamine and dissolve in 25mL Acetonitrile. o Cover in foil, store out of light at 4ºC until use. o Keep powdered fluorescamine covered in foil out of light at room temperature.

Mass Spectrometry Methods for Peptide Quantification

Label-free quantification (LFQ) of peptides

LFQ of peptide precursors requires no additional steps in the protein extraction, digestion, and peptide purification workflow (Figure 3). Samples can be taken straight to the mass spectrometer and are injected one at a time, each sample necessitating their own LC-MS/MS experiment and raw file. Quantification of peptides by LFQ is routinely performed by many commercial and freely available proteomics software (see Data Analysis section below). In LFQ, peptide abundances across LC-MS/MS experiments are usually calculated by computing the area under the extracted ion chromatograms for signals that are specific to each peptide; this involves aligning windows of accurate peptide mass and retention time. LFQ can be performed using precursor MS1 signals from DDA, or using multiple fragment ion signals from DIA (see Data Acquisition section).

Stable isotope labeling of peptides

One approach to improve the throughput and quantitative completeness within a group of samples is sample multiplexing via stable isotope labeling. Multiplexing enables pooling of samples and parallel LC-MS/MS analysis within one run. Quantification can be achieved at the MS1- or MSn-level, dictated by the upstream labeling strategy.

Stable isotope labeling methods produce peptides that are chemically identical from each sample that differ only in their mass due. Methods include stable isotope labeling in amino acid cell culture (SILAC) [230] and chemical labeling such as amine-modifying tags for relative and absolute quantification (mTRAQ) [231] or dimethyl labeling [232]. The labeling of each sample imparts mass shifts (e.g. 4 Da, 8 Da) which can be detected within the MS1 full scan. The ability to label samples in cell culture has enabled impactful quantitative biology experiments [233,234]. These approaches have nearly exclusively been performed using data-dependent acquisition (DDA) strategies. However, recent work employing faster instrumentation has shown the benefits of chemical labeling with 3-plex mTRAQ or dimethyl labels for data-independent acquisition (DIA) [235,236], an idea originally developed nearly a decade earlier using chemical labels to quantify lysine acetylation and succinylation stoichiometry [237]. As new tags with higher plexing become available, strategies like plexDIA and mDIA are sure to benefit [235,236].

Peptide labeling with isobaric tags

Another approach to improve throughput and quantitative completeness within a group of samples is multiplexing via isobaric labels, a strategy which enables parallel data acquisition after pooling of samples. Commercial isobaric tags include tandem mass tags (TMT) [238] and isobaric tags for relative and absolute quantification (iTRAQ) [239] amongst others, and several non-commercial options have also been developed [240]. 10- and 11-plex TMT kits were recently supplanted by proline-based TMT tags (TMTpro), originally introduced as 16-plex kits in 2019 [241] and upgraded to an 18-plex platform in 2021 [242].

The isobaric tag labeling-based peptide quantitation strategy uses derivatization of every peptide sample with a different isotopic incorporation from a set of isobaric mass tags. All isobaric tags have a common structural theme consisting of 1) an amine-reactive groups (usually triazine ester or N-hydroxysuccinimide [NHS] esters) which react with peptide N-termini and ε-amino group of the lysine side chain of peptides, 2) a balancer group, and 3) a reporter ion group (Figure 4).
Peptide labeling is followed by pooling the labelled samples, which undergo MS and MS/MS analysis simultaneously. As the isobaric tags are used, peptides labeled with these tags give a single MS peak with the same precursor m/z value in an MS1 scan and identical retention time of liquid chromatography analysis. The modified parent ions undergo fragmentation during MS/MS analysis generating two kinds of fragment ions: (a) reporter ions and (b) peptide fragment ions. Each reporter ions’ relative intensity is directly proportional to the peptide abundance in each of the starting samples that were pooled. As usual, b- and y-type fragment ion peaks are still used to identify amino acid sequences of peptides, from which proteins can be inferred. Since it is possible to label most tryptic peptides with an isobaric mass tag at least at the N-termini, numerous peptides from the same protein can be detected and quantified, thus leading to an increase in the confidence in both protein identification and quantification [244].

Because the size of the reporter ions is small and sometimes the mass difference between reporter ions is small (i.e., a ~6 mDa difference when using 13C versus 15N), these methods neary exclusively employ high-resolution mass analyzers, not classical ion traps [245]. There are examples, however, of using isobaric tags with pulsed q dissociation on linear ion traps (LTQs) [246]. Suitable instruments are the Thermo Q-Exactive, Exploris, Tribrid, and Astral lines, or Q-TOFs such as the TripleTOF or timsTOF platforms [247,248].

isobaric Tags for Relative and Absolute Quantitation (iTRAQ)

The iTRAQ tagging method covalently labels the peptide N-terminus and side-chain primary amines with tags of different masses through the NHS-ester bond. This is followed by mass spectrometry analysis [249]. Reporter ions for an 8-plex iTRAQ are measured at roughly 113, 114, 115, 116, 117, 118, 119, and 121 m/z. Currently, two kinds of iTRAQ reagents are available: 4-plex and 8-plex [250]. Using 4-plex reagents, a maximum of four different biological conditions can be analyzed simultaneously (i.e., multiplexed), whereas using 8-plex reagents enables the simultaneous analysis of eight different biological conditions [251,252].

iTRAQ hydrazide (iTRAQH)

iTRAQH is an isobaric tagging reagent for the selective labeling and relative quantification of carbonyl (CO) groups in proteins [253]. The reactive CO and oxygen groups which are generated as the byproducts of oxidation of lipids at the time of oxidative stress causes protein carbonylation [254]. iTRAQH is produced from iTRAQ and surplus of hydrazine. This reagent reacts with peptides which are carbonylated, thus forming a hydrazone group. iTRAQH is a novel method for analyzing carbonylation sites in proteins utilizing an isobaric tag for absolute and relative quantitation iTRAQ derivative, iTRAQH, and the analytical power of linear ion trap instruments (QqLIT). This new strategy seems to be well suited for quantifying carbonylation at large scales because it avoids time-consuming enrichment procedures [253]. Thus, there is no need for enriching modified peptides before LC-MS/MS analysis.

Tandem Mass Tag (TMT)

TMT labeling is based on a similar principle as that of iTRAQ. The TMT label is based on a glycine backbone and this limits the amount of sites for heavy atom incorporation In the case of 6-plex-TMT, the masses of reporter groups are roughly 126, 127, 128, 129, 130, and 131 Da [245]. TMT works best with MS platforms which allow quantitation at the MS3 level (e.g., Thermo Fisher Orbitrap Tribrid instruments) [243,255]. In experiments performed on Q-Orbitrap or Q-TOF platforms, MS2-based sequence identification (via b- and y-type ions) and quantitation (via low m/z reporter ion intensities) is performed. In experiments performed on Q-Orbitrap-LIT platfroms, MS3-based quantitation can be performed wherein the top ~10 most abundant b- and y-type ions are synchronously co-isolated in the linear ion trap and fragmented once more before product ions are scanned out in the Orbitrap mass analzer. Adding an additional layer of gas-phase purification limits the ratio distortion of co-isolated precursors within isobaric multiplexed quantitative proteomics [256,257]. Infrared photoactivation of co-isolated TMT fragment ions generates more quantitative reporter ion generation and sensitivity relative to standard beam-type collisional activation [258]. High-field asymmetric waveform spectrometry (FAIMS) also aids the accuracy of TMT-based quantitation on Tribrid systems [259]. TMT is widely used for quantitative protein biomarker discovery. In addition, TMT labeling technique helps multiplex sample analysis enabling efficient use of instrument time. TMT labelling also controls for technical variation because after samples are mixed the ratios are locked in, and any sample loss would be equal across channels. A wide range of TMT reagents with different multiplexing capabilities are available, such as TMT zero, TMT duplex, TMT 6-plex, TMT 10-plex, and TMT 11-plex. The recent addition of TMTpro tags, slight adaptations of the TMT structure based on proline, allow for higher plexing with TMTpro 16-plex [241] and now TMTpro 18-plex [242]. These TMT reagents have a similar chemical structure, which allows the efficient transition from method development to multiplexed peptide quantification [248].

iodoTMT

IodoTMT reagents are isobaric reagents used for tagging cysteine residues of peptides. The commercially available IodoTMT reagents are iodoTMTzero and iodoTMT 6-plex [260,261].

aminoxyTMT Isobaric Mass Tags

Also referred to as glyco-TMTs, these reagents have chemistry similar to iTRAQH. The stable isotope-labeled glyco-TMTs are utilized for quantitating N-linked glycans. They are derived from the original TMT reagents with an addition of carbonyl-reactive groups, which involve either hydrazide or aminoxy chemistry as functional groups. These aminoxy TMTs show a better performance as compared to its iTRAQH counterparts in terms of efficiency of labeling and quantification. The glyco-TMT compounds consist of stable isotopes thus enabling (i) isobaric quantification using MS/MS spectra and (ii) quantification in MS1 spectra using heavy/light pairs. Aminoxy TMT6-128 and TMT6-131 along with the hydrazide TMT2-126 and TMT2-127 reagents can be used for isobaric quantification. In the quantification at MS1 level, the light TMT0 and the heavy TMT6 reagents have a difference in mass of 5.0105 Da which is sufficient to separate the isotopic patterns of all common N-glycans. Glycan quantification based on glyco-TMTs generates more accurate quantification in MS1 spectra over a broad dynamic range. Intact proteins or their digests obtained from biological samples are treated with PNGase F/A glycosidases to release the N-linked glycans during the process of labeling using aminoxyTMT reagents. The free glycans are then purified and labeled with the aminoxyTMT reagent at the reducing end. The labeled glycans from individual samples are subsequently pooled and then undergo analysis in MS for identification of glycoforms in the sample and quantification of relative abundance of reporter ions at MS/MS level [262].

N,N-Dimethyl leucine (DiLeu)

The N,N-Dimethyl leucine, also referred to as DiLeu, is an tandem mass tag reagent which is isobaric and has reporter ions of isotope-encoded dimethylated leucine [263]. Each incorporated label produces a 145.1 Da mass shift. A maximum of four samples can be simultaneously analyzed using DiLeu at a highly reduced cost. MS/MS analysis shows intense reporter ions i.e., dimethylated leucine a1 ions at 115, 116, 117, and 118 m/z. The labeling efficiency of DiLeu tags are similar to that of the iTRAQ tags. Although, DiLeu-labeled peptides offer increased confidence of identification of peptides and more reliable quantification as they undergo better fragmentation, generating higher reporter ion intensities [263].

Deuterium isobaric Amine Reactive Tag (DiART)

DiART is an isobaric tagging method used in quantitative proteomics [264,265]. The reporter group in DiART tags is a N,N′-dimethyl leucine reporter group with a mass to charge range of 114–119. DiART reagents can a label a maximum of six samples and further analyzed by MS. The isotope purity of DiART reagents is very high hence correction of isotopic impurities is not needed at the time of data analysis [266]. The performances of DiART including the mechanism of fragmentation, the number of proteins identified and the quantification accuracy are similar to iTRAQ. Irrespective of the sequence of the peptide, reporter ions of high-intensity are produced by DiART tags in comparison to those with iTRAQ and thus, DiART labeling can be used to quantify more peptides as well as those with lower abundance, and with reliable results [264]. DiART serves as a cheaper alternative to TMT and iTRAQ while also having a comparable labeling efficiency. It has been observed that these tags are useful in labeling huge protein quantities from cell lysates before TiO2 enrichment in quantitative phosphoproteomics studies [267].

Hyperplexing or higher-order multiplexing

Some studies have combined metabolic labels (i.e., SILAC) with chemical tags (i.e., iTRAQ or TMT) to expand the multiplexing capacity of proteomics experiments referred to as hyperplexing [268,269] or higher order multiplexing [270,271,272]. This technique combines MS1- and MS2-based quantitative methods to achieve enhanced multiplexing by multiplying the channels used in each dimension. This allows for the quantitation of proteomes across multiple samples in a single MS run. The technique uses two types of mass encoding to label different biological samples. The labeled samples are then mixed together, which increases the MS1 peptide signal. Protein turnover rates were studied using SILAC-iTRAQ multitagging [273], while various cPILOT studies employed MS1 dimethyl labeling with iTRAQ [274,275,276,277]. SILAC-TMT hyperplexing was used to study the temporal response to rapamycin in yeast [278]. SILAC-iTRAQ-TAILS method was developed to study matrix metalloproteinases in the secretomes of keratinocytes and fibroblasts [279]. TMT-SILAC hyperplexing was used to study synthesis and degradation rates in human fibroblasts [280]. Variants of SILAC-iTRAQ and BONCAT, namely BONPlex [281] and MITNCAT [282] were also developed to study temporal proteome dynamics.

Peptide/Protein Enrichment and Depletion

In order to study low abundance protein modifications, or to study rare proteins in complex mixtures, various methods have been developed to enrich or deplete specific proteins or peptides.

Peptide enrichment

Glycosylation

Mass spectrometry-based analysis of protein glycosylation has emerged as the premier technology to characterize such a universal and diverse class of biomolecules. Glycosylation is a heterogenous post-translational modification that decorates many proteins within the proteome, conferring broad changes in protein activity. [58,283] This PTM can take many forms. The covalent linkage of mono- or oligosaccharides to polypeptide backbones through a nitrogen atom of asparagine (N) or an oxygen atom of serine (S) or threonine (T) side-chains creates N- and O-glycans, respectively. The heterogenity of proteoglycans is not directly tied to the genome, and thus cannot be inferred. Rather, the abundance and activity of protein glycosylation is governed by glycosyltransferases and glycosidases which add and remove glycans, respectively. The fields of glycobiology and bioanalytical chemistry are intricately intertwined with mass spectrometry at the center thanks in part to its power of detecting any modification that imparts a mass shift.

Due to the myriad glycan structures and proteins which harbor them, the enrichment of glycoproteins or glycopeptides is not as streamlined as that of other PTMs [284]. The enrichment of glycoproteome from the greater proteome inherently introduces bias prior to the LC-MS/MS analysis. One must take into account which class or classes of glycopeptides they are interested in analyzing before enrichment for optimal LC-MS/MS results. Glycopeptides can be enriched via glycan affinity, for example to glycan-binding proteins, chemical properties like charge or hydrophilicity, chemical coupling of glycans to stationary phases, and by bioorthogonal, chemical biology approaches. Glycan affinity-based enrichment strategies include the use of lectins, antibodies, inactivated enzymes, immobilized metal affinity chromatography (IMAC), and metal oxide affinity chromatography (MOAC). The enrichment of glycopeptides by their chemical properties, for example by biopolymer charge and hydrophobicity, include hydrophilic interaction chromatography (HILIC), electrostatic repulsion-hydrophilic interaction chromatography (ERLIC), and porous graphitic carbon (PGC). One variation of ERLIC combines strong anion exchange, electrostatic repulsion, and hydrophilic interaction chromatography (SAX-ERLIC) has risen in popularity thanks to robustness and commercially available enrichment kits [285,286].

Chemical coupling methods most often used to enrich the glycoproteome employ hydrazide chemistry for sialylated glycopeptides. Glycan are cleaved from the stationary phase by PNGase F. The dependence of chemical coupling methods on PNGase F biases their output toward N-glycopeptides. Alkoxyamine compounds and boronic acid-based methods have also shown utility. We direct readers to several reviews on glycopeptide enrichment strategies [284,287,288,289,290]

Phosphoproteomics

Protein phosphorylation, a hallmark of protein regulation, dictates protein interactions, signaling, and cellular viability. This post-translational modification (PTM) involves the installation of a negatively charged phosphate moiety (PO 4-) onto the hydroxyl side-chain of serine (Ser, S), threonine (Thr, T), and tyrosine (Tyr, Y), residues on target proteins. Protein kinases catalyze the transfer of PO 4- group from ATP to the nucleophile (OH) group of serine, threonine, and tyrosine residues, while protein phosphatases catalyze the removal of PO4-. Phosphorylation changes the charge of a protein, often altering protein conformation and therefore function [291]. Protein phosphorylation is one of the major PTMs that alters the stability, subcellular location, enzymatic activity complex formation, degradation of protein, and cell signaling of protein with a diverse role in cells [293]. Phosphorylation can regulate almost all cellular processes, including metabolism, growth, division, differentiation, apoptosis, and signal transduction pathways [32]. Rapid changes in protein phosphorylation are associated with several diseases [294].

Several methods are used to characterize phosphorylation using modification-specific enrichment techniques combined with advanced MS/MS methods and computational data analysis [295]. MS-based phosphoproteomics tools are pivotal for the comprehensive study for the structural and dynamics of cellular signaling networks [296], but there are many challenges [297]. For example, phosphopeptides are low stoichiometry compared to non-phosphorylated peptides, which makes them difficult to identify. Phosphopeptides also exhibit low ionization efficiency [298]. To overcome these challenges, it is important to reduce sample complexity to detect large numbers of phosphorylation sites. This is accomplished using enrichment the modified proteins and/or peptides [299,300,301]. Prefractionation techniques such as strong anionic ion-exchange chromatography (SAX), strong cationic ion-exchange chromatography (SCX), and hydrophilic interaction liquid chromatography (HILIC) are also often useful for reducing sample complexity before enrichment to observe more phosphorylation sites [302].

As with any proteomics experiment, phosphoproteomics studies require protein extraction, proteolytic enzyme digestion, phosphopeptide enrichment, peptide fractionation, LC-MS/MS, bioinformatics data analysis, and biological function inference. Special consideration is required during protein extraction where the cell lysis buffer should include phosphatase inhibitors such as sodium orthovanadate, sodium pyrophosphatase and beta-glycerophosphate [303].

Enrichment can be done at the protein level before proteolysis. Phosphoprotein enrichment typically involves the use of immobilized metal-affinity chromatography (IMAC) to selectively capture phosphorylated proteins based on their high-affinity binding to metal ions such as Ga(III), Fe(III), Zn(II) and Al(III) [304,305,306,307,308].

Enrichment is more commonly done at the peptide level because there are several advantages over phosphoprotein enrichment. First, peptides have simpler three-dimensional structures than proteins, which makes them easier to separate and analyze. Second, phosphopeptide enrichment is not hindered by small, lipophilic, and very acidic or alkaline proteins [301]. Third, prefractionation techniques such as strong anionic ion-exchange chromatography (SAX), strong cationic ion-exchange chromatography (SCX) and hydrophilic interaction liquid chromatography (HILIC) are easier to use for peptide separation than they are for protein separation, and they are more sensitive than 2D-gel electrophoresis, allowing for the identification of less abundant phosphopeptides [309]. As a result, phosphopeptide enrichment has yielded more experimental data than phosphoprotein enrichment [307]. Phosphopeptide enrichment is typically done after any isobaric labeling strategy, although several have investigated the importance of order at these stages.

Phosphopeptide enrichment often uses titanium dioxide (TiO2) [310] and/or IMAC such as Fe3+ coupled to solid-phase materials [303,306,311]. The most common cost-effective beads for phosphopeptide extraction with Ti are ReSyn and GL Sciences, and CubeBio for Fe-based beads. Often organic acids such as glutamic acid, lactic acid, glycolic acid is added to compete with acidic non-phosphopeptides for binding to the metal-ions. Carr and coworkers even demonstrated phosphoproteome analysis without any enrichment [312].

The use of Fe-IMAC column chromatography allows for the improved phosphopeptide from complex peptide mixtures [313]. Compared to other formats like StageTips or batch incubations with TiO2 or Ti-IMAC beads, Fe-IMAC columns have do not suffer from problems with poor binding or elution of phosphopeptides, and the efficiency of enrichment increases linearly with the amount of starting material [314]. Also with recent improvements to Ti based beads, the MagReSyn Ti-IMAC HP with Ti4+ attached with a flexible linker (to reduce steric hindrance) activated with phosphonate groups for Ti4+ chelation, and the MagReSyn Zr-IMAC HP, also with a flexible linker activated with phosphonate groups for Zr4+ chelation, have shown superior phosphopeptide extraction as compared to FE-IMAC.

Multiple IMAC steps can be used in parallel or sequentially to improve phosphopeptide coverage. Lai et al., (2012) showed that the combined use of Fe3+-IMAC and Ti(4+)-IMAC chromatography enables complementary identification of more phosphorylation sites than either technique alone [315]. A novel phosphopeptide enrichment technique using sequential enrichment with magnetic Fe3O4 and TiO2 particles was developed to detect mono- and multi-phosphorylated peptides [316].

More recently, the use of Src Homology 2 (SH2) domains as specific affinity reagents for phosphotyrosine is an emerging technology allowing an expanded fractionation of tyrosine phosphopeptides. Here, short chain protein domains have been constructed and affinity enhanced through yeast two hybrid screening to arrive at high affinity matrices capable of outperforming traditional IMAC approaches [317,318].

General protocol for phosphoproteomics:

• Collect cell line or tissue samples.
• For cell samples, suspend the cell pellet in 2% SDS lysis buffer, heat at 90°C for 5 min, and sonicate.
• For tissue samples, homogenize in liquid nitrogen and add to 4% SDS lysis buffer, then heat at 90°C for 5 min and sonicate.
• Centrifuge the samples at 3,000 rcf to remove insoluble material and remove supernatant to a new tube.
• Add 5 mM Tris (2-carboxyethyl) phosphine (TCEP) and 10 mM chloroacetamide to the samples for alkylation and reduction in the dark at room temperature for 30 minutes.
• Precipitate the protein with acetone to remove SDS.
• Dissolve the protein pellet in 8M Urea with 50 mM TEAB.
• Quantify the protein using a BCA assay.
• Perform proteolysis with trypsin using 1:100 trypsin:substrate (wt:wt). For example, if you have 1 mg of protein, add 10 ug of trypsin.
• Desalt the resulting peptides using Sep-Pak C18 columns or stage tips.
• Subject the fractions to phosphopeptide enrichment using TiO2/ Fe‐IMAC beads.
• Desalt the peptides again using C18 stage tips.
• Perform LC-MS/MS.

Tips for studying phosphorylation:

• Cell lysates should always be prepared using phosphatase inhibitors and samples should be placed on the ice during sonication for protein extraction.
• Increase the amount of starting material of your sample for phosphoenrichment to at least 1 mg of protein or more for optimal results.
• If using anti-phosphorylation antibodies, ensure their specificity is confirmed with other methods.
• Make sure to select a suitable method for the phosphoenrichment that fits the experiment goals.
• TiO2-based phosphopeptide enrichment methods have different enrichment specificities; selecting non-phosphopeptide excluders such as glutamic acid, lactic acid, glycolic acid, and dihydroxybenzoic acid are the key part of the study [319].
• Do not use milk as a blocking agent when western blotting for phosphorylation because milk contains the phosphoprotein casein and can lead to a higher background due to non-specific binding.

Antibody enrichments of modifications

Western blot analysis is used to detect the PTMs in a protein through the use of antibodies [320]. As an extension, pan-PTM antibodies have been used to isolate peptides bearing the PTM of interest [321]. One benefit of this approach is that peptides are less likely to experience non-specific binding than proteins [295]. Initially peptide immunoaffinity precipitation was developed to enrich for phosphotyrosine-containing peptides. This protocol was initially designed to enrich for phosphotyrosine-containing peptides [322]. Peptide immunoprecipitation yielded significantly greater coverage of the phosphotyrosine proteome than global phosphorylation enrichment strategies by enriching for a subset of the phosphoproteome.
Since then, peptide immunoaffinity precipitation has been used successfully to enrich for peptides with other phosphorylation motifs [323,324] as well as peptides with other modifications such as the diglycyl-lysine residue of ubiquitin modification after trypsin proteolysis [325,326,327], acetyl-lysine [328,329,330,331,332], arginine methylation [333], tyrosine nitration [334], and tyrosine phosphorylation [335,336].

The O-linked β-D-N-acetylglucosamine (O-GlcNac) is found on serine and threonine residues of nucleocytoplasmic proteins a one of PTMs is involved in involved in the occurrence and progression of cancers in multiple systems throughout the body [337]. Anti-O-GlcNAc monoclonal antibody enables enrichment from O-GlcNAcylated peptides of cells and tissues. These antibodies have high sensitivity and specificity toward O-GlcNAc-modified peptides and do not identify O-GalNAc or GlcNAc in extended glycans [338].

Abundant protein depletion (Blood samples)

Many plasma proteomics studies involve the analysis of untreated, unenriched plasma (i.e., neat plasma) [339,340]. However, the abundance range of proteins in the blood/plasma proteome exceeds 10 orders of magnitude. Due to this wide dynamic range, detection of proteins with medium and low abundance by proteomic analyses is difficult [341], and identifying protein biomarkers from biological samples such as blood is often obstructed by proteins present at higher concentrations. In fact, the top 14 most abundant proteins in human plasma constitute over 99% of the total protein mass. The removal of these high-abundant proteins enables the detection of less abundant and unique proteins. The ability to deplete abundant proteins with specificity, reproducibility, and selectivity is extremely important in proteomic studies [342].

Dye-ligand depletion:

This method is used for the depletion of serum albumin based on the interaction between albumin and dyes like Cibacron Blue (CB) through electrostatic force, hydrogen bonding and hydrophobic interactions. The method is relatively low cost, widely available, robust and has high binding capacity. However, it lacks specificity and has varying efficiency [343,344].

Protein-ligand depletion:

This method is used for depletion of immunoglobulins (Ig) based on the interaction between the Fragment crystallizable (Fc) region of these Igs [345] and cell wall protein A, G or A/G of Staphylococcus aureus and Streptococcus spp [346,347]. It is highly selective and has high yield and purity. However, non-specific binding may occur due to co-absorption of other proteins [348].

Immunodepletion:

This method is used for depletion of proteins having high abundance in plasma or serum on the basis of the specific interaction of these proteins with their respective antibodies (antigen-antibody interaction) [349]. Immunodepletion has high specificity and commercial kits based on columns (Agilent MARS column) or loose beads (Thermo-Fisher High-Select depletions beads) both deplete the Top 14 most abundant protein in blood and are also readily available but expensive. For some protocols, non-specific binding to these immunodepletion columns or beads by proteins of interest is highly dependent on washing conditions [348].

Combinatorial peptide ligand library:

This method is used for partial depletion of major proteins i.e., those with high abundance and for relative enrichment of lower and medium abundant proteins [350]. It is based on the interaction with an array of ligands which are essentially peptides of 6 amino acids in length. It is also used for normalization of the global protein abundance [351]. However, the drawbacks include non-specific binding as well as loss of proteins due to incomplete elution or inefficient binding [348].

Precipitation:

This method of abundant protein depletion works by altering the solubility of proteins using a chemical reagent including inorganic salt solution [352], organic solvents [353], non-ionic polymer [354] and reducing agents [355]. It is extremely simple and cost-effective. However, it is less specific with a risk of protein loss, difficulty in protein resolubilization as well as time consuming [348].

New technologies:

Newer methods of highly abundant protein depletion are based on the interaction between polymers such as bacterial cellulose nanofibers [356], cryogels [357], and nanomaterials [358].
These techniques are highly specific, relatively cheap, and very stable. They can also be reused since they have larger binding capacity and less cross-reactivity [348].

Protein enrichment/depletion strategies which make use of protein coronas [359,360] or extracellular vesicle enrichment [361] are enabling researchers to probe deeper into the plasma, serum, lymph, and cerebrospinal fluid proteomes. Automated nanoparticle (NP) protein corona-based proteomics workflows are a novel approach to perform deep blood-based proteomics analysis at unprecedented protein IDs above 6,000 proteins [362]. NPs can efficiently compress the dynamic range of protein abundances into a mass spectrometry accessible detection range and allow full automation of the protein preparation process providing a platform that can rival affinity based approaches with equivalent reproducibility and sensitivity [363].

Peptide Purification and Fractionation

Peptide purification methods

Solid phase extraction (SPE)

Solid phase extraction (SPE) is a common MS-based proteomics technique employed in the sample preparation. In this method, compound isolation is based on chemical and physical properties, which determines the distribution of compounds between a mobile phase (liquid) and a stationary phase (solid). After the molecules bind, washing of the bound compounds is performed and then molecules are made to elute from the stationary phase after replacing the mobile phase with the elution buffer. The material used for SPE is usually discarded after every sample and no gradient is applied for elution (single-step procedure of elution) [364]. Thus, using SPE only a specific analyte group gets separated, which depends on the stationary phase. Hence, SPE is primarily used for sample clean-up and for reducing complexity of the sample. For MS-based proteomic analysis, it is largely used to get rid of salts and other contaminants that might lead to ion suppression. The major drawback of this technique is that with SPE only a small fraction of the sample is examined because not all compounds are captured, but only those with binding capabilities same as that of the sorbent. The material for SPE is available in various types, including (micro-) columns, cartridges, plates, micropipette tips, and functionalized magnetic beads (MBs) [365,366]. Reversed-phase is the most widely used material for SPE in proteomic studies for the proteins and peptide fractionation and rarely, ion-exchange material. For the separation of glycosylated proteins and peptides, the preferred material is normal phase such as HILIC [367,368]. SPE materials which are less commonly used are silica- or polystyrene-based ones [369,370]. The other types of SPE methods are IEX, metal chelation, and affinity-based [371].

The basic idea behind the choice of binding and wash versus elution solutions for SPE is that that the binding and wash solutions should favor the interaction between the analytes of interest and the solid phase, whereas the elution solution should favor the interaction of the analyte with the liquid phase (Figure 5). For example, with reversed phase SPE, the solid phase is C18 or some other hydrophobic chemistry. Binding of peptides to this solid phase is based on the hydrophobicity of peptides, mostly due to their peptide backbone, but also due to the presence of amino acid side chains like leucine and phenylalanine. To encourage peptides to ‘like’ the stationary phase more than the liquid phase, the peptides are loaded in aqueous solution. This will enable washing of the hydrophilic contaminants like salts, small polar buffer molecules, and polar denaturants like urea. After washing the bound peptides, they can be eluted by switching the liquid phase to something hydrophobic, which allows the peptides to partition more into the liquid phase and elute from the solid phase.

Specific Types of peptide purification

There are many additional peptide purification methods that are commonly used in proteomics currently. These methods include the following:

Peptide fractionation methods

The number of peptides produced from proteolysis of the whole proteome is immense. Thus, after peptides are cleaned from interferences, they are often fractionated into subsets to enable increased proteome coverage. The characterization of the whole proteome is expected from higher order organisms, and with rising interest in post-translational modifications, an elaborate coverage of protein sequence is required. There are different methods for peptide fractionation as follows:

Ion-exchange chromatography (IEC)

This method involves the separation based on contrasting electric charge [375]. In this approach, the mechanism of analyte retention is based on the principle of electrostatic attraction between the sample and the stationary phase functional groups (FGs), having opposite charges. IEC is classified into two types: cation-exchange and anion-exchange chromatography. In cation-exchange chromatography, at an acidic pH, the negatively charged functional groups such as sulfates are attracted to positively charged peptides, whereas, in anion-exchange chromatography, positively charged FGs such as quaternary ammoniums are attracted to peptides with negative charge at an alkaline pH. These techniques are further classified into: strong (cation [SCX] and anion [SAX] exchange), and weak exchangers (cation [WCX] and anion [WAX] exchange), based on the type of FG attached [376]. These functional groups are most commonly supported in resins made up of silica and synthetic polymers, however, some inorganic materials are sometimes used [375]. In the IEC method, peptide elution is performed using a mobile phase with higher ionic strength, to ensure peptide partition into the liquid phase. SCX along with a salt gradient/plug is a routinely used proteomics technique. In the SCX method, peptides are resolved according to their net charge, in which the peptide with the lowest positive charge is eluted first. Increasing the salt concentration decreases the peptide retention time due to competition with the electrostatic interactions between the peptides and the solid phase. However, SCX resolution is limited compared to reversed phase chromatography and will thus limit the suitability of this technique for complex mixtures [377].

Reversed-phase chromatography (RPLC)

Reversed-phase chromatography is the most commonly used chromatographic technique which separates molecules in solution having neutral pH based on their hydrophobicity. The separation occurs on the basis of the partition coefficient of analytes between the mobile phase and the hydrophobic stationary phase. Highly polar peptides elute before the ones having less polarity because of the strong interaction with the hydrophobic functional groups forming a layer similar to a liquid around the silica resin [378]. RPLC has been widely used in separation of peptides because of its compatibility with gradient elution and aqueous samples and its retention mechanism, which modulates separation owing to changes in the properties like pH, additives and organic modifier [379]. Numerous factors influence the capacity of chromatographic peaks, such as temperature, column length, stationary phase, particle size, mobile-phase ion-pairing reagent, mobile-phase modifier and gradient slope[380]. Usually online RPLC is done at acidic pH to ensure peptide ionization, but it can be paired with offline high pH RPLC and multiple fraction concatenation to produce orthogonal separation due to altered ionization of amino acids changing peptide hydrophobicity [381].

Hydrophilic interaction liquid chromatography (HILIC)

Inverse-gradient chromatography was the forerunner to HILIC [382] HILIC is similar in its principle to normal-phase chromatography where the stationary phase is polar and the intitial solvent conditions are nonpolar. Gradient elution in HILIC is accomplished by increasing the polarity of the mobile phase, by decreasing the concentration of organic solvent, i.e., in the “opposite” direction compared to RPLC separations. With charged HILIC stationary phases there is also a possibility of increasing the salt or buffer concentration during a gradient to disrupt electrostatic interactions with the solute [383,384]. Thus, the peptides with less polarity elute before the more polar peptides. It is used for the separation of hydrophilic peptides and polar analytes [385]. This separation is achieved by a stationary phase that is hydrophilic in nature, for example: cyano-, diol-, amino- bonded phases [386], and an organic and hydrophobic mobile phase [383]. HILIC can also be used for enrichment and targeted proteomic analysis of PTMs, such as glycosylation, N-acetylation and phosphorylation, which increase the polarity of peptides and therefore also their retention on HILIC [378].

Isoelectric focusing (IEF)

IEF is a type of high-resolution (HR) technique of electrophoresis used for the separation as well as concentration of peptides that are amphoteric in nature on the basis of their isoelectric point (pI) using a solution without buffer consisting of either carrier ampholytes or a gel with immobilized pH gradient (IPG). After IEF separation, the separated amphoteric peptides in the liquid phase are recovered for further analysis by RPLC-MS/MS [387]. Along with being a technique with improved resolution and capacity, for separation of peptides, IEF provides with additional information on physicochemical properties of the peptides, for example: peptide iso electric point (pI) which acts as a tool for validation and filtration for identifying MS/MS peptide sequence during the step of database search [388]. The IEF system is not only used for increasing the coverage of proteome but also in quantitative label-free [389] and stable isobaric labeling experiments [388]. IEF and gel-based separations have fallen out of favor in the last decade due to improvements in liquid chromatography.

Electrostatic repulsion-hydrophilic interaction chromatography (ERLIC)

ERLIC is a method based on use of a weak anion exchange column operated at low pH with high organic solvent enabling isocratic elution [390]. Acidic peptides are retained by electrostatic interaction, basic and neutral peptides are retained through hydrophilic interaction made favorable by high organic solvent. This improves retention of acidic peptides and reduces retention of basic peptides compared to normal HILIC [391].

Liquid Chromatography (LC)

Chromatography is the physical sorting of a mixture of molecular species that are dissolved in a mobile phase through the strength of binding, or affinity, to the chromatographic column’s stationary phase [392]. The mobile phase is pressure driven through the column and molecular species, or analytes, that have a strong affinity to the stationary phase are retained, or slowed, while those with a weak affinity pass through quickly. Thusly the analytes are separated by order of elution from the column. Chromatography can exploit most physical properties of the analytes, including ionic charge (anion/cation exchange chromatography), hydrogen binding (hydrophilic interaction), and size (size exclusion chromatography, capillary electrophoresis). In some chromatographic separations the mobile phase composition is adjusted by mixing two or more buffers at different ratios to influence the strength of affinity of individual analytes to the stationary phase and exquisitely regulate retention.

Mass spectrometers suffer from ion suppression, a phenomenon where the over-abundance of one or a few species within the ion population entering the mass spectrometer masks the presence of less abundant species [393]. Complex biological samples, such as tissue, cell lysate, or physiological fluids contain a wide dynamic range of molecule concentrations that span many orders of magnitude. The physical separation of analytes from biological samples by LC reduces the complexity of the ion population presented to the mass spectrometer at a given time, thus allowing the instrument to carry out the necessary fragmentation scans to identify and quantify the detectable species. Therefore, one major benefit of LC is that it allows detection of low abundant analytes in other elution windows.

The field of proteomics predominantly separates peptides using reversed phase liquid chromatography [394,395,396]. Reversed stationary phase is most commonly composed of microscopic (1-3 μm) silica beads coated with covalently bound long (e.g. C18) hydrophobic alkyl chains. The hydrophobic side chains of certain residues and the peptide backbone bind to this stationary phase through non-polar interactions. These interactions are strong in an aqueous solvent but are disrupted when the organic composition of the solvent is increased. Thus, in a reversed phase separation the proportion of non-polar, or organic, solvent in the mobile phase is gradually increased to release analytes from the stationary phase based on the strength of hydrophobic binding: weakly bound hydrophilic analytes elute with a low organic level in the mobile phase and strongly bound hydrophobic analytes only elute when the organic composition reaches a higher percentage. By far the most popular combination of solvents for peptide analysis is water and acetonitrile with dilute acid modifier (such as 0.1% formic acid or 0.5% acetic acid). The programmed rate at which the proportion of organic solvent is increased in the mobile phase is called the “gradient”, which you will often find described in the methods sections for reversed phase separations.

LC Considerations Related to Electrospray Ionization (ESI)

LC is paired to MS through ESI, and LC parameters greatly influence ESI. The analytes are eluted in a liquid mobile phase and must be released into the gas phase as charged ions for detection by mass spectrometry. This is achieved by spraying the eluent from the chromatographic separation through a narrow nozzle under a high voltage potential (1,000-4,000 volts) between the nozzle, or emitter, and the mass spectrometer inlet. The eluent is sprayed as a mist of small charged droplets that explode into smaller droplets as the solvent evaporates and the repelling columbic force of the charged analytes increases [397]. The droplets become progressively smaller until individual analyte molecules are ejected. The ejected analytes are ionized by the retained charge and can thus be manipulated by the electric fields in the mass spectrometer to measure their mass and perform the necessary fragmentations to elucidate structure. The chromatographic flowrate (the volume of mobile phase driven through the chromatographic column per unit time e.g. uL/min) dictates the efficiently of electrospray ionization (proportion of analytes eluting from the column that are ionized and into the gas phase) and is thus a key consideration for sensitivity of analysis [398]. Reduced flowrates generate smaller droplets which degrade into ejected charged analytes rapidly, thus resulting in more detectable analytes and higher ionization efficiency. Electrospray ionization efficiency is also aided by an inert sheath gas, high temperature, and reduced pressure between the nozzle and ion lensing elements, thus decent sensitivity can still be achieved at high flowrates. For more detailed discussion of ionization, see the “Ionization” section.

Quality Attributes of Chromatographic Separation

The quality of chromatographic separation defines the number of analytes that are identified and quantified by LC-MS analysis. The theory around chromatographic separation was developed when LCs were paired with spectrophotometer detectors that only measure the combined signal intensity from all co-eluting analytes. The ability of MS to simultaneously detect the masses of individual components re-defines the significance of certain LC attributes. For those looking for mathematical descriptions of chromatographic quality, refer to the “Van Deemter equation”, which we do not cover here to maintain simplicity [399]. The following attributes are the most important to consider in LC-MS.

Chromatographic Resolution

Chromatographic resolution is defined as the ability to fully resolve adjacent chromatographic peaks containing analytes with nearly equal affinities to the solid phase. In mass spectrometry analytes are distinguished by mass even if they are not resolved by LC. Thus in LC-MS, the more relevant, but closely related concept is the peak width at the half maximum (FWHM) of the peak. A low FWHM indicates a sharp elution peak. In a sharp peak the entirety of the analyte population is electrosprayed into the mass spectrometer in a short time thus increasing the signal. Low FWHM of high abundance species also confines their ionization suppression to narrow time windows, which means a lower number of co-eluting analytes are hidden. Conversely, high FWHM means that the analyte signal is spread out over time, thus reducing sensitivity. Furthermore, at a high FWHM, high abundance species mask analytes through ion suppression over a larger portion of the separation.

Peak Capacity

Peak capacity is defined as the maximal number of peaks that ideally can be completely resolved in a pre-established time window. A long separation in which FWHM remains low would have a large peak capacity and thus allow identification of many species. Unfortunately increasing the length of a reversed phase gradient also increases the FWHM due to an increase in diffusion, which results in a diminishing return for longer analytical methods. A longer separation provides more time and opportunities for the mass spectrometer to sample each analyte to acquire fragmentation spectra required for identification and the selection of gradient length should consider both the desired throughput and the speed of the MS data acquisition strategy.

Reproducibility and Robustness

Reproducibility is defined as the ability to repeatedly obtain the same measurement for the same analytes each time that the analysis is repeated. In liquid chromatography this means that each analyte should elute at nearly the same retention time (the time elapsed since the start of the analysis until the analyte’s elution from the chromatographic column) with the same peak width. Robustness is the ability of the system to maintain reproducible performance despite nonoptimal conditions. The most typical obstacles to robustness are mechanical wear of the system components and the analytical column, fouling of the system by contaminants introduced in the samples, and clogging due to accumulation of contaminants. High flow methods tend to be more robust due to reduced impact of pump and plumbing configurations and changes in dwell volumes, and the wider bore of the components used is more resilient to clogging. However, higher flowrate comes at the cost of reduced sensitivity due to reduced ionization efficiency at higher flow rates and increases in the overall peak volume at constant sample loading, thus nanoflow (100-300 nL/min flowrate) chromatography remains a widely utilized strategy in proteomics. For applications where sample is not limited, slightly higher amounts of applied samples can take advantage of robustness of higher flow rates in the microflow range using newer optimized electrospray sources [400].

Throughput and Instrument Utilization

Throughput is the number of samples that are analyzed in a given timeframe, for example samples per day. High throughput is required to analyze thousands of samples that truly represent biological diversity in a timely manner. Increasing throughput means less data are collected for individual samples. Furthermore, many steps in the LC process are required for sample analysis in which no useful data is collected including sample injection, and system cleaning and equilibration, which reduce the ratio of data collected to instrument operation time, or instrument utilization. The ability to perform these steps while a different sample is analyzed, or parallelization, increases instrument utilization and the amount of data collected by several minutes which is a significant increase when several samples are analyzed per hour.

Trapping and Pre-Columns

Trapping and pre-columns are short chromatographic columns that are used to increase robustness of an LC-MS system. A pre-column is connected directly to the front of the analytical column and is intended to be disposable and to absorb contaminants and protect the analytical column. The trapping column is a connected indirectly to the analytical column through a valve. The valve can be switched to redirect the flow through the trapping column away from the analytical column. This allows analytes to be loaded on the trapping column while analytes that are hydrophilic and poorly retained are washed away and do not contaminate the analytical column or the mass spectrometer. This process is referred to as desalting, and once it is complete, the valve configuration is changed to connect the trapping column to the analytical column, and analytes captured on the trapping column can be eluted off the trap and through the analytical column for analysis by MS. Certain trapping columns can be operated in both directions, which allows aggregates to be flushed away when the trapping column is cleaned in the reverse direction. Additionally trapping columns are shorter and have less backpressure so they can be loaded with sample quickly at a fast flowrate. Whereas loading the sample directly on the analytical column requires a slower flowrate. Two trapping columns can be used in tandem to provide parallelization, while one trapping column is cleaned and loaded with samples the second trapping column is in line with the analytical column analyzing the sample that was loaded on it in the previous run [401,402].

Multi Dimensional LC

Depth of profiling has previously been increased by combining two or more orthogonal LC separations. Orthogonal in this context means that each separation sorts the analytes into different populations [403]. For example, a separation based on positive charge (strong cation exchange, SCX) separates analytes based on positive charge, and when paired with reversed phase chromatography results a higher peak capacity and more analytes identified. The first highly popular method was multidimensional protein identification technology (MudPIT), which used online separation by SCX followed by C18 reversed phase [404]. However, the resolution of peptide separation by SCX is low, leading to the presence of peptides in many fractions. The currently accepted most popular method for two-dimensional separation combines iterative reversed phase at different high and then low pH to sort analytes by changes in hydrophobicity due to changes in amino acid side chain ionization. Although the separations are not entirely orthogonal, multiple fraction concatenation across the high pH elution can produce entirely orthogonal peptide sets [405]. In recent years the focus of proteomics has shifted from deep profiling of fewer samples to rapid profiling of large cohorts. Thus, lengthy multidimensional methods have been replaced with single shot experiments only using one dimension of high resolution reversed phase separation [406]. However peak capacity is regained by using ion mobility spectrometry (separation of ionized peptides in the gas phase).

Peptide Ionization

Until the early 1990s, peptides analysis by mass spectrometry was challenging. Hard ionization techniques in use at the time, like fast atom bombardment, were not directly applicable to peptides without destroying or breaking them. The soft ionization techniques however, revolutionized the proteomics field and it became possible to routinely ionize and analyze peptides using MALDI and ESI techniques at high-throughput scale. These two techniques were so impactful that the 2002 Nobel Prize in Chemistry was co-awarded to John Fenn (ESI) and Koichi Tanaka (MALDI) “for their development of soft desorption ionization methods for mass spectrometric analyses of biological macromolecules” [407].

MALDI

The term “Matrix-assisted LASER desorption” was coined by Hillenkamp and Karas in 1985, although this orignal paper only applied the technique to dipeptides [408]. It was Koichi Tanaka who first applied this idea to proteins above 10,000 Daltons in size and published a paper in the Proceedings of the 2nd Japan-China Joint Symposium on Mass spectrometry in 1987 (Tanaka, K., Ido, Y., Akita, S., Yoshida, Y. and Yoshida, T. (1987) Detection of high mass molecules by laser desorption time-of-flight mass spectrometry. Proceedings of the 2nd Japan-China Joint Symposium on Mass spectrometry, 185-187), and then in a follow-up paper published in 1988 [7]. A few months later, Karas and Hillenkamp also demonstrated MALDI applied to proteins above 10kDa with MALDI [409]. This resulted in some controversy about who should have won the Nobel prize [410] as it was felt by the community that Hillenkamp and Karas had provided the technology several years before but it was Koichi Tanaka that was the first to apply the MALDI technology to proteins a year before Hillenkamp and Karas.

MALDI first requires the peptide sample to be co-crystallized with a matrix molecule, which is usually a volatile, low molecular-weight, organic aromatic compound (Figure 6). Some examples of such compounds are cyno-hydroxycinnamic acid, dihyrobenzic acid, sinapinic acid, alpha-hydroxycinnamic acid, ferulic acid etc [411]. Subsequently, the analyte is placed in a vacuum chamber in which it is irradiated with a LASER, usually at 337nm [412]. This laser energy is absorbed by the matrix, which then transfers that energy along with its free protons to the co-crystalized peptides without significantly breaking them. The matrix and co-crystallized sample generate plumes, and the volatile matrix imparts its protons to the peptides as it gets ionized first. The weak acidic conditions used as well as the acidic nature of the matrix allows easy exchange of protons for the peptides to get ionized and fly under the electrical field in the mass spectrometer. These ionized peptides generally form the metastable ions, most of them will fragment quickly [413]. However, it can take several milliseconds and the mass spectrometry analysis can be performed before this time. Peptides ionized by MALDI almost always take up a single charge and thus observed and detected as [M+H]+ species.

MALDI Mechanism

Electrospray Ionization

ESI was first applied to peptides by John Fenn and coworkers in 1989 [6]. Concepts related to electrospray Ionization (ESI) were published at least as early as 1882, when Lord Rayleigh described the number of charges that could assemble on the surface of a droplet [397]. ESI is usually coupled with reverse-phase liquid-chromatography of peptides directly interfaced to a mass spectrometer. A high voltage (~ 2 kV) is applied between the spray needle and the mass spectrometer (Figure 7). As solvent exits the needle, it forms droplets that take on charge at the surface, and through a debated mechanism, those charges are imparted to peptide ions. The liquid phase is generally kept acidic to help impart protons easily to the analytes.

Tryptic peptides ionized by ESI usually carry one charge one the side chain of their C-terminal residue (Arg or Lys) and one charge at their n-terminal amine. Peptides can have more than one charge if they have a longer peptide backbone, have histidine residues, or have missed cleavages leaving extra Arg and Lys. In most cases, peptides ionized by ESI are observed at more than one charge state. Evidence suggests that the distribution of peptide charge states can be manipulated through chemical additives [414].

Electrospray Mechanism

The main goal of ESI is the production of gas-phase ions from electrolyte ions in solution. During the process of ionization, the solution emerging from the electrospray needle or capillary is distorted into a Taylor cone and charged droplets are formed. The charged droplets subsequently decrease in size due to solvent evaporation. As the droplets shrink, the charge density and Coulombic repulsion increase. This process destabilizes the droplets until the repulsion between the charges is higher than the surface tension and they fission (Coulomb explosion) [415] [416]. Typical bottom-up proteomics experiments make use of acidic analyte solutions which leads to the formation of positively charged analyte molecules due to an excess presence of protons.

Types of Mass Spectrometers used for Proteomics

Mass spectrometry

Mass spectrometry is a science of ions; mass spectrometers serve as sophisticated instruments for determining the masses of compounds and elements. Mass spectrometers can therefore be likened to an ultra-precise weigh scale that can differentiate mass variations down to a single electron, or even lighter. Since J.J. Thomson’s initial exploration in 1912, the field of mass spectrometry has undergone numerous improvements, spanning from isotope assessment to the interpretation of biomacromolecules [417], all thanks to the combined efforts of diverse fields like chemistry, physics, electronic engineering, and computer science. Nowadays, with the rapid improvement of sensitivity, mass resolution, tandem mass spectrometry methods and ion dissociation methods, mass spectrometers have evolved as a core tool for proteomic (and metabolomic) analysis. It is precisely the widespread application of mass spectrometry in proteomics analysis that has given rise to more instrument manufacturers and a greater diversity of mass spectrometer types. This also brings a happy annoyance to many beginners or researchers in other fields who have no background in mass spectrometry: which manufacturer and which type of mass spectrometry should I choose to analyze my samples? Here, to help new learners build a basic understanding faster, we will briefly introduce some basic concepts, common types of mass spectrometers, and their suitable application scenarios.

Mass Spectrometer Structure and Basic Principles

The fundamental principle of mass spectrometry revolves around specific physical processes that can be described by various mathematical formulas. Since this article serves as a guide for those new to the field, particularly those from a biology background, we’ve chosen to steer clear of delving too deeply into intricate mathematical and physical explanations. However, for those keen on a deeper understanding, we’ve included references pertaining to these foundational principles. Our focus lies on introducing fundamental concepts and outlining the typical workflow in mass spectrometry.

The process of mass spectrometry (MS) is to generate gas phase ions from compounds in samples by any suitable method, to separate these ions by their m/z ratio, and then detect them by their respective m/z and abundance. The successful implementation and demonstration of this process requires participation of five fundamental systems (Figure 8):

1) The ion source.

The ion source is where gas phase ions are generated. Common methods of ionization in mass spectrometry include electrospray ionization (ESI), matrix assisted laser desorption ionization (MALDI), atmospheric pressure chemical ionization (APCI), electron ionization (EI) and chemical ionization (CI) [418,419]. For proteomic analysis, soft ionization methods such as ESI and MALDI are the most widely applied techniques [6,7], which will be discussed in next chapter in more detail.

2) The mass analyzer.

The mass analyzer is where gas phase ions are separated according to their m/z ratio based on physical principles. There are several types of mass analyzers applied in mass spectrometry, including the quadrupole, linear ion trap and three-dimensional ion trap, Orbitrap, Fourier transform-ion cyclotron resonance (FT-ICR), time-of-flight (TOF), and the magnetic sector analyzers [420,421], each with unique advantages and applications (Table 12.1). For proteomic analysis, tandem mass spectrometry, which involves combining two or more mass analyzers, is typically used to achieve precursor selection, structural analysis, improved sensitivity, and better mass resolution [422]. The mass analyzer is the core component of a mass spectrometer, it is also the most important factor that we need to take into consideration when choosing a mass spectrometer for a specific project.

3) The detector.

The detector is where ions are detected and their respective m/z values and abundances are recorded, generating a mass spectrum. Common types of ion detectors, including the Electron Multiplier (EM), Photomultiplier Tube (PMT), Microchannel Plate (MP) and Faraday Cup (FC), along with a summary of their strengths and limitations, are illustrated in Table 12.2. It is worth noting that Orbitrap and FT-ICR mass analyzers don’t use conventional detectors as listed above. Instead, these analyzers detect an image current produced by oscillating ions [423,424,425]. In both mass analyzers, the detector is essentially measuring an electrical current (or more accurately, a voltage that’s proportional to the current) that’s induced by the motion of the ions. This signal is then processed to extract the frequencies of oscillation and Fourier-transformed into a mass spectrum, which is quite different from other types of detectors that count individual ions or particles striking a surface. Longer transients generate higher resolution spectra.

4) The vacuum system.

This is designed to maintain a high-vacuum environment for ions’ transmission inside the instrument. The vacuum system consists of different type of pumps including roughing vacuum pumps (rotary vane pumps, scroll pumps) and high-vacuum pumps (turbo molecular pumps, diffusion pumps). Maintaining a high vacuum is essential to reduce collisions between analyte ions and inert gas molecules during their transmission from one region of the mass spectrometer to another, or during oscillations within a mass analyzer. Collisions within the vacuum chamber may lead to unstable ion trajectories and poorer transmission efficiency, in turn leading to lower resolving powers and poorer sensitivities. Even so, some inert gas is intentionally plumbed into the mass spectrometer either for collisional activated dissociation (CAD), typically with nitrogen, helium, or argon, or to dampen ions’ energy so that they don’t fly out of the back of the instrument. FT-ICR and Orbitrap mass analyzers require higher vacuum in the 10-9 to 10-11 Torr range, while TOFs require medium vacuum in the 10-7 to 10-8 Torr range, and quadrupole and ion trap insturments require a relatively low vacuum in the 10-5 to 10-6 Torr range.

5) The control system.

This is needed to regulate and coordinate the various parts of the mass spectrometer to ensure seamless functioning. This typically includes ion source control, mass analyzer control, detector control, data acquisition control, interfacing with auxiliary systems (such as a liquid chromatograph and gas chromatograph), and modules for instrument diagnostics and calibration.

Types of mass spectrometers used for proteomics.

Typically, mass spectrometers are named based on the abbreviations of their principal or tandem mass analyzers. This naming convention stems from the fact that the mass analyzer forms the core component of a mass spectrometer, and it also dictates key performance attributes such as mass resolution, scanning speed, sensitivity, and cycle time. These performance metrics, in turn, determine what type of analysis we can conduct, its speed and its accuracy. Next, we will focus on introducing several classic tandem mass spectrometry types commonly used in proteomics.

1. Triple quadrupole (QqQ).

Triple quadrupole mass spectrometer (often abbreviated as QqQ, QQQ, TQ, or TQMS) is a type of tandem mass spectrometer where three quadrupole mass analyzers are combined in series (Figure 9). Each quadrupole is essentially a set of four parallel metal rods to which radio frequency (RF) and direct current (DC) voltages are applied to each opposing pair of rods. The QqQ operates in a synchronized manner to isolate ions of interest (according to the Mathieu function) in the first quadrupole, induce fragmentation with inert gas in the second, and then detect the resulting product ions in the third quadrupole. Specifically, the first quadrupole (Q1) is a mass filter, where ions of a specific m/z are selected from the incoming ion beam. This is achieved by adjusting the voltage applied to the pair rods within the quadrupole, allowing ions with a particular m/z value to pass through while deflecting others. The second quadrupole (Q2), also known as the collision cell, is where selected ions from Q1 are fragmented into product ions. This fragmentation happens due to the collisions between inert gas molecules (nitrogen, argon, or helium) and ions, which causes the ions to break up (fragment) into smaller pieces (fragment ions). For more detail about peptide fragmentation, see the Tandem Mass Spectrometry section. This process is known as collision-induced dissociation (CID) [426,427]. The Q2 is usually only subjected to RF potential and does not filter ions; instead, it transmits the product ions to the third quadrupole. In some tandem mass spectrometry, hexapoles or octupoles are also used to replace a quadrupole as the collision cell. Lastly, the third quadrupole (Q3) acts as a secondary mass filter, similar to Q1, but with the purpose of selecting specific fragment ions produced in the collision cell while excluding other ions. The chosen ions are then directed to the detector, where their abundance is measured (Figure 9). This process, involving precursor ion selection, precursor ion fragmentation, and product ion detection, is a general operating principle in tandem mass spectrometry and determines what kind of scan mode you can utilize. While discovery-based proteomics approaches can be performed on triple-quadrupole systems, selected ion monitoring (SRM), also refered to as multiple reaction monitoring (MRM) has contirbuted to their popularity. A key characteristic and advantage of QqQ is the flexibility of choosing various scan modes [427,428,429], such as the following.

1. Product Ion Scan:

Q1 is set to filter a specific precursor ion, which is then fragmented in Q2. Q3 scans the full range of product ion masses. This mode is usually used to identify the structure of a particular compound.

2. Precursor Ion Scan:

Q3 is set to filter a specific product ion. Q1 scans the full range of precursor ions, that when fragmented in Q2, yield the selected product ion. This mode is used to find compounds that yield a specific fragment ion, which can be particularly useful when looking for compounds with a common structural motif.

3. Neutral Loss Scan:

Both Q1 and Q3 scan the full range of ions, but with a mass difference equal to a specific “neutral loss”. This mode is used to identify compounds that, when fragmented, lose a specific neutral molecule.

4. Multiple/Selected Reaction Monitoring (M/SRM):

Both Q1 and Q3 are set to filter specific ions (precursor and product, respectively). This highly selective mode is used for quantitative analysis of specific compounds, offering excellent sensitivity and specificity [430,431].

The triple quadrupole mass spectrometer is a highly versatile instrument, capable of both qualitative and quantitative analysis. Enke and Yost at Michigan State University developed the first commercial triple-quadrupole mass spectrometer in the late 1970s [432]. QqQ is particularly well-suited for targeted quantitative analysis due to its high sensitivity, selectivity, and dynamic range, which has made it a go-to instrument in areas such as drug metabolism studies, environmental monitoring, food safety analysis, pharmaceuticals, and clinical diagnostics [433,434,435,436].

However, Quadrupoles suffer from inherent limitations in mass resolution due to the constraints of principles and precision in mechanical manufacturing. Consequently, they face difficulties in accurately identifying unknown molecules within complex mixtures and thus not appropriate for applications like structure analysis and biomarker discovery.

2. Q-TOF

Even though quadrupoles face difficulties in accurately identifying unknown peptides within complex mixtures due to its mass resolution, they serve effectively as mass filters, making them an excellent choice for combining with other high-resolution mass analyzers to form tandem mass spectrometry systems. One commonly used approach is Quadrupole-Time-of-Flight Mass Spectrometer (Q-TOF-MS), a ‘hybrid’ device, integrating quadrupole techniques with a time-of-flight mass analyzer. W.E. Stephens constructed and published the design of the first time-of-flight (TOF) analyzer in 1946 [437,438]. The principle of TOF is quite straightforward: ions of different m/z are imparted with the same initial kinetic energy (E = Uq = ½ mv2) and then separated over time as they travel along a field-free drift path of known length. If all ions begin their flight simultaneously, or at least within a short enough time span, the lighter ions will reach the detector before the heavier ones due to their faster velocity (V)[439]. Based on this principle, the m/z of different ions can be calculated according to the order in which they reach the detector. Similarly, we can easily conclude that the longer the drift path, the higher of the mass resolution can reach if keep the response time of detector the same. In fact, in pursuit of higher mass resolution, researchers have indeed built time-of-flight (TOF) drift tubes that are tens of meters long. However, apparently, this is not practical for widely application in a regular lab place. An alternative way to expand drift length and achieve higher resolution is to apply reflector (often called a reflectron). The principles and advantages of using a reflector can be summarized as follows.

Under ideal circumstances within a TOF mass spectrometer, ions sharing the same m/z would reach the detector concurrently post-acceleration, thus generating a sharp peak on the mass spectrum. However, the inherent oscillation path variability of ions within the mass spectrometer makes it challenging to maintain uniform initial kinetic energy amongst all ions, leading to peak broadening and a substantial reduction in mass resolution. The reflector is designed to rectify this issue. Comprising a series of electrodes that set to different voltages, the reflector generates a retarding electric field that reverses ion trajectories back through the flight tube. Notably, the reflector is engineered such that ions carrying lower kinetic energy delve less into the reflector and have a reduced flight path, while those with higher kinetic energy permeate more deeply and follow a longer flight path. This equalizes the variances in initial kinetic energy, enabling ions of the same m/z to hit the detector almost simultaneously, thereby enhancing the resolution of TOF.

Furthermore, the usage of reflector effectively expands the flight path length within the same physical confines, resulting in superior ion separation and consequently, higher resolution. This reflection comes at the cost of some ion loss, and therefore some sensitivity loss. As such, reflecting TOFs are the basis of most commercial instruments currently in use.

The construction of a Q-TOF bears significant resemblance to a triple-quadrupole mass spectrometer, with the critical distinction that the third quadrupole has been replaced by a time-of-flight tube. Figure 10 delineates the schematic of a typical Quadrupole-Time-of-Flight (Q-TOF) mass spectrometer, which comprises three fundamental components:

1. Quadrupole mass analyzer (Q).

This part of the instrument is basically the same to the Q1 in QqQ, which selects specific m/z values to pass through by applying a combination of DC and RF voltages across the rods.

2. Collision cell.

Here, selected ions undergo collision-induced dissociation (CID) by interacting with a neutral gas, leading to their fragmentation into smaller constituents. This process yields structural information about the original molecules. Usually, quadrupole, hexapole, or even octopoles are used as the collision cell for better focusing and transporting.

3. Time-of-Flight (TOF) mass analyzer.

Upon exiting the collision cell, the fragmented ions are reaccelerated into the ion modulator region of the time-of-flight analyzer. There, they undergo pulsing by a strong electric field (typically 20 kV or higher) and get accelerated to a field free drift tube, and then reflected to the detector.

TOFs generally offer mass resolutions surpassing 50,000, rendering it a reliable instrument for identifying unknown compounds. Moreover, the rapid travel time of ions in the vacuum tube (at the nanosecond level) confers the Q-TOF with distinctive benefits in short gradient and high-throughput analyses [440,441,442]. Another advantage of TOF is its broad mass range, which allows for the detection of large proteins, nanoclusters, and even large particles [443,444,445]. However, it should be noted that due to ion numbers and detector limitations, mass resolution is typically difficult to maintain over a wide mass range.

Presently, Q-TOF related instruments are available from all leading instrument manufacturers, and the main models are listed below: Sciex: “TripleTOF® 6600+”, “TripleTOF® 5600+” System and “X500R QTOF” System. Bruker Corporation: “Impact II”, “timsTOF” series, “microTOF-Q III”, “ultrafleXtreme-MALDI-TOF/TOF” and “maXis II”. Agilent Technologies: “Agilent 6530 Accurate-Mass Q-TOF”, “Agilent 6545 Accurate-Mass Q-TOF”, and “Agilent 6550 iFunnel Q-TOF”. Waters Corporation: “SYNAPT G2-Si HDMS”, “Xevo G2-XS QToF” and “SYNAPT XS”.

3. Q-Orbitrap

Mass spectrometry that uses Orbitrap as the core mass analyzer is another critical pillar in the field of proteomics. In the late 20th century, Russian scientist Alexander Makarov invented the Orbitrap [446], which is a novel mass analyzer that operates based on the principle of electrodynamic ion trapping and Fourier Transform. The orbitrap consists of two main components: an inner spindle-like electrode and a coaxial outer barrel-like electrode (Figure 11A). The ions are trapped in an orbit around the spindle electrode due to the electrostatic attraction. Once inside, the ions begin oscillating along the central axis of the device, or “orbiting”, due to the electric field formed by the inner and outer electrodes. The oscillation frequency of an ion is inversely proportional to the square root of its mass-to-charge ratio. The frequency at which each ion oscillates induces an image current on the detector, which can be measured and transformed into a mass spectrum using Fourier transform.

The biggest difference between Orbitrap and other mass spectrometers (TOF, Q) is that it does not use ions to hit an induction device like an electron multiplier. One of the main advantages of the Orbitrap is its ultra-high mass resolution, often exceeding 240,000 or even higher. This gives the Orbitrap a significant superiority in the identification of unknown molecules such as peptides and metabolites [421,447]. Moreover, Orbitrap spectrometers are also appreciated for their compact structure, small size, robustness, and reliability. Just like the Q-TOF, the Orbitrap is also usually used for tandem mass spectrometry. Figure 11B demonstrates a typical 2D schematic diagram of Q-Orbitrap. Ions first pass through an ion optics module, which consists of a high-capacity ion transfer tube (HCTT), an electrodynamic ion funnel (EDIF), and an advanced active beam guide (AABG). These are designed to capture ions, reduce ion losses, prevent neutrals and high-velocity clusters from entering the quadrupole, and increase sensitivity. The ions are then segmented by the quadrupole for precursor ion selection, and the selected ions are trapped by the ion-routing multipole for higher energy collisional dissociation. Finally, the fragmented ions are captured once again by the C-trap and injected into the Orbitrap batch-by-batch for accurate mass-to-charge analysis. Overall, this process still follows the logical sequence of precursor ions selection, precursor ions fragmentation, and fragment ions detection.

Compared to a TOF, one disadvantage of the Orbitrap is its longer cycle time (AGC pre-scan, ion injection, ion isolation, ion activation and mass analysis, usually >100ms), which is a negative factor for the currently favored short gradient, high-throughput analysis. Another minor flaw of Orbitrap is the challenge encountered when trying to pair it with MALDI. This primarily stems from the fact that MALDI uses a pulsed ionization technique, whereas Orbitrap operates continuously. This mismatch can lead to inefficiencies and challenges in coupling the two techniques. At present, the Orbitrap still dominates important applications in almost all aspects of proteomics including biomarker discovery [448], post-translational modification (PTM) analysis [27,449], quantitative proteomics (LFQ, TMT, iTRAQ)[20,21,450], protein-protein interaction studies [451] and structural proteomics [452,453]. It can perform both top-down and bottom-up analyses owing to its broad mass range, and is suitable for both Data-Dependent Acquisition (DDA) and Data-Independent Acquisition (DIA) methods. Right now, the Orbitrap is still under patent protection and only one company, ThermoFisher, is allowed to manufacture related products. Classic models from ThermoFisher include Orbitrap Ascend Tribrid, Orbitrap Eclipse™ Tribrid™, Orbitrap Fusion™ Lumos™, Orbitrap Exploris series (120, 240, 480) and Q Exactive™ series.

4. Quadrupole Fourier Transform Ion Cyclotron Resonance (Q-FT-ICR)

The Fourier Transform Ion Cyclotron Resonance (FT-ICR) mass spectrometer is a type of mass spectrometry that uses magnetic fields to separate ions based on their mass-to-charge ratio. FT-ICR was first invented in 1974 by Alan G. Marshall and Melvin B. Comisarow from the University of British Columbia [454] and is widely recognized for its high mass resolution and precision, making it a highly valuable tool in many scientific fields including proteomics, metabolomics, petroleum analysis, and environmental science. The central feature of an FT-ICR mass spectrometer is a superconducting magnet coupled with an ICR cell (Figure 12A). This magnet creates a strong and homogeneous magnetic field in which ions are injected. Once the ions are inside ICR cell, under the influence of the strong magnetic field, they follow a circular path with a very small orbital radius at a specific frequency directly proportional to their mass-to-charge ratio. At this point, no detectable image current signal is generated by detector plates located inside the ICR cell. To improve the signal, a voltage is applied by excitation plates and resonance occurs when the frequency of the strong magnetic field matches the cyclotron frequency of the ions. The ions absorb radio frequency energy, which increases the radius of their circular path, and consequently, the excited ions move closer to the detector plates and generate a current. The resulting signal is an oscillating pattern or a time-domain signal.

Similar to Orbitraps, this time-domain signal is then transformed into a frequency-domain signal using Fourier transform, hence the name Fourier Transform ion cyclotron resonance (ICR). The Fourier transformed data forms a mass spectrum where each peak corresponds to a specific ion present in the sample. One of the most important advantages of FT-ICR mass spectrometry is its exceptionally high mass resolution and mass accuracy, even for large and complex molecules. This enables precise identification and characterization of a wide range of compounds in complex mixtures [455,456]. Moreover, FT-ICR mass spectrometry can be used for multiple stages of mass analysis (MSn), including tandem mass spectrometry (MS/MS), providing detailed information about the structure of ions. Another significant benefit of FT-ICR is its broad mass range, making it possible to identify macromolecules like proteins for top-down proteomics [19,457].

Despite its advantages, FT-ICR mass spectrometry is not without challenges. The technique requires high-performance superconducting magnets, which are expensive for both initial purchase and further maintenance. This is because FT-ICR requires liquid nitrogen and liquid helium cooling systems to keep the magnet at a sufficiently low temperature to maintain its superconducting state. Moreover, the device demands high vacuum conditions and careful temperature control to maintain the stability of the magnetic field and the ion trajectories. A schematic representation of a Q-FT-ICR system is shown in Figure 12B. In congruence with the tandem mass spectrometers elucidated earlier, ions pass through an array of ion optics modules which designed for ion focusing and purification. Following this, the ions are selectively filtered by the first quadrupole. After this filtration, precursor ions undergo fragmentation in the collision cell, which can be a quadrupole, hexapole, or octopole. The fragmented ions are subsequently re-concentrated by the ensuing focusing lens. Ultimately, these fragmented ions are trapped, excited, and detected within the ICR cell. At present, commercial FT-ICR mass spectrometers are available in both Thermo Fisher Scientific (“LTQ FT Ultra” and “LTQ FT Ultra Hybrid” systems) and Bruker Daltonics (“solariX” and “apex” series).

5. Ion mobility

In the context of omics research, a fundamental task is the separation, identification, and quantification of molecules in complex mixtures. Mass spectrometry alone can only provide two-dimensional data including mass-to-charge ratio and their intensity. Liquid chromatography contributes to the separation of compounds and further provides the third dimension of information, retention time (RT), which make LC-MS evolves as the “golden standard” for proteomic analysis [458,459]. Despite the substantial improvements in mass spectrometry resolution and liquid chromatography consistency, accurately identifying extremely similar molecules such as isomers with LC-MS remains a challenge. Ion mobility mass spectrometry (IM-MS), a technique that utilizes electric fields to transport analytes through a buffer gas, is beneficial for separating and identifying ions based on their size, shape, and charge state. This technique provides the fourth dimension of information, collision cross section (CCS), which allows for more comprehensive characterization of molecules [460]. Apparently, multi-dimensional data is always beneficial for us to understand things comprehensively and accurately, thus getting closer to the truth.

In terms of mass spectrometry based proteomic analysis, adding CCS data can help us better separate, identify, and quantify peptides.

The core principle of ion mobility spectrometry is to separate ions in an inert gas under the influence of an electric field (E), and then measure the amount of time it takes for each ion to pass through drift tube, which is defined to be the steady-state drift velocity (Vd) correlated to the specific analyte’s mobility (K), as shown in Eq. 1. Vd = KE (Eq.1) While the primary measurement in IMS analyses is the mobility (K), for many analytical applications, it has become routine to convert K into the calculated collision cross-section value (CCS or Ω) using Mason-Schamp equation (Eq. 3)[461].
Ω=(3/16 〖(2π/μKT)〗^(1/2) ze)/N0K0 (Eq.2)
The components of the equation are defined as follows: e, charge of an electron; z, ion charge; N0, buffer gas density; μ, reduced mass of the collision partners; kb, Boltzmann’s constant; and T, the drift region temperature. Although the Mason-Schamp equation isn’t universally embraced, it is currently the primary formula the community uses to compute CCS. In basic terms, the CCS serves as a standard metric for the size in the gas phase, generally expressed in units of square Angströms (Å2). However, according to the Eq.2, parameters including gas composition, working pressure, temperature within the mobility region, path of analyte movement, and the strength of the applied field can influence the final CCS value and may differ for each specific IMS platform. Hence, direct comparison of CCS value between different platforms often requires calibration.

Generally, ion mobility techniques can be categorized into three separation concepts: (1) temporally dispersive, (2) spatially dispersive, and (3) ion confinement (trapping) and selective release (Figure 13A) [458]. Temporally dispersive methods produce an arrival time spectrum based on differences in the time it takes for ions to traverse a similar gas-filled drift region under the influence of an electric field. Time-dispersive technique inherently provides an extensive examination of all signals detected during a given observation window. However, a fundamental limitation of this wide-ranging analysis is the diminished sensitivity linked to a single time dispersion occurrence, which usually requires many (10−100) events to be aggregated to achieve statistically significant ion mobility measurements. In contrast, spatially dispersive methods separate ions based on mobility differences (charge, shape and size), leading them on distinct drift paths or trajectories, but without significant time differences. A characteristic of spatially dispersive techniques is the scanning of voltage to obtain a broad-band ion mobility spectrum. Types of spatially dispersive ion mobility include High Field Asymmetric Waveform Ion Mobility Spectrometry (FAIMS), uniform-field differential mobility analyzers (DMA), and the newly introduced scanned frequency ion mobility filter called transverse modulation ion mobility spectrometry (TMIMS). Ion confinement and release strategies are recently developed techniques which trap ions in a pressurized drift cell by electric field, and then release them based on mobility distinctions. This technique relies on the ability to control the position of ions under elevated pressure conditions using precisely adjustable electrodynamic fields. It requires a precise fabrication craft and more complicated control system. While it has only been perfected recently, typical products like trapped ion mobility spectrometry (TIMS) [462,463] and cyclic traveling wave IMS have become commercially available [464]. Table 10.3 summarized typical ion mobility separation techniques, their separation concept, electric field direction, gas flow direction, strengths, and drawbacks. Also, for three categories of ion mobility techniques, we have selected a typical technique from each for brief introduction.

‘#’ means stationary drift gas; →, ←, ↑↓ indicates drift gas direction or electric force direction; →→→ represents a wave and gradient electric field.

10.5.1. Drift Tube Ion Mobility Spectrometry (DTIMS)

The principle of Drift Tube Ion Mobility Spectrometry (DTIMS) is based on the differential migration (time) of ions through a neutral buffer gas (commonly helium or nitrogen) under the influence of a weak uniform electric field (typically tens of V/cm). The mobility (K) of an ion is proportional to its drift velocity (V) and inversely proportional to the strength of the applied electric field (E). For ions with same charge states, the drift velocities are primarily determined by their collisional interactions with a buffer gas, namely, mainly affected by their shape and size. To illustrate this process, imagine two objects with identical mass: a solid metal ball and a feather. Due to its lower density, the feather should have a larger volume than the ball. When both are dropped from the same height, the solid ball reaches the ground before the feather because of air resistance. This observation doesn’t contradict Newton’s law of universal gravitation, as we have accounted for air resistance. In the context of DTIMS, the buffer gas in the drift tube acts as the “air resistance”, while the uniform electric field represents the “gravity”. Hence, ions with the same mass-to-charge ratio are separated based on their shape and size. This capability allows DTIMS to distinguish between isomeric compounds with identical masses but different structural configurations, given that these isomers might have distinct interactions with the drift gas. Also, follow the intuition of the free fall example, in DTIMS, smaller ions will move faster and hit the detector earlier than larger ions in DTIMS (Figure 13B).
DTIMS possess the strengths including high resolving power and allows for straightforward measurement of an ion’s CCS from first principles[465,466]. However, DTIMS also suffers from disadvantages including: 1) separation time is too long for all ions passing through the drift tube, relative to the accumulation time, which decreases the duty cycle. 2) A longer drift tube or higher pressure is needed for greater resolving power. However, this inevitably increases ion diffusion and ion losses unless ion focusing techniques are employed. 3) Segmentation and collision between ions and gas molecules during the traveling process in drift tube reduces the sensitivity. Continual advancements in DTIMS design and application of ion focusing techniques further pushed the mobility resolution of same DTIMS platforms to 100 to 250 (t/Δt) range or even greater.

10.5.2 High Field Asymmetric Waveform Ion Mobility Spectrometry (FAIMS)

High Field Asymmetric Waveform Ion Mobility Spectrometry (FAIMS) represents a distinct version of spatially dispersive ion mobility spectrometry. This technique differentiates ions utilizing a pronounced asymmetric oscillating electric field combined with a moving gas. The principle of FAIMS is based on the different trajectories of ions as they move through a high asymmetric electric field, which are determined by their physical structure and charge states [467,468,469]. In FAIMS, gas-phase ions are carried by a flow of carrier gas between two electrodes in a direction orthogonal to the direction of asymmetric electric field (E). The asymmetric waveform electric field is typically characterized by a short, high-voltage pulse of one polarity followed by a longer, lower-voltage pulse of the opposite polarity. An ion’s mobility within such an electric field is determined by its charge state, its physical structure, and the properties of the surrounding gas it moves through. Once the ions are subjected to an asymmetric electric field, the ions will alternate between travelling toward one electrode or the other as the field oscillates in polarity, resulting in a curved trajectories between the electrodes. Some ions move more in the high field relative to the low field, and vice versa (Figure 13C). To differentiate between ions, a so-called “compensation voltage” (CV), which is a DC offset voltage that compensates for the differential ion movement in the high and low fields, is applied [470]. In this case, only ions with a specific response to the changing electric field and those that match the applied compensation voltage (CV) will have a zero net movement and are able to traverse the drift region to the detector, while others hit the electrode plate and be neutralized. By scanning or modulating the CV, different ion species can be selectively transmitted through the FAIMS device. In contrast to drift tube IMS in which the ion stream is sampled in discrete packets and all ions reach the detector, FAIMS is a continuous filtration technique that allows uninterrupted sampling of the ion stream, but only for a selected subset of the ion population. One of the primary advantages of this continuous collection technique is greatly increase the signal-to-noise ratio for the ion(s) of interest by removing unwanted chemical noise, which make FAIMS more similar to a m/z filter than other ion mobility spectrometry tools. FAIMS also has the advantage of operating at atmospheric pressure. Drawbacks of FAIMS, however, are that it does not produce any CCS values and it has relatively low resolution separations. Commercial FAIMS products from vendors including Thermo Fisher and Waters are available now.

10.5.3 Trapped ion mobility spectrometry (TIMS)

Trapped ion mobility spectrometry (TIMS) is a common type of ion mobility which uses ion refinement and release strategy [471]. The basic idea behind TIMS is a combination of traditional ion mobility spectrometry and ion trapping techniques. Instead of driving ions through a drift tube filled with stationary gas, TIMS holds the ions stationary in a drift cell under a moving buffer gas and then releases them by adjusting electric fields (voltages on electrodes). This process was realized by applying two different electric fields: 1) Radially confining pseudopotential. An RF (radio frequency) voltage is applied to the electrodes of the TIMS analyzer to generate a radially confining pseudopotential, which essentially no axial component and only use for “focusing” ions in the central region of TIMS tube, preventing them from diffusion or hitting electrodes. 2) Axially electric field. An axially electric field gradient, produced by superimposing DC potentials on tunnel electrodes, is applied for “trapping” ions based on the equilibrium between the force of drift gas and the opposing force from the electric field gradient, which is stronger at the entrance and becomes progressively weaker moving deeper into the tunnel.

As a result, once ions entered the device, lower mobilities ones are trapped at positions where the magnitude of axially electric field is larger, while higher mobilities ones are confined to deeper positions of tunnel where axially electric field is lower. Then, after enough ions have been accumulated in the TIMS tunnel, additional ions are prevented from entering the tunnel region and residing ions are trapped for a short time (usually few milliseconds) which can be defined by users. Finally, the magnitude of axially electric field is decreased at a user defined rate so that ions are eluted as an order of mobilities value (K) from high to low (Figure 13D). The axially electric field gradient is set by a resistor divider. Importantly, like other ion mobility strategies, the resolving power of TIMS is highly dependent on the length of the gas column through which the ions traverse. In TIMS, ions are trapped in a specific location while buffer gas continuously flows past them. Thus, the resolving power achieved by TIMS depends on the “quantity” of gas, specifically the length of the gas column, that passes by the ions during the separation time. This offers the direct benefit of allowing the analyzer to maintain a compact physical size (around 5 cm) and achieve a high resolving power (R ∼ 300), while the analytical gas column – the portion that flows during an analysis – can be extensive (up to 10 m) and tailored to the user’s needs. Moreover, by leveraging the “trapping” capability (trapping time) of TIMS and the high scanning speeds of TOF, platforms such as TIMS-Q-TOF can implement a full duty cycle acquisition protocol known as Parallel Accumulation-Serial Fragmentation (PASEF) [462,472]. This is particularly meaningful for identifying more peptides within a given time frame, such as capture more precursors from co-eluted peptides in the same liquid chromatography peak. Currently, Bruker is the primary provider of commercial mass spectrometers that utilize TIMS-tof technology. (TIMS-tof pro, TIMS-tof pro2, SCP. etc.).

10.5.4 Structures for Lossless Ion Manipulation (SLIM)

A final type of ion mobility spectrometry discussed here is Structures for Lossless Ion Manipulation (SLIM), invented by Richard Smith and colleagues at Pacific Northwest National Labs [473]. SLIM uses printed circuit boards to confine ions in long path lengths for high resolution ion mobility. Ions can be passed through the board multiple times to achieve path lengths of several meters to over 1 km for high-resolution IMS separation [474,474]. This technology is currently under commercial development by Mobilion, in a platform named “Mobie” [475].

Tandem Mass Spectrometry and Peptide Fragmentation

Tandem Mass Spectrometry

Tandem MS, where precursor ions are selected and fragmented to generate an MS/MS spectrum containing peptide-derived product ions, is a fundamental process in modern proteomics [476,477]. This is largely because intact peptide mass alone cannot unambiguously provide a peptide’s sequence [478]; however, MS/MS spectra provide more information due to predictable fragmentation behavior of peptide ions to generate sequence-informative fragments [476,479]. Some more advanced proteomic acquisition methods use MS1-only feature detection in combination with retention time to maximize information used for downstream quantitation [480]. In most of these, identifications are fundamentally based on MS/MS spectra, either acquired as part of a specific LC-MS/MS analysis that contains the MS/MS spectra themselves or on a spectral library of MS/MS spectra acquired previously [481,482]. True MS1-only methods that use only accurate mass and retention time for identification have been discussed, but these have yet to be widely adopted [480].

The value of MS/MS spectra for peptide identification comes from predictable fragmentation behavior of peptide ions to generate sequence-informative fragments [476,479]. Multiple dissociation methods exist to generate product ions in MS/MS spectra through various mechanisms (Figure 14). In non-modified peptides, the most labile bonds are typically peptide bonds (i.e., amide bonds) between amino acids. Depending on where peptides dissociate along the peptide backbone, the fragments are assigned different ion types (Figure 14A). Fragment ion nomenclature was first developed by Roepstorff and Fohlman in 1984 [483] and then refined by Biemann in 1990 [484]. The main ion types are the fragments that contain the original peptide N-terminus (i.e., a-, b-, and c-type ions), or the original peptide C-terminus (i.e., x-, y-, and z-type ions). The number associated with each fragment ion indicates how many amino acids from each terminus are included.

One of the earliest and most ubiquitous peptide fragmentation methods is collision-induced dissociation (CID, also called collisionally-activated dissociation, CAD) [426] (Figure 14B). Here, collisions with inert gas molecules are used to increase the internal energy of peptide ions to reach bond dissociation energies that fragment them into products. Various inert gases can be used; helium, nitrogen, and argon are the most common. Preferences for which gas is used is often a function of how much energy per collision is desired. Two main versions of CID are used in proteomics, with the most common being beam-type CID (beamCID, sometimes called higher-energy collisional dissociation, HCD) [485,486]. BeamCID typically uses nitrogen or argon as a collision gas, and peptide ions are accelerated into a collision cell filled with several mTorr of bath gas. The kinetic energy used to accelerate precursor ions (often generated using direct current voltage differentials between the source of the ions and the collision cell) determines the energy imparted through collisions with the bath gas, which in turn governs their fragmentation behavior.

Since in non-modified peptides the most labile bonds are typically peptide bonds (i.e., amide bonds) between amino acids, the increase in internal energy from beamCID generates b- and y-type ions that represent this peptide bond cleavage, as shown in Biemann fragment ion nomenclature (Figure 14A). b-type ions provide sequence information for fragments that have an intact N-terminus, while y-type ions denote fragment ions with an intact C-terminus. Collisions in beamCID cause near instantaneous generation of primary fragment ions. Because the increase in internal energy happens rapidly before energy can be redistributed, beamCID can generate fragments that are not necessarily derived from cleavage of the most labile bonds (e.g., PTM-modified peptides, discussed below), but spectra are often dominated by b/y-type ions from amide bond cleavage (Figure 14B). BeamCID can also generate secondary fragments, such as immonium ions from side chain losses [487] or a-type fragment ions that come from water loss from b-type ions due to multiple collision events (note: a-type ions can form as primary fragmentation products in other dissociation methods). The simplicity of beamCID, which simply requires an rf-only collision cell, has made it widely implemented on most instrument platforms used in modern proteomics.

A second form of CID is called resonant CID (resCID), where the internal energy of peptide ions is slowly increased through multiple low-energy collisions. Here, helium gas is most often used, as it imparts less energy per collision, and activation typically happens in ion trap devices where supplemental frequencies can be used to excite ions. In other words, ions are trapped using axial rf-frequencies, and an additional rf-frequency is applied to the electrodes of the ion trap [488]. This supplemental rf is selected to have a frequency resonant with the fundamental frequency of the ions to be fragmented, as determined by the Mathieu equations, which excites the ions of interest so that they have increased kinetic energy as they move in the ion trap [489,490]. The increased kinetic energy creates more collisions with the background helium gas to slowly build up the internal energy of the precursor ions until the dissociation energy of the most labile bond is reached, causing fragmentation. Once ions dissociate, the fragments have different m/z values than the precursor ions, meaning they fall out of resonance with the supplemental rf and are no longer activated. Thus, resCID typically fragments only the most labile bonds in precursor ions and does not have secondary fragmentation behavior. As above, for non-modified peptide ions, this typically generates sequence-informative b- and y-type product ions. For modified peptides where the bonds connecting the modification to an amino acid are more labile than peptide bonds (e.g., phosphopeptides and glycopeptides), resCID MS/MS spectra can be dominated by product ions only of the PTM-loss rather than sequence-informative fragment ions, although many factors govern this behavior [491,492]. Because of this, and because this method requires an ion trap device with the ability to apply supplemental rfs, resCID is less prevalent than beamCID. For both beamCID and resCID, the mobile proton model has been widely accepted to explain fragmentation behavior [493], and this largely predictable behavior has greatly helped in manual and algorithm-assisted spectral interpretation.

Despite the utility and broad adoption of CID, alternative dissociation methods have been explored for a variety of uses, including applications where CID is inadequate for the experimental question [494,495,496]. The most popular of these alternative dissociation methods are electron-based dissociation (ExD) approaches, which include electron capture dissociation (ECD) and electron transfer dissociation (ETD). In both of these, peptide cations capture thermal electrons (ECD [497]) or abstract an electron from a reagent anion (ETD [498]) to generate radical-driven dissociation of the N-Ca bond that predominantly generates sequence-informative c- and z-type product ions (Figure 14C). The mechanisms of ExD methods have been widely explored [499,500], and the preferential cleavage of N-Ca bonds along the peptide backbone have been particularly useful for PTM-modified species because the modifications remain largely intact even during peptide backbone bond fragmentation. ExD methods have shown promise for analysis of numerous PTMs, including phosphorylation, glycosylation, ADP-ribosylation, and more [501,502]. Electron-based dissociation is also more suitable than collision-based dissociation for MS analyses of intact proteins [503,504] and larger oligonucleotides [505,506,507,508,509,510]

Two fundamental challenges exist with ExD methods. First, ExD implementation requires instruments that can manipulate cations and anions (or free electrons) within the same scan sequence and can trap both simultaneously for electron capture/transfer events to occur. This has been successfully accomplished on a number of instruments, including FT-ICR systems, ion traps, ToFs with quadrupole ion traps, and hybrid Orbitrap instruments, but it is not a ubiquitous feature of all platforms. That said, several exciting advances in recent years have made ExD methods more accessible on numerous instrument configurations [501,502,511,512,513]. A second challenge is the dependence of ExD dissociation efficiency on precursor ion charge density [514]. ExD methods generally produce robust fragmentation for charge dense precursor ions (i.e., those with relatively low m/z values and higher z). Alternatively, precursors with low charge density (i.e., higher m/z values) have relatively condensed secondary gas-phase structure that leads to non-covalent interactions. Even in the cases when ExD methods drive peptide backbone cleavage, product ions (i.e., c- and z-type fragments) are held together by the non-covalent interactions so that few (or no) sequence-informative product ions are produced. This process is called non-dissociative electron-capture/transfer (ECnoD/ETnoD) [515]. Several strategies to mitigate ECnoD/ETnoD have been successfully explored, including supplemental activation of product ions with resCID (ETcaD [516]) or beamCID (EThcD [517,518]), supplemental activation with infrared photons (AI-ECD [519,520] and AI-ETD [521,522,523,524]) or ultraviolet photons (ETuvPD [525]), and use of higher energy electrons [513,526,527]. Despite their successes, these methods still require instrumentation capable of ExD in addition to extra hardware needed for a given strategy (e.g., a CO₂ laser in AI-ETD [528]). As with ExD in general, recent advances in supplemental activation strategies for ExD are making these tools more accessible [501,502].

Photoactivation is another family of alternative dissociation strategies that has been steadily gaining popularity [529,530]. Infrared multi-photon dissociation (IRMPD) is canonically the photodissociation method used in early proteomic applications [530], but ultraviolet photodissociation (UVPD) has been the more widely used approach in the recent decade [531]. IRMPD functions similarly to resCID; it is a slow heating approach that causes vibrational excitation due to absorption of low energy photons, generally 10.6 μm photons from a CO₂ laser [532,533]. Predominant fragments are b- and y-type fragments, although secondary fragmentation occurs because fragment ions remain in the photon path after the initial dissociation event (Figure 14D). Despite limited use in the past decade, recent work shows that IRMPD, or more generally activation with IR photons, may still have value in the proteomics toolkit [258,523]. UVPD has been explored with a number of wavelengths, including 157 nm, 193 nm, 213 nm, 266 nm, and 355 nm [534,535,536,537,538,539]. Higher-energy UVPD approaches, like 193 and 213 nm photons, are typically used for underivatized peptide and protein ions [531], while others, like 266 and 355 nm, can be used for directed fragmentation at specific residues with natural chromophores (e.g., tyrosine) or exogenously added chromophore tags [540,541]. UVPD with 193 and 213 nm generate multiple fragment types, including sequence-informative a-, b-, c-, x-, y-, and z-ions in addition to other fragmentation pathways, which occur through vibrational and electronic excitation [542]. UVPD has been explored for bottom-up proteomic applications, but its more impactful utility, arguably, has been realized for intact protein characterization [543]. The laser needed for UVPD (i.e., the photon wavelength desired) determines much about its implementation. 193 nm photons are typically generated using an Excimer laser with ArF gas [544], while 213 nm photons can be generated with a solid-state laser that is easier to integrate into an instrument platform and maintain [536,545]. That said, 213 nm photons tend to provide more directed, preferential cleavage pathways compared to 193 nm photons that cleave more broadly in non-directed fashion [546]. Outside of ExD and photoactivation approaches, other alternative dissociation methods have been explored for various proteomic applications, although they are not as widely adopted at ExD and UVPD methods [529].

Data Acquisition

Hybrid mass spectrometers used for modern proteome analysis offer the flexibility to collect data in many different ways. Data acquisition strategies differ in the sequence of precursor scans and fragment ion scans, and in how analytes are chosen for MS/MS. Constant innovation to develop better data collection methods improves our view of the proteome, but many method options may confuse newcomers. This section provides an overview of the general classes of data collection methods.

DDA and DIA can both be further subdivided in to targeted and untargeted methods.

DDA

In most cases, the peptide masses that will be observed are not known before doing the experiment. Data collection methods must account for this. DDA was invented in the early 1990s, which enabled collecting MS/MS spectra for observed peptides as they eluting from the LC column [547,548,549].

Untargeted DDA

A common method currently used in modern proteomics is untargeted DDA. The MS collects precursor (MS1) scans iteratively until precursor mass envelopes meeting certain criteria are detected. Criteria for selection are usually specific charge states and a minimum signal intensity. When those ions meet these criteria, the MS selects those masses for fragmentation.

Because ions are selected as they are observed, repeated DDA of the same sample will produce a different set of identifications. This stochasticity is the main drawback of DDA. To ameliorate this issue, often strategies are used to transfer identifications between multiple sample analyses. This transfer of IDs across runs is known as “match between runs”, which was originally made famous by the processing software MaxQaunt [550,551]. There are several other similar tools and strategies, including the accurate mass and time approach [552], Q-MEND [553], IDEAL-Q [554] and superHIRN [555]. More recent work has introducted statistical assessment of MBR methods using a two-proteome model [556]. Statistically controlled MBR is currently available in the IonQuant tool [557].

Because DDA is required for quantification of proteins using isobaric tags like TMT, this stochasticity of DDA limits the ability to compare quantities across batches. For example, if you have 30 samples, you can use two sets of the 16-plex kit to label 15 samples in each set with one channel labeled by a pooled sample to enable comparison across the groups. When you collect DDA data from each of those sets, each set will have MS/MS data from an overlapping but different set of peptides. If one set has MS/MS from a peptide but the other set does not, then that peptide cannot be quantified in the whole sample group. This limits the number of quantified proteins in large TMT experiments with multiple batches.

Targeted DDA

Targeted DDA is not common in modern proteomics. In targeted DDA, in addition to general criteria like a minimum intensity and a certain charge state, the mass spectrometer looks for specific masses. These masses might be previously observed signals that were previously missed by MS/MS [558,559]. In these studies, the sample is first analyzed by LC-MS to detect precursor ion features with some software, and then subsequent analyses target those masses for fragmentation with inclusion lists until they are all fragmented. This was shown to increase proteome coverage.

DDA methods for modifications

Resonant CID [560] and beam-type HCD [561] are the most popular methods for unmodified and modified peptides due to their speed, accessibility, and efficiency. Due to the weak phosphoester bond relative to the peptide backbone, resonant CID usually produces spectra that are dominated by only the neutral loss of the phosphate. For this reason, the optimal dissociation methods for phosphopeptide identification and phosphosite localization include HCD or ExD-based methods, discussed later in more depth [562,563]. ExD methods generate phosphopeptide MS/MS spectra with many c- and z•-type fragment ions for peptide sequencing and localization of labile phosphate modifications, typically disrupted with CID [498]. Gas-phase phosphate rearrangement induced by collisional activation represents a glaring challenge for the field and several have explored site localization in the face of rearrangement [564,565,566].

Advanced data acquisition schemes trigger predetermined MS/MS events when a specific fragment ion or neutral loss is detected in a spectrum. Certain decision-tree strategies have arisen to increase data acquisition efficiency, including pseudo-MS3 scans which are triggered on detection of phosphate losses [492] and the use of site-specific x-type ions [567]. For example, when linear ion traps were the main proteomics workhorses, resonant CID analysis of phosphopeptides would result in predominantly neutral loss of the phosphate with limited sequence ion information. To gain sequence ions in these experiments, instruments could be set to isolate a loss of 98 Daltons for MS3 activation [568,569]. The newer collisional dissociation technique HCD, or beam-type collisional activation, significantly improves the detection of peptide fragments with the phosphorylation intact on fragment ions, and thus, this neutral loss scanning technique is no longer common.

Recently developed approaches to phosphopeptide identification include DIA-based phosphoproteomics with Spectronaut [570,571], “plug-and-play” high-resolution MS [572], SureQuant for phosphotyrosine [573], PIQED for direct identification and quantification of phosphorylation from DIA without a prior spectral library [449], and FAIMS front-end separations which yield 15-20% more phosphosite identifications than non-FAIMS experiments [469]. For quantification of phosphoproteins, Hogrebe et al. investigated several of the most common strategies and concluded that TMT-based MS2 strategies may be the current best approach [574].

Additionally, while less commonly modified than serine and threonine, histidine [575,576,577], arginine [578], and tyrosine [573,579,580] phosphorylation also represent intriguing cell signaling biology. Going forward, we expect that faster instruments will enable investigations of high phosphoproteomic depth and reproducibility in rapid timeframes, such that many proteomes can be analyzed for temporal and spatial insight.

A similar product-dependent MS/MS triggering strategy was introduced for N-linked glycopeptides [581]. Collisional dissociation of glycosylated peptides produces oxonium ions, for example at m/z 204.09 (HexNAc) or m/z 366.14 (HexHexNAc). If oxonium ions from the fragmented glycan are detected among the most abundant fragment ions of the HCD spectra, then an ETD scan is triggered. This ETD scan provides information about the peptide sequence, while the original HCD scan provides glycan structure information.

DIA

The simplest method to operate a mass spectrometer is to have predefined scans that are collected for each sample analysis. This is data-independent acquisition (DIA); the scans that are collected do not depend on the data that the instrument observes. Thus, the scan sequence is repetitive, looping through binned windows of predetermined width, and/or a predetermined m/z range. Although simple in terms of data collection, when the scan sequence includes MS/MS, sophisticated software is required to analyze the data. Like DDA, DIA can also be either targeted or untargeted [582]: The two targeted DIA methods are selected reaction monitoring (SRM) or multiple reaction monitoring (MRM), and untargeted DIA (uDIA) is often referred to simply as “DIA” or “SWATH” (Sequential Window Acquisition of All Theoretical Mass Spectra) (Figure 15).

Targeted DIA

The first type of targeted DIA is called SRM or MRM [583]. The popularity of this method in the literature peaked in 2014, with just under 1,500 documents on PubMed that year resulting from a search for “MRM”. In this strategy, the QQQ MS is set so that the first quadrupole selects the precursor mass of the peptide(s) of interest, the second quadrupole fragments the peptide, and the third quadrupole monitors the product of specific fragments from that peptide. This strategy is very sensitive and has the benefit of very low noise. The fragments monitored in Q3 are chosen such that it is unlikely these fragments could arise from another peptide. Usually at least a few transitions are monitored for each peptide in order to get multiple measures for that peptide.

An early example of MRM applied to quantify c-reactive protein was in 2004 [584]. Around the same time, SRM was combined with antibody enrichment of peptides from target proteins [585]. This approach was popular for analysis of plasma proteins [430]. These early examples led to many more studies that used QQQ MS instruments to get accurate quantitation of many proteins in one injection [586,587]. Scheduling MRM measurement when chromatography is stable additionally enabled better utilization of instrument duty cycle and therefore monitoring of more peptides per injection [588]. Efforts even developed libraries of transitions that allow quantification of any protein in model organisms [589].

Another similar targeted DIA method is called parallel reaction monitoring (PRM) [590]. Instead of using a QQQ instrument, PRM uses a hybrid MS with a quadrupole and a high-resolution mass analyzer, such as an Q-TOF or Q-Exactive. The idea is that instead of monitoring specific fragments in Q3, the high mass accuracy can be used to filter peptide fragments for high selectivity and accurate quantification. Studies have found that PRM and MRM/SRM have comparable dynamic range and linearity [591].

Untargeted DIA

There were many implementations of uDIA over the years, starting in 2003 by Purvine et al from the Goodlett lab [592]. In this first work they demonstrated uDIA using a Q-TOF with in source fragmentation and showed that extracted ion chromatograms of precursor and fragment ions matched in shape suggesting that this could be used to identify and quantify peptides. The following year, Venable et al from the Yates lab introduced uDIA with an ion trap [593]. Subsequent methods include MSE [594], PAcIFIC [595], all ions fragmentation (AIF) [596]. Computational methods were also developed to automate interpretation of this data, such as DeMux [596], XDIA [597], and ETISEQ [598].

The paper that is often cited for uDIA that led to widespread adoption was by Gillet et al. from the Aebersold group in 2012 [599]. In this paper they branded the idea as SWATH. Widespread adoption may have been facilitated by the co-marketing of this idea by ABSciex as a proteomics solution on their new 5600 Q-TOF (called “tripleTOF” despite containing only one TOF, likely a portmanteau of “triple quadrupole” and “Q-TOF”). Importantly, in the Gillet et al. paper the authors described a computational method to extract information from SWATH where peptides of interest were queried against the data. They also demonstrated the application of SWATH to measure proteomic changes that happen in diauxic shift, and showed that SWATH can reveal modified peptides, in this case a methionine oxidation.

There are also many papers describing uDIA with orbitraps. One early example described combining random isolation windows together and then demultiplexing the chimeric spectra [600]. In another landmark paper, over 6,000 proteins were identified from mouse tissue by at least 2 peptides [601]. In 2018, the new model orbitrap at that time (HF-X) enabled identification of nearly 6,000 human proteins in only 30 minutes. Currently orbitraps have all but replaced the Sciex Q-TOFs for DIA data collection.

A new direction in uDIA is the addition of ion separation by ion mobility. This has appeared in two forms. On the timsTOF, diaPASEF makes use of the trapped ion mobility to increase speed and sensitivity of analysis [602]. On the orbitrap, the combination of FAIMS and DIA has enabled the identification of over 10,000 proteins from one sample, which is a major milestone [406].

Analysis of Raw Data

The goal of basic data analysis is to convert raw spectral data into identities and quantities of peptides and proteins that can be used for biologically focused analysis (Figure 16). This step may often include measures of quality control, cross-run data normalization, quantification on different levels (precursor, peptide, protein), protein inference, PTM (post translational modification) localization and also first steps of data analysis, such as statistical hypothesis tests.

In typical bottom-up proteomics experiments, proteins are digested into peptides and further analyzed with LC-MS/MS systems. Peptides can have different PTMs and ionize differently depending on their length and amino acid distributions. Therefore, mass spectrometers often record different charge and modification states of one single peptide. The entity that is recorded on a mass spectrometer is usually referred to as a precursor ion (peptide with its modification and charge state). This precursor ion is fragmented, and the precursor or peptide sequences are obtained though spectral matching. The quantity of a precursor is estimated with various methods. The measured precursor quantities are combined to generate a peptide quantity. Peptides are also often combined into a protein group through protein inference, which combines multiple peptide identifications into a single protein identification [603,604]. Protein inference is still a challenge in bottom-up proteomics.

Due to the inherent differences in the data structures of DDA and DIA measurements, there exist different types of software that can facilitate the steps mentioned above. The existing software for DDA and DIA analysis can be further divided into freeware and non-freeware:

15-1 DDA freeware:

15-2 DIA freeware:

15-3 Targeted proteomics freeware:

15-4 DDA non-freeware:

15-5 DIA non-freeware:

15-6 Data Summary and Interpretation

15-7 Data Summary and Interpretation

Analysis of DDA data

DDA data analysis either directly uses the vendor proprietary data format directly with a proprietary search engine like Mascot, SEQUEST (through Proteome Discoverer), Paragon (through Protein Pilot), or it can be processed through one of the many freely available search engines or pipelines, for example, Comet, MaxQuant, MSGF+, X!Tandem, Morpheus, MS-Fragger, and OMSSA. Tables 15-1 and 15-4 give weblinks and citations for these software tools. For analysis with freeware, raw data is converted to either text-based MGF (mascot generic format) or into a standard open XML format like mzML [619,620,621]. The appropriate FASTA file containing proteins predicted from that organism’s genome is chosen as a reference database to search the experimental spectra. All search parameters like peptide and fragment mass errors (i.e. MS1 and MS2 tolerances), enzyme specificity, number of missed cleavages, chemical artefacts (fixed modifications) and potential biological modifications (variable/dynamic modifications) are specified before executing the search. The search algorithm scores each query spectrum against its possible peptide matches [622]. A spectrum and its best scoring candidate peptide are called a peptide spectrum match (PSM). The scores reflect a goodness-of-fit between an experimental spectrum and a theoretical one and do not necessarily depict the correctness of the peptide assignment.

For evaluating the matches, a decoy database is preferred as a null model for peptide matching. A randomized or reversed version of target database is used as a nonparametric null model. The decoy database can be searched separate from the target database (Kall’s method)[623] or it can be combined with the target database before search (Elias and Gygi method)[624]. Using either separate method or concatenated database search method, an estimate of false hits can be calculated which is used to estimate the false discovery rate (FDR) [625]. The FDR denotes the proportion of false hits in the population accepted as true. For Kall’s method: the false hits are estimated to be the number of decoys above a given threshold. It is assumed that the number of decoy hits that pass a threshold are the false hits. A similar number of target population may also be false. Therefore, the FDR is calculated as [626]:

For Elias and Gygi Method, the target population in which FDR is estimated changes. The target and decoy hits coming from a joint database compete against each other. For any spectrum, either a target or a decoy peptide can be the best hit. It is argued that the joint target-decoy population has decoy hits as confirmed false hits. However, due to the joint database search, the target database may also have equal number of false hits. Thus, the number of false hits is multiplied by two for FDR estimation.

Integrated MS Data Analysis Platforms

Given the complexity of proteomic data analysis and the requirement for many steps to get from raw data to quantified proteins, there are some integrated software enviroments that easily allow users to complete everything in one place.

Trans-Proteomic Pipeline (TPP)

The Trans-Proteomic Pipeline (TPP) is a free and open-source mass spectrometry data analysis suite for end-to end analysis that remains in continual development to provide ever expansive data analysis capabilities since its inception over twenty years ago [73,627,628,629,630,631,632,633,634,635,636]. The current release provides tools for mass spectrometry spectral processing, spectrum searching, search validation, abundance computation, protein inference, and statistical evaluation of the data to ensure controlled false-discovery rates. Many of the tools include machine-learning modeling to extract the most information from datasets and build robust statistical models to compute probabilities that derived information is correct.

One of the major advantages of TPP is its ability to be deployed in a wide variety of environments, from personal Windows laptops to extensive large Linux clusters for automated use within cloud computing environments. While the command-line interfaces are appreciated by many power users, others prefer a graphical user interface (GUI), which is provided by the TPP GUI called Petunia, allowing users to use the TPP from any web browser on any platform. Petunia has the advantages that the same exact GUI is available on a modest Windows laptop, a powerful expandable Linux server shared by a research group, or a remote cloud computing instance running on Amazon Web Services (AWS) [631].

The TPP incudes many statistical validation tools such as PeptideProphet [637], ProteinProphet [638], iProphet [630], and PTMProphet [635], where Bayesian machine learning techniques are applied to the various search engine scores to model the correct and incorrect assignment distributions and then use these models to assign a probability of being correct based on these learned models. With these tools it is possible to validate search engine results on large-scale datasets and in short order, enabling users to select probability thresholds based on a selected tolerable false discovery rate (FDR). The TPP is made fully interoperable via the open XML-based formats pepXML and protXML for different aspects of processing data-dependent acquisition (DDA), and Data-independent acquisition (DIA) proteomics data, resulting in a complete suite of tools for processing the increasingly larger datasets from start to finish.

DIA workflows are supported via the DISCO tool which reads mzML files containing the instrument-produced spectra and uses signal processing approaches to isolate the fragment ions in the multiplexed MS2 spectra that correlate with precursors in the MS1 and writes the results to new mzML files that may then be searched with standard DDA search engines and downstream tools, including target-decoy analysis. This provides a comprehensive analysis of DIA data without the need for building a spectral library first.

From its inception, the TPP has been and will always be free and open-source software, allowing anyone to use it without cost and to inspect its source code, alter the source code for their own needs, or even incorporate parts of it into their own products. Others have performed these tasks and include various analysis routines as addons such as TAILS N-terminomics analysis [639], quantitation analysis with PyQuant [640], SimPhospho [641], WinProphet [642], ProtyQuant [643], and inclusion of R-tools for metaproteomic analysis [644]. As a collection of individual tools, they are easily amenable to pipelining in a very flexible manner to support a huge variety of combinations and workflows, and a custom program may easily be inserted into the pipeline to support technology development.

Search engines supported by TPP

The heart of MS proteomics DDA data continues to be the “search engine” that interprets collections of mass spectra to determine the peptide or peptides that yielded them. Spectral library search engines and de novo search engines, which are less common, are also available and are included in software suites such as the Trans Proteomic Pipeline. A sequence search engine most commonly used is the open-source version of SEQUEST called Comet, which is actively maintained and updated with new functionality as needs arise. For spectral library searching, SpectraST uses an approach where new spectra are matched against a library of previously identified spectra in the form of a spectral library [645]. This approach is much faster, more sensitive, and more specific than sequence database searching, although is only as good as the reference spectral library provided. There is renewed interest in spectral libraries because of data-independent acquisition (DIA) approaches being increasingly deployed and therefore the quality and coverage of libraries is paramount and likely to improve in the coming years, aided by the standard spectral library format being developed by the PSI [646]. For de novo sequence analysis, Novor [647] and Casanovo [648] are very fast and capable de novo sequence search engines that are available.

For chemical crosslinking proteomics analysis, open-source programs such as Kojak [72,73] are available for standard or cleavable MS2-based crosslinking techniques. Crosslinking-based MS analyses are employed to elucidate protein-protein interactions and facilitate protein structure and topology predictions. Kojak is designed to identify two independent peptides covalently bonded with a crosslinker and fragmented in a single MS2 scan event using a database search approach. Kojak algorithm also includes support for cleavable cross-linkers, and identification of cross-links between 15N-labeled homomultimers and is integrated into the Trans-Proteomic Pipeline, enabling access to dozens of additional tools, in particular, the PeptideProphet and iProphet tools for validation of cross-links improve the sensitivity and accuracy of correct cross-link identifications at user-defined thresholds. Development of Kojak has continued over the last ten years culminating in many improvements and new features. These improvements include support for additional open formats and standards, further refinement to the search algorithm for efficiency, E-values to normalize the scores of the results, support for cleavable cross-linkers, and methods to identify cross-links between homomultimer subunits.

For open modification database searching, programs such as Magnum ([649]) are also now available which is specialized in identification of non-peptide masses that are bound to peptides. The tool is capable of identifying xenobiotic mass adducts, in addition to PTMs that were uncharacterized in the search parameters.

Strategies for analysis of DIA data

DIA data analysis is fundamentally different from DDA data analysis because, instead of a single MS/MS spectrum for each peptide, we can observe the elution of peptide fragments for any peptide over chromatography time. There are two general approaches for peptide identification from DIA data: peptide-centric and spectrum-centric.

Peptide-centric approaches looks for evidence of specific peptides that are in some assay library of MS/MS spectra. That library could be predicted spectra (e.g., using Prosit) [650], or previously measured spectra (e.g., from a organism-wide knowledge base) [651]. Examples of software that perform peptide-centric analysis include OpenSWATH [652], Spectronaut [601], csoDIAq [653], and DIA-NN [613].

Spectrum-centric approaches instead ask if there is evidence for any peptide based on analysis of the observed spectra. Examples of spectrum-centric approaches include DIA-Umpire [654] and PECAN [655]. Spectrum-centric approaches may assemble pseudo-MS/MS spectra from co-elution of fragments that can then be used with any DDA database search [654]. Spectrum-centric may be less sensitive at peptide identification than peptide-centric approaches.

Quality control

Quality control should be a central aspect of any mass spectrometry-based study to ensure reproducibility of generated results. There are two types of quality controls that can be conducted for any kind of mass spectrometry experiment. The first one is focused on monitoring the performance of the instruments themselves (e.g. HPLC and mass spectrometer), whereas the second one is focused on your experiments. For further reading, we recommend to take a look at issue 11 on quality control published in the journal Proteomics in 2011 [656], especially the review by Köcher et al. [657], as well as the review published by Bittremieux et al. in 2017 [658].

Instrument Performance

It is generally advisable to monitor instrument performance regularly. Instrument calibrations in regular intervals help ensure that performance is maintained. Often basic calibration and sensitivity can be checked by direct infusion of a standard. During the calibration you can check injection times (for ion trap instruments) and intensity of the ions in the calibration mix.

After ensuring good calibration and signal with the simple calibration mixture, it is advisable to analyze complex samples, such as tryptic digests of whole-cell lysates (e.g. HeLa cells, HEK cells, yeast, etc.) or tryptic digests of purified proteins. The additional check with a complex sample ensures all aspects of the system are working together correctly, especially the liquid chromatography and emitter. These digests should be analyzed after every instrument calibration and periodically between samples when acquiring more extensive batches. Data measured from tryptic digests should be analyzed by the software of your choice and the numbers of identified peptide precursors and proteins can be compared with previous controls for consistency.

Another strategy is to analyze digested purified proteins, which easily enable discovery of retention time shifts and mass accuracy problems. In case you are working with a Thermo mass spectrometer, you can open the acquired .raw file directly either in FreeStyle or in Qual Browser and look for specific m/z values of your peptides. Looking at the intensity of the extracted peaks will help identify sensitivity fluctuations.

Carry-over between different measurements can be identified from blank measurements which are subsequently analyzed with your search software of choice. Blank measurements can be injections of different buffers, water or the starting conditions of your liquid chromatography. In case of increased detection of carry-over, injections with trifluoroethanol can be performed.

Another factor to take into consideration is the stability of your electrospray. Electrospray stability tends to worsen over time as columns wear, as well as when measuring samples with residual contaminants, such as salts or detergents. You will notice spray instabilities either in the total ion chromatogram (TIC) as thin spikes with short periods of no measured signal or if you install cameras at your ESI source. Suboptimal spray conditions will usually result in droplets forming on the emitter, being released into the mass spectrometer (also referred to as “spitting”). Real-time quality control software (listed in the table below) can help you identify instrument issues right away.

Data Quality Control

Apart from instrument performance, any kind of data analysis should have proper quality control in place to identify problematic measurements and to exclude them if necessary. It is recommended to develop a standardized system for data quality control early on and to keep this consistent over time. Adding indexed retention time (iRT) peptides can help identify and correct gradient and retention time inconsistencies between samples at the data analysis stage. Decoy searches help monitor and control the false-discovery rate. Including common contaminants, such as keratins, in the FASTA files used for searches can help identify sample preparation issues. Other parameters to check in your analysis are the consistency of the number of peptide-spectrum matches, identified peptides and proteins over all samples of your study, as well as your coefficients of variation between your replicates. Before and after data normalization (if normalization is performed) it is good to compare the median intensities of all measurements to identify potential measurement or normalization issues. Precursor charge distributions, missed cleavage numbers, peak width, as well as the number of points per peak are additional parameters that can be checked. In case you are analyzing different conditions, you can perform hierarchical clustering or a principal component analysis to check if your samples cluster as expected.

Quality Control Software

Raw file and real-time analysis

Search result QC

Quantitative Proteomic Data Analysis Best Practices

This section aims to provide an overview of the best practices when conducting large scale proteomics quantitative data analysis. The proteome is more complex than the genome and transcriptome due to PTMs and splicing, therefore careful selection of data analysis techniques is required to make capture the true biological signals in the data [672]. A well-established workflow for proteomic data analysis does not currently exist [672]. Analyzing proteomic data requires knowledge of a multitude of pre-processing techniques where order matters, and it can be challenging knowing where to start. This review will cover tools to reduce bias due to nonbiological variability, statistical methods to identify differential expression and machine learning (ML) methods for supervised or unsupervised interpretation of proteomic data.

Data Transformation

Peptide or protein quantities are generally assumed to be logarithm (log) transformed before any subsequent processing [673,674,675,676]. Log transformation allows data to more closely conform to a normal distribution and reduces the effect of highly abundant proteins [674]. Many normalization techniques also assume data to be symmetric, so log transformation should precede any downstream analysis in these cases [674]. If there are missing values present, a simple approach would be to use log(1+x) to avoid taking the log of zero. After the transformation, zero quantities will remain as zero and the other quantities should be large enough that adding one will have a minor effect.

Data Normalization

Data normalization, the process for adjusting data to be comparable between samples, should be performed prior to batch correction and any subsequent data analysis [674,677]. Normalization removes systematic bias in peptide/protein abundances that could mask true biological discoveries or give rise to false conclusions [678]. Bias may be due to factors such as measurement errors and protein degradation [674], although the causes for these variations are often unknown [676]. As data scaling methods should be kept at a minimum [679], a normalization technique well suited to address the nuances specific to one’s data should be selected. The assumptions for a given normalization technique should not be violated, otherwise choosing the wrong technique can lead to misleading conclusions [680]. There are a multitude of data normalization techniques and knowing the most suitable one for a dataset can be challenging.

Visualization of peptide or protein intensity distributions among samples is an important step prior to selecting a normalization technique. Normalization is suggested to be done on the peptide level [679]. If the technical variability causes the peptide/protein abundances from each sample to be different by a constant factor, and thus intensities are graphically similar across samples, then a central tendency normalization method such as mean, median or quantile normalization may be sufficient [674,679]. However, if there is a linear relationship between bias and the peptide/protein abundances, a different method may be more appropriate. To visualize linear and nonlinear trends due to bias, we can plot the data in a ratio versus intensity, or a M (minus) versus A (average), plot [674,681]. Linear regression normalization is an available technique if bias is linearly dependent on peptide/protein abundance magnitudes [674,675]. Alternatively, local regression (LOESS) normalization assumes nonlinearity between protein intensity and bias [675]. Another method, removal of unwanted variation (RUV), uses information from negative controls and a linear mixed effect model to estimate unwanted noise, which is then removed from the data [682].

If sample distributions are drastically different, for example due to different treatments or samples are obtained from various tissues, one must use a method that preserves the heterogeneity in the data, including information present in outliers, meanwhile reducing systematic bias [679]. For example, Hidden Markov Model (HMM)-assisted normalization [679], RobNorm [683] or EigenMS [684] may be suitable for this type of data. These techniques assume error is only due to the batch and order of processing. The first method that addresses correlation of errors between compounds by using the information from the variation of one variable to predict another is systematic error removal using random forest (SERRF) [685]. SERRF, among 14 normalization methods, was the most effective in significantly reducing systematic error [685].

Studies aiming to compare these methods for omics data normalization have come to different conclusions. Ranking of different normalization methods can be done by assessing the percent decrease in median log2(standard deviation) and log2 pooled estimate of variance (PEV) in comparison to the raw data [686]. One study found linear regression ranked the highest compared to central tendency, LOESS and quantile normalization for peptide abundance normalization for replicate samples with and without biological differences [674]. A paper comparing multiple normalization methods using a large proteomic dataset found that mean/median centering, quantile normalization and RUV had the highest known associations between proteins and clinical variables [673]. Rather than individually implementing normalization techniques, which can be challenging for non-domain experts, there are several R and Python packages that automate mass spectrometry data analysis and visualization. These tools assist with making an appropriate selection of a normalization technique. For example, NormalyzerDE, an R package, includes several popular methods for normalization and differential expression analysis of LC-MS data [687]. AlphaPeptStats [688], a Python package, allows for comprehensive mass spectrometry data analysis, including normalization, imputation, batch correction, visualization, statistical analysis and graphical representations including heatmaps, volcano plots, and scatter plots. AlphaPeptStats allows for analysis of label-free proteomics data from several platforms (MaxQuant, AlphaPept, DIA-NN, Spectronaut, FragPipe) in Python but also has web version that does not require installation.

Data Imputation

Missing peptide intensities, which are common in proteomic data, may need to be addressed, although this is a controversial topic in the field. Normalization should be performed before imputation since bias may not be removed to detect group differences if imputation occurs prior to normalization [676]. Reasons for missing data include the peptide not being biologically present, being present but at too low of a quantity to be detected, or present at quantifiable abundance but misidentified or incorrectly undetected [676]. If the quantity is not at the detectable limit, the quantity is called censored and these values are missing not at random [676]. Imputing these censored values will lead to bias as the imputed values will be overestimated [676]. However, if the quantity is present at detectable limits but was missed due to a problem with the instrument, this peptide is missing completely at random (MCAR) [676]. While imputation of values that are MCAR using observed values would be a reasonable approach, censored peptides should not be imputed because their missingness is informative [676]. Peptides MCAR are a less frequent problem compared to censored peptides [676]. Understanding why the peptide is missing can be challenging [676], however there are techniques such as maximum likelihood model [689] or logistic regression [690] that may distinguish censored versus MCAR values.

Commonly used imputation methods for omics data are random forest (RF) imputation[691], k-nearest neighbors (kNN) imputation [692], and single value decomposition (SVD) [693]. Using the mean or median of the non-missing values for a variable is an easy approach to imputation but may lead to underestimating the true biological differences [676]. Choice of the appropriate imputation method is critical as how these missing values are filled in has a substantial impact on downstream analysis and conclusions [694]. In one study, RF imputation was the most accurate among nine imputation methods across several combinations of types and rates of missingness and does not require preprocessing (e.g., does not require normal distribution) for metabolomics data [695]. Another study found RF, among eight imputation methods, had the lowest normalized root mean squared error (NRMSE) between imputed values and the actual values when MCAR values were randomly replaced with missing values, followed by SVD and KNN using metabolomics data [694]. Lastly, a study found RF also had the lowest NRMSE when comparing seven imputation methods using a large-scale label-free proteomics dataset [696].

Batch Correction

Normalization is assumed to occur prior to batch effect correction [679]. Batch effect correction is still a critical step after normalization as proteins may still be affected by batch effects and diagnosing a batch effect may be easier once data is normalized [679]. Prior to performing any statistical analysis of data, we must start with distinguishing signals in the data due to biological versus batch effects. A batch effect occurs when differences in preparation of samples and how data was acquired between batches results in altered quantities of peptides (or genes or metabolites) which results in reduced statistical power in detecting true differences [679,679]. This non-biological variability originates from the time of sample collection to peptide/protein quantification [673] and is often a problem when working with large numbers of samples, involving multiple plates run by different technicians, on different instruments and/or using different reagent batches [697]. Results from these different batches ultimately need to be aggregated and data analysis to be performed on the whole dataset, so it may be difficult to measure and then control for exact changes due to non-biological variability once the data has been aggregated [673]. Batch correction methods remove technical variability, however they should not remove any true biological effect [673,697]. Although it is agreed upon that these biases should be accounted for to prevent misleading conclusions, there is no one gold standard batch correction method.

Batch effects can manifest as continuous, such as from MS signal drift, or as discrete, such as a shift that affects the entire batch [679]. To visualize batch effects, one can plot the average intensity per sample in the order each was measured by the MS to see if intensities are shifted in a certain batch [679]. Measuring protein-protein correlations is another method to check for batch effects; if proteins within a batch are more correlated compared to those from other batches, there are likely batch effects[679]. Prior to batch correction, one should ensure the experimental design is not irreversibly flawed due to batch effects and whether a change in design should be implemented. Studies spanning multiple days and experiments involving samples from different centers are vulnerable to batch effects [698]. One example of technical variability that may irreversibly flaw an experiment would be running samples at varying time points, or ‘as they came in’ [699]. This problem can be circumvented by balancing biological groups in each batch [699]. Additionally, collection of samples at different institutions introduces non-biological variability due to differences in a multitude of conditions such as collection protocols, storage, and transportation [673]. A solution to this problem would be to evenly distribute samples between centers or batches [673].

There are several batch correction methods, the most popular method being Combating Batch Effects When Combining Batches of Gene Expression Microarray Data (ComBat), originally designed for genomics data [697,700]. ComBat uses Bayesian inference to estimate batch effects across features in a batch and applies a modified mean shift, but requires peptides to be present in all batches which can lead to loss of a large number of peptides [697]. Out of six batch correction methods using microarray data, ComBat was the best in reducing batch effects across several performance metrics and was effective using high dimensional data with small sample sizes [701]. ComBat may be more suitable for small datasets when the source of batch effects are known [697]. However if potential batch variables are not known or processing time or group does not adequately control for batch effects, surrogate variable analysis (SVA) may be used where the source of batch effect is estimated from the data [697,698]. A third option for batch effect correction uses negative control proteins to estimate unwanted variation, called “Remove Unwanted Variation, 2-step” (RUV-2) [702]. There are many additional batch effect correction methods for single cell data, such as mutual nearest neighbors [703], or Scanorama, which generalizes mutual nearest neighbors matching [704].

Quality Control

Prior to conducting any statistical analysis, the raw data matrix should be compared to the data after the above-described pre-processing steps have been performed to ensure bias is removed. We can compare data using boxplots of peptide intensities from the raw data matrix versus corrected data in sample running order to look at batch associated patterns; after correction, we should see uniform intensities across batches [679]. We can also use clustering methods such as Principal Component analysis (PCA), Uniform Manifold Approximation and Projection (UMAP), or t-SNE (t-Distribute Stochastic Neighbor Embedding) and plot protein quantities colored by batches or technical versus biological samples to see how proteins cluster in space based on similarity. We can measure the variability each PC contributes; we want to see similar variability among all PCs, however if see one PC contributing to overall variability highly then means variables are dependent [705]. tSNE and UMAP allow for non-linear transformations and allow for clusters to be more visually distinct [705]. Grouping of similar samples by batch or other non-biological factors, such as time or plate, indicates bias [679]. Quantitative measures of whether batch effects have been removed are principal variance components analysis (PVCA), which provides information on factors driving variance between biological and technical differences, and checking correlation of samples between different batches, within the same batch and between replicates. When batch effects are present, samples in the same batch will have higher correlation than samples from different batches and between replicates [679]. Once batch effects are removed, proteins in the same batch should be correlated at the same level with proteins from other batches [679]. Similarity between technical replicates can be measured using pooled median absolute deviation (PMAD), pooled coefficient of variation (PCV) and pooled estimate of variance (PEV); high similarity would mean batch effects are removed and there is low non-biological effects [675].

Lastly, it is also important to show that batch correction leads to improvement in finding true biological differences between samples. We can show the positive effect that batch correction has on the data by demonstrating reproducibility after batch correction. One way to provide evidence for reproducibility is to show that prior to batch correction, there was no overlap between differentially expressed proteins between groups in one batch with those found between the same groups in another batch and, after batch correction, the differentially expressed proteins between the groups become the same between batches [679]. This applies generally datasets with large numbers (e.g., hundreds) of samples to allow for meaningful statistical comparisons [679].

Statistical Analysis

Once the above pre-processing steps have been applied to the dataset, we can investigate which proteins discriminate between groups. There is an urgent need for biomarkers for disease prediction and there is large potential for protein based biomarker candidates [706]. However, omics datasets are often limited due to having many more features than number of samples, which is termed the ‘curse of dimensionality’[672]. Attributes that are redundant or not informative can reduce the accuracy of a model [707].

Univariate statistical tests including t-tests and analysis of variance (ANOVA) provide p-values to allow ranking the importance of variables [672]. T-tests are used in pairwise comparisons, and ANOVA is used when there are multiple groups to ask whether any group is different from the rest. After ANOVA, the Tukey’s posthoc test can reveal which pairwise differences are present among the multiple groups that were compared. Wilcoxon rank-sum tests can be used if the data are still not normal after the above approaches and therefore violates the assumptions required for a t-test. Kruskal-Wallis test is the non-parametric version of ANOVA useful for three or more groups when assumptions of ANOVA are violated.

Data can be reduced using a feature selection method, which includes either feature subset selection, where irrelevant features are removed, or feature extraction, where there is a transformation that generates new, aggregated variables and do not lead to loss of information [672]. An example of a commonly used multivariate feature extraction method using proteomic data is principal component analysis (PCA) [672].

Proteomics data analyses commonly involve multiple testing, which can lead to false positives (i.e., a p-value will appear significant by chance) [705] and multiple testing correction should be applied to main the overall false positive rate at less than a specified cut-off [672]. Benjamini-Hochberg correction is less stringent than the Bonferroni correction, which leads to too many false negatives, and thus is a more commonly used multiple testing correction method [672].

Volcano plots allow visualization of differentially abundant proteins by displaying the negative log of the adjusted p-value as a function of the log fold change, a measure of effect size, for each protein. Points with larger y axis values are more statistically significant and those further away from zero on the x axis have a larger fold change.
There are two methods for identifying differentially expressed proteins. The first method involves a combined adjusted p-value cut-off (y axis) and fold change cut-off (x axis) to create a ‘square cut-off’[705]. The second involves a non-linear cut-off, where a systematic error is added to all the standard deviations used in the t-tests [705].

There are other statistical tests to consider for quantitative proteomics data. Another popular statistical method in proteomics when dealing with high dimensional data is lasso linear regression, which removes regression coefficients from the model by applying a penalty parameter [708]. Bayesian models are an emerging technique for protein based biomarker discovery that are more powerful than standard t-tests [708] and have outperformed linear models [708,709]. Bayesian models incorporate external information into the prior distribution; for example, knowledge of peptides that usually have more technical variability are assigned a less informative prior [708]. Prior to implementing machine learning (ML), one can start with the simpler models, such as linear regression or naïve Bayes [706].

Machine Learning Tools

Despite ML methods being highly effective in finding signals in a high dimensional feature space to distinguish between classes [706], the application of ML to proteomic data analysis is still in its early stages [706] as only 2% of proteomics studies involve ML [710].

Supervised classification is the most common type of ML used for proteomic biomarker discovery, where an algorithm has been trained on variables to predict the class labels of unseen test data [707]. Supervised means the class labels, such as disease versus controls, is known [710]. Decision trees are common model choice due to their many advantages: variables are not assumed to be linearly related, models are able to rank more important variables on their own, and interactions between variables do not need to be pre-specified by the user [708]. There are three phases of model development and evaluation [711]. In the first step, the dataset is split into training and testing splits, commonly 70% training and 30% testing. Second, the model is constructed using only the training data, which is further subdivided into training and test sets. During this process, an internal validation strategy, or cross-validation (CV), is employed [672]. Commonly used CV methods in proteomics are k-fold and leave-one-out cross-validation[672]. The final step is to evaluate the model on the testing set that was held-out in step one. There should not be overlap between the training and testing data, and the testing data should only be evaluated once after all training has been completed. The dataset used for training and testing should be representative of the population that is to be eventually tested. If underrepresented groups are lacking from models during training, these models will not generalize to these populations [712]. Proteomic data and patient specific factors derived from the electronic health record (EHR) like age, race, and smoking status can be employed as inputs to a model [706]. However, addition of EHR data may not be informative in some instances; in studying Alzheimer’s Disease, adding these patient specific variables were informative for non-Hispanic white participants, but not for African Americans [712].

A common mistake in proteomics ML studies is allowing the test data to leak into the feature selection step [710,713]. It has been reported that 80% of ML studies on the gut microbiome performed feature selection using all the data, including test data [713]. Including the testing data in the feature selection step leads to development of an artificially inflated model [713] that is overfit on the training data and performs poorly on new data [706]. Feature selection should occur only on the training set and final model performance should be reported using the unseen testing set. The number of samples should be ten times the number of features to make statistically valid comparisons, however this may not be possible in many cases [714]. If a study is limited by its number of samples, one can perform classification without feature selection [713].

Pitfalls also arise when a ML classifier is trained using an imbalanced dataset [711]. Proteomics biomarker studies commonly have imbalanced groups, where the number of samples in one group is drastically different from another group. Most ML algorithms assume balanced number of samples per class and not accounting for these differences can lead to reduced performance and construction of a biased classifier [715].

Care should be practiced when choosing an appropriate metric when dealing with imbalanced data. A high accuracy may be meaningless in the case of imbalanced classification; the number of correction predictions will be high even with a blind guess for the majority class [716]. F1 score, Matthews correlation coefficient (MCC), and area under the precision recall curve (AUPR) are preferred metrics for imbalanced data classification [717,718].
MCC, for example, is preferred since it is only high if the model predicts correctly on both the positive and negative classes [711]. Over- and under-sampling to equalize the number of samples in classes are potential methods to address class imbalance, but can be ineffective or even detrimental to the performance of the model [715]. These sampling methods may lead to a poorly calibrated model that overestimates the probability of the minority class samples and reduce the model’s applicability to clinical practice [716].

Protein Sequence Databases

What are they and where do you get them?

Protein Database Sources and Types

Many mass spectrometry-based proteomic techniques use search algorithms that require a defined theoretical search space to identify peptide sequences based on precursor mass and fragmentation patterns, which are then used to infer the presence and abundance of a protein. The search space is calculated from the potential proteins in a sample, which includes the proteome (often a single species) and expected contaminants. This is called database searching and the flat file of protein sequences in FASTA format acts as a protein database. In this section, we will describe major resources for proteome FASTA files (protein sequence collections), how to retrieve them, and suggested best practices for preserving FASTA file provenance to improve reproducibility.

In general, FASTA sequence collections can be retrieved from three central clearing houses: UniProt, RefSeq, and Ensembl. These will be discussed separately below as they each have specific design goals, data products, and unique characteristics. It is important to learn the following three points for each resource: the source of the underlying data, canonical versus non-canonical sequences, and how versioning works. These points, along with general best practices, such as using a taxonomic identifier, are essential to understand and communicate search settings used in analyses of proteomic datasets. Finally, it is critical to understand that sequence collections from these three resources are not the same, nor do they offer the same sets of species.

Key terminology may vary between resources, so these terms are defined here. The term “taxon identifier” is used across resources and is based on the NCBI taxonomy database. Every taxonomic node has a number, e.g., Homo sapiens (genus species) is 9606 and Mammalia (class) is 40674. This can be useful when retrieving and describing protein sequence collections. Another term used is “annotation”, which has different meanings in different contexts. Broadly, a “genome annotation” is the result of an annotation pipeline to predict coding sequences, and often a gene name/symbol if possible. Two examples are MAKER [719] and the RefSeq annotation pipeline [720]. Alternatively, “protein annotation” (or gene annotation) often refers to the annotation of proteins (gene products) using names and ontology (i.e., protein names, gene names/symbols, functional domains, gene onotology, keywords, etc.). Protein annotation is termed “biocuration” and described in detail by UniProt [721]. Lastly, there are established minimum reporting guidelines for referring to FASTA files established in MIAPE: Mass Spectrometry Informatics that are taxon identifier and number of sequences [722,723]. The FASTA file naming suggestions below are not official but are suggested as a best practice.

UniProt

The Universal Protein Resource (UniProt) [724], has three different products: UniProt Knowledgebase (UniProtKB), the UniProt Reference Clusters (UniRef), and the UniProt Archive (UniParc). The numerous resources and capabilities associated with the UniProt are not explored in this section, but these are well described on UniProt’s website. UniProtKB is the source of proteomes across the Tree of Life and is the resource we will be describing herein. There are broadly two types of proteome sequence collections: Swiss-Prot/TrEMBL and designated proteomes. The Swiss-Prot/TrEMBL type can be understood by discussing how data is integrated into UniProt. Most protein sequences in UniProt are derived from coding sequences submitted to EMBL-Bank, GenBank and DDBJ. These translated sequences are initially imported into TrEMBL database, which is why TrEMBL is also termed “unreviewed”. There are other sources of protein sequences, as described by UniProt [725]. These include the Protein Data Bank (PDB), direct protein sequencing, sequences derived from the literature, gene prediction (from sources such as Ensembl) or in-house prediction by UniProt itself. Protein sequences can then be manually curated into the Swiss-Prot database using multiple outlined steps (described in detail by UniProt here [726]) and is why Swiss-Prot is also termed “reviewed”. Note that more than one TrEMBL entry may be removed and replaced by a single Swiss-Prot entry during curation. A search of “taxonomy_id:9606” at UniProtKB will retrieve both the Swiss-Prot/reviewed and TrEMBL/unreviewed sequences for Homo sapiens. The entries do not overlap, so users often either use just Swiss-Prot or Swiss-Prot combined with TrEMBL, the latter being the most exhaustive option. With ever-increasing numbers of high-quality genome assemblies processed with robust automated annotation pipelines, TrEMBL entries will contain higher quality protein sequences than in the past. In other words, if a mammal species has 20 000 to 40 000 entries in UniProtKB and many of these are TrEMBL, users should be comfortable using all the protein entries to define their search space (more on this later when discussing proteomes at UniProtKB). Determining the expected size of a well-annotated proteome requires additional knowledge, but tools to answer these questions continue to improve. As more and more genome annotations are generated, the backlog of manual curation continues to increase. However, automated genome annotations are also rapidly improving, blurring the line between Swiss-Prot and TrEMBL utility.

The second type of protein sequence collections available at UniProtKB are designated proteomes, with subclasses of “proteome”, “reference proteome” or “pan-proteome”. As defined by UniProt, a proteome is the set of proteins derived from the annotation of a completely sequenced genome assembly (one proteome per genome assembly). This means that a proteome will include both Swiss-Prot and TrEMBL entries present in a single genome annotation, and that all entries in the proteome can be traced to a single complete genome assembly. This aids in tracking provenance as assemblies change, and metrics of these assemblies are available. These metrics include Benchmarking Universal Single-Copy Ortholog (BUSCO) score, and “Completeness” as Standard, Close Standard or Outlier based on the Complete Proteome Detector (CPD). Given the quality of genome annotation pipelines, using a proteome as a FASTA file for a species is the preferred method of defining search spaces now. Outside of humans, no higher eukaryotic Swiss-Prot sequence collections are complete enough for use in proteomics analyses, but this does not mean that the available Swiss-Prot plus TrEMBL protein sequence collection precludes accurate proteomic data analysis. Lastly, the difference between reference proteome and proteome is used to highlight model organisms or organisms of interest, but not to imply improved quality. UniProt also has support for the concept of “pan proteomes” (consensus proteomes for a closely related set of organisms) but this is mostly used for bacteria (e.g., strains of a given species will share a pan proteome).

When retrieving protein sequence collections as Swiss-Prot/TrEMBL or designated proteomes, there is an option of downloading “FASTA (canonical)” or “FASTA (canonical & isoform)”. The later includes additional manually annotated isoforms for Swiss-Prot sequences. Each Swiss-Prot entry has one canonical sequence chosen by the manual curator. Any additional sequence variants (mostly from alternative slicing) are annotated as differences with respect to the canonical sequence. Specifying “canonical” will select only one protein sequence per Swiss-Prot entry while specifying “canonical & isoforms” will download additional protein sequences by including isoforms for Swiss-Prot entries. Recently, an option to “download one protein sequence per gene (FASTA)” has been added. These FASTA files include Swiss-Prot and TrEMBL sequences to number about 20 000 protein sequences for a wide range of higher eukaryotic organisms.

The number of additional isoforms in a proteome varies considerably by species. In the human, mouse, and rat proteomes of the total number of entries, 25 %, 40 % and 48 % are canonical, respectively. The choice of including isoforms is related to the search algorithm and experimental goals. For instance, if differentiating isoforms is relevant, they should be included otherwise they will not be detected. In cases where isoforms are present in the FASTA (evident by shared protein names) but these cannot be removed prior to downloading (e.g., California sea lion, Zalophus californianus, proteome UP000515165, release 2023_04 has no options for downloading one protein sequence per gene), non-redundant FASTA files can be manually generated (i.e., “remove_duplicates.py” via [727]). If possible, retrieving canonical protein sequences via proteomes is the most straight forward approach and in general appropriate for most search algorithms, versus the method of searching and downloading Swiss-Prot and/or TrEMBL entries.

Though FASTA files are the typical input of many search algorithms, UniProt also offers an XML and GFF format download. In contrast to the flat FASTA file format, the XML format includes sequence information as well as associated information like PTMs, which is used in some search algorithms like MetaMorpheus [728].

Once a protein sequence collection has been selected and retrieved, there is the evergreen question of how to name and report this to others in a way that allows them to reproduce the retrieval. The minimum reporting information is the taxon identified and number of sequences used [722,723]. The following naming format (and those below) augments this and is suggested for UniProtKB FASTA files (the use of underscores or hyphens is not critical):

[common or scientific name]-[taxon id]-uniprot-[swiss-prot/trembl/proteome]-[UP# if used]-[canonical/canonical plus isoform]-[release]

The importance of the taxon identifier has already been described above and is a consistent identifier across time and shared across resources. The choices of Swiss-Prot and TrEMBL in some combination was discussed above, and Proteome can be “proteome”, “reference proteome” or “pan-proteome”. The proteome identifier (‘UP’ followed by 9 digits) is conserved across releases, and release information should also be included. A confusing issue to newcomers is what the term “release” means. This is a year_month format (e.g., 2023_04), but it is not the date a FASTA file was downloaded or created, nor does it imply there are monthly updates. This release “date” is a traceable release identifier that is listed on UniProt’s website. Including all this information ensures that the exact provenance of a FASTA file is known and allows the FASTA file to be regenerated.

RefSeq

NCBI is a clearing house of numerous types of data and databases. Specific to protein sequence collections, NCBI Reference Sequence Database (RefSeq) provides annotated genomes across the Tree of Life. The newly developed NCBI Datasets portal [729] is the preferred method for accessing the myriad of NCBI data products, though protein sequence collections can also be retrieved from RefSeq directly[730,731]. Like UniProt described above, most of the additional functionality and information available through NCBI Datasets and RefSeq will not be described here, although the Eukaryotic RefSeq annotation dashboard [732] is a noteworthy resource to monitor the progress of new or re-annotations. We recommend exploring the resources available from NCBI [733], utilizing their tutorials and help requests.

RefSeq is akin to the “proteome” sequence collection from UniProtKB, where a release is based on a single genome assembly. If a more complete genome assembly is deposited or additional secondary evidence (e.g., RNA sequencing) is deposited, RefSeq can update the annotation with a new annotation release. Every annotation release will have an annotation report that contains information on the underlying genome assembly, the new genome annotation, secondary evidence used, and various statistics about what was updated. The current annotation release is referred to as the “reference annotation”, but each annotation is numbered sequentially starting at 100 (the first release), though a recent naming change has abandoned the sequential release numbering and instead is the RefSeq assembly “-RS” and then the year month when it was annotated (e.g., the current human reference annotation is GCF_000001405.40-RS_2023_10). Certain species are on scheduled re-annotation, like human and mouse, while other species are updated as needed based on new data and community feedback (ex. release 100 of taxon 9704 was in 2018, but a more contiguous genome assembly resulted in re-annotation to release 101 in 2020). This general process for new and existing species is described in Heck and Neely [734].

Since RefSeq is genome assembly-centric, its protein sequence collections are retrieved for each species. This contrasts with being able to use a higher-level taxon identifier like 40674 (Mammalia) in UniProt to retrieve a single FASTA. To accomplish this same search in NCBI Datasets requires a Mammalia search, followed by browsing all 2847 genomes and then filtering the results to reference genomes with RefSeq annotations, and those resulting 223 could be bulk downloaded, though this will still be 223 individual FASTA files. It is possible to download a single FASTA from an upper-level taxon identifier using the NCBI Taxonomy Browser, though this service may be redundant with the new NCBI Datasets portal. Given the constant development of NCBI Datasets, these functionalities may change, but the general RefSeq philosophy of single species FASTA should be kept in mind. Likewise, when retrieving genome annotations there is no ability to specify canonical entries only, but it is possible to use computational tools to remove redundant entries (“remove_duplicates.py” from [727]).

Similar to the UniProtKB FASTA file naming suggestion, the following naming format is suggested for RefSeq protein sequence collection FASTA (the use of underscores or hyphens is not critical):

The release number starts at 100 and is consecutively numbered. Note, the human releases previously had a much longer number to be included (e.g., NCBI Release 109.20211119), then began following a consecutive numbering for Release 110, but have now switched to the new format related to assembly and annotation date. Also, in a few species (Human, Chinese hamster, and Dog, currently), there is a reference and an alternate assembly, both with an available annotation. In these cases, including the underlying assembly identifier would be needed. Note that when you retrieve the protein FASTA from NCBI it will include two more identifiers that aren’t required in the file name since it can be determined from the taxon identifier and release number. These are the genome assembly used (this is generated by the depositor and follows no naming scheme) and the RefSeq identifier (GCF followed by a number string). These aren’t essential for FASTA naming, but are for comparing between UniProt, RefSeq and Ensembl when the same underlying assembly is used (or not, indicating how up to date one is versus the other).

Ensembl

There are two main web portals for Ensembl sequence collections: the Ensembl genome browser [735] has vertebrate organisms and the Ensemble Genome project [736] has specific web portals for different non-vertebrate branches of the Tree of Life. This contrasts with NCBI and UniProt where all branches are centrally available. Recently, Ensembl has created a new portal “Rapid Release” focusing on quickly making annotations available (replacing the “Pre-Ensemble” portal), albeit without the full functionality of the primary Ensembl resources. Overall, Ensembl provides diverse comparative and genomic tools that should be explored, but, specific to this discussion, they provide species-specific genome annotation products similar to RefSeq.

To retrieve a protein sequence collection from Ensemble at any of the portals, a species can be searched using a name, which will then have taxon identifier displayed (but searching by identifier is not readily apparent). From the results you can select your species and follow links for genome annotation. Caution should be used when browsing the annotation products since the protein coding sequence (abbreviated “cds”) annotations are nucleic acid sequences (a useable via 3-frame translation if using certain software), while actual translated peptide sequences are in the “pep” folders. The pep folders contain file names with “ab initio” and “all” in the FASTA file names (file extensions are “fa” for FASTA and “gz” indicating gzip compression algorithm), while there may only be one pep product for certain species in the “Rapid Release” portal. The “ab initio” FASTA files contain mostly predicted gene products. The “all” FASTA files are the usable protein sequence collections. Ensembl FASTA files usually have some protein sequence redundancy.

Ensembl provides a release number for all the databases within each portal. Similar to the UniProt file naming suggestion, the following naming format is suggested for Ensembl protein sequence collection FASTA (the use of underscores or hyphens is not critical):

[common or scientific name]-[taxon id]-ensembl-[abinitio/all]-[rapid]-[release number]

Similar to the FASTA download from RefSeq, the downloaded file name can include additional identifying information related to the underlying genome assembly. Again, this is not required for labeling, but is useful to easily compare assembly versions.

Since much of the data from Ensembl is also regularly processed into UniProt, using UniProt sequence collections instead may be preferred. That said, they are not on the same release schedule nor will the FASTA files contain the same proteins. Ensembl sequences still must go through the established protein sequence pipeline at UniProt to remove redundancy and conform to UniProt accession and FASTA header formats. Moreover, the gene-centric and comparative tools built into Ensembl may be more experimentally appropriate and using an Ensembl protein sequence collection can better leverage those tools.

Other resources

There are other locations of protein sequence collections, and these will likewise have different FASTA file formatting; sequences may have unusual characters, and formats of accessions and FASTA header lines may need to be reformatted to be compatible with search software. These alternatives include institutes like the Joint Genome Institute’s microbial genome clearing house, species-specific community resource (e.g., PomBase, FlyBase, WormBase, TryTrypDB, etc.), and one-off websites tenuously hosting in-house annotations. It is preferred to use protein sequence collection from the main three sources described here, since provenance can be tracked, and versions maintained. It is beyond the scope of this discussion to address other genome annotation resources, how they are versioned, or the best way to describe FASTA files retrieved from those sources. In these cases, defaulting to the minimum requirements of listing number of entries and supplying the FASTA along with data are necessary.

Contaminants

Samples are rarely comprised of only proteins from the species of interest. There can be protein contamination during sample collection or processing. This may include proteins from human skin, wool from clothing, particles from latex, or even porcine trypsin itself, all of which contain proteins that can be digested along with the intended sample and analyzed in the mass spectrometer. Avoiding unwanted matching of mass spectra originating from contaminant proteins to the cellular proteins due to sequence similarities is important to the identification and quantitation of as many cellular proteins as possible. To avoid random matching, repositories of supplementary sequences for contaminant proteins have been added to a reference database for MS data searches. Appending a contaminants database to the reference database allows the identification of peptides that are not exclusive to one species. Peptides that are exclusive to the organism of interest are used to calculate abundance to avoid inflated quantitative results due to potential contaminant peptides.

As early as 2004, The Global Proteome Machine was providing a protein sequence collection of these common Repository of Adventitious Proteins (cRAP), while another contaminant list was published in 2008 [737]. The current cRAP version (v1.0) was described in 2012 [738] and is still widely in use today. cRAP is the contaminant protein list used in nearly all modern database searching software, though the documentation, versioning or updating of many of these “built-in” contaminant sequence collections is difficult to follow. There is also another contaminant sequence collection distributed with MaxQuant. Together, the cRAP and MaxQuant contaminant protein sequence collections are found in some form across most software, including MetaMorpheus and Philosopher (available in FragPipe) [739]. This list of known frequently contaminating proteins can either be automatically included by the software or can be retrieved as a FASTA to be used along with the primary search FASTA(s). Recently the Hao Lab has revisited these common contaminant sequences in an effort to update the protein sequences (ProtContLib), test their utility on experimental data, and add or remove entries [740].

In addition to these environmentally unintended contaminants, there are known contaminants that also have available protein sequence collections (or can be generated using the steps above) and should be included in the search space. These can include the media cells were grown in (e.g., fetal bovine serum [741,742], food fed to cells/animals (e.g., Caenorhabditis elegans grown on Escherichia coli) or known non-specific binders in affinity purification (i.e., CRAPome [743]). The common Repository of Fetal Bovine Serum Proteins (cRFP)[744] are protein lists of common protein contaminants and fetal serum bovine sequences used to reduced the number of falsely identified proteins in cell culture experiments. Cells washed or cultured in contaminant free media before harvest or the collection of secreted proteins depletes most high abundance contaminant proteins but the sequence similarity between contaminant and secreted proteins can cause false identifications and overestimation of the true protein abundance leading to wasted resources and time on validating false leads. As emphasized throughout this section, accurately defining the search space is essential for accurate results and, especially in the case of contaminants, requires knowledge of the experiment and sample processing to adequately define possible background proteins.

Choosing the right database

Proteomics data analysis requires carefully matching the search space (defined by the database choice) with the expected proteins. A properly chosen database will minimize false positives and false negatives. Choosing a database that is too large will increase the number of false positives, or decoy hits, which in turn will reduce the total number of identifiable proteins. For this reason it is ill advised to search against all possible protein sequences ever predicted from any genomic sequence. On the other hand, choosing a database that is too small may increase false negatives, or missed protein identifications, because in order for a protein to be identified it must be present in the database. Some search algorithms can self-correct when a database is overly large such that higher identity thresholds are required for identification to minimize false positives (e.g., Mascot), while smaller experiment-specific search spaces (also referred to as “subsets”) can have unintended effects on false positives if not managed appropriately [745,746,747] or may even improve protein identifications [748]. Whether to employ a search space that is sample-specific (i.e., subset), species-specific (with only canonical proteins, described below), exhaustive species-specific (including all isoforms), or even larger clade-level protein sequence set (e.g., the over 14 million protein sequences associated with Fungi, taxon identifier 4751) is a complex issue that is experiment and software dependent. Moreover, in cases where no species-specific protein sequence collection exists, homology-based searching can be used (as described in [734]). In each of these cases, proteomics practitioners must understand their specific experimental sample and search algorithm in order to know how to best define the search space, which is essential to yielding accurate results.

Protein Knowledge Bases

PeptideAtlas and SRMAtlas

For most shared raw mass spectrometry data, none of the data was compared in toto to derive at a knowledge base of all detectable proteins in an organism. In addition, given the vast array of software for MS data analysis, the results are not directly comparable, nor combinable given the problem of false discovery rates (FDR) that pile up when dataset results are combined. For example, if we combine 3 datasets that were each filtered to 1% FDR, the maximum FDR of the combined dataset is now 3% because it is unlikely that the random decoy hits are shared across each dataset. To address this, in 2005 the PeptideAtlas concept was started to ingest as many publically available datasets as possible per organism, search the data through a single pipeline in total and arrive at a datasets with a total controlled 1% FDR at the protein level [749,750]. The PeptideAtlas website (www.peptideatlas.org) is a therefore a multi-organism, publicly accessible compendium of peptides identified in large sets of tandem mass spectrometry proteomics experiments. Mass spectrometer output files are collected for human, mouse, yeast, and many other organisms of research interest, and searched using the latest search engines and genome derived protein sequences. All results of sequence and spectral library searching on PeptideAtlas are processed through the Trans Proteomic Pipeline to derive a probability of correct identification for all results in a uniform manner to insure a high quality database, along with false discovery rates at the whole atlas level.

The most recognizable MS data compendium is the Human PeptideAtlas which is produced yearly since 2005 to derive all the peptide sequence knowledge of the current human proteome (Figure 17A). As of 2023, the Human PeptideAtlas contains the knowledge of over 93% of the human proteome, with over 189K MS runs and 3.6B spectra searched resulting in 3.4m peptides identified and 17,245 proteins identified from the 19,600 total proteins possible. The number of proteins has been incrementally increases year over year as new public data becomes available (Figure 17B).

For the presentation of selected reaction monitoring (SRM) targeted peptide assays, there are two components of the PeptideAtlas ecosystem where the PeptideAtlas SRM Experiment Library (PASSEL) is presented to enable submission, dissemination, and reuse of SRM experimental results from analysis of biological samples [751,752]. The PASSEL system acts as a data repository by allowing researchers with SRM data to deposit their data in parallel with journal publication. and other users can search existing data to obtain the parameters for replication in their own laboratory. Another unique component for SRM data repositories is the SRMAtlas website, which provides definitive coordinates for all possible proteins within an organism to conduct targeted SRM assays that conclusively identify the respective peptide in biological samples. As an example, the Human SRMAtlas provides data on 166,174 synthetic proteotypic human peptides, providing multiple, independent assays to quantify any human protein and numerous spliced variants, non-synonymous mutations, and post-translational modifications [753]. The data are freely accessible as a resource at http://www.srmatlas.org/.

Other knowledge bases

There are many more proteomics knowledgebases, such as PRIDE [754,755], the proteomics standards initiative (PSI) [756], Massive [651], Proteometools [757], Panorama [758], Chorus [759], and iProX [760].

Biological Interpretation

The most common untargeted proteomics experiment will produce a list of proteins or peptides of interest which require further validation and biological interpretation. This list usually results from statistical data analysis; the typical output of differentially expressed proteins usually contains hundreds of hits. In this section, we aim to present a concise overview of how proteomic data can be effectively contextualized and used to generate new hypotheses.

The simplest approach is to start manual lookup of every protein in the list to uncover groups that function together. Starting with a list of hundreds of protein changes, a smaller list can be prioritized by considering the level of significance and effect size. For example, proteins with the smallest p-values (significance) and largest abundance fold-changes (effect size). It is tempting to focus on proteins with the most extreme fold changes. In this case, the assumption is that the more significant the fold change (in either direction, up- or down-regulation), the higher the impact of those proteins on cellular behavior. This assumption is not always valid because protein signal in MS depends on abundance. The manual data interpretation approach is typically infeasible due to the number of proteins that would need to be individually looked up one-by-one.

A better strategy is to use computational methods. These methods may consider the whole list of proteins including some ranking by significance or fold change. One common interpretation method is to construct a protein network, which then lends itself to network analyses. Another method is to consider functional enrichment through annotation databases. These databases offer insights by examining the enrichment of certain functional annotations amongst the interesting proteins. Secondly, one could consider other evolutionary, structurally or regulatory based methods to identify interpretation of the data. To fully interpret analysis, it may be required to perform or examine other data such as data from biophysical, biochemical and alternative proteomic approaches. Finally, the data can further be interpreted using multi-omic, native or clinical approaches. Below we summarize these approaches and point out potential pitfalls with these methods.

Constructing a protein network

A network is a representation of the relations between objects. Nodes are the entities of the network (e.g., users of a social platform, train stations, proteins), while edges are the connections between them (e.g., friendship, routes, and protein interactions, respectively). In the case of protein-protein interactions, evidence for the functional associations between proteins can be obtained experimentally. For example, co-immunoprecipitation, crosslinking, and proximity labeling can be used to reveal physical interactions [761]. The data is presented in a table with nodes and edges (e.g., “protein A interacts with protein B”) from which the network can be constructed. A considerable wealth of protein-protein association data is stored in free databases like IntAct, which contain interactions derived from literature curation or direct user submissions [762]. Protein interactions can also be predicted by classifiers that consider many features, like orthology and co-localization, to produce a posterior odds ratio of interaction [763,764]. Finally, large repositories like STRING (Search Tool for the Retrieval of Interacting Genes/Proteins) collect and integrate protein-protein interaction data from several databases [764]. STRING also provides a web-based interface to survey the data, and users only have to feed a search box with the identifiers of the protein(s) of interest. STRING will retrieve the network and show the evidence supporting each interaction. Importantly, these databases do not indicate the direction of the interaction, so they produce undirected networks. If edges have directions (e.g., A influences B and not vice versa), then the network is directed. Signaling pathways are examples of directed graphs.

Network analysis

Network analysis is a group of techniques that explore and investigate the network, yielding valuable knowledge about its structure and unveiling key players regulating the flow of information. One of the first steps in network analysis relates to centrality measurements. Centralities are indicators of the relative importance of a node corresponding to its position in the network, and each centrality measure provides new insights to interpret the data in new ways [765,766].

Degree centrality

The degree of a node measures the number of edges incident to that node. Nodes with a high degree interact with many other nodes, called first neighbors. In particular, the node degree distribution in protein networks is highly skewed, with most nodes having a low degree and a few having high degrees, known as hubs. Hubs are usually regulatory proteins, being notable examples oncogenes and transcription factors. Moreover, hubs are attractive targets for directed interventions, as their alteration has a profound effect on the stability of the network [767].

Closeness centrality

The route from one node to another is a path, and the shortest path is the one connecting them in the least amount of steps. Closeness centrality is the inverse of the average length of a node’s shortest paths to all other nodes in the network. Nodes with a high closeness score have the shortest distances to all the others, so closeness centrality calculations detect nodes that can spread information very efficiently, as they are in a better position in the network for this task [768,769].

Betweenness centrality

This centrality index is related to the amount of shortest paths transversing a node. Nodes with a high betweenness centrality usually bridge different parts of the network and strongly influence the flow of information, as they lie in communication paths. These connector hubs (or bottlenecks) are also interesting for follow–up experiments because their removal can disconnect different regions of the network [770].

Centrality measurements add new layers of information and allow for ranking differentially expressed proteins apart from their fold-change in abundance. Figure 18 depicts a simple network consisting of proteins A to L, with A having the highest fold change (10) and L the lowest (2). In Panel A, the fill color for the nodes indicates this metric, where it can be easily seen that A stands out. However, protein A is a peripheral protein, only interacting with B. In Panel B, nodes are colored according to node degree. Clearly, protein F has the highest number of interactions and is also the closest to all other nodes, which can be appreciated when nodes are colored according to closeness centrality (Panel C). On the other hand, protein G acts as a bridge between two regions of the network and thus, has the highest betweenness centrality (Panel D). Except for fold change, node A has the lowest indices, and it will be up to the researcher to decide whether this protein warrants further examination.

Network clustering

In the small network presented in Figure 18, two groups of densely connected nodes exist. This topology suggests that these communities (or “clusters”) work together or participate in a protein complex. Dividing a network into clusters helps identify underlying relationships among nodes, which is especially useful in large networks. In a broad sense, network clustering groups nodes according to a topological property, generally interconnectedness. There are many network clustering algorithms, each with its own merits and approaches [771,772]. The MCL (Markov CLustering) algorithm is suitable for protein networks in most situations . On the other hand, the Molecular COmplex DEtection (MCODE) algorithm helps detect very densely connected nodes, thus unveiling protein complexes [773]. In this regard, network clustering is useful for tentatively assigning the function of an uncharacterized protein. If the protein appears in a cluster, its function should be closely related to the cluster members, a principle known as “guilty by association.” [774]

Network visualization

A critical step in network analysis is to display the data in a structured and uncluttered graph. Networks can rapidly become a hairball unamenable to interpretation. Software platforms like Cytoscape can be used to visualize networks orderly by applying layout algorithms and format styles [775]. Since many of these platforms are open source, community-designed plugins enhance their capabilities. In Cytoscape, the stringApp adds a search bar to query the STRING database with accession numbers or protein names [776]. The network is directly retrieved into Cytoscape, where its built-in network analyzer can be used to calculate centralities. Moreover, user-defined information, like fold-change values, can be integrated and mapped into the network.

Functional term enrichment analysis: KEGG, String, GO, GSEA, ORA, Reactome, and others

Term enrichment analysis is performed to assess whether particular ‘functional terms’ are over-represented in a list of proteins (e.g. from a proteomics experiment) [777,778,779]. For example, after a differential abundance analysis, we may wish to examine whether there is any shared function amongst the proteins which were determined to have significant changes. The simplest analysis to test whether this subset contains more of any particular functional terms than we would expect given the background of proteins. For example, the Gene Ontology is split into the classes: Cellular Component, Molecular Function and Biological Function and we might be interested as to whether our proteins may be more likely to localize to a particular subcellular niche [780]. The Cellular Component terms could give us a starting point if this might be the case, by examining if Cellular Component annotations are enriched.

There are a number of databases and tools to perform such analysis, which can even be extended to examine whole pathways, networks, post-translational modification and literature representation. For example, databases such as KEGG [781], String [764], Reactome [PMID:31691815] and PhosphoSitePlus [782] can be used to test or annotate a list of proteins. For example, proteomics analysis of human cardiac 3D microtissue exposed to anthracyclines (drugs used in cancer chemotherapy) unearthed several proteins with altered levels [783]. Many of these were specifically grouped under GO terms related to mitochondrial dysfunction, indicating the detrimental effects of these drugs on the organelle. GO terms [780] or descriptors from other annotation libraries (like KEGG [781] or REACTOME [784]) can be retrieved from STRING when constructing a network or from other freely available compendiums. We refer to a number of articles on the topics, including tools, reviews and best-practice [785,786,787]. The main points from such analysis is that we can obtain an insight about protein function by looking at whether our list of proteins have similar or the same annotations. A number of limitations should be taken into account for interpretation. The first is that proteins that are more abundant are more likely to be studied, measured and examined in the literature. Hence, abundant proteins will have more annotations than less abundant ones. One key part of the analysis is also to correctly select the background set; that is, the universe of protein which our list is being compared against. By including contaminates or proteins that are not expressed in our system within the list, the results may be unfaithful.

We may also have access to our own curated set of annotations derived either computational or experimental. One may be interested in seeing whether we have enrichment of these annotations amongst the differentially abundant proteins. Our list of proteins could be divided into two groups: differentially abundant or not. These groups could be divided into whether they have a particular annotation: yes or no. This information can be summarized in a two-by-two table, to which we can apply a statistical test to examine whether that annotation is enriched within our differentially abundant proteins. One test that could be used is the hypergeometric test, and another would be a Fisher Exact test.

There are many methods for performing functional enrichment analysis on the data, but they can mainly be classified into three categories (Figure 19), as follows.

Over-representation analysis

In modern proteomics analysis, usually thousands of proteins are identified and quantified. Fold-change and significance thresholds are chosen (e.g., fold-change ≥ 2 and p ≤ 0.05) to obtain a list of proteins with altered levels among the tested conditions. In over-representation methods, a contingency table is created for every protein set to establish whether proteins with altered abundance show an enrichment or a depletion of the ontology term compared to the background observed proteome [788]. For example, suppose that 2000 proteins were quantified in a proteomics analysis, being 40 of these members of the set “tricarboxylic acid cycle (TCA).” Also, let us assume that 200 proteins showed altered abundance, with 15 belonging to the TCA set. Then, the contingency table can be constructed as follows:

Then, a suitable statistical test is conducted to ascertain if proteins with altered levels are enriched in members of the TCA cycle (in this case, they are; p < 0.00001). This is commonly achieved using Fisher’s exact test [789]. The process is then repeated for every set as desired. Since multiple comparisons are tested, p values must be adjusted by a false discovery rate [790].

Functional class scoring

The caveat of over-representation methods is that they rely on a list of differentially expressed genes or proteins with altered abundance, selected due to arbitrarily chosen cut-off values. For example, if we set a fold change cutoff of 2, a protein with a fold-change of 1.99 would not be included in the analysis. Moreover, several proteins belonging to the same set may have altered levels but are below the fold change threshold. However, moderate alterations of their abundance as a group could drive the observed phenotype, even more so than a single protein over the cut-off. Functional class scoring strategies aim at countering these limitations by disregarding thresholds altogether. GSEA (Gene Set Enrichment Analysis) is a widely used functional class scoring method in which all detected entities are first ranked according to a quantitative measurement (fold change, p-value, or their combination) [791]. Then, the distribution of members of a set is obtained. A scoring scheme based on the Kolmogorov – Smirnov test is used to assess whether there is an enrichment of the category towards the top or bottom of the ranked list.

Pathway topology-based methods

Both methods mentioned above do not consider the functional relationships among proteins put forth by network analysis; i.e., they assume functional independence. Topology-based enrichment methods incorporate this information by, for example, assigning an importance value to a set when its members also participate in a pathway or cluster together in a network [792]. Figure 19 shows how topology-based methods consider non-significant hits (grey nodes) that other strategies may not pick up, due to their position in a network.

Other computational approaches: Network analysis, Isoform correlation analysis, AlphaFold, BLAST, protein language models

Additional computational analysis of a list of interesting proteins may uncover additional substructure, correlation or biologically useful hypothesis. Building a network between the proteins based on the experiments performed might be a useful approach to identify additional structure. For example, co-expression network analysis can be used to build a network from these proteins [793]. In these networks, proteins are nodes and edges describe relationships between those proteins. Network-specific methods can then be applied, such as community detection algorithms which could uncover clusters of proteins with shared functions [794,795].

One way the proteome generates complexity is through alternative-splicing, which results in protein isoforms [796].

Recently, a number of tools have been proposed to identify peptide isoforms that are quantitatively different across conditions by using a principle called peptide correlation analysis [797,798]. The idea is that the quantitative behavior of peptides should match each other. If there are subgroups that behave coherently within the group but not across groups suggest that peptide may have come from a different proteoform. These approaches can be used to identify specific proteoforms that are functional across different conditions.

For many, a protein’s structure reveals important functional details [799]. There are a plethora of approaches to predict a protein’s structure [800,801,802]. Recently, AlphaFold and RoseTTAFold have become dominant methods for predicting protein structures with high resolution [801,802]. If intrinsically disordered domains are of particular interest, methods explicitly designed for this task are recommended [803]. Once a structure is obtained more elaborate computational methods might be useful such as docking or molecular dynamics [804,805]. These approaches can give insight into how protein or molecules fit together and the dynamics of a protein’s structure (conformational heterogeneity). A complete discussion of these topics is beyond the scope of this section.

Another way to obtain insights into a protein function is to look for protein with similar sequences or motifs. Using BLAST, a sequence alignment tool, one can align two or more protein sequences and determine their level of similarity [806]. For example, if a human protein of unknown function has a similar sequence to a yeast protein with known function this may be a starting place for the putative function of that protein.

Novel approaches to representing the similarity of proteins have proved successful at predicting the functional properties of proteins. Protein language models seek to learn “representation” of proteins, these are usually numerical vectors that represent a protein sequence [807,808]. Abstractly, these vectors preserve protein similarity or a notion of “proteinness”. This usually means that two proteins that have a close vector may share similarities in protein function. These representations are also advantageous because they can easily become the inputs for machine learning algorithms to predict valuable protein properties; for example, thermal stability values [809], protein-protein binding affinities [810], secondary protein structure, and more.

Orthogonal experimental methods

The importance of orthogonal experimental validation

The computational workflows to interpret mass spectrometry data are sophisticated, powerful tools, but also show important limitations and caveats due to their dependence on limited prior knowledge, specific experimental parameters or data quality restraints (see section ‘Analysis of Raw Data’). These inherent biases can give rise to ambiguous or spurious interpretation of the data even when these workflows are applied correctly and to the best of the experimenter’s knowledge. Therefore, researchers will oftentimes be asked by scientific journals to provide independent orthogonal validation of their proteomics data and not performing such can be a major roadblock in the publication process.

The aim of validating data obtained by proteomics approaches should always be two-fold by demonstrating that the conclusions arrived at by proteomics data acquisition and analysis are, firstly, valid and, secondly, relevant. Depending on the question at hand, researchers can draw on an overabundance of techniques to validate MS-derived hypotheses in appropriate cellular, organismal or in vitro models. In the following paragraphs we aim to present only a high-level, stringent, non-exhaustive selection of orthogonal validation approaches and emphasize the importance of implementing assays that challenge assumptions gained from proteomics data analysis pipelines.

Before embarking on orthogonal validation of any hit, the success of the experiment should be established by assessing (internal) positive controls. Internal positive controls can be proteins whose behavior under the experimental conditions applied can be deduced from prior knowledge (i.e. the scientific literature or public databases). Once the expected changes in internal controls have been confirmed by computational analysis (see the above section), the orthogonal experimental validation of novel, perhaps unexpected findings can begin.

Orthogonal validation of new insights obtained from quantitative proteomics experiments can be a very time-consuming process and often requires familiarity with techniques not directly related to proteomics workflows. Given these challenges, the method(s) of choice warrant(s) careful consideration and is highly context-dependent. Importantly, proteomics experiments in one way or another generally yield comprehensive lists of potentially interesting candidate proteins or pathways, the researcher will have to shortlist candidates to be taken forward to the validation stage of the project. Which candidates should you validate by an orthogonal approach and which ones might not require further validation?

In general, candidates representing abundant proteins that show high sequence coverage and are detected with high confidence might not necessarily need extensive orthogonal validation when compared with proteins of intermediate to low abundance that might be more challenging to faithfully quantify by proteomics alone (i.e., many membrane proteins or transcription factors). Similarly, since the proteome is rarely comprehensively quantified in any single proteomics experiment, proteins of interest (POIs) that are critical for an observed biological change might not be part of the dataset. In these cases, additional, targeted analyses might help to support or discredit proteomics-based hypotheses.

Validation techniques are as manifold as biological questions and discussions thereof may easily fill multiple textbooks. The following sections are therefore merely meant to paint with a broad brush stroke a picture of useful methodologies with which to validate and follow up MS-data derived observations. As this is meant to orient the reader, wherever possible, we will explicitly point out useful literature reviews for a deeper dive into each of these techniques.

General considerations

Once POIs have been selected based on prior agreed-upon selection criteria (i.e. (adjusted) p value and/or fold change thresholds), orthogonal validation experiments should ideally be conducted under physiologically relevant conditions to mitigate artificial and misleading outcomes. Therefore, in vitro experiments, while useful to isolate and dissect particular aspects of a biological system, can give highly artificial results as conditions are far removed from the POI’s native environment. To investigate the biological function of a protein or pathway, direct genetic manipulation of the biological system at hand (e.g., modulating the expression of a POI by overexpression or knockout-/down experiments) can be minimally invasive when performed correctly. Should the POI be encoded by an essential gene, by definition, a complete and stable knockout might not be advisable [811,812]. In these extreme cases, attenuated expression (i.e., using RNA interference (RNAi) or controlled degradation, see below) rather than complete repression of a gene can be used to probe for protein function. Epitope tagging and/or exogenous expression of a gene of interest can be a powerful approach in assessing PPIs and investigating proteins of low abundance. However, overexpression artifacts are common [813].

It is not always possible to fully avoid the pleiotropic effects of protein (over-)expression or depletion, but a number of mitigation strategies (i.e., inducible expression, the use of multiple independent RNAi strategies) will be discussed below.

Extensive biochemical characterization of any overexpressed gene is critical to ensure it closely reflects the functions of its endogenous counterpart. These assays might involve assessing protein localization (i.e., by imaging techniques such as microscopy and flow cytometry), protein abundance (i.e., by mass spectrometry or immunoblot analysis) and phenotypic assays where applicable and practical.

Functional genomics techniques in the validation of MS hits

Typical follow-up experiments to validate mass-spectrometry derived insights often involve the acute depletion or induction of a POI and assessing the impact on specific cellular phenotypes. Here we present a selection of methodologies to effectively modulate gene expression and discuss important considerations when planning functional genomics experiments for target validation.

Gene deletion or knockdown to prevent production of a functional protein is a powerful means to interrogate the role of one or more proteins in the phenotype(s) under investigation. To this end, well-established technologies deserving mention at this point are RNA interference (RNAi) in the form of siRNA/shRNA- or miRNA-mediated gene knockdown abd CRISPR/Cas9-or TALEN-mediated gene knockout [814]. Since each one of these technologies comes with its own unique advantages and caveats, the approach taken depends on the biological question at hand.

Clustered regularly interspaced short palindromic repeats (CRISPR)/Cas-based gene deletion technologies allow for the targeting of individual genes with relative ease, high efficiency and specificity [815]. When expressed in mammalian cells, the bacterially-derived Cas9 endonuclease can be guided with the help of a short guide RNA (gRNA) to a genomic location of interest, where it creates a DNA double strand break in a highly controlled manner (for a detailed discussion see [816]). The cell’s DNA double-stand break repair machinery then introduces base pair insertions or deletions (indels) via non-homologous-end-joining (NHEJ), thus causing missense, and frameshift mutations (i.e. resulting in premature stop codons), leading to premature termination of gene expression or non-functional, aberrant gene products. Similarly, the concomitant provision of a complementary DNA donor template encoding a desired gene modification (i.e. insertion of a stretch of DNA or base pair modification) will trigger homology-directed repair (HDR), resulting in gene knock in or base editing [816].
Practical considerations of CRISPR/Cas9-mediated gene knock-in and base editing will not be addressed in detail but are expertly discussed in [817,818,819,820].

The relative ease-of-use and high efficiency of the CRISPR/Cas9 gene editing technology has rendered it the method of choice for gene manipulation in many fields of cell biology. However, it should be noted that CRISPR/Cas9-mediated gene deletion is not free from off-target effects ([821] for advice on how to minimize these off-target effects). Moreover, long-term depletion (or upregulation) of a POI itself can in some cases have dramatic systemic consequences and constitute an acute selection pressure leading to compensatory stress-induced adaptation that might obfuscate primary loss-of-function phenotypes and pose a substantial hurdle to the interpretability of biological data. As these compensatory mechanisms often manifest with time, controlled, transient genetic manipulation (gene depletion or transgene expression) is advised. Small interfering RNA (siRNA)-mediated knockdown by transient transfection is typically achieved at shorter time frames (24 – 96h), depending on the turnover of the POI. On an even shorter timescale, targeted, degron-based degradation systems enable depletion of a POI within minutes and further reduce off-target effects, but require the exogenous expression of a transgene and therefore some genetic manipulation. A more comprehensive discussion of a selection of these systems (anchor-away, deGradFP, auxin-inducible degron (AID), dTAG technologies) and their advantages and potential pitfalls is presented in [822].

Multiple eukaryotic and prokaryotic transcription-based systems have been developed that allow for the controlled biosynthesis or depletion of one or more POIs. Amongst these, a popular and dependable choice for mammalian cells are tetracycline-controlled operon systems, which allow up- or downregulation of a POI in the presence of the antibiotic tetracycline or its derivative doxycycline. These systems rely on the insertion of a bacteria-derived Tet operon (TetO) between the promoter and coding sequence of a GOI. In this configuration, the TetO binds a co-expressed Tet-repressor protein blocking transcription the of GOI. When tetracycline is added to the cells, the repressor then dissociates from the operon, thus de-repressing the GOI. Different variations of this potent system exist, allowing for more flexibility in experimental design. For instance, in the Tet-OFF system, the Tet repressor is fused to a eukaryotic transactivator (the chimeric fusion construct is termed tTA) and addition of tetracycline, or the related doxycycline, abolishes TetO binding and thus suppresses transcriptional activation [823]. Alternatively, a mutant form of tTA (rtTA) binds the TetO only in the presence of tetracycline, allowing for tetracycline-induced gene expression. For a detailed discussion of these systems, we refer the reader to an excellent review [824].

When generating stable expression cell lines, being able to precisely control the genomic integration site of the transgene reduces overall genetic heterogeneity in a cell population and thereby reduces potential off-target or pleiotropic effects. This ability is realised in the FlpIn-T-REx technology which harnesses Flp-recombinase mediated DNA recombination at a strictly defined genomic locus (the FRT site) [825]. Site-directed isogenic integration of any GOI at the FRT site, which is under a tetracycline-inducible promoter and a hygromycin resistance gene, allows for facile generation of tetracycline/doxycycline-inducible isogeneic expression cell lines with minimal leaky expression (for an example, see [826]).

Validation and interpretation of protein abundance changes

To validate protein abundance changes observed by quantitative bottom-up proteomics or simply assess the success of targeted genetic manipulation as part of an orthogonal follow-up experiment (see above), the experimenter typically resorts to antibody-based techniques such as immunoblotting analysis or immunofluorescence and immunohistological imaging of POIs. The latter also allows for validation of protein expression and localization in intact tissue or cells. However, these semi-quantitative methods are strongly influenced by the quality of the antibodies used and might not be sensitive enough to detect small changes in protein levels. In this case, more accurate orthogonal quantitation of proteins might be achieved by stable isotope labelling (SILAC/TMT/iTRAQ) and/or SRM/PRM (see section ‘Experiment Types’). SDS-PAGE and immunoblot analysis are powerful and facile low-throughput tools to quickly validate protein abundance changes. However, short of introducing epitope tags to the endogenous POI, the success of immunoblotting is contingent on the availability of specific antibodies, which can present a formidable problem when investigating poorly characterized proteins or working with model organisms for which the commercial availability of specific antibodies is limited (this is particularly problematic for ‘unconventional’ or even well-established model organisms such as yeast). A detailed discussion of the strengths and pitfalls of immunoblotting for validation of semi-quantitative proteomics data can be found in an excellent review by Handler et al. [827].

Protein abundance changes detected in a proteomics experiment can be the result of a range of different cellular processes. The abundance of a protein in a complex sample (e.g. cell lysate or biological fluid) directly reflects a combination of the protein’s intrinsic stability and the translational rate under the conditions of interest.

Both protein stability as well as gene expression activity can be quantified independently. Altered protein stability might be a direct consequence of specific or global changes in protein turnover. Radioisotope labelling is a well-established, accurate way to monitor protein synthesis, maturation and turnover [828,829]. This ‘pulse-chase’ methodology relies on the incorporation (‘pulsing’) of radioisotopes (typically 35S-labelled cysteine and methionine) into de-novo synthesized proteins. Upon withdrawal of the labeled amino acids from the culture medium, the decay of signal is monitored over time (‘the chase’) by SDS-PAGE and phosphoimaging, resulting in a temporal readout of protein abundances. The advantage of this technology is that a subpopulation (newly synthesized proteins) can be monitored directly, giving an accurate assessment of protein stability. Once a change in protein stability has been validated, the underlying mechanisms can be addressed by inhibiting protein degradation pathways; prominently proteasome-mediated degradation (using specific proteasome inhibitors such as bortemzomib/velcade or MG132), autophagy (pharmacologically inhibiting autophagic flux) or degradation by proteases (using protease inhibitors). The type of radiolabeling described above is relatively labor-intense, of low-throughput and has the obvious disadvantage of requiring radioactive material, which needs to be handled under strict safety precautions. Moreover, it critically depends on the presence of one or more methionines and/or cysteines in the POIs.

It is also possible to measure protein stability within complex protein mixtures (i.e. cell lysates or biological fluids) using an array of specialized mass spectrometry techniques as discussed in [830] and [114].

For purified proteins, well-established in vitro spectrometric and calorimetric methods such as circular dichroism, differential scanning calorimetry or differential scanning fluorometry can be used, but the relatively high sample amounts might be restrictive.

Finally, gene expression changes can also be determined with high fidelity using quantitative real-time PCR (qRT-PCR) or RNA-Seq can measure changes in gene transcription or mRNA turnover (for an extensive discussion of both technologies, please see [831] and [832], respectively).

Validation of protein-protein interactions

The interaction of a protein with other proteins determines its function. Protein-protein interactions (PPIs) can be either mostly static (i.e. core subunits of a protein complex) or dynamic, varying with cellular state (i.e. cell cycle phase or cellular stress responses, posttranslational modifications) or environmental factors (i.e. availability of nutrients, presence of extracellular ligands of cell-surface receptors). Therefore, any given protein can typically bind a range of interaction partners in a spatially and temporally restricted manner, thus forming complex PPI networks (the interactome of a protein). The method of choice to experimentally examine altered PPI states depends on the model system and biological question (i.e. purified proteins vs complex protein mixtures, monitoring of PPIs in live cells or cell lysate etc). Popular methods for the validation of PPIs in vivo include protein fragment complementation (split protein systems), 2-hybrid assays (mammalian, yeast and bacterial), proximity ligation, proximity labelling and FRET / BRET. Protein fragment complementation assays rely on the principle that the two self-associating halves of reporter proteins can be expressed in an inactive form but when in spatial proximity bind one another to complement the functional, active reporter. When these split reporters are fused to two interacting proteins (so-called bait and prey proteins), the binding of bait to prey induces the spatial restriction needed to fully complement the reporter. Commonly used reporter complementation systems are split fluorescent proteins (i.e. GFP, YFP) [833], ubiquitin [834], luciferase [835], TEV protease [836], beta-lactamase [837], beta-galactosidase, Gal4, or DHFR [838]. The resulting functional readout of these complementation system depends on which split reporter is used. In general, the split luciferase system shows enhanced sensitivity over fluorescence-based systems as background luminescence is low.

Two-hybrid assays are based on a similar functional complementation strategy as fragment complementation systems. Conventionally, two self-complementing transcription factor fragments are fused to bait and prey proteins, respectively, leading to the restoration of a functional transcription factor only upon prey-bait interaction. The complemented transcription factor then induces the expression of a reporter gene that can be measured. Multiple variations of this system abound for different model organisms, but they almost always involve transcriptional activation or repression of a reporter gene ([839] for a detailed discussion).

The yeast-2-hybrid system (Y2H) is deserving of mention here as it had been the very first 2-hybrid system established [840] and has ever since proven to be extremely versatile (multiple auxotrophic reporters and markers of phenotypic sensitivity available), cheap, lends itself to functional high-throughput screening and variants have been developed that allow for the investigation of membrane-protein interactions (i.e. membrane Y2H) [839,841].

Despite the many advantages the Y2H offers, critical drawbacks include the potential of misfolding of bait and prey proteins when fused to a complementation reporter, expression at non-physiological levels, the lack of control over posttranslational modifications that might be important for the PPI under investigation, and the potential requirement of kingdom- or species-specific folding factors for the bait/prey under investigation (i.e. when probing PPI of mammalian proteins in Y2H). Principles of the Y2H technology have also been adapted to mammalian systems, which circumvent some of the aforementioned drawbacks of Y2H [842].

Perhaps the most commonly applied method of detecting and validating PPIs in vitro is affinity purification (AP, also known as affinity chromatography) of co-immunoprecipitation (Co-IP) either coupled with SDS-PAGE/immunoblotting or mass spectrometry to determine the identity of interacting proteins. AP typically relies on the isolation of a transgenic POI by an epitope tag (using epitope-specific matrix-conjugated proteins (antibodies or epitope-binding proteins)), while Co-IP harnesses specific antibodies directly targeting the POI. Specific interactors are expected to be enriched compared to the negative control (i.e an isotype control antibody, a knockout cell line or empty matrix). AP is not solely restricted to detecting PPIs, but can also be adapted to protein interactions with other biomolecules such as RNA [843]. It should be noted that AP and Co-IP can return multiple potential binding partners, many of which might be artefactual due to loss of cellular compartmentalization during sample preparation.

To reduce the probability of such artefacts and increase the confidence of a specific interaction, reciprocal affinity purification (by pulldown of each interaction partner) or in situ imaging might be performed (i.e. using fluorescence resonance energy transfer (FRET) [844], split-protein systems [845], proximity ligation assay [846] and immunofluorescence microscopy).

Forster and bioluminescence resonance energy transfer (FRET / BRET) can be used for in situ visualization of protein proximities and therefore PPIs. In FRET, non-radiative energy transfer between donor and receptor chromophores (each fused to prey and bait proteins, respectively), results in the emission of a characteristic fluorescence signal only when both prey and bait are in very close proximity (1-10 nm distance) and a suitable light source for donor excitation is provided [847].

The underlying principle of BRET is similar to that of FRET but with the exception of using a chemical substrate which activates bioluminescent donor, such as luciferase, resulting in energy transfer to a fluorescent acceptor molecule [848,849]. The main advantages of BRET over FRET are independence from an external light source (which can result in photobleaching), but requires at least one of the POIs to be fused to the donor (while in FRET, donor and acceptor can be chemically conjugated to POI-specific antibodies) [848]. FRET can be particularly useful in investigating cell surface protein interactions when using specific antibodies conjugated to donor and acceptor probes as antibodies are not cell-permeable and therefore restricted to targets presented on the cell surface in the absence of membrane permeabilization agents. Other fluorescence-based PPI assays encompass Fluorescence correlation spectroscopy (FCS) and fluorescence cross-correlation spectroscopy (FCCS). These methods use small volumes of fluorescently labelled proteins and can determine their diffusion coefficients, which change in when proteins form a complex [850].

Proximity labelling methods (Proximity ligation and enzymatic proximity labelling (BirA, APEX2, HRP) can surveil labile or transient interaction in live cells in a high-throughput format when coupled with target identification by MS [851], [852]. These approaches harness a biotin ligase (i.e. BirA, BioID2, AirID, BASU, APEX2, HRP) fused to a POI whose interactome is to be determined. In the presence of biotin (for BirA, BioID2, AirID, BASU, APEX2 and HRP) or a biotin-phenol derivative (for APEX2), the biotin ligase will activate the biotin(-phenol) which then covalently biotinylates any protein in close proximity. The activated biotin has a short half-life, ensuring that the effective labelling radius is typically restricted to approximately 10 nm. Biotinylated proteins are isolated by affinity purification with streptavidin-conjugated beads and identified by mass spectrometry or SDS-PAGE/immunoblotting. TurboID, miniTurboID and ultraID, promiscuous biotin ligases faster than BirA, have been developed allowing for shorter treatment times and decreased background signal. The choice of a biotin ligase variant depends on the POI and experimental setup, but in general HRP does not work in cytoplasmic environments where conditions are chemically reducing, but is suitable for labelling proteins extracellular face of the plasma membrane or in the endoplasmic reticulum and golgi apparatus. While TurboID and similar variants have fast kinetics, they can cause depletion of endogenous biotin and therefore cytotoxicity.

A major drawback shared by all variants described above is that they necessitate fusion to the POI, which might alter its physiological behavior and give rise to false positives or false negatives. Moreover, detecting a biotin-labelled protein does not unequivocally designate it as an interaction partner as spatial proximity to the POI-biotin ligase fusion protein without direct binding can result in biotinylation. The inclusion of controls, such as expression of the biotinylating enzyme alone in the cellular compartment of interest, is therefore particularly important for enzymatic proximity labelling methods.

The in situ proximity ligation assay (PLA) combines the specificity of antibodies with the signal amplification capacity of a DNA polymerase reaction. Here, two antibodies, each conjugated to a short single-strand DNA (ssDNA) tag and each specific to one of the two proteins whose interaction is under investigation, are added to fixed cells or tissue. Once bound to their respective targets and only when in direct proximity, the addition of two connector oligonucleotides complementary to each tag ssDNA tag and phi29 DNA polymerase, triggers isothermal rolling circle amplification, eventually resulting in the generation of continuous stretches of repetitive DNA. These DNA products can then be visualized by in situ hybridization with fluorescently labelled oligonucleotides (see [853] for a detailed discussion). PLA has the advantage of visualizing the two interacting proteins in their native environment when high-resolution microscopy is used as a readout.

Chemical cross-linking (XL) of proteins can determine PPIs with amino-acid level resolution, and can thereby give valuable insights into the orientation of two or more proteins relative to one another [854]. Recent technical advances also enabled the visualization of protein-RNA interaction [855]. Various XL chemistries are available (amine-reactive, sulfhydryl and photoreactive crosslinkers; reversible vs irreversible) and cross-linked proteins detected by mass spectrometry [856]. In general, applying XL-MS to a mixture of interacting, purified proteins is preferable to in situ XL of complex protein mixtures (i.e. cell lysate) as detection and deconvolution of XL peptides is technically and computationally challenging.

Surface plasmon resonance can accurately measure several key kinetics of PPIs with high accuracy (e.g. association and dissociation kinetics, stoichiometry, affinity) [857]. It relies on the quantification of refractive index changes of polarized light shone onto a sensor chip containing a prey protein immobilized on a metal surface (typically gold). When prey and bait proteins interact, the mass concentration at the metal interface changes, altering the refractive index and SPR angle (intensity of the refracted light).

Acknowledgements

The authors thank Phil Wilmarth for helpful input. Identification of certain commercial equipment, instruments, software, or materials does not imply recommendation or endorsement by the National Institute of Standards and Technology, nor does it imply that the products identified are necessarily the best available for the purpose. The authors thank Dasom Hwang for help with graphic design. The authors thank Anthony Gitter and Daniem Himmelstein for assistance using manubot. The authors thank Jordan Burton and Pierre-Alexander Mücke for minor edits to the text. This manuscript was written collaboratively using manubot [858]. The live and evolving version where anyone can contribute can be found here https://github.com/jessegmeyerlab/proteomics-tutorial/tree/main.

Author contributions

JGM was assigned last author as the project initiator and leader. RLM was assigned second to last author based on their leadership role in curating all sections. All other authors were ordered by estimating their contributions using a quantitative score. The score for each author was a sum of the number of sentences added plus 33 lines for each figure added. Scores were adjusted for confounding factors, such as split contributions between multiple contributors. Authors with similar scores were assigned equal contributions.

References

Enzyme-less nanopore detection of post-translational modifications within long polypeptides

Pablo Martin-Baniandres, Wei-Hsuan Lan, Stephanie Board, Mercedes Romero-Ruiz, Sergi Garcia-Manyes, Yujia Qing, Hagan Bayley

Nature Nanotechnology (2023-07-27) https://doi.org/gs3f47

DOI: 10.1038/s41565-023-01462-8 · PMID: 37500774

Nanopore Detection Using Supercharged Polypeptide Molecular Carriers

Xiaoyi Wang, Tina-Marie Thomas, Ren Ren, Yu Zhou, Peng Zhang, Jingjing Li, Shenglin Cai, Kai Liu, Aleksandar P Ivanov, Andreas Herrmann, Joshua B Edel

Journal of the American Chemical Society (2023-03-10) https://doi.org/gs3f46

DOI: 10.1021/jacs.2c13465 · PMID: 36897933 · PMCID: PMC10037339

Real-time shape approximation and fingerprinting of single proteins using a nanopore

Erik C Yusko, Brandon R Bruhn, Olivia M Eggenberger, Jared Houghtaling, Ryan C Rollings, Nathan C Walsh, Santoshi Nandivada, Mariya Pindrus, Adam R Hall, David Sept, … Michael Mayer

Nature Nanotechnology (2016-12-19) https://doi.org/gfx2jk

DOI: 10.1038/nnano.2016.267 · PMID: 27992411

Nanopore-Based Protein Identification

Mazdak Afshar Bakshloo, John J Kasianowicz, Manuela Pastoriza-Gallego, Jérôme Mathé, Régis Daniel, Fabien Piguet, Abdelghani Oukhaled

Journal of the American Chemical Society (2022-02-04) https://doi.org/gr9grc

DOI: 10.1021/jacs.1c11758 · PMID: 35120294

Highly parallel single-molecule identification of proteins in zeptomole-scale mixtures

Jagannath Swaminathan, Alexander A Boulgakov, Erik T Hernandez, Angela M Bardo, James L Bachman, Joseph Marotta, Amber M Johnson, Eric V Anslyn, Edward M Marcotte

Nature Biotechnology (2018-10-22) https://doi.org/gfg4bk

DOI: 10.1038/nbt.4278 · PMID: 30346938 · PMCID: PMC6482110

Electrospray Ionization for Mass Spectrometry of Large Biomolecules

John B Fenn, Matthias Mann, Chin Kai Meng, Shek Fu Wong, Craig M Whitehouse

Science (1989-10-06) https://doi.org/cq2q43

DOI: 10.1126/science.2675315 · PMID: 2675315

Protein and polymer analyses up tom/z 100 000 by laser ionization time-of-flight mass spectrometry

Koichi Tanaka, Hiroaki Waki, Yutaka Ido, Satoshi Akita, Yoshikazu Yoshida, Tamio Yoshida, T Matsuo

Rapid Communications in Mass Spectrometry (1988-08) https://doi.org/ffbwwr

DOI: 10.1002/rcm.1290020802

An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database.

JK Eng, AL McCormack, JR Yates

Journal of the American Society for Mass Spectrometry (1994-11) https://www.ncbi.nlm.nih.gov/pubmed/24226387

DOI: 10.1016/1044-0305(94)80016-2 · PMID: 24226387

An Automated Multidimensional Protein Identification Technology for Shotgun Proteomics

Dirk A Wolters, Michael P Washburn, John R Yates

Analytical Chemistry (2001-10-25) https://doi.org/bn4kq6

DOI: 10.1021/ac010617e · PMID: 11774908

10.

A Statistical Model for Identifying Proteins by Tandem Mass Spectrometry

Alexey I Nesvizhskii, Andrew Keller, Eugene Kolker, Ruedi Aebersold

Analytical Chemistry (2003-07-15) https://doi.org/b2xv45

DOI: 10.1021/ac0341261 · PMID: 14632076

11.

Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry

Joshua E Elias, Steven P Gygi

Nature Methods (2007-02-27) https://doi.org/djz7fz

DOI: 10.1038/nmeth1019 · PMID: 17327847

12.

Mass-spectrometric exploration of proteome structure and function

Ruedi Aebersold, Matthias Mann

Nature (2016-09) https://doi.org/f83zqm

DOI: 10.1038/nature19949 · PMID: 27629641

13.

Top Down versus Bottom Up Protein Characterization by Tandem High-Resolution Mass Spectrometry

Neil L Kelleher, Hong Y Lin, Gary A Valaskovic, David J Aaserud, Einar K Fridriksson, Fred W McLafferty

Journal of the American Chemical Society (1999-01-16) https://doi.org/ddc6cm

DOI: 10.1021/ja973655h

14.

Proteoform: a single term describing protein complexity

Lloyd M Smith, Neil L Kelleher

Nature Methods (2013-02-27) https://doi.org/gwcc

DOI: 10.1038/nmeth.2369 · PMID: 23443629 · PMCID: PMC4114032

15.

Peer Reviewed: Top-Down Proteomics

Neil L Kelleher

Analytical Chemistry (2004-06-01) https://doi.org/btvgmx

DOI: 10.1021/ac0415657

16.

High-throughput quantitative top-down proteomics

Kellye A Cupp-Sutton, Si Wu

Molecular Omics (2020) https://doi.org/gnx98p

DOI: 10.1039/c9mo00154a · PMID: 31932818 · PMCID: PMC7529119

17.

Proteoforms as the next proteomics currency

Lloyd M Smith, Neil L Kelleher

Science (2018-03-09) https://doi.org/gn6p4x

DOI: 10.1126/science.aat1884 · PMID: 29590032 · PMCID: PMC5944612

18.

How many human proteoforms are there?

Ruedi Aebersold, Jeffrey N Agar, IJonathan Amster, Mark S Baker, Carolyn R Bertozzi, Emily S Boja, Catherine E Costello, Benjamin F Cravatt, Catherine Fenselau, Benjamin A Garcia, … Bing Zhang

Nature Chemical Biology (2018-02-14) https://doi.org/gczhrc

DOI: 10.1038/nchembio.2576 · PMID: 29443976 · PMCID: PMC5837046

19.

Top-Down Proteomics: Ready for Prime Time?

Bifan Chen, Kyle A Brown, Ziqing Lin, Ying Ge

Analytical Chemistry (2017-11-21) https://doi.org/gssrqr

DOI: 10.1021/acs.analchem.7b04747 · PMID: 29161012 · PMCID: PMC6138622

20.

Quantitative shotgun proteome analysis by direct infusion

Jesse G Meyer, Natalie M Niemi, David J Pagliarini, Joshua J Coon

Nature Methods (2020-11-23) https://doi.org/ghnrz4

DOI: 10.1038/s41592-020-00999-z · PMID: 33230323 · PMCID: PMC8009190

21.

Label-Free Quantification from Direct Infusion Shotgun Proteome Analysis (DISPA-LFQ) with CsoDIAq Software

Yuming Jiang, Alexandre Hutton, Caleb W Cranney, Jesse G Meyer

Analytical Chemistry (2022-12-17) https://doi.org/gssrqq

DOI: 10.1021/acs.analchem.2c02249 · PMID: 36527718 · PMCID: PMC9850400

22.

Simultaneous Multi-Omics Analysis by Direct Infusion Mass Spectrometry (SMAD-MS)

Yuming Jiang, Ivan Salladay-Perez, Amanda Momenzadeh, Anthony J Covarrubias, Jesse G Meyer

Cold Spring Harbor Laboratory (2023-06-29) https://doi.org/gsk478

DOI: 10.1101/2023.06.26.546628 · PMID: 37425781 · PMCID: PMC10326973

23.

The 2022 Report on the Human Proteome from the HUPO Human Proteome Project.

Gilbert S Omenn, Lydie Lane, Christopher M Overall, Charles Pineau, Nicolle H Packer, Ileana M Cristea, Cecilia Lindskog, Susan T Weintraub, Sandra Orchard, Michael HA Roehrl, … Eric W Deutsch

Journal of proteome research (2022-11-01) https://www.ncbi.nlm.nih.gov/pubmed/36318223

DOI: 10.1021/acs.jproteome.2c00498 · PMID: 36318223 · PMCID: PMC10081950

24.

The quantitative proteome of a human cell line

Martin Beck, Alexander Schmidt, Johan Malmstroem, Manfred Claassen, Alessandro Ori, Anna Szymborska, Franz Herzog, Oliver Rinner, Jan Ellenberg, Ruedi Aebersold

Molecular Systems Biology (2011-01) https://doi.org/drjmfj

DOI: 10.1038/msb.2011.82 · PMID: 22068332 · PMCID: PMC3261713

25.

A Quantitative Proteome Map of the Human Body

Lihua Jiang, Meng Wang, Shin Lin, Ruiqi Jian, Xiao Li, Joanne Chan, Guanlan Dong, Huaying Fang, Aaron E Robinson, Michael P Snyder, … Simona Volpi

Cell (2020-10) https://doi.org/ghbjrk

DOI: 10.1016/j.cell.2020.08.036 · PMID: 32916130 · PMCID: PMC7575058

26.

Global detection of human variants and isoforms by deep proteome sequencing

Pavel Sinitcyn, Alicia L Richards, Robert J Weatheritt, Dain R Brademan, Harald Marx, Evgenia Shishkova, Jesse G Meyer, Alexander S Hebert, Michael S Westphall, Benjamin J Blencowe, … Joshua J Coon

Nature Biotechnology (2023-03-23) https://doi.org/gr6g65

DOI: 10.1038/s41587-023-01714-x · PMID: 36959352

27.

Post-translational modifications in proteins: resources, tools and prediction methods

Shahin Ramazi, Javad Zahiri

Database (2021-01-01) https://doi.org/gpjs7g

DOI: 10.1093/database/baab012 · PMID: 33826699 · PMCID: PMC8040245

28.

Posttranslational modifications in proteins: resources, tools and prediction methods.

Shahin Ramazi, Javad Zahiri

Database : the journal of biological databases and curation (2021-04-07) https://www.ncbi.nlm.nih.gov/pubmed/33826699

DOI: 10.1093/database/baab012 · PMID: 33826699 · PMCID: PMC8040245

29.

Protein post-translational modifications and regulation of pluripotency in human stem cells.

Yu-Chieh Wang, Suzanne E Peterson, Jeanne F Loring

Cell research (2013-11-12) https://www.ncbi.nlm.nih.gov/pubmed/24217768

DOI: 10.1038/cr.2013.151 · PMID: 24217768 · PMCID: PMC3915910

30.

Proteolytic post-translational modification of proteins: proteomic tools and methodology.

Lindsay D Rogers, Christopher M Overall

Molecular & cellular proteomics : MCP (2013-07-25) https://www.ncbi.nlm.nih.gov/pubmed/23887885

DOI: 10.1074/mcp.m113.031310 · PMID: 23887885 · PMCID: PMC3861706

31.

A global view of the human post-translational modification landscape

Naoya Kitamura, James J Galligan

Biochemical Journal (2023-08-23) https://doi.org/gszdh3

DOI: 10.1042/bcj20220251 · PMID: 37610048 · PMCID: PMC10586784

32.

The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review).

Fatima Ardito, Michele Giuliani, Donatella Perrone, Giuseppe Troiano, Lorenzo Lo Muzio

International journal of molecular medicine (2017-06-22) https://www.ncbi.nlm.nih.gov/pubmed/28656226

DOI: 10.3892/ijmm.2017.3036 · PMID: 28656226 · PMCID: PMC5500920

33.

Mitochondrial phosphorylation in apoptosis: flipping the death switch.

Natalie M Niemi, Jeffrey P MacKeigan

Antioxidants & redox signaling (2012-12-07) https://www.ncbi.nlm.nih.gov/pubmed/23088365

DOI: 10.1089/ars.2012.4982 · PMID: 23088365 · PMCID: PMC3717198

34.

Phosphorylation of Bcl2 and regulation of apoptosis.

PP Ruvolo, X Deng, WS May

Leukemia (2001-04) https://www.ncbi.nlm.nih.gov/pubmed/11368354

DOI: 10.1038/sj.leu.2402090 · PMID: 11368354

35.

Protein degradation by the ubiquitin-proteasome pathway in normal and disease states.

Stewart H Lecker, Alfred L Goldberg, William E Mitch

Journal of the American Society of Nephrology : JASN (2006-05-31) https://www.ncbi.nlm.nih.gov/pubmed/16738015

DOI: 10.1681/asn.2006010083 · PMID: 16738015

36.

SUMOylation-Mediated Regulation of Cell Cycle Progression and Cancer.

Karolin Eifler, Alfred CO Vertegaal

Trends in biochemical sciences (2015-10-22) https://www.ncbi.nlm.nih.gov/pubmed/26601932

DOI: 10.1016/j.tibs.2015.09.006 · PMID: 26601932 · PMCID: PMC4874464

37.

Site-specific identification and quantitation of endogenous SUMO modifications under native conditions.

Ryan J Lumpkin, Hongbo Gu, Yiying Zhu, Marilyn Leonard, Alla S Ahmad, Karl R Clauser, Jesse G Meyer, Eric J Bennett, Elizabeth A Komives

Nature communications (2017-10-27) https://www.ncbi.nlm.nih.gov/pubmed/29079793

DOI: 10.1038/s41467-017-01271-3 · PMID: 29079793 · PMCID: PMC5660086

38.

Palmitoylation is a post-translational modification of Alix regulating the membrane organization of exosome-like small extracellular vesicles.

Daniele P Romancino, Valentina Buffa, Stefano Caruso, Ines Ferrara, Samuele Raccosta, Antonietta Notaro, Yvan Campos, Rosina Noto, Vincenzo Martorana, Antonio Cupane, … Antonella Bongiovanni

Biochimica et biophysica acta. General subjects (2018-09-07) https://www.ncbi.nlm.nih.gov/pubmed/30251702

DOI: 10.1016/j.bbagen.2018.09.004 · PMID: 30251702

39.

T cells modulate glycans on CD43 and CD45 during development and activation, signal regulation, and survival.

Mary C Clark, Linda G Baum

Annals of the New York Academy of Sciences (2012-01-30) https://www.ncbi.nlm.nih.gov/pubmed/22288421

DOI: 10.1111/j.1749-6632.2011.06304.x · PMID: 22288421 · PMCID: PMC4190024

40.

Mammalian glycosylation in immunity.

Jamey D Marth, Prabhjit K Grewal

Nature reviews. Immunology (2008-11) https://www.ncbi.nlm.nih.gov/pubmed/18846099

DOI: 10.1038/nri2417 · PMID: 18846099 · PMCID: PMC2768770

41.

Deciphering protein post-translational modifications using chemical biology tools

Anne C Conibear

Nature Reviews Chemistry (2020-10-06) https://doi.org/gqnxhb

DOI: 10.1038/s41570-020-00223-8 · PMID: 37127974

42.

Analysis of yeast protein kinases using protein chips.

H Zhu, JF Klemic, S Chang, P Bertone, A Casamayor, KG Klemic, D Smith, M Gerstein, MA Reed, M Snyder

Nature genetics (2000-11) https://www.ncbi.nlm.nih.gov/pubmed/11062466

DOI: 10.1038/81576 · PMID: 11062466

43.

Peptide arrays: from macro to micro.

Ulf Reimer, Ulrich Reineke, Jens Schneider-Mergener

Current opinion in biotechnology (2002-08) https://www.ncbi.nlm.nih.gov/pubmed/12323352

DOI: 10.1016/s0958-1669(02)00339-7 · PMID: 12323352

44.

Engineered SH2 Domains for Targeted Phosphoproteomics.

Gregory D Martyn, Gianluca Veggiani, Ulrike Kusebauch, Seamus R Morrone, Bradley P Yates, Alex U Singer, Jiefei Tong, Noah Manczyk, Gerald Gish, Zhi Sun, … Sachdev S Sidhu

ACS chemical biology (2022-05-25) https://www.ncbi.nlm.nih.gov/pubmed/35613471

DOI: 10.1021/acschembio.2c00051 · PMID: 35613471 · PMCID: PMC9251651

45.

Intrinsically Disordered Proteins and Intrinsically Disordered Protein Regions

Christopher J Oldfield, AKeith Dunker

Annual Review of Biochemistry (2014-06-02) https://doi.org/gfw6t4

DOI: 10.1146/annurev-biochem-072711-164947 · PMID: 24606139

46.

A Review: Molecular Chaperone-mediated Folding, Unfolding and Disaggregation of Expressed Recombinant Proteins

Komal Fatima, Fatima Naqvi, Hooria Younas

Cell Biochemistry and Biophysics (2021-02-25) https://doi.org/gpd4pb

DOI: 10.1007/s12013-021-00970-5 · PMID: 33634426

47.

Highly accurate protein structure prediction with AlphaFold.

John Jumper, Richard Evans, Alexander Pritzel, Tim Green, Michael Figurnov, Olaf Ronneberger, Kathryn Tunyasuvunakool, Russ Bates, Augustin Žídek, Anna Potapenko, … Demis Hassabis

Nature (2021-07-15) https://www.ncbi.nlm.nih.gov/pubmed/34265844

DOI: 10.1038/s41586-021-03819-2 · PMID: 34265844 · PMCID: PMC8371605

48.

The Protein Structure Prediction Revolution and Its Implications for Medicine: 2023 Albert Lasker Basic Medical Research Award.

John Jumper, Demis Hassabis

JAMA (2023-10-17) https://www.ncbi.nlm.nih.gov/pubmed/37732824

DOI: 10.1001/jama.2023.17095 · PMID: 37732824

49.

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

Yoav Benjamini, Yosef Hochberg

Journal of the Royal Statistical Society: Series B (Methodological) (1995-01) https://doi.org/gfpkdx

DOI: 10.1111/j.2517-6161.1995.tb02031.x

50.

Methods for the proteomic identification of protease substrates

Nicholas J Agard, James A Wells

Current Opinion in Chemical Biology (2009-12) https://doi.org/b3swpj

DOI: 10.1016/j.cbpa.2009.07.026 · PMID: 19729334 · PMCID: PMC2787889

51.

Large-scale phosphorylation analysis of mouse liver

Judit Villén, Sean A Beausoleil, Scott A Gerber, Steven P Gygi

Proceedings of the National Academy of Sciences (2007-01-30) https://doi.org/c7zbpm

DOI: 10.1073/pnas.0609836104 · PMID: 17242355 · PMCID: PMC1785252

52.

PhosphoPep—a phosphoproteome resource for systems biology research in Drosophila Kc167 cells

Bernd Bodenmiller, Johan Malmstrom, Bertran Gerrits, David Campbell, Henry Lam, Alexander Schmidt, Oliver Rinner, Lukas N Mueller, Paul T Shannon, Patrick G Pedrioli, … Ruedi Aebersold

Molecular Systems Biology (2007-01) https://doi.org/fg6rnn

DOI: 10.1038/msb4100182 · PMID: 17940529 · PMCID: PMC2063582

53.

Quantitative Analysis of Phosphotyrosine Signaling Networks Triggered by CD3 and CD28 Costimulation in Jurkat Cells

Ji-Eun Kim, Forest M White

The Journal of Immunology (2006-03-01) https://doi.org/gr3m64

DOI: 10.4049/jimmunol.176.5.2833 · PMID: 16493040

54.

Quantitative Phosphoproteomic Analysis of T Cell Receptor Signaling Reveals System-Wide Modulation of Protein-Protein Interactions

Viveka Mayya, Deborah H Lundgren, Sun-Il Hwang, Karim Rezaul, Linfeng Wu, Jimmy K Eng, Vladimir Rodionov, David K Han

Science Signaling (2009-08-18) https://doi.org/d3czmn

DOI: 10.1126/scisignal.2000007 · PMID: 19690332

55.

Quantitative phosphoproteomic analysis of signaling network dynamics

Forest M White

Current Opinion in Biotechnology (2008-08) https://doi.org/bhd9vx

DOI: 10.1016/j.copbio.2008.06.006 · PMID: 18619541 · PMCID: PMC2567239

56.

Glycoproteomics

Ieva Bagdonaite, Stacy A Malaker, Daniel A Polasky, Nicholas M Riley, Katrine Schjoldager, Sergey Y Vakhrushev, Adnan Halim, Kiyoko F Aoki-Kinoshita, Alexey I Nesvizhskii, Carolyn R Bertozzi, … Nichollas E Scott

Nature Reviews Methods Primers (2022-06-23) https://doi.org/gr3m6w

DOI: 10.1038/s43586-022-00128-4

57.

Biological roles of glycans

Ajit Varki

Glycobiology (2016-08-24) https://doi.org/f9v9j5

DOI: 10.1093/glycob/cww086 · PMID: 27558841 · PMCID: PMC5884436

58.

Glycosylation in Cellular Mechanisms of Health and Disease

Kazuaki Ohtsubo, Jamey D Marth

Cell (2006-09) https://doi.org/d2qc7z

DOI: 10.1016/j.cell.2006.08.019 · PMID: 16959566

59.

Neurological Aspects of Human Glycosylation Disorders

Hudson H Freeze, Erik A Eklund, Bobby G Ng, Marc C Patterson

Annual Review of Neuroscience (2015-07-08) https://doi.org/f3pb3r

DOI: 10.1146/annurev-neuro-071714-034019 · PMID: 25840006 · PMCID: PMC4809143

60.

Universal sample preparation method for proteome analysis

Jacek R Wiśniewski, Alexandre Zougman, Nagarjuna Nagaraj, Matthias Mann

Nature Methods (2009-04-19) https://doi.org/cfbrvh

DOI: 10.1038/nmeth.1322 · PMID: 19377485

61.

Suspension trapping (STrap) sample preparation method for bottom‐up proteomics analysis

Alexandre Zougman, Peter J Selby, Rosamonde E Banks

PROTEOMICS (2014-03-26) https://doi.org/f2rdw4

DOI: 10.1002/pmic.201300553 · PMID: 24678027

62.

Protein Aggregation Capture on Microparticles Enables Multipurpose Proteomics Sample Preparation*

Tanveer S Batth, MaximAX Tollenaere, Patrick Rüther, Alba Gonzalez-Franquesa, Bhargav S Prabhakar, Simon Bekker-Jensen, Atul S Deshmukh, Jesper V Olsen

Molecular & Cellular Proteomics (2019-05) https://doi.org/gf3vvs

DOI: 10.1074/mcp.tir118.001270 · PMID: 30833379 · PMCID: PMC6495262

63.

S-Trap, an Ultrafast Sample-Preparation Approach for Shotgun Proteomics

Milkessa HaileMariam, Rodrigo Vargas Eguez, Harinder Singh, Shiferaw Bekele, Gobena Ameni, Rembert Pieper, Yanbao Yu

Journal of Proteome Research (2018-08-16) https://doi.org/gd9kf5

DOI: 10.1021/acs.jproteome.8b00505 · PMID: 30114372

64.

Multiplexed CuAAC Suzuki–Miyaura Labeling for Tandem Activity-Based Chemoproteomic Profiling

Jian Cao, Lisa M Boatner, Heta S Desai, Nikolas R Burton, Ernest Armenta, Neil J Chan, José O Castellón, Keriann M Backus

Analytical Chemistry (2021-01-20) https://doi.org/gr3m6q

DOI: 10.1021/acs.analchem.0c04726 · PMID: 33470097 · PMCID: PMC8849040

65.

SP3-FAIMS Chemoproteomics for High Coverage Profiling of the Human Cysteinome

Tianyang Yan, Heta Desai, Lisa Boatner, Stephanie Yen, Jian Cao, Maria Palafox, Yasaman Jami-Alahmadi, Keriann Backus

American Chemical Society (ACS) (2020-12-28) https://doi.org/gr3m63

DOI: 10.26434/chemrxiv.13487364.v1

66.

Expanding Proteome Coverage with Orthogonal-specificity α-Lytic Proteases

Jesse G Meyer, Sangtae Kim, David A Maltby, Majid Ghassemian, Nuno Bandeira, Elizabeth A Komives

Molecular & Cellular Proteomics (2014-03) https://doi.org/f5vgcg

DOI: 10.1074/mcp.m113.034710 · PMID: 24425750 · PMCID: PMC3945911

67.

XL-MS: Protein cross-linking coupled with mass spectrometry

Andrew N Holding

Methods (2015-11) https://doi.org/gftzb6

DOI: 10.1016/j.ymeth.2015.06.010 · PMID: 26079926

68.

To Cleave or Not To Cleave in XL-MS?

B Steigenberger, P Albanese, AJR Heck, RA Scheltema

Journal of the American Society for Mass Spectrometry (2019-12-27) https://doi.org/gr3m6s

DOI: 10.1021/jasms.9b00085 · PMID: 32031400

69.

Cross-Linking Mass Spectrometry: An Emerging Technology for Interactomics and Structural Biology

Clinton Yu, Lan Huang

Analytical Chemistry (2017-11-21) https://doi.org/gfvmcj

DOI: 10.1021/acs.analchem.7b04431 · PMID: 29160693 · PMCID: PMC6022837

70.

A New in Vivo Cross-linking Mass Spectrometry Platform to Define Protein–Protein Interactions in Living Cells

Robyn M Kaake, Xiaorong Wang, Anthony Burke, Clinton Yu, Wynne Kandur, Yingying Yang, Eric J Novtisky, Tonya Second, Jicheng Duan, Athit Kao, … Lan Huang

Molecular & Cellular Proteomics (2014-12) https://doi.org/f6r7qw

DOI: 10.1074/mcp.m114.042630 · PMID: 25253489 · PMCID: PMC4256503

71.

Identification of cross-linked peptides from complex samples

Bing Yang, Yan-Jie Wu, Ming Zhu, Sheng-Bo Fan, Jinzhong Lin, Kun Zhang, Shuang Li, Hao Chi, Yu-Xin Li, Hai-Feng Chen, … Meng-Qiu Dong

Nature Methods (2012-07-08) https://doi.org/f38rv2

DOI: 10.1038/nmeth.2099 · PMID: 22772728

72.

Kojak: efficient analysis of chemically cross-linked protein complexes.

Michael R Hoopmann, Alex Zelter, Richard S Johnson, Michael Riffle, Michael J MacCoss, Trisha N Davis, Robert L Moritz

Journal of proteome research (2015-04-15) https://www.ncbi.nlm.nih.gov/pubmed/25812159

DOI: 10.1021/pr501321h · PMID: 25812159 · PMCID: PMC4428575

73.

Improved Analysis of Cross-Linking Mass Spectrometry Data with Kojak 2.0, Advanced by Integration into the Trans-Proteomic Pipeline.

Michael R Hoopmann, David D Shteynberg, Alex Zelter, Michael Riffle, Andrew S Lyon, David A Agard, Qing Luan, Brad J Nolen, Michael J MacCoss, Trisha N Davis, Robert L Moritz

Journal of proteome research (2023-01-11) https://www.ncbi.nlm.nih.gov/pubmed/36629399

DOI: 10.1021/acs.jproteome.2c00670 · PMID: 36629399 · PMCID: PMC10234491

74.

Identification of cross-linked peptides from large sequence databases

Oliver Rinner, Jan Seebacher, Thomas Walzthoeni, Lukas N Mueller, Martin Beck, Alexander Schmidt, Markus Mueller, Ruedi Aebersold

Nature Methods (2008-03-09) https://doi.org/bfk675

DOI: 10.1038/nmeth.1192 · PMID: 18327264 · PMCID: PMC2719781

75.

Proteome-wide profiling of protein assemblies by cross-linking mass spectrometry

Fan Liu, Dirk TS Rijkers, Harm Post, Albert JR Heck

Nature Methods (2015-12) https://doi.org/f72pgx

DOI: doi.org/10.1038/nmeth.3603

76.

ProXL (Protein Cross-Linking Database): A Platform for Analysis, Visualization, and Sharing of Protein Cross-Linking Mass Spectrometry Data.

Michael Riffle, Daniel Jaschob, Alex Zelter, Trisha N Davis

Journal of proteome research (2016-06-24) https://www.ncbi.nlm.nih.gov/pubmed/27302480

DOI: 10.1021/acs.jproteome.6b00274 · PMID: 27302480 · PMCID: PMC4977572

77.

Proxl (Protein Cross-Linking Database): A Public Server, QC Tools, and Other Major Updates.

Michael Riffle, Daniel Jaschob, Alex Zelter, Trisha N Davis

Journal of proteome research (2018-12-19) https://www.ncbi.nlm.nih.gov/pubmed/30525651

DOI: 10.1021/acs.jproteome.8b00726 · PMID: 30525651 · PMCID: PMC6417915

78.

HADDOCK: A Protein−Protein Docking Approach Based on Biochemical or Biophysical Information

Cyril Dominguez, Rolf Boelens, Alexandre MJJ Bonvin

Journal of the American Chemical Society (2003-01-21) https://doi.org/bsn3bc

DOI: 10.1021/ja026939x · PMID: 12580598

79.

Recommendations for performing, interpreting and reporting hydrogen deuterium exchange mass spectrometry (HDX-MS) experiments

Glenn R Masson, John E Burke, Natalie G Ahn, Ganesh S Anand, Christoph Borchers, Sébastien Brier, George M Bou-Assaf, John R Engen, SWalter Englander, Johan Faber, … Kasper D Rand

Nature Methods (2019-06-27) https://doi.org/ghh62q

DOI: 10.1038/s41592-019-0459-y · PMID: 31249422 · PMCID: PMC6614034

80.

Hydrogen exchange mass spectrometry for studying protein structure and dynamics

Lars Konermann, Jingxi Pan, Yu-Hong Liu

Chem. Soc. Rev. (2011) https://doi.org/db943b

DOI: 10.1039/c0cs00113a · PMID: 21173980

81.

Hydrogen exchange in proteins.

A Hvidt, SO Nielsen

Advances in protein chemistry (1966) https://www.ncbi.nlm.nih.gov/pubmed/5333290

DOI: 10.1016/s0065-3233(08)60129-1 · PMID: 5333290

82.

Hydrogen exchange and structural dynamics of proteins and nucleic acids

SWalter Englander, Neville R Kallenbach

Quarterly Reviews of Biophysics (1983-11) https://doi.org/cxj4z7

DOI: 10.1017/s0033583500005217 · PMID: 6204354

83.

Differential hydrogen/deuterium exchange mass spectrometry analysis of protein–ligand interactions

Michael J Chalmers, Scott A Busby, Bruce D Pascal, Graham M West, Patrick R Griffin

Expert Review of Proteomics (2011-02) https://doi.org/btrkr9

DOI: 10.1586/epr.10.109 · PMID: 21329427 · PMCID: PMC3113475

84.

Hydrogen Exchange Mass Spectrometry: Are We Out of the Quicksand?

Roxana E Iacob, John R Engen

Journal of the American Society for Mass Spectrometry (2012-04-03) https://doi.org//10.1007/s13361-012-0377-z

DOI: /10.1007/s13361-012-0377-z

85.

Replication in bioanalytical studies with HDX MS: aim as high as possible

Jamie A Moroco, John R Engen

Bioanalysis (2015-05) https://doi.org/gr3m65

DOI: 10.4155/bio.15.46 · PMID: 26039804 · PMCID: PMC4837975

86.

Development of a Peptide Probe for the Occurrence of Hydrogen (1H/2H) Scrambling upon Gas-Phase Fragmentation

Kasper D Rand, Thomas JD Jørgensen

Analytical Chemistry (2007-10-13) https://doi.org/c24d6z

DOI: 10.1021/ac0710782 · PMID: 17935303

87.

Hydroxyl Radical-Mediated Modification of Proteins as Probes for Structural Proteomics

Guozhong Xu, Mark R Chance

Chemical Reviews (2007-08-01) https://doi.org/c769n8

DOI: 10.1021/cr0682047 · PMID: 17683160

88.

Structural Mass Spectrometry of Proteins Using Hydroxyl Radical Based Protein Footprinting

Liwen Wang, Mark R Chance

Analytical Chemistry (2011-08-01) https://doi.org/fvrx3k

DOI: 10.1021/ac200567u · PMID: 21770468 · PMCID: PMC3184339

89.

Mapping nucleic acid structure by hydroxyl radical cleavage

Thomas D Tullius, Jason A Greenbaum

Current Opinion in Chemical Biology (2005-04) https://doi.org/cdcbtp

DOI: 10.1016/j.cbpa.2005.02.009 · PMID: 15811796

90.

Probing DNA Structure with Hydroxyl Radicals

Thomas D Tullius

Current Protocols in Nucleic Acid Chemistry (2001-12) https://doi.org/bf493d

DOI: 10.1002/0471142700.nc0607s07 · PMID: 18428898

91.

Targeted DNA oxidation and trajectory of radical DNA using DFT based QM/MM dynamics

Pradip K Biswas, Sandipan Chakraborty

Nucleic Acids Research (2019-02-18) https://doi.org/gr3m6z

DOI: 10.1093/nar/gkz089 · PMID: 30773597 · PMCID: PMC6451130

92.

<scp>MS</scp> ‐Based Hydroxyl Radical Footprinting: Methodology and Application of Fast Photochemical Oxidation of Proteins ( <scp>FPOP</scp> )

Ben Niu, Michael L Gross

Mass Spectrometry‐Based Chemical Proteomics (2019-07-26) https://doi.org/gr3m6d

DOI: 10.1002/9781118970195.ch15

93.

Fenton and Fenton-like catalysts for electrochemical immunoassay: A mini review

Jiejie Feng, Changshun Chu, Zhanfang Ma

Electrochemistry Communications (2021-04) https://doi.org/gr3m6h

DOI: 10.1016/j.elecom.2021.106970

94.

Inactivation of MS2 coliphage in Fenton and Fenton-like systems: role of transition metals, hydrogen peroxide and sunlight

Jessica I Nieto-Juarez, Katarzyna Pierzchła, Andrzej Sienkiewicz, Tamar Kohn

Environmental Science & Technology (2010-03-31) https://doi.org/fmmv29

DOI: 10.1021/es903739f · PMID: 20356037

95.

The use of the methods of radiolysis to explore the mechanisms of free radical modifications in proteins

Chantal Houée-Levin, Krzysztof Bobrowski

Journal of Proteomics (2013-10) https://doi.org/f5kn8p

DOI: 10.1016/j.jprot.2013.02.014 · PMID: 23454334

96.

High voltage electrical discharges followed by deep eutectic solvents extraction for the valorization of pomegranate seeds (Punica granatum L.)

Ester Hernández-Corroto, Nadia Boussetta, María Luisa Marina, María Concepción García, Eugène Vorobiev

Innovative Food Science & Emerging Technologies (2022-07) https://doi.org/gr3m6j

DOI: 10.1016/j.ifset.2022.103055

97.

Structural proteomics: Topology and relative accessibility of plant lipid droplet associated proteins

Pascale Jolivet, Laure Aymé, Alexandre Giuliani, Frank Wien, Thierry Chardot, Yann Gohon

Journal of Proteomics (2017-10) https://doi.org/gcnk7p

DOI: 10.1016/j.jprot.2017.09.005 · PMID: 28918933

98.

Proteomic analysis of Saccharomyces cerevisiae response to plasma treatment

Višnja Stulić, Tomislava Vukušić, Ana Butorac, Dean Popović, Zoran Herceg

International Journal of Food Microbiology (2019-03) https://doi.org/gr3m6k

DOI: 10.1016/j.ijfoodmicro.2018.12.017 · PMID: 30639916

99.

Laser flash photolysis of hydrogen peroxide to oxidize protein solvent-accessible residues on the microsecond timescale

David M Hambly, Michael L Gross

Journal of the American Society for Mass Spectrometry (2005-12-01) https://doi.org/cjbbvw

DOI: 10.1016/j.jasms.2005.09.008 · PMID: 16263307

100.

Fast photochemical oxidation of proteins (FPOP): A powerful mass spectrometry–based structural proteomics tool

Danté T Johnson, Luciano H Di Stefano, Lisa M Jones

Journal of Biological Chemistry (2019-08) https://doi.org/ghzz8z

DOI: 10.1074/jbc.rev119.006218 · PMID: 31262727 · PMCID: PMC6690683

101.

Laser flash photochemical oxidation to locate heme binding and conformational changes in myoglobin

David Hambly, Michael Gross

International Journal of Mass Spectrometry (2007-01) https://doi.org/fvzqsq

DOI: 10.1016/j.ijms.2006.08.018

102.

Modifications generated by fast photochemical oxidation of proteins reflect the native conformations of proteins

Emily E Chea, Lisa M Jones

Protein Science (2018-04-14) https://doi.org/gdpkmn

DOI: 10.1002/pro.3408 · PMID: 29575296 · PMCID: PMC5980583

103.

Fast Photochemical Oxidation of Protein Footprints Faster than Protein Unfolding

Brian C Gau, Joshua S Sharp, Don L Rempel, Michael L Gross

Analytical Chemistry (2009-07-23) https://doi.org/djvkzx

DOI: 10.1021/ac901054w · PMID: 20337372 · PMCID: PMC3164994

104.

Protein painting reveals solvent-excluded drug targets hidden within native protein–protein interfaces

Alessandra Luchini, Virginia Espina, Lance A Liotta

Nature Communications (2014-07-22) https://doi.org/gr3m6t

DOI: 10.1038/ncomms5413 · PMID: 25048602 · PMCID: PMC4109009

105.

Protein painting, an optimized MS-based technique, reveals functionally relevant interfaces of the PD-1/PD-L1 complex and the YAP2/ZO-1 complex

Amanda Haymond, Douglass Dey, Rachel Carter, Angela Dailing, Vaishnavi Nara, Pranavi Nara, Sravani Venkatayogi, Mikell Paige, Lance Liotta, Alessandra Luchini

Journal of Biological Chemistry (2019-07) https://doi.org/ghmhrd

DOI: 10.1074/jbc.ra118.007310 · PMID: 31167787 · PMCID: PMC6643031

106.

Detecting Protein–Small Molecule Interactions Using Limited Proteolysis–Mass Spectrometry (LiP-MS)

Monika Pepelnjak, Natalie de Souza, Paola Picotti

Trends in Biochemical Sciences (2020-10) https://doi.org/gr3m6m

DOI: 10.1016/j.tibs.2020.05.006 · PMID: 32475682

107.

Measuring protein structural changes on a proteome-wide scale using limited proteolysis-coupled mass spectrometry

Simone Schopper, Abdullah Kahraman, Pascal Leuenberger, Yuehan Feng, Ilaria Piazza, Oliver Müller, Paul J Boersema, Paola Picotti

Nature Protocols (2017-10-26) https://doi.org/gcf7zn

DOI: 10.1038/nprot.2017.100 · PMID: 29072706

108.

Proteome-wide structural changes measured with limited proteolysis-mass spectrometry: an advanced protocol for high-throughput applications

Liliana Malinovska, Valentina Cappelletti, Devon Kohler, Ilaria Piazza, Tsung-Heng Tsai, Monika Pepelnjak, Patrick Stalder, Christian Dörig, Fabian Sesterhenn, Franziska Elsässer, … Paola Picotti

Nature Protocols (2022-12-16) https://doi.org/gr3m6v

DOI: 10.1038/s41596-022-00771-x · PMID: 36526727

109.

Structural basis of calmodulin modulation of the rod cyclic nucleotide-gated channel

Diane C A Barret, Dina Schuster, Matthew J Rodrigues, Alexander Leitner, Paola Picotti, Gebhard F X Schertler, U Benjamin Kaupp, Volodymyr M Korkhov, Jacopo Marino

Proceedings of the National Academy of Sciences (2023-04-03) https://doi.org/gs27gg

DOI: 10.1073/pnas.2300309120 · PMID: 37011209 · PMCID: PMC10104587

110.

https://www.eubopen.org/sites/www.eubopen.org/files/attachments/2022/LiP-MS%20protocol.pdf

111.

Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay.

Daniel Martinez Molina, Rozbeh Jafari, Marina Ignatushchenko, Takahiro Seki, EAndreas Larsson, Chen Dan, Lekshmy Sreekumar, Yihai Cao, Pär Nordlund

Science (New York, N.Y.) (2013-07-05) https://www.ncbi.nlm.nih.gov/pubmed/23828940

DOI: 10.1126/science.1233606 · PMID: 23828940

112.

CETSA in integrated proteomics studies of cellular processes

Nayana Prabhu, Lingyun Dai, Pär Nordlund

Current Opinion in Chemical Biology (2020-02) https://doi.org/gh9nqs

DOI: 10.1016/j.cbpa.2019.11.004 · PMID: 31838273

113.

Thermal proteome profiling for interrogating protein interactions

André Mateus, Nils Kurzawa, Isabelle Becher, Sindhuja Sridharan, Dominic Helm, Frank Stein, Athanasios Typas, Mikhail M Savitski

Molecular Systems Biology (2020-03) https://doi.org/gr3m62

DOI: 10.15252/msb.20199232 · PMID: 32133759 · PMCID: PMC7057112

114.

Thermal proteome profiling: Insights into protein modifications, associations, and functions

Cecile Le Sueur, Henrik M Hammarén, Sindhuja Sridharan, Mikhail M Savitski

Current Opinion in Chemical Biology (2022-12) https://doi.org/grhp63

DOI: 10.1016/j.cbpa.2022.102225 · PMID: 36368297

115.

Thermal Proteome Profiling Reveals the O-GlcNAc-Dependent Meltome

Dustin T King, Jesús E Serrano-Negrón, Yanping Zhu, Christopher L Moore, Matthew D Shoulders, Leonard J Foster, David J Vocadlo

Journal of the American Chemical Society (2022-03-01) https://doi.org/gqqm4n

DOI: 10.1021/jacs.1c10621 · PMID: 35230102 · PMCID: PMC8969899

116.

Target Discovery Using Thermal Proteome Profiling

Sindhuja Sridharan, Ina Günthner, Isabelle Becher, Mikhail Savitski, Marcus Bantscheff

Mass Spectrometry‐Based Chemical Proteomics (2019-07-26) https://doi.org/gr3m6c

DOI: 10.1002/9781118970195.ch11

117.

Quantitative proteomics: A strategic ally to map protein interaction networks

Miguel Marcilla, Juan Pablo Albar

IUBMB Life (2012-12-24) https://doi.org/f4gpwr

DOI: 10.1002/iub.1081 · PMID: 23281033

118.

Next-generation proteomics: towards an integrative view of proteome dynamics

AFMaarten Altelaar, Javier Munoz, Albert JR Heck

Nature Reviews Genetics (2012-12-04) https://doi.org/ghkhz2

DOI: 10.1038/nrg3356 · PMID: 23207911

119.

Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS

Markku Varjosalo, Roberto Sacco, Alexey Stukalov, Audrey van Drogen, Melanie Planyavsky, Simon Hauri, Ruedi Aebersold, Keiryn L Bennett, Jacques Colinge, Matthias Gstaiger, Giulio Superti-Furga

Nature Methods (2013-03-03) https://doi.org/f4t647

DOI: 10.1038/nmeth.2400 · PMID: 23455922

120.

The BioPlex Network: A Systematic Exploration of the Human Interactome

Edward L Huttlin, Lily Ting, Raphael J Bruckner, Fana Gebreab, Melanie P Gygi, John Szpyt, Stanley Tam, Gabriela Zarraga, Greg Colby, Kurt Baltier, … Steven P Gygi

Cell (2015-07) https://doi.org/f7kc5h

DOI: 10.1016/j.cell.2015.06.043 · PMID: 26186194 · PMCID: PMC4617211

121.

Architecture of the human interactome defines protein communities and disease networks

Edward L Huttlin, Raphael J Bruckner, Joao A Paulo, Joe R Cannon, Lily Ting, Kurt Baltier, Greg Colby, Fana Gebreab, Melanie P Gygi, Hannah Parzen, … JWade Harper

Nature (2017-05) https://doi.org/f96974

DOI: 10.1038/nature22366 · PMID: 28514442 · PMCID: PMC5531611

122.

Dual proteome-scale networks reveal cell-specific remodeling of the human interactome

Edward L Huttlin, Raphael J Bruckner, Jose Navarrete-Perea, Joe R Cannon, Kurt Baltier, Fana Gebreab, Melanie P Gygi, Alexandra Thornock, Gabriela Zarraga, Stanley Tam, … Steven P Gygi

Cell (2021-05) https://doi.org/gkcn2g

DOI: 10.1016/j.cell.2021.04.011 · PMID: 33961781 · PMCID: PMC8165030

123.

Engineered ascorbate peroxidase as a genetically encoded reporter for electron microscopy

Jeffrey D Martell, Thomas J Deerinck, Yasemin Sancak, Thomas L Poulos, Vamsi K Mootha, Gina E Sosinsky, Mark H Ellisman, Alice Y Ting

Nature Biotechnology (2012-10-21) https://doi.org/f4czsn

DOI: 10.1038/nbt.2375 · PMID: 23086203 · PMCID: PMC3699407

124.

Proteomic Mapping of Mitochondria in Living Cells via Spatially Restricted Enzymatic Tagging

Hyun-Woo Rhee, Peng Zou, Namrata D Udeshi, Jeffrey D Martell, Vamsi K Mootha, Steven A Carr, Alice Y Ting

Science (2013-03-15) https://doi.org/f4qdfc

DOI: 10.1126/science.1230593 · PMID: 23371551 · PMCID: PMC3916822

125.

Proteomic Mapping of the Human Mitochondrial Intermembrane Space in Live Cells via Ratiometric APEX Tagging

Victoria Hung, Peng Zou, Hyun-Woo Rhee, Namrata D Udeshi, Valentin Cracan, Tanya Svinkina, Steven A Carr, Vamsi K Mootha, Alice Y Ting

Molecular Cell (2014-07) https://doi.org/f6d4pk

DOI: 10.1016/j.molcel.2014.06.003 · PMID: 25002142 · PMCID: PMC4743503

126.

A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells

Kyle J Roux, Dae In Kim, Manfred Raida, Brian Burke

Journal of Cell Biology (2012-03-12) https://doi.org/f3wp8h

DOI: 10.1083/jcb.201112098 · PMID: 22412018 · PMCID: PMC3308701

127.

Proximity Dependent Biotinylation: Key Enzymes and Adaptation to Proteomics Approaches

Payman Samavarchi-Tehrani, Reuben Samson, Anne-Claude Gingras

Molecular & Cellular Proteomics (2020-05) https://doi.org/gr3r3r

DOI: 10.1074/mcp.r120.001941 · PMID: 32127388 · PMCID: PMC7196579

128.

Meet the neighbors: Mapping local protein interactomes by proximity‐dependent labeling with BioID

Renata Varnaitė, Stuart A MacNeill

PROTEOMICS (2016-07-27) https://doi.org/f3qr9p

DOI: 10.1002/pmic.201600123 · PMID: 27329485 · PMCID: PMC5053326

129.

An improved smaller biotin ligase for BioID proximity labeling

Dae In Kim, Samuel C Jensen, Kyle A Noble, Birendra KC, Kenneth H Roux, Khatereh Motamedchaboki, Kyle J Roux

Molecular Biology of the Cell (2016-04-15) https://doi.org/f8ndt9

DOI: 10.1091/mbc.e15-12-0844 · PMID: 26912792 · PMCID: PMC4831873

130.

BioID: A Proximity-Dependent Labeling Approach in Proteomics Study

Peipei Li, Yuan Meng, Li Wang, Li-jun Di

Functional Proteomics (2018-10-02) https://doi.org/gr3m6f

DOI: 10.1007/978-1-4939-8814-3_10 · PMID: 30276738

131.

Guide to protein purification

Richard R Burgess, Murray P Deutscher

Elsevier/Academic Press (2009)

ISBN: 9780123745361

132.

The protein protocols handbook

John M Walker (editor)

Humana Press (2009)

ISBN: 9781597451987

133.

Strategies and considerations for protein purifications.

Stuart Linn

Methods in enzymology (2009) https://www.ncbi.nlm.nih.gov/pubmed/19892162

DOI: 10.1016/s0076-6879(09)63002-0 · PMID: 19892162

134.

Proteins and proteomics: a laboratory manual

Richard J Simpson (editor)

Cold Spring Harbor Laboratory Press (2003)

ISBN: 9780879695538

135.

Effective interactions between chaotropic agents and proteins.

Giovanni Salvi, Paolo De Los Rios, Michele Vendruscolo

Proteins (2005-11-15) https://www.ncbi.nlm.nih.gov/pubmed/16152629

DOI: 10.1002/prot.20626 · PMID: 16152629

136.

A quantitative study of the effects of chaotropic agents, surfactants, and solvents on the digestion efficiency of human plasma proteins by trypsin.

Jennifer L Proc, Michael A Kuzyk, Darryl B Hardie, Juncong Yang, Derek S Smith, Angela M Jackson, Carol E Parker, Christoph H Borchers

Journal of proteome research (2010-10-01) https://www.ncbi.nlm.nih.gov/pubmed/20722421

DOI: 10.1021/pr100656u · PMID: 20722421 · PMCID: PMC2996461

137.

Best practices and benchmarks for intact protein analysis for top-down mass spectrometry.

Daniel P Donnelly, Catherine M Rawlins, Caroline J DeHart, Luca Fornelli, Luis F Schachner, Ziqing Lin, Jennifer L Lippens, Krishna C Aluri, Richa Sarin, Bifan Chen, … Jeffrey N Agar

Nature methods (2019-06-27) https://www.ncbi.nlm.nih.gov/pubmed/31249407

DOI: 10.1038/s41592-019-0457-0 · PMID: 31249407 · PMCID: PMC6719561

138.

Inhibition of protein carbamylation in urea solution using ammonium-containing buffers.

Shisheng Sun, Jian-Ying Zhou, Weiming Yang, Hui Zhang

Analytical biochemistry (2013-10-23) https://www.ncbi.nlm.nih.gov/pubmed/24161613

DOI: 10.1016/j.ab.2013.10.024 · PMID: 24161613 · PMCID: PMC4072244

139.

Integrated analysis of gene expression, CpG island methylation, and gene copy number in breast cancer cells by deep sequencing.

Zhifu Sun, Yan W Asmann, Krishna R Kalari, Brian Bot, Jeanette E Eckel-Passow, Tiffany R Baker, Jennifer M Carr, Irina Khrebtukova, Shujun Luo, Lu Zhang, … EAubrey Thompson

PloS one (2011-02-25) https://www.ncbi.nlm.nih.gov/pubmed/21364760

DOI: 10.1371/journal.pone.0017490 · PMID: 21364760 · PMCID: PMC3045451

140.

A generic protein purification method for protein complex characterization and proteome exploration.

G Rigaut, A Shevchenko, B Rutz, M Wilm, M Mann, B Séraphin

Nature biotechnology (1999-10) https://www.ncbi.nlm.nih.gov/pubmed/10504710

DOI: 10.1038/13732 · PMID: 10504710

141.

New mass-spectrometry-compatible degradable surfactant for tissue proteomics.

Ying-Hua Chang, Zachery R Gregorich, Albert J Chen, Leekyoung Hwang, Huseyin Guner, Deyang Yu, Jianyi Zhang, Ying Ge

Journal of proteome research (2015-01-30) https://www.ncbi.nlm.nih.gov/pubmed/25589168

DOI: 10.1021/pr5012679 · PMID: 25589168 · PMCID: PMC4384424

142.

Photocleavable Surfactant-Enabled Extracellular Matrix Proteomics.

Samantha J Knott, Kyle A Brown, Harini Josyer, Austin Carr, David Inman, Song Jin, Andreas Friedl, Suzanne M Ponik, Ying Ge

Analytical chemistry (2020-11-24) https://www.ncbi.nlm.nih.gov/pubmed/33232116

DOI: 10.1021/acs.analchem.0c03104 · PMID: 33232116 · PMCID: PMC7961849

143.

Investigation of solubilization and digestion methods for microsomal membrane proteome analysis using data-independent LC-MSE.

Flaubert Mbeunkui, Michael B Goshe

Proteomics (2011-01-31) https://www.ncbi.nlm.nih.gov/pubmed/21280217

DOI: 10.1002/pmic.200900698 · PMID: 21280217

144.

Sodium laurate, a novel protease- and mass spectrometry-compatible detergent for mass spectrometry-based membrane proteomics.

Yong Lin, Linju Huo, Zhonghua Liu, Jianglin Li, Yi Liu, Quanze He, Xianchun Wang, Songping Liang

PloS one (2013-03-28) https://www.ncbi.nlm.nih.gov/pubmed/23555778

DOI: 10.1371/journal.pone.0059779 · PMID: 23555778 · PMCID: PMC3610932

145.

Evaluation of the application of sodium deoxycholate to proteomic analysis of rat hippocampal plasma membrane.

Jian Zhou, Tieyang Zhou, Rui Cao, Zhen Liu, Jianying Shen, Ping Chen, Xianchun Wang, Songping Liang

Journal of proteome research (2006-10) https://www.ncbi.nlm.nih.gov/pubmed/17022626

DOI: 10.1021/pr060112a · PMID: 17022626

146.

Identification of Poly(ethylene glycol) and Poly(ethylene glycol)-Based Detergents Using Peptide Search Engines.

Shiva Ahmadi, Dominic Winter

Analytical chemistry (2018-05-15) https://www.ncbi.nlm.nih.gov/pubmed/29726681

DOI: 10.1021/acs.analchem.8b00365 · PMID: 29726681

147.

Quantitative assessment of in-solution digestion efficiency identifies optimal protocols for unbiased protein analysis.

Ileana R León, Veit Schwämmle, Ole N Jensen, Richard R Sprenger

Molecular & cellular proteomics : MCP (2013-06-21) https://www.ncbi.nlm.nih.gov/pubmed/23792921

DOI: 10.1074/mcp.m112.025585 · PMID: 23792921 · PMCID: PMC3790306

148.

Proteomic challenges: sample preparation techniques for microgram-quantity protein analysis from biological samples.

Peter Feist, Amanda B Hummon

International journal of molecular sciences (2015-02-05) https://www.ncbi.nlm.nih.gov/pubmed/25664860

DOI: 10.3390/ijms16023537 · PMID: 25664860 · PMCID: PMC4346912

149.

An overview of cell disruption methods for intracellular biomolecules recovery

Tatiane Aparecida Gomes, Cristina Maria Zanette, Michele Rigon Spier

Preparative Biochemistry & Biotechnology (2020-02-19) https://doi.org/gqpdr5

DOI: 10.1080/10826068.2020.1728696 · PMID: 32074000

150.

Mechanical forces used for cell fractionation can create hybrid membrane vesicles.

Izhar Salomon, Hans Janssen, Jacques Neefjes

International journal of biological sciences (2010-10-20) https://www.ncbi.nlm.nih.gov/pubmed/21060726

DOI: 10.7150/ijbs.6.649 · PMID: 21060726 · PMCID: PMC2974167

151.

Lyophilization and homogenization of biological samples improves reproducibility and reduces standard deviation in molecular biology techniques.

Agnes Molnar, Tamas Lakat, Adam Hosszu, Beata Szebeni, Anna Balogh, Laszlo Orfi, Attila J Szabo, Andrea Fekete, Judit Hodrea

Amino acids (2021-05-17) https://www.ncbi.nlm.nih.gov/pubmed/34002278

DOI: 10.1007/s00726-021-02994-w · PMID: 34002278 · PMCID: PMC8128086

152.

Assays for determination of protein concentration.

Bradley JSC Olson, John Markwell

Current protocols in protein science (2007-05) https://www.ncbi.nlm.nih.gov/pubmed/18429326

DOI: 10.1002/0471140864.ps0304s48 · PMID: 18429326

153.

Development and characterization of the NanoOrange protein quantitation assay: a fluorescence-based assay of proteins in solution.

Laurie J Jones, Richard P Haugland, Victoria L Singer

BioTechniques (2003-04) https://www.ncbi.nlm.nih.gov/pubmed/12703310

DOI: 10.2144/03344pt03 · PMID: 12703310

154.

Fast and Sensitive Total Protein and Peptide Assays for Proteomic Analysis

Jacek R Wiśniewski, Fabienne Z Gaugaz

Analytical Chemistry (2015-04-09) https://doi.org/f3nsk2

DOI: 10.1021/ac504689z · PMID: 25837572

155.

Evaluation of colorimetric assays for analyzing reductively methylated proteins: Biases and mechanistic insights.

Pamlea N Brady, Megan A Macnaughtan

Analytical biochemistry (2015-09-03) https://www.ncbi.nlm.nih.gov/pubmed/26342307

DOI: 10.1016/j.ab.2015.08.027 · PMID: 26342307 · PMCID: PMC4631703

156.

Quantification of Intrinsically Disordered Proteins: A Problem Not Fully Appreciated.

Sara Contreras-Martos, Hung H Nguyen, Phuong N Nguyen, Nevena Hristozova, Mauricio Macossay-Castillo, Denes Kovacs, Angela Bekesi, Jesper S Oemig, Dominique Maes, Kris Pauwels, … Pierre Lebrun

Frontiers in molecular biosciences (2018-09-04) https://www.ncbi.nlm.nih.gov/pubmed/30234128

DOI: 10.3389/fmolb.2018.00083 · PMID: 30234128 · PMCID: PMC6131523

157.

Evaluation and optimization of reduction and alkylation methods to maximize peptide identification with MS-based proteomics.

Suttipong Suttapitugsakul, Haopeng Xiao, Johanna Smeekens, Ronghu Wu

Molecular bioSystems (2017-11-21) https://www.ncbi.nlm.nih.gov/pubmed/29019370

DOI: 10.1039/c7mb00393e · PMID: 29019370 · PMCID: PMC5698164

158.

A simplified procedure for the reduction and alkylation of cysteine residues in proteins prior to proteolytic digestion and mass spectral analysis.

John E Hale, Jon P Butler, Valentina Gelfanova, Jin-Sam You, Michael D Knierman

Analytical biochemistry (2004-10-01) https://www.ncbi.nlm.nih.gov/pubmed/15351294

DOI: 10.1016/j.ab.2004.04.013 · PMID: 15351294

159.

Systematic Evaluation of Protein Reduction and Alkylation Reveals Massive Unspecific Side Effects by Iodine-containing Reagents.

Torsten Müller, Dominic Winter

Molecular & cellular proteomics : MCP (2017-05-24) https://www.ncbi.nlm.nih.gov/pubmed/28539326

DOI: 10.1074/mcp.m116.064048 · PMID: 28539326 · PMCID: PMC5500753

160.

Discovery of a Redox Thiol Switch: Implications for Cellular Energy Metabolism.

Xing-Huang Gao, Ling Li, Marc Parisien, Jing Wu, Ilya Bederman, Zhaofeng Gao, Dawid Krokowski, Steven M Chirieleison, Derek Abbott, Benlian Wang, … Maria Hatzoglou

Molecular & cellular proteomics : MCP (2020-03-04) https://www.ncbi.nlm.nih.gov/pubmed/32132231

DOI: 10.1074/mcp.ra119.001910 · PMID: 32132231 · PMCID: PMC7196587

161.

Residue Modification and Mass Spectrometry for the Investigation of Structural and Metalation Properties of Metallothionein and Cysteine-Rich Proteins.

Gordon W Irvine, Martin J Stillman

International journal of molecular sciences (2017-04-26) https://www.ncbi.nlm.nih.gov/pubmed/28445428

DOI: 10.3390/ijms18050913 · PMID: 28445428 · PMCID: PMC5454826

162.

Chasing cysteine oxidative modifications: proteomic tools for characterizing cysteine redox status.

Christopher I Murray, Jennifer E Van Eyk

Circulation. Cardiovascular genetics (2012-10-01) https://www.ncbi.nlm.nih.gov/pubmed/23074338

DOI: 10.1161/circgenetics.111.961425 · PMID: 23074338 · PMCID: PMC3500588

163.

Comparison of protein precipitation methods for sample preparation prior to proteomic analysis.

Lei Jiang, Lin He, Michael Fountoulakis

Journal of chromatography. A (2004-01-16) https://www.ncbi.nlm.nih.gov/pubmed/14753699

DOI: 10.1016/j.chroma.2003.10.029 · PMID: 14753699

164.

Protein precipitation techniques.

Richard R Burgess

Methods in enzymology (2009) https://www.ncbi.nlm.nih.gov/pubmed/19892180

DOI: 10.1016/s0076-6879(09)63020-2 · PMID: 19892180

165.

Facile Preparation of Peptides for Mass Spectrometry Analysis in Bottom-Up Proteomics Workflows.

Melinda Wojtkiewicz, Linda Berg Luecke, Maia I Kelly, Rebekah L Gundry

Current protocols (2021-03) https://www.ncbi.nlm.nih.gov/pubmed/33750040

DOI: 10.1002/cpz1.85 · PMID: 33750040 · PMCID: PMC8011989

166.

Universal sample preparation method for proteome analysis.

Jacek R Wiśniewski, Alexandre Zougman, Nagarjuna Nagaraj, Matthias Mann

Nature methods (2009-04-19) https://www.ncbi.nlm.nih.gov/pubmed/19377485

DOI: 10.1038/nmeth.1322 · PMID: 19377485

167.

Filter-Aided Sample Preparation for Proteome Analysis.

Jacek R Wiśniewski

Methods in molecular biology (Clifton, N.J.) (2018) https://www.ncbi.nlm.nih.gov/pubmed/30259475

DOI: 10.1007/978-1-4939-8695-8_1 · PMID: 30259475

168.

[Group and type distribution of hemolytic streptococci isolated from clinical specimens--prevalence of group A type 3 isolates in 1985 in Toyama Prefecture].

H Kodama, N Tokuman, I Yasui, Y Gyobu, Y Kashiwagi

Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases (1987-04) https://www.ncbi.nlm.nih.gov/pubmed/3117935

DOI: 10.11150/kansenshogakuzasshi1970.61.482 · PMID: 3117935

169.

Evaluation of FASP, SP3, and iST Protocols for Proteomic Sample Preparation in the Low Microgram Range.

Malte Sielaff, Jörg Kuharev, Toszka Bohn, Jennifer Hahlbrock, Tobias Bopp, Stefan Tenzer, Ute Distler

Journal of proteome research (2017-10-11) https://www.ncbi.nlm.nih.gov/pubmed/28948796

DOI: 10.1021/acs.jproteome.7b00433 · PMID: 28948796

170.

Protein Aggregation Capture on Microparticles Enables Multipurpose Proteomics Sample Preparation.

Tanveer S Batth, MaximA X Tollenaere, Patrick Rüther, Alba Gonzalez-Franquesa, Bhargav S Prabhakar, Simon Bekker-Jensen, Atul S Deshmukh, Jesper V Olsen

Molecular & cellular proteomics : MCP (2019-03-04) https://www.ncbi.nlm.nih.gov/pubmed/30833379

DOI: 10.1074/mcp.tir118.001270 · PMID: 30833379 · PMCID: PMC6495262

171.

Comparison of In-Solution, FASP, and S-Trap Based Digestion Methods for Bottom-Up Proteomic Studies.

Katelyn R Ludwig, Monica M Schroll, Amanda B Hummon

Journal of proteome research (2018-05-24) https://www.ncbi.nlm.nih.gov/pubmed/29754492

DOI: 10.1021/acs.jproteome.8b00235 · PMID: 29754492 · PMCID: PMC9319029

172.

Phase transfer surfactant-aided trypsin digestion for membrane proteome analysis.

Takeshi Masuda, Masaru Tomita, Yasushi Ishihama

Journal of proteome research (2008-02) https://www.ncbi.nlm.nih.gov/pubmed/18183947

DOI: 10.1021/pr700658q · PMID: 18183947

173.

Colorimetric protein assay techniques.

CV Sapan, RL Lundblad, NC Price

Biotechnology and applied biochemistry (1999-04) https://www.ncbi.nlm.nih.gov/pubmed/10075906

PMID: 10075906

174.

Measurement of protein using bicinchoninic acid.

PK Smith, RI Krohn, GT Hermanson, AK Mallia, FH Gartner, MD Provenzano, EK Fujimoto, NM Goeke, BJ Olson, DC Klenk

Analytical biochemistry (1985-10) https://www.ncbi.nlm.nih.gov/pubmed/3843705

DOI: 10.1016/0003-2697(85)90442-7 · PMID: 3843705

175.

The bicinchoninic acid (BCA) assay for protein quantitation.

JM Walker

Methods in molecular biology (Clifton, N.J.) (1994) https://www.ncbi.nlm.nih.gov/pubmed/7951748

DOI: 10.1385/0-89603-268-x:5 · PMID: 7951748

176.

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

MM Bradford

Analytical biochemistry (1976-05-07) https://www.ncbi.nlm.nih.gov/pubmed/942051

DOI: 10.1006/abio.1976.9999 · PMID: 942051

177.

Bradford Assay for Determining Protein Concentration.

Clara L Kielkopf, William Bauer, Ina L Urbatsch

Cold Spring Harbor protocols (2020-04-01) https://www.ncbi.nlm.nih.gov/pubmed/32238597

DOI: 10.1101/pdb.prot102269 · PMID: 32238597

178.

An assay for the measurement of the protein content of cells immobilized in carrageenan.

A Jones, T Razniewska, BH Lesser, R Siqueira, D Berk, LA Behie, GM Gaucher

Canadian journal of microbiology (1984-04) https://www.ncbi.nlm.nih.gov/pubmed/6744121

DOI: 10.1139/m84-069 · PMID: 6744121

179.

UV-Vis Spectra-Activated Droplet Sorting for Label-Free Chemical Identification and Collection of Droplets.

Todd A Duncombe, Aaron Ponti, Florian P Seebeck, Petra S Dittrich

Analytical chemistry (2021-09-17) https://www.ncbi.nlm.nih.gov/pubmed/34533299

DOI: 10.1021/acs.analchem.1c02822 · PMID: 34533299

180.

Fast and sensitive total protein and Peptide assays for proteomic analysis.

Jacek R Wiśniewski, Fabienne Z Gaugaz

Analytical chemistry (2015-04-09) https://www.ncbi.nlm.nih.gov/pubmed/25837572

DOI: 10.1021/ac504689z · PMID: 25837572

181.

3-(4-Carboxybenzoyl)quinoline-2-carboxaldehyde, a reagent with broad dynamic range for the assay of proteins and lipoproteins in solution.

WW You, RP Haugland, DK Ryan, RP Haugland

Analytical biochemistry (1997-01-15) https://www.ncbi.nlm.nih.gov/pubmed/9025944

DOI: 10.1006/abio.1996.9920 · PMID: 9025944

182.

Getting intimate with trypsin, the leading protease in proteomics

Elien Vandermarliere, Michael Mueller, Lennart Martens

Mass Spectrometry Reviews (2013-06-15) https://doi.org/gn64qb

DOI: 10.1002/mas.21376 · PMID: 23775586

183.

Value of using multiple proteases for large-scale mass spectrometry-based proteomics.

Danielle L Swaney, Craig D Wenger, Joshua J Coon

Journal of proteome research (2010-03-05) https://www.ncbi.nlm.nih.gov/pubmed/20113005

DOI: 10.1021/pr900863u · PMID: 20113005 · PMCID: PMC2833215

184.

Proteomics beyond trypsin.

Liana Tsiatsiani, Albert JR Heck

The FEBS journal (2015-04-14) https://www.ncbi.nlm.nih.gov/pubmed/25823410

DOI: 10.1111/febs.13287 · PMID: 25823410

185.

Jesse G Meyer

ISRN computational biology (2014-04-22) https://www.ncbi.nlm.nih.gov/pubmed/30687733

DOI: 10.1155/2014/960902 · PMID: 30687733 · PMCID: PMC6347401

186.

In SilicoProteome Cleavage Reveals Iterative Digestion Strategy for High Sequence Coverage

Jesse G Meyer

ISRN Computational Biology (2014-04-22) https://doi.org/gb6s2r

DOI: 10.1155/2014/960902 · PMID: 30687733 · PMCID: PMC6347401

187.

Multiple enzymatic digestion for enhanced sequence coverage of proteins in complex proteomic mixtures using capillary LC with ion trap MS/MS.

Gargi Choudhary, Shiaw-Lin Wu, Paul Shieh, William S Hancock

Journal of proteome research (2003) https://www.ncbi.nlm.nih.gov/pubmed/12643544

DOI: 10.1021/pr025557n · PMID: 12643544

188.

Six alternative proteases for mass spectrometry-based proteomics beyond trypsin.

Piero Giansanti, Liana Tsiatsiani, Teck Yew Low, Albert JR Heck

Nature protocols (2016-04-28) https://www.ncbi.nlm.nih.gov/pubmed/27123950

DOI: 10.1038/nprot.2016.057 · PMID: 27123950

189.

Combination of Proteogenomics with Peptide

B Blank-Landeshammer, I Teichert, R Märker, M Nowrousian, U Kück, A Sickmann

mBio (2019-10-15) https://www.ncbi.nlm.nih.gov/pubmed/31615963

DOI: 10.1128/mbio.02367-19 · PMID: 31615963 · PMCID: PMC6794485

190.

Precision

Hao Yang, Yan-Chang Li, Ming-Zhi Zhao, Fei-Lin Wu, Xi Wang, Wei-Di Xiao, Yi-Hao Wang, Jun-Ling Zhang, Fu-Qiang Wang, Feng Xu, … Ping Xu

Molecular & cellular proteomics : MCP (2019-01-08) https://www.ncbi.nlm.nih.gov/pubmed/30622160

DOI: 10.1074/mcp.tir118.000918 · PMID: 30622160 · PMCID: PMC6442358

191.

Mass spectrometry-assisted venom profiling of Hypnale hypnale found in the Western Ghats of India incorporating de novo sequencing approaches.

Muralidharan Vanuopadath, Nithin Sajeev, Athira Radhamony Murali, Nayana Sudish, Nithya Kangosseri, Ivy Rose Sebastian, Nidhi Dalpatraj Jain, Amit Pal, Dileepkumar Raveendran, Bipin Gopalakrishnan Nair, Sudarslal Sadasivan Nair

International journal of biological macromolecules (2018-07-07) https://www.ncbi.nlm.nih.gov/pubmed/29990557

DOI: 10.1016/j.ijbiomac.2018.07.016 · PMID: 29990557

192.

Venomics and antivenomics of Indian spectacled cobra (Naja naja) from the Western Ghats

Muralidharan Vanuopadath, Dileepkumar Raveendran, Bipin Gopalakrishnan Nair, Sudarslal Sadasivan Nair

Acta Tropica (2022-04) https://doi.org/gpbzf7

DOI: 10.1016/j.actatropica.2022.106324 · PMID: 35093326

193.

Sequencing-Grade De novo Analysis of MS/MS Triplets (CID/HCD/ETD) From Overlapping Peptides

Adrian Guthals, Karl R Clauser, Ari M Frank, Nuno Bandeira

Journal of Proteome Research (2013-05-30) https://doi.org/f47kqd

DOI: 10.1021/pr400173d · PMID: 23679345 · PMCID: PMC4591044

194.

Multiple-Enzyme-Digestion Strategy Improves Accuracy and Sensitivity of Label- and Standard-Free Absolute Quantification to a Level That Is Achievable by Analysis with Stable Isotope-Labeled Standard Spiking.

Jacek R Wiśniewski, Christine Wegler, Per Artursson

Journal of proteome research (2018-10-30) https://www.ncbi.nlm.nih.gov/pubmed/30336047

DOI: 10.1021/acs.jproteome.8b00549 · PMID: 30336047

195.

Improved Protein Inference from Multiple Protease Bottom-Up Mass Spectrometry Data

Rachel M Miller, Robert J Millikin, Connor V Hoffmann, Stefan K Solntsev, Gloria M Sheynkman, Michael R Shortreed, Lloyd M Smith

Journal of Proteome Research (2019-08-04) https://doi.org/gpqmp2

DOI: 10.1021/acs.jproteome.9b00330 · PMID: 31378069 · PMCID: PMC6733628

196.

Multi-protease Approach for the Improved Identification and Molecular Characterization of Small Proteins and Short Open Reading Frame-Encoded Peptides

Philipp T Kaulich, Liam Cassidy, Jürgen Bartel, Ruth A Schmitz, Andreas Tholey

Journal of Proteome Research (2021-03-24) https://doi.org/gpqmpz

DOI: 10.1021/acs.jproteome.1c00115 · PMID: 33760615

197.

A Multiple Protease Strategy to Optimise the Shotgun Proteomics of Mature Medicinal Cannabis Buds

Delphine Vincent, Vilnis Ezernieks, Simone Rochfort, German Spangenberg

International Journal of Molecular Sciences (2019-11-11) https://doi.org/gpqmp3

DOI: 10.3390/ijms20225630 · PMID: 31717952 · PMCID: PMC6888629

198.

Confetti: A Multiprotease Map of the HeLa Proteome for Comprehensive Proteomics

Xiaofeng Guo, David C Trudgian, Andrew Lemoff, Sivaramakrishna Yadavalli, Hamid Mirzaei

Molecular & Cellular Proteomics (2014-06) https://doi.org/f56bwx

DOI: 10.1074/mcp.m113.035170 · PMID: 24696503 · PMCID: PMC4047476

199.

An Augmented Multiple-Protease-Based Human Phosphopeptide Atlas

Piero Giansanti, Thin Thin Aye, Henk van den Toorn, Mao Peng, Bas van Breukelen, Albert JR Heck

Cell Reports (2015-06) https://doi.org/gpqmpx

DOI: 10.1016/j.celrep.2015.05.029 · PMID: 26074081

200.

Use of endoproteinase Lys-C from Lysobacter enzymogenes in protein sequence analysis.

PA Jekel, WJ Weijer, JJ Beintema

Analytical biochemistry (1983-10-15) https://www.ncbi.nlm.nih.gov/pubmed/6359954

DOI: 10.1016/0003-2697(83)90308-1 · PMID: 6359954

201.

Large-scale quantitative assessment of different in-solution protein digestion protocols reveals superior cleavage efficiency of tandem Lys-C/trypsin proteolysis over trypsin digestion.

Timo Glatter, Christina Ludwig, Erik Ahrné, Ruedi Aebersold, Albert JR Heck, Alexander Schmidt

Journal of proteome research (2012-10-16) https://www.ncbi.nlm.nih.gov/pubmed/23017020

DOI: 10.1021/pr300273g · PMID: 23017020

202.

The alpha-lytic protease gene of Lysobacter enzymogenes. The nucleotide sequence predicts a large prepro-peptide with homology to pro-peptides of other chymotrypsin-like enzymes.

DM Epstein, PC Wensink

The Journal of biological chemistry (1988-11-15) https://www.ncbi.nlm.nih.gov/pubmed/3053694

PMID: 3053694

203.

Purification and properties of an extracellular protease of Staphylococcus aureus.

GR Drapeau, Y Boily, J Houmard

The Journal of biological chemistry (1972-10-25) https://www.ncbi.nlm.nih.gov/pubmed/4627743

PMID: 4627743

204.

Mildly acidic conditions eliminate deamidation artifact during proteolysis: digestion with endoprotease Glu-C at pH 4.5.

Shanshan Liu, Kevin Ryan Moulton, Jared Robert Auclair, Zhaohui Sunny Zhou

Amino acids (2016-01-09) https://www.ncbi.nlm.nih.gov/pubmed/26748652

DOI: 10.1007/s00726-015-2166-z · PMID: 26748652 · PMCID: PMC4795971

205.

Specificity of endoproteinase Asp-N (Pseudomonas fragi): cleavage at glutamyl residues in two proteins.

D Ingrosso, AV Fowler, J Bleibaum, S Clarke

Biochemical and biophysical research communications (1989-08-15) https://www.ncbi.nlm.nih.gov/pubmed/2669754

DOI: 10.1016/0006-291x(89)90848-6 · PMID: 2669754

206.

Chymotrypsin: molecular and catalytic properties.

W Appel

Clinical biochemistry (1986-12) https://www.ncbi.nlm.nih.gov/pubmed/3555886

DOI: 10.1016/s0009-9120(86)80002-9 · PMID: 3555886

207.

Mass-spectrometry-based draft of the human proteome.

Mathias Wilhelm, Judith Schlegl, Hannes Hahne, Amin Moghaddas Gholami, Marcus Lieberenz, Mikhail M Savitski, Emanuel Ziegler, Lars Butzmann, Siegfried Gessulat, Harald Marx, … Bernhard Kuster

Nature (2014-05-29) https://www.ncbi.nlm.nih.gov/pubmed/24870543

DOI: 10.1038/nature13319 · PMID: 24870543

208.

Confetti: a multiprotease map of the HeLa proteome for comprehensive proteomics.

Xiaofeng Guo, David C Trudgian, Andrew Lemoff, Sivaramakrishna Yadavalli, Hamid Mirzaei

Molecular & cellular proteomics : MCP (2014-04-02) https://www.ncbi.nlm.nih.gov/pubmed/24696503

DOI: 10.1074/mcp.m113.035170 · PMID: 24696503 · PMCID: PMC4047476

209.

Quantitative and qualitative proteome characteristics extracted from in-depth integrated genomics and proteomics analysis.

Teck Yew Low, Sebastiaan van Heesch, Henk van den Toorn, Piero Giansanti, Alba Cristobal, Pim Toonen, Sebastian Schafer, Norbert Hübner, Bas van Breukelen, Shabaz Mohammed, … Victor Guryev

Cell reports (2013-11-27) https://www.ncbi.nlm.nih.gov/pubmed/24290761

DOI: 10.1016/j.celrep.2013.10.041 · PMID: 24290761

210.

Protease bias in absolute protein quantitation.

Mao Peng, Nadia Taouatas, Salvatore Cappadona, Bas van Breukelen, Shabaz Mohammed, Arjen Scholten, Albert JR Heck

Nature methods (2012-05-30) https://www.ncbi.nlm.nih.gov/pubmed/22669647

DOI: 10.1038/nmeth.2031 · PMID: 22669647

211.

Studies on the active site of clostripain. The specific inactivation by the chloromethyl ketone derived from -N-tosyl-L-lysine.

WH Porter, LW Cunningham, WM Mitchell

The Journal of biological chemistry (1971-12-25) https://www.ncbi.nlm.nih.gov/pubmed/4332560

PMID: 4332560

212.

LysargiNase mirrors trypsin for protein C-terminal and methylation-site identification.

Pitter F Huesgen, Philipp F Lange, Lindsay D Rogers, Nestor Solis, Ulrich Eckhard, Oded Kleifeld, Theodoros Goulas, FXavier Gomis-Rüth, Christopher M Overall

Nature methods (2014-11-24) https://www.ncbi.nlm.nih.gov/pubmed/25419962

DOI: 10.1038/nmeth.3177 · PMID: 25419962

213.

Proteomic analyses using Grifola frondosa metalloendoprotease Lys-N.

Laura Hohmann, Carly Sherwood, Ashley Eastham, Amelia Peterson, Jimmy K Eng, James S Eddes, David Shteynberg, Daniel B Martin

Journal of proteome research (2009-03) https://www.ncbi.nlm.nih.gov/pubmed/19195997

DOI: 10.1021/pr800774h · PMID: 19195997 · PMCID: PMC2798736

214.

Straightforward ladder sequencing of peptides using a Lys-N metalloendopeptidase.

Nadia Taouatas, Madalina M Drugan, Albert JR Heck, Shabaz Mohammed

Nature methods (2008-04-20) https://www.ncbi.nlm.nih.gov/pubmed/18425140

DOI: 10.1038/nmeth.1204 · PMID: 18425140

215.

Cleavage specificities of the brother and sister proteases Lys-C and Lys-N.

Reinout Raijmakers, Pieter Neerincx, Shabaz Mohammed, Albert JR Heck

Chemical communications (Cambridge, England) (2010-10-18) https://www.ncbi.nlm.nih.gov/pubmed/20953479

DOI: 10.1039/c0cc02523b · PMID: 20953479

216.

A history of pepsin and related enzymes.

Joseph S Fruton

The Quarterly review of biology (2002-06) https://www.ncbi.nlm.nih.gov/pubmed/12089768

DOI: 10.1086/340729 · PMID: 12089768

217.

CRYSTALLINE PEPSIN : I. ISOLATION AND TESTS OF PURITY.

JH Northrop

The Journal of general physiology (1930-07-20) https://www.ncbi.nlm.nih.gov/pubmed/19872561

DOI: 10.1085/jgp.13.6.739 · PMID: 19872561 · PMCID: PMC2141071

218.

CRYSTALLINE PEPSIN : II. GENERAL PROPERTIES AND EXPERIMENTAL METHODS.

JH Northrop

The Journal of general physiology (1930-07-20) https://www.ncbi.nlm.nih.gov/pubmed/19872562

DOI: 10.1085/jgp.13.6.767 · PMID: 19872562 · PMCID: PMC2141088

219.

CRYSTALLINE PEPSIN.

JH Northrop

Science (New York, N.Y.) (1929-05-31) https://www.ncbi.nlm.nih.gov/pubmed/17758437

DOI: 10.1126/science.69.1796.580 · PMID: 17758437

220.

The Nobel Prize in Chemistry 1946

NobelPrize.org

https://www.nobelprize.org/prizes/chemistry/1946/speedread/

221.

Protein disulfide bond determination by mass spectrometry.

Jeffrey J Gorman, Tristan P Wallis, James J Pitt

Mass spectrometry reviews (2002) https://www.ncbi.nlm.nih.gov/pubmed/12476442

DOI: 10.1002/mas.10025 · PMID: 12476442

222.

Facilitating protein disulfide mapping by a combination of pepsin digestion, electron transfer higher energy dissociation (EThcD), and a dedicated search algorithm SlinkS.

Fan Liu, Bas van Breukelen, Albert JR Heck

Molecular & cellular proteomics : MCP (2014-06-30) https://www.ncbi.nlm.nih.gov/pubmed/24980484

DOI: 10.1074/mcp.o114.039057 · PMID: 24980484 · PMCID: PMC4189002

223.

Online, High-Pressure Digestion System for Protein Characterization by Hydrogen/Deuterium Exchange and Mass Spectrometry

Lisa M Jones, Hao Zhang, Ilan Vidavsky, Michael L Gross

Analytical Chemistry (2010-01-22) https://doi.org/b993rm

DOI: 10.1021/ac902477u · PMID: 20095571 · PMCID: PMC2826105

224.

Hydrogen/deuterium exchange in mass spectrometry

Yury Kostyukevich, Thamina Acter, Alexander Zherebker, Arif Ahmed, Sunghwan Kim, Eugene Nikolaev

Mass Spectrometry Reviews (2018-03-30) https://doi.org/gffzx8

DOI: 10.1002/mas.21565 · PMID: 29603316

225.

Proteinase K from Tritirachium album Limber.

W Ebeling, N Hennrich, M Klockow, H Metz, HD Orth, H Lang

European journal of biochemistry (1974-08-15) https://www.ncbi.nlm.nih.gov/pubmed/4373242

DOI: 10.1111/j.1432-1033.1974.tb03671.x · PMID: 4373242

226.

Proteinase K

W Saenger

Handbook of Proteolytic Enzymes (2013) https://doi.org/gkfkcz

DOI: https://doi.org/10.1016/b978-0-12-382219-2.00714-6 · ISBN: 9780123822192

227.

Measuring protein structural changes on a proteome-wide scale using limited proteolysis-coupled mass spectrometry.

Simone Schopper, Abdullah Kahraman, Pascal Leuenberger, Yuehan Feng, Ilaria Piazza, Oliver Müller, Paul J Boersema, Paola Picotti

Nature protocols (2017-10-26) https://www.ncbi.nlm.nih.gov/pubmed/29072706

DOI: 10.1038/nprot.2017.100 · PMID: 29072706

228.

Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range.

S Udenfriend, S Stein, P Böhlen, W Dairman, W Leimgruber, M Weigele

Science (New York, N.Y.) (1972-11-24) https://www.ncbi.nlm.nih.gov/pubmed/5085985

DOI: 10.1126/science.178.4063.871 · PMID: 5085985

229.

A comparison of fluorescamine and naphthalene-2,3-dicarboxaldehyde fluorogenic reagents for microplate-based detection of amino acids.

T Bantan-Polak, M Kassai, KB Grant

Analytical biochemistry (2001-10-15) https://www.ncbi.nlm.nih.gov/pubmed/11673879

DOI: 10.1006/abio.2001.5338 · PMID: 11673879

230.

Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics

Shao-En Ong, Blagoy Blagoev, Irina Kratchmarova, Dan Bach Kristensen, Hanno Steen, Akhilesh Pandey, Matthias Mann

Molecular & Cellular Proteomics (2002-05) https://doi.org/djw454

DOI: 10.1074/mcp.m200025-mcp200 · PMID: 12118079

231.

iTRAQ Labeling is Superior to mTRAQ for Quantitative Global Proteomics and Phosphoproteomics

Philipp Mertins, Namrata D Udeshi, Karl R Clauser, DR Mani, Jinal Patel, Shao-en Ong, Jacob D Jaffe, Steven A Carr

Molecular & Cellular Proteomics (2012-06) https://doi.org/fx5pb3

DOI: 10.1074/mcp.m111.014423 · PMID: 22210691 · PMCID: PMC3433912

232.

Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics.

Paul J Boersema, Reinout Raijmakers, Simone Lemeer, Shabaz Mohammed, Albert JR Heck

Nature protocols (2009) https://www.ncbi.nlm.nih.gov/pubmed/19300442

DOI: 10.1038/nprot.2009.21 · PMID: 19300442

233.

In Vivo SILAC-Based Proteomics Reveals Phosphoproteome Changes during Mouse Skin Carcinogenesis

Sara Zanivan, Alexander Meves, Kristina Behrendt, Erwin M Schoof, Lisa J Neilson, Jürgen Cox, Hao R Tang, Gabriela Kalna, Janine H van Ree, Jan M van Deursen, … Matthias Mann

Cell Reports (2013-02) https://doi.org/f4r3vk

DOI: 10.1016/j.celrep.2013.01.003 · PMID: 23375375

234.

Large-scale phosphosite quantification in tissues by a spike-in SILAC method

Mara Monetti, Nagarjuna Nagaraj, Kirti Sharma, Matthias Mann

Nature Methods (2011-07-10) https://doi.org/d28v54

DOI: 10.1038/nmeth.1647 · PMID: 21743459

235.

Increasing the throughput of sensitive proteomics by plexDIA

Jason Derks, Andrew Leduc, Georg Wallmann, RGray Huffman, Matthew Willetts, Saad Khan, Harrison Specht, Markus Ralser, Vadim Demichev, Nikolai Slavov

Nature Biotechnology (2022-07-14) https://doi.org/gss5jp

DOI: 10.1038/s41587-022-01389-w · PMID: 35835881 · PMCID: PMC9839897

236.

Robust dimethyl‐based multiplex‐DIA doubles single‐cell proteome depth via a reference channel

Marvin Thielert, Ericka CM Itang, Constantin Ammar, Florian A Rosenberger, Isabell Bludau, Lisa Schweizer, Thierry M Nordmann, Patricia Skowronek, Maria Wahle, Wen‐Feng Zeng, … Matthias Mann

Molecular Systems Biology (2023-08-21) https://doi.org/gss5jt

DOI: 10.15252/msb.202211503 · PMID: 37602975 · PMCID: PMC10495816

237.

Quantification of Lysine Acetylation and Succinylation Stoichiometry in Proteins Using Mass Spectrometric Data-Independent Acquisitions (SWATH)

Jesse G Meyer, Alexandria K D’Souza, Dylan J Sorensen, Matthew J Rardin, Alan J Wolfe, Bradford W Gibson, Birgit Schilling

Journal of the American Society for Mass Spectrometry (2016-09-02) https://doi.org/f86vtw

DOI: 10.1007/s13361-016-1476-z · PMID: 27590315 · PMCID: PMC5059418

238.

Tandem Mass Tags: A Novel Quantification Strategy for Comparative Analysis of Complex Protein Mixtures by MS/MS

Andrew Thompson, Jürgen Schäfer, Karsten Kuhn, Stefan Kienle, Josef Schwarz, Günter Schmidt, Thomas Neumann, Christian Hamon

Analytical Chemistry (2003-03-01) https://doi.org/bghhcr

DOI: 10.1021/ac0262560 · PMID: 12713048

239.

Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents

Philip L Ross, Yulin N Huang, Jason N Marchese, Brian Williamson, Kenneth Parker, Stephen Hattan, Nikita Khainovski, Sasi Pillai, Subhakar Dey, Scott Daniels, … Darryl J Pappin

Molecular & Cellular Proteomics (2004-12) https://doi.org/cqjzsb

DOI: 10.1074/mcp.m400129-mcp200 · PMID: 15385600

240.

N,N-Dimethyl Leucines as Novel Isobaric Tandem Mass Tags for Quantitative Proteomics and Peptidomics

Feng Xiang, Hui Ye, Ruibing Chen, Qiang Fu, Lingjun Li

Analytical Chemistry (2010-03-10) https://doi.org/b7smr6

DOI: 10.1021/ac902778d · PMID: 20218596 · PMCID: PMC2859709

241.

TMTpro: Design, Synthesis, and Initial Evaluation of a Proline-Based Isobaric 16-Plex Tandem Mass Tag Reagent Set

Andrew Thompson, Nikolai Wölmer, Sasa Koncarevic, Stefan Selzer, Gitte Böhm, Harald Legner, Peter Schmid, Stefan Kienle, Petra Penning, Claudia Höhle, … Ian Pike

Analytical Chemistry (2019-11-18) https://doi.org/gss5jj

DOI: 10.1021/acs.analchem.9b04474 · PMID: 31738517

242.

TMTpro-18plex: The Expanded and Complete Set of TMTpro Reagents for Sample Multiplexing

Jiaming Li, Zhenying Cai, Ryan D Bomgarden, Ian Pike, Karsten Kuhn, John C Rogers, Thomas M Roberts, Steven P Gygi, Joao A Paulo

Journal of Proteome Research (2021-04-26) https://doi.org/gjt6rs

DOI: 10.1021/acs.jproteome.1c00168 · PMID: 33900084 · PMCID: PMC8210943

243.

Isobaric labeling-based relative quantification in shotgun proteomics.

Navin Rauniyar, John R Yates

Journal of proteome research (2014-11-04) https://www.ncbi.nlm.nih.gov/pubmed/25337643

DOI: 10.1021/pr500880b · PMID: 25337643 · PMCID: PMC4261935

244.

Computational Methods for Understanding Mass Spectrometry–Based Shotgun Proteomics Data

Pavel Sinitcyn, Jan Daniel Rudolph, Jürgen Cox

Annual Review of Biomedical Data Science (2018-07-20) https://doi.org/gjtq4h

DOI: 10.1146/annurev-biodatasci-080917-013516

245.

Peptide Labeling Using Isobaric Tagging Reagents for Quantitative Phosphoproteomics.

Lei Cheng, Trairak Pisitkun, Mark A Knepper, Jason D Hoffert

Methods in molecular biology (Clifton, N.J.) (2016) https://www.ncbi.nlm.nih.gov/pubmed/26584918

DOI: 10.1007/978-1-4939-3049-4_4 · PMID: 26584918 · PMCID: PMC6169521

246.

Discovery- and target-based protein quantification using iTRAQ and pulsed Q collision induced dissociation (PQD).

Wells W Wu, Guanghui Wang, Paul A Insel, Cheng-Te Hsiao, Sige Zou, Bronwen Martin, Stuart Maudsley, Rong-Fong Shen

Journal of proteomics (2012-03-03) https://www.ncbi.nlm.nih.gov/pubmed/22397766

DOI: 10.1016/j.jprot.2012.02.027 · PMID: 22397766 · PMCID: PMC3321122

247.

Insights into protein post-translational modification landscapes of individual human cells by trapped ion mobility time-of-flight mass spectrometry

Benjamin C Orsburn, Yuting Yuan, Namandjé N Bumpus

Nature Communications (2022-11-25) https://doi.org/grhnzj

DOI: 10.1038/s41467-022-34919-w · PMID: 36433961 · PMCID: PMC9700839

248.

TMT Labeling for the Masses: A Robust and Cost-efficient, In-solution Labeling Approach.

Jana Zecha, Shankha Satpathy, Tamara Kanashova, Shayan C Avanessian, MHarry Kane, Karl R Clauser, Philipp Mertins, Steven A Carr, Bernhard Kuster

Molecular & cellular proteomics : MCP (2019-04-09) https://www.ncbi.nlm.nih.gov/pubmed/30967486

DOI: 10.1074/mcp.tir119.001385 · PMID: 30967486 · PMCID: PMC6601210

249.

Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents.

Philip L Ross, Yulin N Huang, Jason N Marchese, Brian Williamson, Kenneth Parker, Stephen Hattan, Nikita Khainovski, Sasi Pillai, Subhakar Dey, Scott Daniels, … Darryl J Pappin

Molecular & cellular proteomics : MCP (2004-09-22) https://www.ncbi.nlm.nih.gov/pubmed/15385600

DOI: 10.1074/mcp.m400129-mcp200 · PMID: 15385600

250.

Dissecting the iTRAQ Data Analysis

Suruchi Aggarwal, Amit Kumar Yadav

Methods in Molecular Biology (2016) https://doi.org/f79jsd

DOI: 10.1007/978-1-4939-3106-4_18 · PMID: 26519184

251.

Peptide labeling with isobaric tags yields higher identification rates using iTRAQ 4-plex compared to TMT 6-plex and iTRAQ 8-plex on LTQ Orbitrap.

Peter Pichler, Thomas Köcher, Johann Holzmann, Michael Mazanek, Thomas Taus, Gustav Ammerer, Karl Mechtler

Analytical chemistry (2010-08-01) https://www.ncbi.nlm.nih.gov/pubmed/20593797

DOI: 10.1021/ac100890k · PMID: 20593797 · PMCID: PMC3093924

252.

Comparison of 4-plex to 8-plex iTRAQ quantitative measurements of proteins in human plasma samples.

Gwenael Pottiez, Jayme Wiederin, Howard S Fox, Pawel Ciborowski

Journal of proteome research (2012-05-30) https://www.ncbi.nlm.nih.gov/pubmed/22594965

DOI: 10.1021/pr300414z · PMID: 22594965 · PMCID: PMC3390908

253.

Novel method to investigate protein carbonylation by iTRAQ strategy.

Angelo Palmese, Chiara De Rosa, Giovanni Chiappetta, Gennaro Marino, Angela Amoresano

Analytical and bioanalytical chemistry (2012-08-29) https://www.ncbi.nlm.nih.gov/pubmed/22926130

DOI: 10.1007/s00216-012-6324-9 · PMID: 22926130

254.

Role of oxidative carbonylation in protein quality control and senescence.

Thomas Nyström

The EMBO journal (2005-03-03) https://www.ncbi.nlm.nih.gov/pubmed/15775985

DOI: 10.1038/sj.emboj.7600599 · PMID: 15775985 · PMCID: PMC1142534

255.

Evaluation of the Orbitrap Ascend Tribrid Mass Spectrometer for Shotgun Proteomics

Yuchen He, Evgenia Shishkova, Trenton M Peters-Clarke, Dain R Brademan, Michael S Westphall, David Bergen, Jingjing Huang, Romain Huguet, Michael W Senko, Vlad Zabrouskov, … Joshua J Coon

Analytical Chemistry (2023-06-30) https://doi.org/gss5jf

DOI: 10.1021/acs.analchem.3c01155 · PMID: 37389810 · PMCID: PMC10528367

256.

MS3 eliminates ratio distortion in isobaric multiplexed quantitative proteomics.

Lily Ting, Ramin Rad, Steven P Gygi, Wilhelm Haas

Nature methods (2011-10-02) https://www.ncbi.nlm.nih.gov/pubmed/21963607

DOI: 10.1038/nmeth.1714 · PMID: 21963607 · PMCID: PMC3205343

257.

MultiNotch MS3 Enables Accurate, Sensitive, and Multiplexed Detection of Differential Expression across Cancer Cell Line Proteomes

Graeme C McAlister, David P Nusinow, Mark P Jedrychowski, Martin Wühr, Edward L Huttlin, Brian K Erickson, Ramin Rad, Wilhelm Haas, Steven P Gygi

Analytical Chemistry (2014-07-03) https://doi.org/f59sb8

DOI: 10.1021/ac502040v · PMID: 24927332 · PMCID: PMC4215866

258.

Infrared Photoactivation Boosts Reporter Ion Yield in Isobaric Tagging

Kenneth W Lee, Trenton M Peters-Clarke, Keaton L Mertz, Graeme C McAlister, John EP Syka, Michael S Westphall, Joshua J Coon

Analytical Chemistry (2022-02-10) https://doi.org/gssbgz

DOI: 10.1021/acs.analchem.1c05398 · PMID: 35142486 · PMCID: PMC8985229

259.

Characterization and Optimization of Multiplexed Quantitative Analyses Using High-Field Asymmetric-Waveform Ion Mobility Mass Spectrometry

Devin K Schweppe, Satendra Prasad, Michael W Belford, José Navarrete-Perea, Derek J Bailey, Romain Huguet, Mark P Jedrychowski, Ramin Rad, Graeme McAlister, Susan E Abbatiello, … Steven P Gygi

Analytical Chemistry (2019-03-19) https://doi.org/gszdh4

DOI: https://doi.org/10.1021/acs.analchem.8b05399

260.

Mass spectrometry-based quantitative proteomics for dissecting multiplexed redox cysteine modifications in nitric oxide-protected cardiomyocyte under hypoxia.

Kuan-Ting Pan, Yi-Yun Chen, Tsung-Hsien Pu, Yu-Shu Chao, Chun-Yi Yang, Ryan D Bomgarden, John C Rogers, Tzu-Ching Meng, Kay-Hooi Khoo

Antioxidants & redox signaling (2013-10-23) https://www.ncbi.nlm.nih.gov/pubmed/24152285

DOI: 10.1089/ars.2013.5326 · PMID: 24152285 · PMCID: PMC3936484

261.

Proteomic quantification and site-mapping of S-nitrosylated proteins using isobaric iodoTMT reagents.

Zhe Qu, Fanjun Meng, Ryan D Bomgarden, Rosa I Viner, Jilong Li, John C Rogers, Jianlin Cheng, CMichael Greenlief, Jiankun Cui, Dennis B Lubahn, … Zezong Gu

Journal of proteome research (2014-06-13) https://www.ncbi.nlm.nih.gov/pubmed/24926564

DOI: 10.1021/pr401179v · PMID: 24926564 · PMCID: PMC4084841

262.

Carbonyl-reactive tandem mass tags for the proteome-wide quantification of N-linked glycans.

Hannes Hahne, Patrick Neubert, Karsten Kuhn, Chris Etienne, Ryan Bomgarden, John C Rogers, Bernhard Kuster

Analytical chemistry (2012-04-04) https://www.ncbi.nlm.nih.gov/pubmed/22455665

DOI: 10.1021/ac300197c · PMID: 22455665

263.

N,N-dimethyl leucines as novel isobaric tandem mass tags for quantitative proteomics and peptidomics.

Feng Xiang, Hui Ye, Ruibing Chen, Qiang Fu, Lingjun Li

Analytical chemistry (2010-04-01) https://www.ncbi.nlm.nih.gov/pubmed/20218596

DOI: 10.1021/ac902778d · PMID: 20218596 · PMCID: PMC2859709

264.

Comparative evaluation of two isobaric labeling tags, DiART and iTRAQ.

Zhen Chen, Quanhui Wang, Liang Lin, Qi Tang, James L Edwards, Shuwei Li, Siqi Liu

Analytical chemistry (2012-03-08) https://www.ncbi.nlm.nih.gov/pubmed/22404494

DOI: 10.1021/ac203467q · PMID: 22404494

265.

Deuterium isobaric amine-reactive tags for quantitative proteomics.

Junxiang Zhang, Yan Wang, Shuwei Li

Analytical chemistry (2010-09-15) https://www.ncbi.nlm.nih.gov/pubmed/20715779

DOI: 10.1021/ac101306x · PMID: 20715779

266.

A robust error model for iTRAQ quantification reveals divergent signaling between oncogenic FLT3 mutants in acute myeloid leukemia.

Yi Zhang, Manor Askenazi, Jingrui Jiang, CJohn Luckey, James D Griffin, Jarrod A Marto

Molecular & cellular proteomics : MCP (2009-12-17) https://www.ncbi.nlm.nih.gov/pubmed/20019052

DOI: 10.1074/mcp.m900452-mcp200 · PMID: 20019052 · PMCID: PMC2871413

267.

Cost-effective isobaric tagging for quantitative phosphoproteomics using DiART reagents.

Nikhil Ramsubramaniam, Feng Tao, Shuwei Li, Mark R Marten

Molecular bioSystems (2013-10-16) https://www.ncbi.nlm.nih.gov/pubmed/24129742

DOI: 10.1039/c3mb70358d · PMID: 24129742

268.

Hyperplexing: A Method for Higher-Order Multiplexed Quantitative Proteomics Provides a Map of the Dynamic Response to Rapamycin in Yeast

Noah Dephoure, Steven P Gygi

Science Signaling (2012-03-27) https://doi.org/gsw9bw

DOI: 10.1126/scisignal.2002548 · PMID: 22457332 · PMCID: PMC5292868

269.

HyperSCP: Combining Isotopic and Isobaric Labeling for Higher Throughput Single-Cell Proteomics

Yiran Liang, Thy Truong, Aubrianna J Saxton, Hannah Boekweg, Samuel H Payne, Pam M Van Ry, Ryan T Kelly

Analytical Chemistry (2023-05-11) https://doi.org/gsz4ds

DOI: 10.1021/acs.analchem.3c00906 · PMID: 37167627 · PMCID: PMC10246935

270.

Advances in Higher Order Multiplexing Techniques in Proteomics.

Suruchi Aggarwal, Narayan C Talukdar, Amit K Yadav

Journal of proteome research (2019-05-22) https://www.ncbi.nlm.nih.gov/pubmed/31074990

DOI: 10.1021/acs.jproteome.9b00228 · PMID: 31074990

271.

HyperQuant-A Computational Pipeline for Higher Order Multiplexed Quantitative Proteomics.

Suruchi Aggarwal, Ajay Kumar, Shilpa Jamwal, Mukul Kumar Midha, Narayan Chandra Talukdar, Amit Kumar Yadav

ACS omega (2020-05-07) https://www.ncbi.nlm.nih.gov/pubmed/32455206

DOI: 10.1021/acsomega.0c00515 · PMID: 32455206 · PMCID: PMC7240821

272.

Enhanced Multiplexing Technology for Proteomics.

Bailey L Bowser, Renã AS Robinson

Annual review of analytical chemistry (Palo Alto, Calif.) (2023-02-28) https://www.ncbi.nlm.nih.gov/pubmed/36854207

DOI: 10.1146/annurev-anchem-091622-092353 · PMID: 36854207

273.

Multitagging Proteomic Strategy to Estimate Protein Turnover Rates in Dynamic Systems

Karthik P Jayapal, Siguang Sui, Robin J Philp, Yee-Jiun Kok, Miranda GS Yap, Timothy J Griffin, Wei-Shou Hu

Journal of Proteome Research (2010-03-29) https://doi.org/ddffzr

DOI: 10.1021/pr9007738 · PMID: 20184388

274.

Sample multiplexing with cysteine-selective approaches: cysDML and cPILOT.

Liqing Gu, Adam R Evans, Renã AS Robinson

Journal of the American Society for Mass Spectrometry (2015-01-15) https://www.ncbi.nlm.nih.gov/pubmed/25588721

DOI: 10.1007/s13361-014-1059-9 · PMID: 25588721

275.

Global cPILOT analysis of the APP/PS-1 mouse liver proteome.

Adam R Evans, Liqing Gu, Rodolfo Guerrero, Renã AS Robinson

Proteomics. Clinical applications (2015-05-12) https://www.ncbi.nlm.nih.gov/pubmed/25620666

DOI: 10.1002/prca.201400149 · PMID: 25620666

276.

Global combined precursor isotopic labeling and isobaric tagging (cPILOT) approach with selective MS(3) acquisition.

Adam R Evans, Renã AS Robinson

Proteomics (2013-10-20) https://www.ncbi.nlm.nih.gov/pubmed/24124127

DOI: 10.1002/pmic.201300198 · PMID: 24124127

277.

High-throughput endogenous measurement of S-nitrosylation in Alzheimer's disease using oxidized cysteine-selective cPILOT.

Liqing Gu, Renã AS Robinson

The Analyst (2016-05-06) https://www.ncbi.nlm.nih.gov/pubmed/27152368

DOI: 10.1039/c6an00417b · PMID: 27152368 · PMCID: PMC4904844

278.

Hyperplexing: a method for higher-order multiplexed quantitative proteomics provides a map of the dynamic response to rapamycin in yeast.

Noah Dephoure, Steven P Gygi

Science signaling (2012-03-27) https://www.ncbi.nlm.nih.gov/pubmed/22457332

DOI: 10.1126/scisignal.2002548 · PMID: 22457332 · PMCID: PMC5292868

279.

Monitoring matrix metalloproteinase activity at the epidermal-dermal interface by SILAC-iTRAQ-TAILS.

Pascal Schlage, Tobias Kockmann, Jayachandran N Kizhakkedathu, Ulrich auf dem Keller

Proteomics (2015-05-15) https://www.ncbi.nlm.nih.gov/pubmed/25871442

DOI: 10.1002/pmic.201400627 · PMID: 25871442

280.

Time-resolved Analysis of Proteome Dynamics by Tandem Mass Tags and Stable Isotope Labeling in Cell Culture (TMT-SILAC) Hyperplexing.

Kevin A Welle, Tian Zhang, Jennifer R Hryhorenko, Shichen Shen, Jun Qu, Sina Ghaemmaghami

Molecular & cellular proteomics : MCP (2016-10-20) https://www.ncbi.nlm.nih.gov/pubmed/27765818

DOI: 10.1074/mcp.m116.063230 · PMID: 27765818 · PMCID: PMC5141271

281.

Dataset generated using hyperplexing and click chemistry to monitor temporal dynamics of newly synthesized macrophage secretome post infection by mycobacterial strains.

Ajay Kumar, Shilpa Jamwal, Mukul Kumar Midha, Baseerat Hamza, Suruchi Aggarwal, Amit Kumar Yadav, Kanury VS Rao

Data in brief (2016-09-05) https://www.ncbi.nlm.nih.gov/pubmed/27672675

DOI: 10.1016/j.dib.2016.08.055 · PMID: 27672675 · PMCID: PMC5030312

282.

A Proteomics Approach to Profiling the Temporal Translational Response to Stress and Growth.

Daniel A Rothenberg, JMatthew Taliaferro, Sabrina M Huber, Thomas J Begley, Peter C Dedon, Forest M White

iScience (2018-11-05) https://www.ncbi.nlm.nih.gov/pubmed/30466063

DOI: 10.1016/j.isci.2018.11.004 · PMID: 30466063 · PMCID: PMC6249402

283.

Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds

RG Spiro

Glycobiology (2002-04-01) https://doi.org/dvf2t7

DOI: 10.1093/glycob/12.4.43r · PMID: 12042244

284.

A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics

Nicholas M Riley, Carolyn R Bertozzi, Sharon J Pitteri

Molecular & Cellular Proteomics (2021) https://doi.org/gjtq4p

DOI: 10.1074/mcp.r120.002277 · PMID: 33583771 · PMCID: PMC8724846

285.

Enrichment of Intact Glycopeptides Using Strong Anion Exchange and Electrostatic Repulsion Hydrophilic Interaction Chromatography

Abel Bermudez, Sharon J Pitteri

Methods in Molecular Biology (2021) https://doi.org/gss5jb

DOI: 10.1007/978-1-0716-1241-5_8 · PMID: 33908003

286.

Parallel Comparison of N-Linked Glycopeptide Enrichment Techniques Reveals Extensive Glycoproteomic Analysis of Plasma Enabled by SAX-ERLIC

Sarah M Totten, Christa L Feasley, Abel Bermudez, Sharon J Pitteri

Journal of Proteome Research (2017-02-15) https://doi.org/f9qhgh

DOI: 10.1021/acs.jproteome.6b00849 · PMID: 28199111

287.

Quantitative site-specific analysis of protein glycosylation by LC-MS using different glycopeptide-enrichment strategies

Jessica Wohlgemuth, Michael Karas, Thomas Eichhorn, Robertus Hendriks, Sven Andrecht

Analytical Biochemistry (2009-12) https://doi.org/c4hqcn

DOI: 10.1016/j.ab.2009.08.023 · PMID: 19699707

288.

Advances in LC–MS/MS-based glycoproteomics: Getting closer to system-wide site-specific mapping of the N- and O-glycoproteome

Morten Thaysen-Andersen, Nicolle H Packer

Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics (2014-09) https://doi.org/f6ckz2

DOI: 10.1016/j.bbapap.2014.05.002 · PMID: 24830338

289.

Structural analysis of glycoprotein sialylation – Part I: pre-LC-MS analytical strategies

Morten Thaysen-Andersen, Martin R Larsen, Nicolle H Packer, Giuseppe Palmisano

RSC Advances (2013) https://doi.org/gss5jr

DOI: 10.1039/c3ra42960a

290.

Recent Advances in the Analysis of Complex Glycoproteins

Stefan Gaunitz, Gabe Nagy, Nicola LB Pohl, Milos V Novotny

Analytical Chemistry (2016-11-23) https://doi.org/gss5jg

DOI: 10.1021/acs.analchem.6b04343 · PMID: 28105826 · PMCID: PMC5609817

291.

Phosphorylation of Single Stranded RNA Virus Proteins and Potential for Novel Therapeutic Strategies.

Forrest Keck, Pouya Ataey, Moushimi Amaya, Charles Bailey, Aarthi Narayanan

Viruses (2015-10-12) https://www.ncbi.nlm.nih.gov/pubmed/26473910

DOI: 10.3390/v7102872 · PMID: 26473910 · PMCID: PMC4632380

292.

The functional landscape of the human phosphoproteome.

David Ochoa, Andrew F Jarnuczak, Cristina Viéitez, Maja Gehre, Margaret Soucheray, André Mateus, Askar A Kleefeldt, Anthony Hill, Luz Garcia-Alonso, Frank Stein, … Pedro Beltrao

Nature biotechnology (2019-12-09) https://www.ncbi.nlm.nih.gov/pubmed/31819260

DOI: 10.1038/s41587-019-0344-3 · PMID: 31819260 · PMCID: PMC7100915

293.

A review on recent trends in the phosphoproteomics workflow. From sample preparation to data analysis.

Jiří Urban

Analytica chimica acta (2021-07-17) https://www.ncbi.nlm.nih.gov/pubmed/35227377

DOI: 10.1016/j.aca.2021.338857 · PMID: 35227377

294.

The role of protein phosphorylation in human health and disease. The Sir Hans Krebs Medal Lecture.

P Cohen

European journal of biochemistry (2001-10) https://www.ncbi.nlm.nih.gov/pubmed/11589691

DOI: 10.1046/j.0014-2956.2001.02473.x · PMID: 11589691

295.

Modification-specific proteomics: strategies for characterization of post-translational modifications using enrichment techniques.

Yingming Zhao, Ole N Jensen

Proteomics (2009-10) https://www.ncbi.nlm.nih.gov/pubmed/19743430

DOI: 10.1002/pmic.200900398 · PMID: 19743430 · PMCID: PMC2892724

296.

Using phosphoproteomics data to understand cellular signaling: a comprehensive guide to bioinformatics resources.

Sara R Savage, Bing Zhang

Clinical proteomics (2020-07-11) https://www.ncbi.nlm.nih.gov/pubmed/32676006

DOI: 10.1186/s12014-020-09290-x · PMID: 32676006 · PMCID: PMC7353784

297.

Analytical challenges translating mass spectrometry-based phosphoproteomics from discovery to clinical applications.

Anton B Iliuk, Justine V Arrington, Weiguo Andy Tao

Electrophoresis (2014-07-10) https://www.ncbi.nlm.nih.gov/pubmed/24890697

DOI: 10.1002/elps.201400153 · PMID: 24890697 · PMCID: PMC4250476

298.

Estimating the Efficiency of Phosphopeptide Identification by Tandem Mass Spectrometry.

Chuan-Chih Hsu, Liang Xue, Justine V Arrington, Pengcheng Wang, Juan Sebastian Paez Paez, Yuan Zhou, Jian-Kang Zhu, WAndy Tao

Journal of the American Society for Mass Spectrometry (2017-03-10) https://www.ncbi.nlm.nih.gov/pubmed/28283928

DOI: 10.1007/s13361-017-1603-5 · PMID: 28283928 · PMCID: PMC5438756

299.

Preparation of proteins and peptides for mass spectrometry analysis in a bottom-up proteomics workflow.

Rebekah L Gundry, Melanie Y White, Christopher I Murray, Lesley A Kane, Qin Fu, Brian A Stanley, Jennifer E Van Eyk

Current protocols in molecular biology (2009-10) https://www.ncbi.nlm.nih.gov/pubmed/19816929

DOI: 10.1002/0471142727.mb1025s88 · PMID: 19816929 · PMCID: PMC2905857

300.

Phosphopeptide Fragmentation and Site Localization by Mass Spectrometry: An Update.

Clement M Potel, Simone Lemeer, Albert JR Heck

Analytical chemistry (2018-12-05) https://www.ncbi.nlm.nih.gov/pubmed/30457327

DOI: 10.1021/acs.analchem.8b04746 · PMID: 30457327 · PMCID: PMC6322148

301.

Enrichment techniques employed in phosphoproteomics.

Jan Fíla, David Honys

Amino acids (2011-10-15) https://www.ncbi.nlm.nih.gov/pubmed/22002794

DOI: 10.1007/s00726-011-1111-z · PMID: 22002794 · PMCID: PMC3418503

302.

Off-Line High-pH Reversed-Phase Fractionation for In-Depth Phosphoproteomics

Tanveer S Batth, Chiara Francavilla, Jesper V Olsen

Journal of Proteome Research (2014-11-04) https://doi.org/f72pvg

DOI: 10.1021/pr500893m · PMID: 25338131

303.

Temporal Quantitative Phosphoproteomics Profiling of Interleukin-33 Signaling Network Reveals Unique Modulators of Monocyte Activation.

Devasahayam Arokia Balaya Rex, Yashwanth Subbannayya, Prashant Kumar Modi, Akhina Palollathil, Lathika Gopalakrishnan, Yashodhar P Bhandary, Thottethodi Subrahmanya Keshava Prasad, Sneha M Pinto

Cells (2022-01-01) https://www.ncbi.nlm.nih.gov/pubmed/35011700

DOI: 10.3390/cells11010138 · PMID: 35011700 · PMCID: PMC8749991

304.

Immobilized gallium(III) affinity chromatography of phosphopeptides.

MC Posewitz, P Tempst

Analytical chemistry (1999-07-15) https://www.ncbi.nlm.nih.gov/pubmed/10424175

DOI: 10.1021/ac981409y · PMID: 10424175

305.

Effective disruption of phosphoprotein-protein surface interaction using Zn(II) dipicolylamine-based artificial receptors via two-point interaction.

Akio Ojida, Masa-aki Inoue, Yasuko Mito-oka, Hiroshi Tsutsumi, Kazuki Sada, Itaru Hamachi

Journal of the American Chemical Society (2006-02-15) https://www.ncbi.nlm.nih.gov/pubmed/16464107

DOI: 10.1021/ja056585k · PMID: 16464107

306.

Isolation of phosphoproteins by immobilized metal (Fe3+) affinity chromatography.

L Andersson, J Porath

Analytical biochemistry (1986-04) https://www.ncbi.nlm.nih.gov/pubmed/3085541

DOI: 10.1016/0003-2697(86)90523-3 · PMID: 3085541

307.

Purification of phosphoproteins by immobilized metal affinity chromatography and its application to phosphoproteome analysis.

Mitsuyo Machida, Hidetaka Kosako, Kyoko Shirakabe, Michimoto Kobayashi, Masato Ushiyama, Junichi Inagawa, Joe Hirano, Tomoyo Nakano, Yasuhiko Bando, Eisuke Nishida, Seisuke Hattori

The FEBS journal (2007-03) https://www.ncbi.nlm.nih.gov/pubmed/17480206

DOI: 10.1111/j.1742-4658.2007.05705.x · PMID: 17480206

308.

Efficient enrichment of intact phosphorylated proteins by modified immobilized metal-affinity chromatography.

Anna Dubrovska, Serhiy Souchelnytskyi

Proteomics (2005-12) https://www.ncbi.nlm.nih.gov/pubmed/16252304

DOI: 10.1002/pmic.200500002 · PMID: 16252304

309.

A quantitative investigation into the losses of proteins at different stages of a two-dimensional gel electrophoresis procedure.

Shaobo Zhou, Matthew J Bailey, Michael J Dunn, Victor R Preedy, Peter W Emery

Proteomics (2005-07) https://www.ncbi.nlm.nih.gov/pubmed/15966007

DOI: 10.1002/pmic.200401178 · PMID: 15966007

310.

Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns.

Martin R Larsen, Tine E Thingholm, Ole N Jensen, Peter Roepstorff, Thomas JD Jørgensen

Molecular & cellular proteomics : MCP (2005-04-27) https://www.ncbi.nlm.nih.gov/pubmed/15858219

DOI: 10.1074/mcp.t500007-mcp200 · PMID: 15858219

311.

Phosphopeptide Enrichment by Immobilized Metal Affinity Chromatography.

Tine E Thingholm, Martin R Larsen

Methods in molecular biology (Clifton, N.J.) (2016) https://www.ncbi.nlm.nih.gov/pubmed/26584922

DOI: 10.1007/978-1-4939-3049-4_8 · PMID: 26584922

312.

Selective Detection and Sequencing of Phosphopeptides at the Femtomole Level by Mass Spectrometry

Steven A Carr, Michael J Huddleston, Roland S Annan

Analytical Biochemistry (1996-08) https://doi.org/cp2r54

DOI: 10.1006/abio.1996.0313 · PMID: 8811904

313.

Comprehensive and reproducible phosphopeptide enrichment using iron immobilized metal ion affinity chromatography (Fe-IMAC) columns.

Benjamin Ruprecht, Heiner Koch, Guillaume Medard, Max Mundt, Bernhard Kuster, Simone Lemeer

Molecular & cellular proteomics : MCP (2014-11-13) https://www.ncbi.nlm.nih.gov/pubmed/25394399

DOI: 10.1074/mcp.m114.043109 · PMID: 25394399 · PMCID: PMC4288255

314.

Optimized Enrichment of Phosphoproteomes by Fe-IMAC Column Chromatography.

Benjamin Ruprecht, Heiner Koch, Petra Domasinska, Martin Frejno, Bernhard Kuster, Simone Lemeer

Methods in molecular biology (Clifton, N.J.) (2017) https://www.ncbi.nlm.nih.gov/pubmed/28188522

DOI: 10.1007/978-1-4939-6747-6_5 · PMID: 28188522

315.

Complementary Fe(3+)- and Ti(4+)-immobilized metal ion affinity chromatography for purification of acidic and basic phosphopeptides.

Alan Chuan-Ying Lai, Chia-Feng Tsai, Chuan-Chih Hsu, Yu-Ni Sun, Yu-Ju Chen

Rapid communications in mass spectrometry : RCM (2012-09-30) https://www.ncbi.nlm.nih.gov/pubmed/22886815

DOI: 10.1002/rcm.6327 · PMID: 22886815

316.

Sequential Fe3O4/TiO2 enrichment for phosphopeptide analysis by liquid chromatography/tandem mass spectrometry.

Sunkyu Choi, Jaeyoon Kim, Kun Cho, Gunwook Park, Jong Hyuk Yoon, Sehoon Park, Jong Shin Yoo, Sung Ho Ryu, Young Hwan Kim, Jeongkwon Kim

Rapid communications in mass spectrometry : RCM (2010-05-30) https://www.ncbi.nlm.nih.gov/pubmed/20411586

DOI: 10.1002/rcm.4541 · PMID: 20411586

317.

Protein-phosphotyrosine proteome profiling by superbinder-SH2 domain affinity purification mass spectrometry, sSH2-AP-MS.

Jiefei Tong, Biyin Cao, Gregory D Martyn, Jonathan R Krieger, Paul Taylor, Bradley Yates, Sachdev S Sidhu, Shawn SC Li, Xinliang Mao, Michael F Moran

Proteomics (2017-01-17) https://www.ncbi.nlm.nih.gov/pubmed/27880036

DOI: 10.1002/pmic.201600360 · PMID: 27880036

318.

Engineering SH2 Domains with Tailored Specificities and Affinities.

Gregory D Martyn, Gianluca Veggiani, Sachdev S Sidhu

Methods in molecular biology (Clifton, N.J.) (2023) https://www.ncbi.nlm.nih.gov/pubmed/37668982

DOI: 10.1007/978-1-0716-3393-9_17 · PMID: 37668982

319.

Comprehensive Evaluation of Different TiO

Jiaran Li, Jifeng Wang, Yumeng Yan, Na Li, Xiaoqing Qing, Ailikemu Tuerxun, Xiaojing Guo, Xiulan Chen, Fuquan Yang

Cells (2022-06-28) https://www.ncbi.nlm.nih.gov/pubmed/35805136

DOI: 10.3390/cells11132047 · PMID: 35805136 · PMCID: PMC9265536

320.

The necessity of and strategies for improving confidence in the accuracy of western blots.

Rajeshwary Ghosh, Jennifer E Gilda, Aldrin V Gomes

Expert review of proteomics (2014-07-25) https://www.ncbi.nlm.nih.gov/pubmed/25059473

DOI: 10.1586/14789450.2014.939635 · PMID: 25059473 · PMCID: PMC4791038

321.

Mapping protein-protein interactions by affinity-directed mass spectrometry.

Y Zhao, TW Muir, SB Kent, E Tischer, JM Scardina, BT Chait

Proceedings of the National Academy of Sciences of the United States of America (1996-04-30) https://www.ncbi.nlm.nih.gov/pubmed/8633009

DOI: 10.1073/pnas.93.9.4020 · PMID: 8633009 · PMCID: PMC39479

322.

Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.

John Rush, Albrecht Moritz, Kimberly A Lee, Ailan Guo, Valerie L Goss, Erik J Spek, Hui Zhang, Xiang-Ming Zha, Roberto D Polakiewicz, Michael J Comb

Nature biotechnology (2004-12-12) https://www.ncbi.nlm.nih.gov/pubmed/15592455

DOI: 10.1038/nbt1046 · PMID: 15592455

323.

ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.

Shuhei Matsuoka, Bryan A Ballif, Agata Smogorzewska, ERobert McDonald, Kristen E Hurov, Ji Luo, Corey E Bakalarski, Zhenming Zhao, Nicole Solimini, Yaniv Lerenthal, … Stephen J Elledge

Science (New York, N.Y.) (2007-05-25) https://www.ncbi.nlm.nih.gov/pubmed/17525332

DOI: 10.1126/science.1140321 · PMID: 17525332

324.

Akt-RSK-S6 kinase signaling networks activated by oncogenic receptor tyrosine kinases.

Albrecht Moritz, Yu Li, Ailan Guo, Judit Villén, Yi Wang, Joan MacNeill, Jon Kornhauser, Kam Sprott, Jing Zhou, Anthony Possemato, … Michael J Comb

Science signaling (2010-08-24) https://www.ncbi.nlm.nih.gov/pubmed/20736484

DOI: 10.1126/scisignal.2000998 · PMID: 20736484 · PMCID: PMC3137639

325.

Global identification of modular cullin-RING ligase substrates.

Michael J Emanuele, Andrew EH Elia, Qikai Xu, Claudio R Thoma, Lior Izhar, Yumei Leng, Ailan Guo, Yi-Ning Chen, John Rush, Paul Wei-Che Hsu, … Stephen J Elledge

Cell (2011-09-29) https://www.ncbi.nlm.nih.gov/pubmed/21963094

DOI: 10.1016/j.cell.2011.09.019 · PMID: 21963094 · PMCID: PMC3226719

326.

Systematic and quantitative assessment of the ubiquitin-modified proteome.

Woong Kim, Eric J Bennett, Edward L Huttlin, Ailan Guo, Jing Li, Anthony Possemato, Mathew E Sowa, Ramin Rad, John Rush, Michael J Comb, … Steven P Gygi

Molecular cell (2011-09-08) https://www.ncbi.nlm.nih.gov/pubmed/21906983

DOI: 10.1016/j.molcel.2011.08.025 · PMID: 21906983 · PMCID: PMC3200427

327.

A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles.

Sebastian A Wagner, Petra Beli, Brian T Weinert, Michael L Nielsen, Jürgen Cox, Matthias Mann, Chunaram Choudhary

Molecular & cellular proteomics : MCP (2011-09-01) https://www.ncbi.nlm.nih.gov/pubmed/21890473

DOI: 10.1074/mcp.m111.013284 · PMID: 21890473 · PMCID: PMC3205876

328.

Lysine acetylation targets protein complexes and co-regulates major cellular functions.

Chunaram Choudhary, Chanchal Kumar, Florian Gnad, Michael L Nielsen, Michael Rehman, Tobias C Walther, Jesper V Olsen, Matthias Mann

Science (New York, N.Y.) (2009-07-16) https://www.ncbi.nlm.nih.gov/pubmed/19608861

DOI: 10.1126/science.1175371 · PMID: 19608861

329.

Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome.

Alexander S Hebert, Kristin E Dittenhafer-Reed, Wei Yu, Derek J Bailey, Ebru Selin Selen, Melissa D Boersma, Joshua J Carson, Marco Tonelli, Allison J Balloon, Alan J Higbee, … Joshua J Coon

Molecular cell (2012-11-29) https://www.ncbi.nlm.nih.gov/pubmed/23201123

DOI: 10.1016/j.molcel.2012.10.024 · PMID: 23201123 · PMCID: PMC3704155

330.

Deep, Quantitative Coverage of the Lysine Acetylome Using Novel Anti-acetyl-lysine Antibodies and an Optimized Proteomic Workflow.

Tanya Svinkina, Hongbo Gu, Jeffrey C Silva, Philipp Mertins, Jana Qiao, Shaunt Fereshetian, Jacob D Jaffe, Eric Kuhn, Namrata D Udeshi, Steven A Carr

Molecular & cellular proteomics : MCP (2015-05-07) https://www.ncbi.nlm.nih.gov/pubmed/25953088

DOI: 10.1074/mcp.o114.047555 · PMID: 25953088 · PMCID: PMC4563726

331.

High-Resolution Mass Spectrometry to Identify and Quantify Acetylation Protein Targets.

Birgit Schilling, Jesse G Meyer, Lei Wei, Melanie Ott, Eric Verdin

Methods in molecular biology (Clifton, N.J.) (2019) https://www.ncbi.nlm.nih.gov/pubmed/31087289

DOI: 10.1007/978-1-4939-9434-2_1 · PMID: 31087289 · PMCID: PMC6825508

332.

Simultaneous Quantification of the Acetylome and Succinylome by ‘One‐Pot’ Affinity Enrichment

Nathan Basisty, Jesse G Meyer, Lei Wei, Bradford W Gibson, Birgit Schilling

PROTEOMICS (2018-08-19) https://doi.org/gn4cmb

DOI: 10.1002/pmic.201800123 · PMID: 30035354 · PMCID: PMC6175148

333.

Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.

Ailan Guo, Hongbo Gu, Jing Zhou, Daniel Mulhern, Yi Wang, Kimberly A Lee, Vicky Yang, Mike Aguiar, Jon Kornhauser, Xiaoying Jia, … Michael J Comb

Molecular & cellular proteomics : MCP (2013-10-15) https://www.ncbi.nlm.nih.gov/pubmed/24129315

DOI: 10.1074/mcp.o113.027870 · PMID: 24129315 · PMCID: PMC3879628

334.

Selective Affinity Enrichment of Nitrotyrosine-Containing Peptides for Quantitative Analysis in Complex Samples.

Yingxin Zhao, Yueqing Zhang, Hong Sun, Rosario Maroto, Allan R Brasier

Journal of proteome research (2017-07-17) https://www.ncbi.nlm.nih.gov/pubmed/28714690

DOI: 10.1021/acs.jproteome.7b00275 · PMID: 28714690 · PMCID: PMC5656043

335.

In-depth qualitative and quantitative profiling of tyrosine phosphorylation using a combination of phosphopeptide immunoaffinity purification and stable isotope dimethyl labeling.

Paul J Boersema, Leong Yan Foong, Vanessa MY Ding, Simone Lemeer, Bas van Breukelen, Robin Philp, Jos Boekhorst, Berend Snel, Jeroen den Hertog, Andre BH Choo, Albert JR Heck

Molecular & cellular proteomics : MCP (2009-09-21) https://www.ncbi.nlm.nih.gov/pubmed/19770167

DOI: 10.1074/mcp.m900291-mcp200 · PMID: 19770167 · PMCID: PMC2808269

336.

Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules.

Yi Zhang, Alejandro Wolf-Yadlin, Phillip L Ross, Darryl J Pappin, John Rush, Douglas A Lauffenburger, Forest M White

Molecular & cellular proteomics : MCP (2005-06-11) https://www.ncbi.nlm.nih.gov/pubmed/15951569

DOI: 10.1074/mcp.m500089-mcp200 · PMID: 15951569

337.

O-GlcNAcylation: an important post-translational modification and a potential therapeutic target for cancer therapy.

Qingsong Lu, Xiaozhen Zhang, Tingbo Liang, Xueli Bai

Molecular medicine (Cambridge, Mass.) (2022-09-14) https://www.ncbi.nlm.nih.gov/pubmed/36104770

DOI: 10.1186/s10020-022-00544-y · PMID: 36104770 · PMCID: PMC9476278

338.

Novel Antibodies for the Simple and Efficient Enrichment of Native O-GlcNAc Modified Peptides.

Rajan A Burt, Borislav Dejanovic, Hayley J Peckham, Kimberly A Lee, Xiang Li, Johain R Ounadjela, Anjana Rao, Stacy A Malaker, Steven A Carr, Samuel A Myers

Molecular & cellular proteomics : MCP (2021-10-20) https://www.ncbi.nlm.nih.gov/pubmed/34678516

DOI: 10.1016/j.mcpro.2021.100167 · PMID: 34678516 · PMCID: PMC8605273

339.

Highly Reproducible Automated Proteomics Sample Preparation Workflow for Quantitative Mass Spectrometry

Qin Fu, Michael P Kowalski, Mitra Mastali, Sarah J Parker, Kimia Sobhani, Irene van den Broek, Christie L Hunter, Jennifer E Van Eyk

Journal of Proteome Research (2017-11-10) https://doi.org/gjpg2q

DOI: 10.1021/acs.jproteome.7b00623 · PMID: 29083196 · PMCID: PMC6845026

340.

Large-Scale Multi-omic Analysis of COVID-19 Severity

Katherine A Overmyer, Evgenia Shishkova, Ian J Miller, Joseph Balnis, Matthew N Bernstein, Trenton M Peters-Clarke, Jesse G Meyer, Qiuwen Quan, Laura K Muehlbauer, Edna A Trujillo, … Ariel Jaitovich

Cell Systems (2021-01) https://doi.org/gjkp3p

DOI: 10.1016/j.cels.2020.10.003 · PMID: 33096026 · PMCID: PMC7543711

341.

Depletion of abundant plasma proteins and limitations of plasma proteomics.

Chengjian Tu, Paul A Rudnick, Misti Y Martinez, Kristin L Cheek, Stephen E Stein, Robbert JC Slebos, Daniel C Liebler

Journal of proteome research (2010-10-01) https://www.ncbi.nlm.nih.gov/pubmed/20677825

DOI: 10.1021/pr100646w · PMID: 20677825 · PMCID: PMC2948641

342.

Differences among techniques for high-abundant protein depletion.

Nina Zolotarjova, James Martosella, Gordon Nicol, Jerome Bailey, Barry E Boyes, William C Barrett

Proteomics (2005-08) https://www.ncbi.nlm.nih.gov/pubmed/16052628

DOI: 10.1002/pmic.200402021 · PMID: 16052628

343.

Dye-ligand affinity systems.

A Denizli, E Pişkin

Journal of biochemical and biophysical methods (2001-10-30) https://www.ncbi.nlm.nih.gov/pubmed/11694290

DOI: 10.1016/s0165-022x(01)00209-3 · PMID: 11694290

344.

Cibacron blue immobilized poly(glycidyl-methacrylate) nanobeads for albumin removal in proteome studies.

Müge Andaç

Artificial cells, nanomedicine, and biotechnology (2013-10-29) https://www.ncbi.nlm.nih.gov/pubmed/24168355

DOI: 10.3109/21691401.2013.852102 · PMID: 24168355

345.

Protein G genes: structure and distribution of IgG-binding and albumin-binding domains.

U Sjöbring, L Björck, W Kastern

Molecular microbiology (1989-03) https://www.ncbi.nlm.nih.gov/pubmed/2473373

DOI: 10.1111/j.1365-2958.1989.tb00177.x · PMID: 2473373

346.

Staphylococcal protein A consists of five IgG-binding domains.

T Moks, L Abrahmsén, B Nilsson, U Hellman, J Sjöquist, M Uhlén

European journal of biochemistry (1986-05-02) https://www.ncbi.nlm.nih.gov/pubmed/2938951

DOI: 10.1111/j.1432-1033.1986.tb09625.x · PMID: 2938951

347.

Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: structural basis for recognition of B-cell receptors and superantigen activity.

M Graille, EA Stura, AL Corper, BJ Sutton, MJ Taussig, JB Charbonnier, GJ Silverman

Proceedings of the National Academy of Sciences of the United States of America (2000-05-09) https://www.ncbi.nlm.nih.gov/pubmed/10805799

DOI: 10.1073/pnas.97.10.5399 · PMID: 10805799 · PMCID: PMC25840

348.

Plasma/serum proteomics: depletion strategies for reducing high-abundance proteins for biomarker discovery.

Pey Yee Lee, Junaida Osman, Teck Yew Low, Rahman Jamal

Bioanalysis (2019-10-16) https://www.ncbi.nlm.nih.gov/pubmed/31617391

DOI: 10.4155/bio-2019-0145 · PMID: 31617391

349.

Depletion of Highly Abundant Proteins of the Human Blood Plasma: Applications in Proteomics Studies of Psychiatric Disorders.

Sheila Garcia, Paulo A Baldasso, Paul C Guest, Daniel Martins-de-Souza

Methods in molecular biology (Clifton, N.J.) (2017) https://www.ncbi.nlm.nih.gov/pubmed/27896769

DOI: 10.1007/978-1-4939-6730-8_16 · PMID: 27896769

350.

Reduction of dynamic protein concentration range of biological extracts for the discovery of low-abundance proteins by means of hexapeptide ligand library.

Luc Guerrier, Pier Giorgio Righetti, Egisto Boschetti

Nature protocols (2008) https://www.ncbi.nlm.nih.gov/pubmed/18451796

DOI: 10.1038/nprot.2008.59 · PMID: 18451796

351.

Sample treatment methods involving combinatorial peptide ligand libraries for improved proteomes analyses.

Pier Giorgio Righetti, Egisto Boschetti

Methods in molecular biology (Clifton, N.J.) (2015) https://www.ncbi.nlm.nih.gov/pubmed/25384740

DOI: 10.1007/978-1-4939-1872-0_4 · PMID: 25384740

352.

Depletion of highly abundant proteins in blood plasma by ammonium sulfate precipitation for 2D-PAGE analysis.

Andrea Mahn, Maritza Ismail

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (2011-09-18) https://www.ncbi.nlm.nih.gov/pubmed/21963274

DOI: 10.1016/j.jchromb.2011.09.024 · PMID: 21963274

353.

A novel and cost effective method of removing excess albumin from plasma/serum samples and its impacts on LC-MS/MS bioanalysis of therapeutic proteins.

Guowen Liu, Yue Zhao, Aida Angeles, Lora L Hamuro, Mark E Arnold, Jim X Shen

Analytical chemistry (2014-08-08) https://www.ncbi.nlm.nih.gov/pubmed/25083595

DOI: 10.1021/ac501837t · PMID: 25083595

354.

Enhanced Detection of Low-Abundance Human Plasma Proteins by Integrating Polyethylene Glycol Fractionation and Immunoaffinity Depletion.

Zhao Liu, Songhua Fan, Haipeng Liu, Jia Yu, Rui Qiao, Mi Zhou, Yongtao Yang, Jian Zhou, Peng Xie

PloS one (2016-11-10) https://www.ncbi.nlm.nih.gov/pubmed/27832179

DOI: 10.1371/journal.pone.0166306 · PMID: 27832179 · PMCID: PMC5104378

355.

Reducing agent-mediated precipitation of high-abundance plasma proteins.

Scott E Warder, Lora A Tucker, Tamara J Strelitzer, Evelyn M McKeegan, Joseph L Meuth, Paul M Jung, Anita Saraf, Bhawani Singh, Jie Lai-Zhang, Gerard Gagne, John C Rogers

Analytical biochemistry (2009-01-19) https://www.ncbi.nlm.nih.gov/pubmed/19454248

DOI: 10.1016/j.ab.2009.01.013 · PMID: 19454248

356.

Protein depletion with bacterial cellulose nanofibers.

Ilgım Göktürk, Emel Tamahkar, Fatma Yılmaz, Adil Denizli

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (2018-08-29) https://www.ncbi.nlm.nih.gov/pubmed/30219335

DOI: 10.1016/j.jchromb.2018.08.030 · PMID: 30219335

357.

Molecularly imprinted poly(hydroxyethyl methacrylate) based cryogel for albumin depletion from human serum.

Muge Andac, Igor Yu Galaev, Adil Denizli

Colloids and surfaces. B, Biointerfaces (2013-04-17) https://www.ncbi.nlm.nih.gov/pubmed/23668981

DOI: 10.1016/j.colsurfb.2013.03.054 · PMID: 23668981

358.

Bacterial cellulose nanofibers for albumin depletion from human serum

Emel Tamahkar, Ceyhun Babaç, Tülin Kutsal, Erhan Pişkin, Adil Denizli

Process Biochemistry (2010-10) https://doi.org/bzqhtf

DOI: 10.1016/j.procbio.2010.07.007

359.

Rapid, deep and precise profiling of the plasma proteome with multi-nanoparticle protein corona

John E Blume, William C Manning, Gregory Troiano, Daniel Hornburg, Michael Figa, Lyndal Hesterberg, Theodore L Platt, Xiaoyan Zhao, Rea A Cuaresma, Patrick A Everley, … Omid C Farokhzad

Nature Communications (2020-07-22) https://doi.org/gg7cbp

DOI: 10.1038/s41467-020-17033-7 · PMID: 32699280 · PMCID: PMC7376165

360.

Protein Coronas on Functionalized Nanoparticles Enable Quantitative and Precise Large-Scale Deep Plasma Proteomics

Ting Huang, Jian Wang, Alexey Stukalov, Margaret KR Donovan, Shadi Ferdosi, Lucy Williamson, Seth Just, Gabriel Castro, Lee S Cantrell, Eltaher Elgierari, … Daniel Hornburg

Cold Spring Harbor Laboratory (2023-08-29) https://doi.org/gszdjc

DOI: 10.1101/2023.08.28.555225 · PMID: 37693476 · PMCID: PMC10491250

361.

Mag-Net: Rapid enrichment of membrane-bound particles enables high coverage quantitative analysis of the plasma proteome

Christine C Wu, Kristine A Tsantilas, Jea Park, Deanna Plubell, Previn Naicker, Ireshyn Govender, Sindisiwe Buthelezi, Stoyan Stoychev, Justin Jordaan, Gennifer Merrihew, … Michael J MacCoss

Cold Spring Harbor Laboratory (2023-06-10) https://doi.org/gszdh9

DOI: 10.1101/2023.06.10.544439

362.

Protein Coronas on Functionalized Nanoparticles Enable Quantitative and Precise Large-Scale Deep Plasma Proteomics.

Ting Huang, Jian Wang, Alexey Stukalov, Margaret KR Donovan, Shadi Ferdosi, Lucy Williamson, Seth Just, Gabriel Castro, Lee S Cantrell, Eltaher Elgierari, … Daniel Hornburg

bioRxiv : the preprint server for biology (2023-08-29) https://www.ncbi.nlm.nih.gov/pubmed/37693476

DOI: 10.1101/2023.08.28.555225 · PMID: 37693476 · PMCID: PMC10491250

363.

Rapid, deep and precise profiling of the plasma proteome with multi-nanoparticle protein corona.

John E Blume, William C Manning, Gregory Troiano, Daniel Hornburg, Michael Figa, Lyndal Hesterberg, Theodore L Platt, Xiaoyan Zhao, Rea A Cuaresma, Patrick A Everley, … Omid C Farokhzad

Nature communications (2020-07-22) https://www.ncbi.nlm.nih.gov/pubmed/32699280

DOI: 10.1038/s41467-020-17033-7 · PMID: 32699280 · PMCID: PMC7376165

364.

Ultrasensitive proteomics using high-efficiency on-line micro-SPE-nanoLC-nanoESI MS and MS/MS.

Yufeng Shen, Nikola Tolić, Christophe Masselon, Ljiljana Pasa-Tolić, David G Camp, Kim K Hixson, Rui Zhao, Gordon A Anderson, Richard D Smith

Analytical chemistry (2004-01-01) https://www.ncbi.nlm.nih.gov/pubmed/14697044

DOI: 10.1021/ac030096q · PMID: 14697044

365.

Biomarkers discovery by peptide and protein profiling in biological fluids based on functionalized magnetic beads purification and mass spectrometry.

Fulvio Magni, Yuri EM Van Der Burgt, Clizia Chinello, Veronica Mainini, Erica Gianazza, Valeria Squeo, André M Deelder, Marzia Galli Kienle

Blood transfusion = Trasfusione del sangue (2010-06) https://www.ncbi.nlm.nih.gov/pubmed/20606758

DOI: 10.2450/2010.015s · PMID: 20606758 · PMCID: PMC2897205

366.

Magnetic particles as powerful purification tool for high sensitive mass spectrometric screening procedures.

Jochen F Peter, Angela M Otto

Proteomics (2010-02) https://www.ncbi.nlm.nih.gov/pubmed/20099258

DOI: 10.1002/pmic.200900535 · PMID: 20099258

367.

Robust and high-throughput sample preparation for (semi-)quantitative analysis of N-glycosylation profiles from plasma samples.

LRenee Ruhaak, Carolin Huhn, Carolien AM Koeleman, André M Deelder, Manfred Wuhrer

Methods in molecular biology (Clifton, N.J.) (2012) https://www.ncbi.nlm.nih.gov/pubmed/22665312

DOI: 10.1007/978-1-61779-885-6_23 · PMID: 22665312

368.

Utilizing ion-pairing hydrophilic interaction chromatography solid phase extraction for efficient glycopeptide enrichment in glycoproteomics.

Simon Mysling, Giuseppe Palmisano, Peter Højrup, Morten Thaysen-Andersen

Analytical chemistry (2010-07-01) https://www.ncbi.nlm.nih.gov/pubmed/20536156

DOI: 10.1021/ac100530w · PMID: 20536156

369.

On-line 1D and 2D porous layer open tubular/LC-ESI-MS using 10-microm-i.d. poly(styrene-divinylbenzene) columns for ultrasensitive proteomic analysis.

Quanzhou Luo, Guihua Yue, Gary A Valaskovic, Ye Gu, Shiaw-Lin Wu, Barry L Karger

Analytical chemistry (2007-07-11) https://www.ncbi.nlm.nih.gov/pubmed/17625912

DOI: 10.1021/ac070583w · PMID: 17625912 · PMCID: PMC2570646

370.

Development of a monolithic silica extraction tip for the analysis of proteins.

Shota Miyazaki, Kei Morisato, Norio Ishizuka, Hiroyoshi Minakuchi, Yukihiro Shintani, Masahiro Furuno, Kazuki Nakanishi

Journal of chromatography. A (2004-07-16) https://www.ncbi.nlm.nih.gov/pubmed/15317408

DOI: 10.1016/j.chroma.2004.03.025 · PMID: 15317408

371.

Solid-phase extraction strategies to surmount body fluid sample complexity in high-throughput mass spectrometry-based proteomics.

Marco R Bladergroen, Yuri EM van der Burgt

Journal of analytical methods in chemistry (2015-01-27) https://www.ncbi.nlm.nih.gov/pubmed/25692071

DOI: 10.1155/2015/250131 · PMID: 25692071 · PMCID: PMC4322654

372.

Stop and Go Extraction Tips for Matrix-Assisted Laser Desorption/Ionization, Nanoelectrospray, and LC/MS Sample Pretreatment in Proteomics

Juri Rappsilber, Yasushi Ishihama, Matthias Mann

Analytical Chemistry (2002-12-24) https://doi.org/frp8hj

DOI: 10.1021/ac026117i · PMID: 12585499

373.

Minimal, encapsulated proteomic-sample processing applied to copy-number estimation in eukaryotic cells

Nils A Kulak, Garwin Pichler, Igor Paron, Nagarjuna Nagaraj, Matthias Mann

Nature Methods (2014-02-02) https://doi.org/f5vwds

DOI: 10.1038/nmeth.2834 · PMID: 24487582

374.

Automated sample preparation with SP3 for low-input clinical proteomics.

Torsten Müller, Mathias Kalxdorf, Rémi Longuespée, Daniel N Kazdal, Albrecht Stenzinger, Jeroen Krijgsveld

Molecular systems biology (2020-01) https://www.ncbi.nlm.nih.gov/pubmed/32129943

DOI: 10.15252/msb.20199111 · PMID: 32129943 · PMCID: PMC6966100

375.

National continuous surveys on internal quality control for HbA1c in 306 clinical laboratories of China from 2012 to 2016: Continual improvement.

Tingting Li, Wei Wang, Haijian Zhao, Falin He, Kun Zhong, Shuai Yuan, Zhiguo Wang

Journal of clinical laboratory analysis (2016-11-21) https://www.ncbi.nlm.nih.gov/pubmed/27868236

DOI: 10.1002/jcla.22099 · PMID: 27868236 · PMCID: PMC6817230

376.

Abstracts of Presentations at the Association of Clinical Scientists 143

Annals of clinical and laboratory science

(2022-05) https://www.ncbi.nlm.nih.gov/pubmed/35777803

PMID: 35777803

377.

A comparison of immobilized pH gradient isoelectric focusing and strong-cation-exchange chromatography as a first dimension in shotgun proteomics.

Amal S Essader, Benjamin J Cargile, Jonathan L Bundy, James L Stephenson

Proteomics (2005-01) https://www.ncbi.nlm.nih.gov/pubmed/15672457

DOI: 10.1002/pmic.200400888 · PMID: 15672457

378.

Peptide fractionation in proteomics approaches.

Bruno Manadas, Vera M Mendes, Jane English, Michael J Dunn

Expert review of proteomics (2010-10) https://www.ncbi.nlm.nih.gov/pubmed/20973639

DOI: 10.1586/epr.10.46 · PMID: 20973639

379.

The challenges of the analysis of basic compounds by high performance liquid chromatography: some possible approaches for improved separations.

David V McCalley

Journal of chromatography. A (2009-12-03) https://www.ncbi.nlm.nih.gov/pubmed/20031138

DOI: 10.1016/j.chroma.2009.11.068 · PMID: 20031138

380.

Two-dimensional separation of peptides using RP-RP-HPLC system with different pH in first and second separation dimensions.

Martin Gilar, Petra Olivova, Amy E Daly, John C Gebler

Journal of separation science (2005-09) https://www.ncbi.nlm.nih.gov/pubmed/16224963

DOI: 10.1002/jssc.200500116 · PMID: 16224963

381.

High-pH reversed-phase chromatography with fraction concatenation for 2D proteomic analysis.

Feng Yang, Yufeng Shen, David G Camp, Richard D Smith

Expert review of proteomics (2012-04) https://www.ncbi.nlm.nih.gov/pubmed/22462785

DOI: 10.1586/epr.12.15 · PMID: 22462785 · PMCID: PMC3337716

382.

A high-performance liquid chromatography procedure for recovering subnanomole amounts of protein from SDS-gel electroeluates for gas-phase sequence analysis.

RJ Simpson, RL Moritz, EE Nice, B Grego

European journal of biochemistry (1987-05-15) https://www.ncbi.nlm.nih.gov/pubmed/3569294

DOI: 10.1111/j.1432-1033.1987.tb11189.x · PMID: 3569294

383.

Hydrophilic interaction liquid chromatography (HILIC) in proteomics.

Paul J Boersema, Shabaz Mohammed, Albert JR Heck

Analytical and bioanalytical chemistry (2008-02-09) https://www.ncbi.nlm.nih.gov/pubmed/18264818

DOI: 10.1007/s00216-008-1865-7 · PMID: 18264818 · PMCID: PMC2324128

384.

ERK1/2 regulates intracellular ATP levels through alpha-enolase expression in cardiomyocytes exposed to ischemic hypoxia and reoxygenation.

Yoichi Mizukami, Akihiro Iwamatsu, Toshihiko Aki, Masayasu Kimura, Kazuyuki Nakamura, Tomoko Nao, Tomoko Okusa, Masunori Matsuzaki, Ken-Ichi Yoshida, Sei Kobayashi

The Journal of biological chemistry (2004-09-30) https://www.ncbi.nlm.nih.gov/pubmed/15459207

DOI: 10.1074/jbc.m402299200 · PMID: 15459207

385.

Hydrophilic interaction liquid chromatography (HILIC)--a powerful separation technique.

Bogusław Buszewski, Sylwia Noga

Analytical and bioanalytical chemistry (2011-08-31) https://www.ncbi.nlm.nih.gov/pubmed/21879300

DOI: 10.1007/s00216-011-5308-5 · PMID: 21879300 · PMCID: PMC3249561

386.

Stationary phases for hydrophilic interaction chromatography, their characterization and implementation into multidimensional chromatography concepts.

Pavel Jandera

Journal of separation science (2008-05) https://www.ncbi.nlm.nih.gov/pubmed/18428181

DOI: 10.1002/jssc.200800051 · PMID: 18428181

387.

Efficient fractionation and improved protein identification by peptide OFFGEL electrophoresis.

Patric Hörth, Christine A Miller, Tobias Preckel, Christian Wenz

Molecular & cellular proteomics : MCP (2006-07-14) https://www.ncbi.nlm.nih.gov/pubmed/16849286

DOI: 10.1074/mcp.t600037-mcp200 · PMID: 16849286

388.

Improved proteome coverage by using iTRAQ labelling and peptide OFFGEL fractionation.

Emilie Ernoult, Erick Gamelin, Catherine Guette

Proteome science (2008-10-13) https://www.ncbi.nlm.nih.gov/pubmed/18851748

DOI: 10.1186/1477-5956-6-27 · PMID: 18851748 · PMCID: PMC2572582

389.

Combination of peptide OFFGEL fractionation and label-free quantitation facilitated proteomics profiling of extraocular muscle.

Sven Fraterman, Ulrike Zeiger, Tejvir S Khurana, Neal A Rubinstein, Matthias Wilm

Proteomics (2007-09) https://www.ncbi.nlm.nih.gov/pubmed/17708596

DOI: 10.1002/pmic.200700382 · PMID: 17708596

390.

Electrostatic Repulsion Hydrophilic Interaction Chromatography for Isocratic Separation of Charged Solutes and Selective Isolation of Phosphopeptides

Andrew J Alpert

Analytical Chemistry (2007-11-21) https://doi.org/bt84c3

DOI: 10.1021/ac070997p · PMID: 18027909

391.

Novel Application of Electrostatic Repulsion-Hydrophilic Interaction Chromatography (ERLIC) in Shotgun Proteomics: Comprehensive Profiling of Rat Kidney Proteome

Piliang Hao, Tiannan Guo, Xin Li, Sunil S Adav, Jie Yang, Meng Wei, Siu Kwan Sze

Journal of Proteome Research (2010-06-10) https://doi.org/bgkxkx

DOI: 10.1021/pr100037h · PMID: 20450224

392.

Comprehensive liquid chromatography: Fundamental aspects and practical considerations—A review

Isabelle François, Koen Sandra, Pat Sandra

Analytica Chimica Acta (2009-05) https://doi.org/b8mj7m

DOI: 10.1016/j.aca.2009.03.041 · PMID: 19393362

393.

Ion Suppression in Mass Spectrometry

Thomas M Annesley

Clinical Chemistry (2003-07-01) https://doi.org/dh9v2v

DOI: 10.1373/49.7.1041 · PMID: 12816898

394.

Advanced proteomic liquid chromatography

Fang Xie, Richard D Smith, Yufeng Shen

Journal of Chromatography A (2012-10) https://doi.org/gsr7w3

DOI: 10.1016/j.chroma.2012.06.098 · PMID: 22840822 · PMCID: PMC3463731

395.

Multi-dimensional liquid chromatography in proteomics—A review

Xiang Zhang, Aiqin Fang, Catherine P Riley, Mu Wang, Fred E Regnier, Charles Buck

Analytica Chimica Acta (2010-04) https://doi.org/fsb5nk

DOI: 10.1016/j.aca.2010.02.001 · PMID: 20363391 · PMCID: PMC2852180

396.

The role of liquid chromatography in proteomics

Y SHI, R XIANG, C HORVATH, J WILKINS

Journal of Chromatography A (2004-10-22) https://doi.org/fq93q6

DOI: 10.1016/j.chroma.2004.07.044

397.

XX. On the equilibrium of liquid conducting masses charged with electricity

Lord Rayleigh

The London, Edinburgh, and Dublin Philosophical Magazine and Journal of Science (1882-09) https://doi.org/c6bp6h

DOI: 10.1080/14786448208628425

398.

More Sensitive and Quantitative Proteomic Measurements Using Very Low Flow Rate Porous Silica Monolithic LC Columns with Electrospray Ionization-Mass Spectrometry

Quanzhou Luo, Keqi Tang, Feng Yang, Ayesha Elias, Yufeng Shen, Ronald J Moore, Rui Zhao, Kim K Hixson, Sandra S Rossie, Richard D Smith

Journal of Proteome Research (2006-04-01) https://doi.org/bf97wg

DOI: 10.1021/pr050424y · PMID: 16674098

399.

Longitudinal diffusion and resistance to mass transfer as causes of nonideality in chromatography

JJ van Deemter, FJ Zuiderweg, A Klinkenberg

Chemical Engineering Science (1956-09-01) https://www.sciencedirect.com/science/article/pii/0009250956800031

DOI: 10.1016/0009-2509(56)80003-1

400.

Vacuum Insulated Probe Heated Electrospray Ionization Source Enhances Microflow Rate Chromatography Signals in the Bruker timsTOF Mass Spectrometer.

Mukul K Midha, Charu Kapil, Michal Maes, David H Baxter, Seamus R Morrone, Timothy J Prokop, Robert L Moritz

Journal of proteome research (2023-06-09) https://www.ncbi.nlm.nih.gov/pubmed/37294184

DOI: 10.1021/acs.jproteome.3c00305 · PMID: 37294184

401.

Parallelization with Dual-Trap Single-Column Configuration Maximizes Throughput of Proteomic Analysis

Simion Kreimer, Ali Haghani, Aleksandra Binek, Alisse Hauspurg, Saeed Seyedmohammad, Alejandro Rivas, Amanda Momenzadeh, Jesse G Meyer, Koen Raedschelders, Jennifer E Van Eyk

Analytical Chemistry (2022-08-31) https://doi.org/gsr77d

DOI: 10.1021/acs.analchem.2c02609 · PMID: 36044770 · PMCID: PMC9900495

402.

High-Throughput Single-Cell Proteomic Analysis of Organ-Derived Heterogeneous Cell Populations by Nanoflow Dual-Trap Single-Column Liquid Chromatography

Simion Kreimer, Aleksandra Binek, Blandine Chazarin, Jae Hyung Cho, Ali Haghani, Alexandre Hutton, Eduardo Marbán, Mitra Mastali, Jesse G Meyer, Thassio Mesquita, … Sarah Parker

Analytical Chemistry (2023-06-08) https://doi.org/gsr77f

DOI: 10.1021/acs.analchem.3c00213 · PMID: 37289937

403.

“Orthogonal” separations for reversed-phase liquid chromatography

Jackson Pellett, Patrick Lukulay, Yun Mao, William Bowen, Robert Reed, M Ma, RC Munger, JW Dolan, Loren Wrisley, K Medwid, … LR Snyder

Journal of Chromatography A (2006-01) https://doi.org/c76zht

DOI: 10.1016/j.chroma.2005.09.080 · PMID: 16236292

404.

Large-scale analysis of the yeast proteome by multidimensional protein identification technology

Michael P Washburn, Dirk Wolters, John R Yates III

Nature Biotechnology (2001-03) https://doi.org/cpwfkn

DOI: 10.1038/85686 · PMID: 11231557

405.

Reversed‐phase chromatography with multiple fraction concatenation strategy for proteome profiling of human MCF10A cells

Yuexi Wang, Feng Yang, Marina A Gritsenko, Yingchun Wang, Therese Clauss, Tao Liu, Yufeng Shen, Matthew E Monroe, Daniel Lopez‐Ferrer, Theresa Reno, … Richard D Smith

PROTEOMICS (2011-04-18) https://doi.org/c54ggx

DOI: 10.1002/pmic.201000722 · PMID: 21500348 · PMCID: PMC3120047

406.

Single-Shot 10K Proteome Approach: Over 10,000 Protein Identifications by Data-Independent Acquisition-Based Single-Shot Proteomics with Ion Mobility Spectrometry

Yusuke Kawashima, Hirotaka Nagai, Ryo Konno, Masaki Ishikawa, Daisuke Nakajima, Hironori Sato, Ren Nakamura, Tomoyuki Furuyashiki, Osamu Ohara

Journal of Proteome Research (2022-05-06) https://doi.org/gqgg5x

DOI: 10.1021/acs.jproteome.2c00023 · PMID: 35522919 · PMCID: PMC9171847

407.

The Nobel Prize in Chemistry 2002

NobelPrize.org

https://www.nobelprize.org/prizes/chemistry/2002/summary/

408.

Influence of the wavelength in high-irradiance ultraviolet laser desorption mass spectrometry of organic molecules

Michael Karas, Doris Bachmann, Franz Hillenkamp

Analytical Chemistry (1985-12-01) https://pubs.acs.org/doi/abs/10.1021/ac00291a042

DOI: 10.1021/ac00291a042

409.

Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons

Michael Karas, Franz Hillenkamp

Analytical Chemistry (1988-10-15) https://doi.org/d577jp

DOI: 10.1021/ac00171a028 · PMID: 3239801

410.

The Scientist :: Nobel Prize controversy (2007-05-17) https://web.archive.org/web/20070517202246/http://cmbi.bjmu.edu.cn/news/0212/55.htm

411.

α-Cyano-4-hydroxycinnamic acid, sinapinic acid, and ferulic acid as matrices and alkylating agents for matrix-assisted laser desorption/ionization time-of-flight mass spectrometric analysis of cysteine-containing peptides.

Hongmei Yang, Debin Wan, Fengrui Song, Zhiqiang Liu, Shuying Liu

Rapid communications in mass spectrometry : RCM (2013-06-30) https://www.ncbi.nlm.nih.gov/pubmed/23681820

DOI: 10.1002/rcm.6587 · PMID: 23681820

412.

The Desorption Process in MALDI

Klaus Dreisewerd

Chemical Reviews (2003-01-24) https://doi.org/cpzqmq

DOI: 10.1021/cr010375i · PMID: 12580636

413.

Matrix Dependence of Metastable Fragmentation of Glycoproteins in MALDI TOF Mass Spectrometry

Michael Karas, Ute Bahr, Kerstin Strupat, Franz Hillenkamp, Anthony Tsarbopoulos, Birendra N Pramanik

Analytical Chemistry (1995-02-01) https://doi.org/b54gnt

DOI: 10.1021/ac00099a029

414.

Charge state coalescence during electrospray ionization improves peptide identification by tandem mass spectrometry.

Jesse G Meyer, Elizabeth A Komives

Journal of the American Society for Mass Spectrometry (2012-05-18) https://www.ncbi.nlm.nih.gov/pubmed/22610994

DOI: 10.1007/s13361-012-0404-0 · PMID: 22610994 · PMCID: PMC6345509

415.

Electrospray: from ions in solution to ions in the gas phase, what we know now.

Paul Kebarle, Udo H Verkerk

Mass spectrometry reviews (2009) https://www.ncbi.nlm.nih.gov/pubmed/19551695

DOI: 10.1002/mas.20247 · PMID: 19551695

416.

Unraveling the mechanism of electrospray ionization.

Lars Konermann, Elias Ahadi, Antony D Rodriguez, Siavash Vahidi

Analytical chemistry (2012-11-20) https://www.ncbi.nlm.nih.gov/pubmed/23134552

DOI: 10.1021/ac302789c · PMID: 23134552

417.

A Brief History of Mass Spectrometry

Jennifer Griffiths

Analytical Chemistry (2008-07-31) https://doi.org/btwqsg

DOI: 10.1021/ac8013065 · PMID: 18671338

418.

Direct ionization methods in mass spectrometry: An overview

Christian W Klampfl, Markus Himmelsbach

Analytica Chimica Acta (2015-08) https://doi.org/f7qnxc

DOI: 10.1016/j.aca.2015.07.012 · PMID: 26347167

419.

Mass Spectrometry, Review of the Basics: Ionization

Hanan Awad, Mona M Khamis, Anas El-Aneed

Applied Spectroscopy Reviews (2014-09-25) https://doi.org/gh28k8

DOI: 10.1080/05704928.2014.954046

420.

Towards Higher Sensitivity of Mass Spectrometry: A Perspective From the Mass Analyzers

Chang Li, Shiying Chu, Siyuan Tan, Xinchi Yin, You Jiang, Xinhua Dai, Xiaoyun Gong, Xiang Fang, Di Tian

Frontiers in Chemistry (2021-12-21) https://doi.org/gr7v7s

DOI: 10.3389/fchem.2021.813359 · PMID: 34993180 · PMCID: PMC8724130

421.

Evolution of Orbitrap Mass Spectrometry Instrumentation

Shannon Eliuk, Alexander Makarov

Annual Review of Analytical Chemistry (2015-07-22) https://doi.org/ggn4nz

DOI: 10.1146/annurev-anchem-071114-040325 · PMID: 26161972

422.

Hybrid mass spectrometers for tandem mass spectrometry

Gary L Glish, David J Burinsky

Journal of the American Society for Mass Spectrometry (2008-02-01) https://doi.org/cd66p8

DOI: 10.1016/j.jasms.2007.11.013 · PMID: 18187337

423.

Fundamentals and Advances of Orbitrap Mass Spectrometry

Elizabeth S Hecht, Michaela Scigelova, Shannon Eliuk, Alexander Makarov

Encyclopedia of Analytical Chemistry (2019-09-16) https://doi.org/gssrqd

DOI: 10.1002/9780470027318.a9309.pub2

424.

Orbitrap Mass Spectrometry

Roman A Zubarev, Alexander Makarov

Analytical Chemistry (2013-05-13) https://doi.org/f24tv5

DOI: 10.1021/ac4001223 · PMID: 23590404

425.

Advanced fundamentals in Fourier transform mass spectrometry

Yury O Tsybin, Konstantin O Nagornov, Anton N Kozhinov

Fundamentals and Applications of Fourier Transform Mass Spectrometry (2019) https://doi.org/gssrqg

DOI: 10.1016/b978-0-12-814013-0.00005-3

426.

Collision-induced dissociation (CID) of peptides and proteins.

JMitchell Wells, Scott A McLuckey

Methods in enzymology (2005) https://www.ncbi.nlm.nih.gov/pubmed/16401509

DOI: 10.1016/s0076-6879(05)02005-7 · PMID: 16401509

427.

Improved Collisionally Activated Dissociation Efficiency and Mass Resolution on a Triple Quadrupole Mass Spectrometer System

Bruce A Thomson, DJ Douglas, Jay J Corr, James W Hager, Charles L Jolliffe

Analytical Chemistry (1995-05-15) https://doi.org/cmhbkv

DOI: 10.1021/ac00106a008

428.

Tandem-in-space and tandem-in-time mass spectrometry: triple quadrupoles and quadrupole ion traps

Jodie V Johnson, Richard A Yost, Paul E Kelley, Donald C Bradford

Analytical Chemistry (1990-10-15) https://doi.org/cp87w5

DOI: 10.1021/ac00219a003

429.

Ion activation methods for tandem mass spectrometry

Lekha Sleno, Dietrich A Volmer

Journal of Mass Spectrometry (2004-10) https://doi.org/fv3vrk

DOI: 10.1002/jms.703 · PMID: 15481084

430.

Quantitative Mass Spectrometric Multiple Reaction Monitoring Assays for Major Plasma Proteins

Leigh Anderson, Christie L Hunter

Molecular & Cellular Proteomics (2006-04) https://doi.org/c8f5g7

DOI: 10.1074/mcp.m500331-mcp200 · PMID: 16332733

431.

Recent trends in mass spectrometer development

James W Hager

Analytical and Bioanalytical Chemistry (2003-11-04) https://doi.org/dt2dkm

DOI: 10.1007/s00216-003-2287-1 · PMID: 14598011 · PMCID: PMC7079868

432.

Selected ion fragmentation with a tandem quadrupole mass spectrometer

RA Yost, CG Enke

Journal of the American Chemical Society (1978-03) https://doi.org/cm6pp4

DOI: 10.1021/ja00475a072

433.

Triple quadrupole linear ion trap mass spectrometer for the analysis of small molecules and macromolecules

Gérard Hopfgartner, Emmanuel Varesio, Viviane Tschäppät, Chantal Grivet, Emmanuel Bourgogne, Luc Alexis Leuthold

Journal of Mass Spectrometry (2004-08) https://doi.org/fq2dw3

DOI: 10.1002/jms.659 · PMID: 15329837

434.

Recent advances in applications of liquid chromatography–tandem mass spectrometry to the analysis of reactive drug metabolites

Shuguang Ma, Mingshe Zhu

Chemico-Biological Interactions (2009-04) https://doi.org/bwf9sp

DOI: 10.1016/j.cbi.2008.09.014 · PMID: 18848531

435.

The role of GC-MS/MS with triple quadrupole in pesticide residue analysis in food and the environment

F Hernández, MI Cervera, T Portolés, J Beltrán, E Pitarch

Analytical Methods (2013) https://doi.org/gssrqx

DOI: 10.1039/c3ay41104d

436.

Tandem mass spectrometry in the clinical laboratory: A tutorial overview

JGrace van der Gugten

Clinical Mass Spectrometry (2020-01) https://doi.org/gssrqh

DOI: 10.1016/j.clinms.2019.09.002

437.

Proceedings of the American Physical Society

Anonymous

Physical Review (1946-06-01) https://doi.org/ddzhj3

DOI: 10.1103/physrev.69.674.2

438.

A Pulsed Mass Spectrometer with Time Dispersion

MM Wolff, WE Stephens

Review of Scientific Instruments (1953-08-01) https://doi.org/bxz73r

DOI: 10.1063/1.1770801

439.

Time-of-Flight Mass Spectrometer with Improved Resolution

WC Wiley, IH McLaren

Review of Scientific Instruments (1955-12-01) https://doi.org/dxcbgx

DOI: 10.1063/1.1715212

440.

Simplified high-throughput methods for deep proteome analysis on the timsTOF Pro

Jarrod J Sandow, Giuseppe Infusini, Laura F Dagley, Rune Larsen, Andrew I Webb

Cold Spring Harbor Laboratory (2019-06-03) https://doi.org/ggr98j

DOI: 10.1101/657908

441.

Ultrafast and Reproducible Proteomics from Small Amounts of Heart Tissue Enabled by Azo and timsTOF Pro

Timothy J Aballo, David S Roberts, Jake A Melby, Kevin M Buck, Kyle A Brown, Ying Ge

Journal of Proteome Research (2021-07-08) https://doi.org/gmqvmf

DOI: 10.1021/acs.jproteome.1c00446 · PMID: 34236868 · PMCID: PMC8349881

442.

High Throughput Proteome Screening for Biomarker Detection

Sheng Pan, Hui Zhang, John Rush, Jimmy Eng, Ning Zhang, Dale Patterson, Michael J Comb, Ruedi Aebersold

Molecular & Cellular Proteomics (2005-02) https://doi.org/brcr5t

DOI: 10.1074/mcp.m400161-mcp200 · PMID: 15637048

443.

Mass Spectrometry-Based Structural Virology

Tobias P Wörner, Tatiana M Shamorkina, Joost Snijder, Albert JR Heck

Analytical Chemistry (2020-12-04) https://doi.org/gssrqn

DOI: 10.1021/acs.analchem.0c04339 · PMID: 33275424 · PMCID: PMC7807421

444.

Analytical Approaches for Size and Mass Analysis of Large Protein Assemblies

Joost Snijder, Albert JR Heck

Annual Review of Analytical Chemistry (2014-06-12) https://doi.org/gssrqz

DOI: 10.1146/annurev-anchem-071213-020015 · PMID: 25014341

445.

The emergence of mass spectrometry for characterizing nanomaterials. Atomically precise nanoclusters and beyond

Clothilde Comby-Zerbino, Xavier Dagany, Fabien Chirot, Philippe Dugourd, Rodolphe Antoine

Materials Advances (2021) https://doi.org/gsrjtb

DOI: 10.1039/d1ma00261a

446.

Electrostatic Axially Harmonic Orbital Trapping: A High-Performance Technique of Mass Analysis

Alexander Makarov

Analytical Chemistry (2000-02-10) https://doi.org/cs45nz

DOI: 10.1021/ac991131p · PMID: 10740853

447.

Coupling liquid chromatography to Orbitrap mass spectrometry

Alexander Makarov, Michaela Scigelova

Journal of Chromatography A (2010-06) https://doi.org/ff4bjw

DOI: 10.1016/j.chroma.2010.02.022 · PMID: 20299023

448.

Advances in mass spectrometry-based clinical biomarker discovery

Christopher A Crutchfield, Stefani N Thomas, Lori J Sokoll, Daniel W Chan

Clinical Proteomics (2016-01-07) https://doi.org/gh624w

DOI: 10.1186/s12014-015-9102-9 · PMID: 26751220 · PMCID: PMC4705754

449.

PIQED: automated identification and quantification of protein modifications from DIA-MS data

Jesse G Meyer, Sushanth Mukkamalla, Hanno Steen, Alexey I Nesvizhskii, Bradford W Gibson, Birgit Schilling

Nature Methods (2017-07) https://doi.org/gssrqv

DOI: 10.1038/nmeth.4334 · PMID: 28661500 · PMCID: PMC5663633

450.

A Complete Workflow for High Throughput Human Single Skeletal Muscle Fiber Proteomics

Amanda Momenzadeh, Yuming Jiang, Simion Kreimer, Laura E Teigen, Carlos S Zepeda, Ali Haghani, Mitra Mastali, Yang Song, Alexandre Hutton, Sarah J Parker, … Jesse G Meyer

Journal of the American Society for Mass Spectrometry (2023-07-18) https://doi.org/gssrqt

DOI: 10.1021/jasms.3c00072 · PMID: 37463334

451.

Characterizing Protein–Protein Interactions Using Mass Spectrometry: Challenges and Opportunities

Arne H Smits, Michiel Vermeulen

Trends in Biotechnology (2016-10) https://doi.org/f863x9

DOI: 10.1016/j.tibtech.2016.02.014 · PMID: 26996615

452.

Nanoparticles and photochemistry for native-like transmembrane protein footprinting

Jie Sun, Xiaoran Roger Liu, Shuang Li, Peng He, Weikai Li, Michael L Gross

Nature Communications (2021-12-14) https://doi.org/gssrqw

DOI: 10.1038/s41467-021-27588-8 · PMID: 34907205 · PMCID: PMC8671412

453.

Carbocation Footprinting of Soluble and Transmembrane Proteins

Jie Sun, Shuang Li, Weikai Li, Michael L Gross

Analytical Chemistry (2021-09-24) https://doi.org/gssrqp

DOI: 10.1021/acs.analchem.1c03274 · PMID: 34558889 · PMCID: PMC8900486

454.

Fourier transform ion cyclotron resonance spectroscopy

Melvin B Comisarow, Alan G Marshall

Chemical Physics Letters (1974-03-15) https://www.sciencedirect.com/science/article/pii/0009261474891372

DOI: 10.1016/0009-2614(74)89137-2

455.

Developments in FT‐ICR MS instrumentation, ionization techniques, and data interpretation methods for petroleomics

Yunju Cho, Arif Ahmed, Annana Islam, Sunghwan Kim

Mass Spectrometry Reviews (2014-06-18) https://doi.org/f6zb44

DOI: 10.1002/mas.21438 · PMID: 24942384

456.

Molecular composition of urban organic aerosols on clear and hazy days in Beijing: a comparative study using FT-ICR MS

Bin Jiang, Bin Yu Kuang, Yongmei Liang, Jingyi Zhang, XHHilda Huang, Chunming Xu, Jian Zhen Yu, Quan Shi

Environmental Chemistry (2016) https://doi.org/f8523d

DOI: 10.1071/en15230

457.

Proteomics by FTICR mass spectrometry: Top down and bottom up

Bogdan Bogdanov, Richard D Smith

Mass Spectrometry Reviews (2004-03-30) https://doi.org/c2nx8k

DOI: 10.1002/mas.20015 · PMID: 15389855

458.

Multidimensional LC Separations in Shotgun Proteomics

Akira Motoyama, John R Yates III

Analytical Chemistry (2008-09-30) https://doi.org/d3ngn8

DOI: 10.1021/ac8013669 · PMID: 18826178

459.

Application of LC/MS to proteomics studies: current status and future prospects

Guodong Chen, Birendra N Pramanik

Drug Discovery Today (2009-05) https://doi.org/dj8wq2

DOI: 10.1016/j.drudis.2009.02.007 · PMID: 19429505

460.

Ion Mobility-Mass Spectrometry: Time-Dispersive Instrumentation

Jody C May, John A McLean

Analytical Chemistry (2015-01-09) https://doi.org/gcbv8t

DOI: 10.1021/ac504720m · PMID: 25526595 · PMCID: PMC4318620

461.

Ion Mobility Spectrometry: Fundamental Concepts, Instrumentation, Applications, and the Road Ahead

James N Dodds, Erin S Baker

Journal of the American Society for Mass Spectrometry (2019-09-06) https://doi.org/ggfrf7

DOI: 10.1007/s13361-019-02288-2 · PMID: 31493234 · PMCID: PMC6832852

462.

Parallel Accumulation–Serial Fragmentation (PASEF): Multiplying Sequencing Speed and Sensitivity by Synchronized Scans in a Trapped Ion Mobility Device

Florian Meier, Scarlet Beck, Niklas Grassl, Markus Lubeck, Melvin A Park, Oliver Raether, Matthias Mann

Journal of Proteome Research (2015-11-13) https://doi.org/f7289w

DOI: 10.1021/acs.jproteome.5b00932 · PMID: 26538118

463.

Trends in trapped ion mobility – Mass spectrometry instrumentation

Mark E Ridgeway, Christian Bleiholder, Matthias Mann, Melvin A Park

TrAC Trends in Analytical Chemistry (2019-07) https://doi.org/gssrqk

DOI: 10.1016/j.trac.2019.03.030

464.

A Cyclic Ion Mobility-Mass Spectrometry System

Kevin Giles, Jakub Ujma, Jason Wildgoose, Steven Pringle, Keith Richardson, David Langridge, Martin Green

Analytical Chemistry (2019-05-29) https://doi.org/gssrqs

DOI: 10.1021/acs.analchem.9b01838 · PMID: 31141659

465.

Utilizing Drift Tube Ion Mobility Spectrometry for the Evaluation of Metabolites and Xenobiotics

Melanie T Odenkirk, Erin S Baker

Methods in Molecular Biology (2019-11-16) https://doi.org/gssrqf

DOI: 10.1007/978-1-0716-0030-6_2 · PMID: 31729652

466.

Ion Mobility–Mass Spectrometry

Wentao Jiang, Nadjali A Chung, Jody C May, John A McLean, Renã AS Robinson

Encyclopedia of Analytical Chemistry (2019-06-13) https://doi.org/gn2fcc

DOI: 10.1002/9780470027318.a9292.pub2

467.

High-field asymmetric waveform ion mobility spectrometry for mass spectrometry-based proteomics

Kristian E Swearingen, Robert L Moritz

Expert Review of Proteomics (2012-10) https://doi.org/f4hx6v

DOI: 10.1586/epr.12.50 · PMID: 23194268 · PMCID: PMC4777519

468.

High-Field Asymmetric Waveform Ion Mobility Spectrometry and Native Mass Spectrometry: Analysis of Intact Protein Assemblies and Protein Complexes

Oliver J Hale, Eva Illes-Toth, Todd H Mize, Helen J Cooper

Analytical Chemistry (2020-04-28) https://doi.org/gssrqm

DOI: 10.1021/acs.analchem.0c00649 · PMID: 32343119 · PMCID: PMC7304667

469.

Comprehensive Single-Shot Proteomics with FAIMS on a Hybrid Orbitrap Mass Spectrometer

Alexander S Hebert, Satendra Prasad, Michael W Belford, Derek J Bailey, Graeme C McAlister, Susan E Abbatiello, Romain Huguet, Eloy R Wouters, Jean-Jacques Dunyach, Dain R Brademan, … Joshua J Coon

Analytical Chemistry (2018-07-03) https://doi.org/gd4chm

DOI: 10.1021/acs.analchem.8b02233 · PMID: 29969236 · PMCID: PMC6145172

470.

High-field asymmetric waveform ion mobility spectrometry: A new tool for mass spectrometry

R GUEVREMONT

Journal of Chromatography A (2004-11-26) https://doi.org/dsdp9m

DOI: 10.1016/j.chroma.2004.08.119

471.

Trapped ion mobility spectrometry: A short review

Mark E Ridgeway, Markus Lubeck, Jan Jordens, Mattias Mann, Melvin A Park

International Journal of Mass Spectrometry (2018-02) https://doi.org/gc5nw5

DOI: 10.1016/j.ijms.2018.01.006

472.

Trapped Ion Mobility Spectrometry and Parallel Accumulation–Serial Fragmentation in Proteomics

Florian Meier, Melvin A Park, Matthias Mann

Molecular & Cellular Proteomics (2021) https://doi.org/gssrqj

DOI: 10.1016/j.mcpro.2021.100138 · PMID: 34416385 · PMCID: PMC8453224

473.

Characterization of Ion Dynamics in Structures for Lossless Ion Manipulations

Aleksey V Tolmachev, Ian K Webb, Yehia M Ibrahim, Sandilya VB Garimella, Xinyu Zhang, Gordon A Anderson, Richard D Smith

Analytical Chemistry (2014-09-04) https://doi.org/f6jr4m

DOI: 10.1021/ac502054p · PMID: 25152178 · PMCID: PMC4175726

474.

Serpentine Ultralong Path with Extended Routing (SUPER) High Resolution Traveling Wave Ion Mobility-MS using Structures for Lossless Ion Manipulations

Liulin Deng, Ian K Webb, Sandilya VB Garimella, Ahmed M Hamid, Xueyun Zheng, Randolph V Norheim, Spencer A Prost, Gordon A Anderson, Jeremy A Sandoval, Erin S Baker, … Richard D Smith

Analytical Chemistry (2017-04-05) https://doi.org/f9zgxj

DOI: 10.1021/acs.analchem.7b00185 · PMID: 28332832 · PMCID: PMC5627996

475.

High-Resolution Ion-Mobility-Enabled Peptide Mapping for High-Throughput Critical Quality Attribute Monitoring

James R Arndt, Kelly L Wormwood Moser, Gregory Van Aken, Rory M Doyle, Tatjana Talamantes, Daniel DeBord, Laura Maxon, George Stafford, John Fjeldsted, Bryan Miller, Melissa Sherman

Journal of the American Society for Mass Spectrometry (2021-04-09) https://doi.org/gssrrb

DOI: 10.1021/jasms.0c00434 · PMID: 33835810

476.

An Introduction to Mass Spectrometry-Based Proteomics

Steven R Shuken

Journal of Proteome Research (2023-06-01) https://doi.org/gsr77x

DOI: 10.1021/acs.jproteome.2c00838 · PMID: 37260118

477.

Protein Analysis by Shotgun/Bottom-up Proteomics

Yaoyang Zhang, Bryan R Fonslow, Bing Shan, Moon-Chang Baek, John R Yates III

Chemical Reviews (2013-02-26) https://doi.org/ggkd3r

DOI: 10.1021/cr3003533 · PMID: 23438204 · PMCID: PMC3751594

478.

Periodicity of Monoisotopic Mass Isomers and Isobars in Proteomics

Long Yu, Yan-Mei Xiong, Nick C Polfer

Analytical Chemistry (2011-09-20) https://doi.org/dbf94b

DOI: 10.1021/ac201624t · PMID: 21932815

479.

Protein sequencing by tandem mass spectrometry.

DF Hunt, JR Yates 3rd, J Shabanowitz, S Winston, CR Hauer

Proceedings of the National Academy of Sciences (1986-09) https://doi.org/bhq2fw

DOI: 10.1073/pnas.83.17.6233 · PMID: 3462691 · PMCID: PMC386476

480.

DirectMS1: MS/MS-Free Identification of 1000 Proteins of Cellular Proteomes in 5 Minutes

Mark V Ivanov, Julia A Bubis, Vladimir Gorshkov, Irina A Tarasova, Lev I Levitsky, Anna A Lobas, Elizaveta M Solovyeva, Marina L Pridatchenko, Frank Kjeldsen, Mikhail V Gorshkov

Analytical Chemistry (2020-02-20) https://doi.org/gsr77v

DOI: 10.1021/acs.analchem.9b05095 · PMID: 32077687

481.

Robust Algorithm for Alignment of Liquid Chromatography−Mass Spectrometry Analyses in an Accurate Mass and Time Tag Data Analysis Pipeline

Navdeep Jaitly, Matthew E Monroe, Vladislav A Petyuk, Therese RW Clauss, Joshua N Adkins, Richard D Smith

Analytical Chemistry (2006-10-04) https://doi.org/dhxw24

DOI: 10.1021/ac052197p · PMID: 17073405

482.

BoxCar acquisition method enables single-shot proteomics at a depth of 10,000 proteins in 100 minutes

Florian Meier, Philipp E Geyer, Sebastian Virreira Winter, Juergen Cox, Matthias Mann

Nature Methods (2018-05-07) https://doi.org/gdqs9d

DOI: 10.1038/s41592-018-0003-5 · PMID: 29735998

483.

Letter to the editors

P Roepstorff, J Fohlman

Biological Mass Spectrometry (1984-11) https://doi.org/fh4rbm

DOI: 10.1002/bms.1200111109 · PMID: 6525415

484.

Mass spectrometry

James A McCloskey

Academic Press (1990)

ISBN: 9780121820947

485.

Evolution of ion internal energy during collisional excitation in the Paul ion trap: A stochastic approach

Douglas E Goeringer, Scott A McLuckey

The Journal of Chemical Physics (1996-02-08) https://doi.org/fj8nsp

DOI: 10.1063/1.471812

486.

Higher-energy C-trap dissociation for peptide modification analysis

Jesper V Olsen, Boris Macek, Oliver Lange, Alexander Makarov, Stevan Horning, Matthias Mann

Nature Methods (2007-08-26) https://doi.org/csj7f3

DOI: 10.1038/nmeth1060 · PMID: 17721543

487.

Quantification of the Compositional Information Provided by Immonium Ions on a Quadrupole-Time-of-Flight Mass Spectrometer

Laura J Hohmann, Jimmy K Eng, Andrew Gemmill, John Klimek, Olga Vitek, Gavin E Reid, Daniel B Martin

Analytical Chemistry (2008-06-20) https://doi.org/bjb3rm

DOI: 10.1021/ac8006076 · PMID: 18564857 · PMCID: PMC2638499

488.

Ion traps in modern mass spectrometry

Dirk Nolting, Robert Malek, Alexander Makarov

Mass Spectrometry Reviews (2017-10-30) https://doi.org/gg2pjd

DOI: 10.1002/mas.21549 · PMID: 29084367

489.

Mathieu's Equation and Its Generalizations: Overview of Stability Charts and Their Features

Ivana Kovacic, Richard Rand, Si Mohamed Sah

Applied Mechanics Reviews (2018-02-14) https://doi.org/ggj6w7

DOI: 10.1115/1.4039144

490.

Ion Trap Mass Spectrometers

Raymond E March

Encyclopedia of Spectroscopy and Spectrometry (1999) https://doi.org/bpb2z8

DOI: 10.1006/rwsp.2000.0143

491.

Mechanistic Insights into the Multistage Gas-Phase Fragmentation Behavior of Phosphoserine- and Phosphothreonine-Containing Peptides

Amanda M Palumbo, Jetze J Tepe, Gavin E Reid

Journal of Proteome Research (2008-01-09) https://doi.org/d5qsw7

DOI: 10.1021/pr0705136 · PMID: 18181561

492.

A Neutral Loss Activation Method for Improved Phosphopeptide Sequence Analysis by Quadrupole Ion Trap Mass Spectrometry

Melanie J Schroeder, Jeffrey Shabanowitz, Jae C Schwartz, Donald F Hunt, Joshua J Coon

Analytical Chemistry (2004-05-18) https://doi.org/dsk6xz

DOI: 10.1021/ac0497104 · PMID: 15228329

493.

Mobile and localized protons: a framework for understanding peptide dissociation.

VH Wysocki, G Tsaprailis, LL Smith, LA Breci

Journal of mass spectrometry : JMS (2000-12) https://www.ncbi.nlm.nih.gov/pubmed/11180630

DOI: 10.1002/1096-9888(200012)35:12<1399::aid-jms86>3.0.co;2-r · PMID: 11180630

494.

Collisions or Electrons? Protein Sequence Analysis in the 21st Century

Joshua J Coon

Analytical Chemistry (2009-04-13) https://doi.org/dn6rpw

DOI: 10.1021/ac802330b · PMID: 19364119 · PMCID: PMC2714553

495.

Methods for analyzing peptides and proteins on a chromatographic timescale by electron-transfer dissociation mass spectrometry

Namrata D Udeshi, Philip D Compton, Jeffrey Shabanowitz, Donald F Hunt, Kristie L Rose

Nature Protocols (2008-10-16) https://doi.org/dnnp4j

DOI: 10.1038/nprot.2008.159 · PMID: 18927556 · PMCID: PMC2860270

496.

Recent developments and applications of electron transfer dissociation mass spectrometry in proteomics

Mirela Sarbu, Roxana M Ghiulai, Alina D Zamfir

Amino Acids (2014-04-01) https://doi.org/f57nd8

DOI: 10.1007/s00726-014-1726-y · PMID: 24687149

497.

Electron Capture Dissociation of Multiply Charged Protein Cations. A Nonergodic Process

Roman A Zubarev, Neil L Kelleher, Fred W McLafferty

Journal of the American Chemical Society (1998-03-24) https://doi.org/c886tf

DOI: 10.1021/ja973478k

498.

Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry

John EP Syka, Joshua J Coon, Melanie J Schroeder, Jeffrey Shabanowitz, Donald F Hunt

Proceedings of the National Academy of Sciences (2004-06-21) https://doi.org/ds3jcv

DOI: 10.1073/pnas.0402700101 · PMID: 15210983 · PMCID: PMC470779

499.

Where Does the Electron Go? Electron Distribution and Reactivity of Peptide Cation Radicals Formed by Electron Transfer in the Gas phase

Xiaohong Chen, Changtong Hao

Journal of the American Chemical Society (2008-06-14) https://doi.org/dk2t5c

DOI: 10.1021/ja8019005 · PMID: 18597436

500.

Toward a general mechanism of electron capture dissociation

Erik A Syrstad, František Turecček

Journal of the American Society for Mass Spectrometry (2005-02-01) https://doi.org/cqk9pp

DOI: 10.1016/j.jasms.2004.11.001 · PMID: 15694771

501.

The Role of Electron Transfer Dissociation in Modern Proteomics

Nicholas M Riley, Joshua J Coon

Analytical Chemistry (2017-12-12) https://doi.org/gsr77t

DOI: 10.1021/acs.analchem.7b04810 · PMID: 29172454 · PMCID: PMC5750139

502.

Radical solutions: Principles and application of electron‐based dissociation in mass spectrometry‐based analysis of protein structure

Frederik Lermyte, Dirk Valkenborg, Joseph A Loo, Frank Sobott

Mass Spectrometry Reviews (2018-02-09) https://doi.org/gsr77q

DOI: 10.1002/mas.21560 · PMID: 29425406 · PMCID: PMC6131092

503.

Top Down Characterization of Larger Proteins (45 kDa) by Electron Capture Dissociation Mass Spectrometry

Ying Ge, Brian G Lawhorn, Mariam ElNaggar, Erick Strauss, Joo-Heon Park, Tadhg P Begley, Fred W McLafferty

Journal of the American Chemical Society (2002-01-01) https://doi.org/bzwdjg

DOI: https://doi.org/10.1021/ja011335z

504.

Benchmarking Multiple Fragmentation Methods on an Orbitrap Fusion for Top-down Phospho-Proteoform Characterization

Andrea M Brunner, Philip Lössl, Fan Liu, Romain Huguet, Christopher Mullen, Masami Yamashita, Vlad Zabrouskov, Alexander Makarov, AFMaarten Altelaar, Albert JR Heck

Analytical Chemistry (2015-04-21) https://doi.org/f69p6x

DOI: https://doi.org/10.1021/acs.analchem.5b00162

505.

Characterization of nucleic acids by tandem mass spectrometry ‐ The second decade (2004–2013): From DNA to RNA and modified sequences

Stefan Schürch

Mass Spectrometry Reviews (2014-10-06) https://doi.org/f8zctt

DOI: 10.1002/mas.21442 · PMID: 25288464

506.

Ribonucleic Acid Sequence Characterization by Negative Electron Transfer Dissociation Mass Spectrometry

Trenton M Peters-Clarke, Qiuwen Quan, Dain R Brademan, Alexander S Hebert, Michael S Westphall, Joshua J Coon

Analytical Chemistry (2020-02-24) https://doi.org/gszdjg

DOI: 10.1021/acs.analchem.9b05388 · PMID: 32091202 · PMCID: PMC7161943

507.

DNA-Scaffolded Synergistic Catalysis

Edward B Pimentel, Trenton M Peters-Clarke, Joshua J Coon, Jeffrey D Martell

Journal of the American Chemical Society (2021-12-13) https://doi.org/gszdjj

DOI: 10.1021/jacs.1c10757 · PMID: 34898209 · PMCID: PMC9101022

508.

Characterization of Modified RNA by Top‐Down Mass Spectrometry

Monika Taucher, Kathrin Breuker

Angewandte Chemie (2012-10-09) https://doi.org/fz8dhk

DOI: 10.1002/ange.201206232

509.

Top-Down Mass Spectrometry of Synthetic Single Guide Ribonucleic Acids Enabled by Facile Sample Clean-Up

Christopher M Crittenden, Michael B Lanzillotti, Bifan Chen

Analytical Chemistry (2023-01-06) https://doi.org/gszdjf

DOI: 10.1021/acs.analchem.2c03030 · PMID: 36606446

510.

DNA-Compatible Copper/TEMPO Oxidation for DNA-Encoded Libraries

Justice L Merrifield, Edward B Pimentel, Trenton M Peters-Clarke, Daniel J Nesbitt, Joshua J Coon, Jeffrey D Martell

Bioconjugate Chemistry (2023-08-04) https://doi.org/gszdjh

DOI: 10.1021/acs.bioconjchem.3c00254 · PMID: 37540561

511.

Sequencing Grade Tandem Mass Spectrometry for Top–Down Proteomics Using Hybrid Electron Capture Dissociation Methods in a Benchtop Orbitrap Mass Spectrometer

Jared B Shaw, Neha Malhan, Yury V Vasil’ev, Nathan I Lopez, Alexander Makarov, Joseph S Beckman, Valery G Voinov

Analytical Chemistry (2018-08-17) https://doi.org/gfcbtt

DOI: 10.1021/acs.analchem.8b01901 · PMID: 30118589 · PMCID: PMC6604833

512.

Exploring ECD on a Benchtop Q Exactive Orbitrap Mass Spectrometer

Kyle L Fort, Christian N Cramer, Valery G Voinov, Yury V Vasil’ev, Nathan I Lopez, Joseph S Beckman, Albert JR Heck

Journal of Proteome Research (2017-12-28) https://doi.org/gcq6gv

DOI: 10.1021/acs.jproteome.7b00622 · PMID: 29249155 · PMCID: PMC5799867

513.

Dissociation of Biomolecules by an Intense Low-Energy Electron Beam in a High Sensitivity Time-of-Flight Mass Spectrometer

Takashi Baba, Pavel Ryumin, Eva Duchoslav, Keqin Chen, Anjali Chelur, Bill Loyd, Igor Chernushevich

Journal of the American Society for Mass Spectrometry (2021-06-03) https://doi.org/gkcwb4

DOI: 10.1021/jasms.0c00425 · PMID: 34080873

514.

Performance Characteristics of Electron Transfer Dissociation Mass Spectrometry

David M Good, Matthew Wirtala, Graeme C McAlister, Joshua J Coon

Molecular & Cellular Proteomics (2007-11) https://doi.org/c34s8v

DOI: 10.1074/mcp.m700073-mcp200 · PMID: 17673454

515.

Electron-Transfer Ion/Ion Reactions of Doubly Protonated Peptides: Effect of Elevated Bath Gas Temperature

Sharon J Pitteri, Paul A Chrisman, Scott A McLuckey

Analytical Chemistry (2005-08-05) https://doi.org/fgkb9f

DOI: 10.1021/ac050666h · PMID: 16131079 · PMCID: PMC1356655

516.

Supplemental Activation Method for High-Efficiency Electron-Transfer Dissociation of Doubly Protonated Peptide Precursors

Danielle L Swaney, Graeme C McAlister, Matthew Wirtala, Jae C Schwartz, John EP Syka, Joshua J Coon

Analytical Chemistry (2006-12-08) https://doi.org/b8f7sj

DOI: 10.1021/ac061457f · PMID: 17222010 · PMCID: PMC2522365

517.

On performing simultaneous electron transfer dissociation and collision-induced dissociation on multiply protonated peptides in a linear ion trap

JLarry Campbell, James W Hager, JCYves Le Blanc

Journal of the American Society for Mass Spectrometry (2009-09-01) https://doi.org/ftnx68

DOI: 10.1016/j.jasms.2009.05.009 · PMID: 19539496

518.

Toward Full Peptide Sequence Coverage by Dual Fragmentation Combining Electron-Transfer and Higher-Energy Collision Dissociation Tandem Mass Spectrometry

Christian K Frese, AFMaarten Altelaar, Henk van den Toorn, Dirk Nolting, Jens Griep-Raming, Albert JR Heck, Shabaz Mohammed

Analytical Chemistry (2012-10-31) https://doi.org/gsr77s

DOI: 10.1021/ac3025366 · PMID: 23106539

519.

Activated ion electron capture dissociation (AI ECD) of proteins: Synchronization of infrared and electron irradiation with ion magnetron motion

Victor A Mikhailov, Helen J Cooper

Journal of the American Society for Mass Spectrometry (2009-05-01) https://doi.org/d4m48s

DOI: 10.1016/j.jasms.2008.12.015 · PMID: 19200749 · PMCID: PMC2674148

520.

Activated Ion Electron Capture Dissociation for Mass Spectral Sequencing of Larger (42 kDa) Proteins

David M Horn, Ying Ge, Fred W McLafferty

Analytical Chemistry (2000-09-21) https://doi.org/fh8828

DOI: 10.1021/ac000494i · PMID: 11055690

521.

Activated Ion Electron Transfer Dissociation for Improved Fragmentation of Intact Proteins

Nicholas M Riley, Michael S Westphall, Joshua J Coon

Analytical Chemistry (2015-06-26) https://doi.org/f7kv7q

DOI: 10.1021/acs.analchem.5b00881 · PMID: 26067513 · PMCID: PMC9488116

522.

Infrared Photoactivation Reduces Peptide Folding and Hydrogen‐Atom Migration following ETD Tandem Mass Spectrometry

Aaron R Ledvina, Graeme C McAlister, Myles W Gardner, Suncerae I Smith, James A Madsen, Jae C Schwartz, George C Stafford Jr., John E P Syka, Jennifer S Brodbelt, Joshua J Coon

Angewandte Chemie International Edition (2009-10-20) https://doi.org/b7wvdw

DOI: 10.1002/anie.200903557 · PMID: 19795429 · PMCID: PMC2788484

523.

Optical Fiber-Enabled Photoactivation of Peptides and Proteins

Trenton M Peters-Clarke, Kevin L Schauer, Nicholas M Riley, Jean M Lodge, Michael S Westphall, Joshua J Coon

Analytical Chemistry (2020-08-07) https://doi.org/gssbgx

DOI: 10.1021/acs.analchem.0c02087 · PMID: 32786458 · PMCID: PMC8008966

524.

Practical Effects of Intramolecular Hydrogen Rearrangement in Electron Transfer Dissociation-Based Proteomics

Trenton M Peters-Clarke, Nicholas M Riley, Michael S Westphall, Joshua J Coon

Journal of the American Society for Mass Spectrometry (2021-12-07) https://doi.org/gss5jm

DOI: 10.1021/jasms.1c00284 · PMID: 34874726 · PMCID: PMC10291708

525.

Hybridizing Ultraviolet Photodissociation with Electron Transfer Dissociation for Intact Protein Characterization

Joe R Cannon, Dustin D Holden, Jennifer S Brodbelt

Analytical Chemistry (2014-10-13) https://doi.org/f6n992

DOI: 10.1021/ac5036082 · PMID: 25270663 · PMCID: PMC4222623

526.

Dissociative capture of hot (3–13 eV) electrons by polypeptide polycations: an efficient process accompanied by secondary fragmentation

Frank Kjeldsen, Kim F Haselmann, Bogdan A Budnik, Frank Jensen, Roman A Zubarev

Chemical Physics Letters (2002-04-22) https://www.sciencedirect.com/science/article/pii/S0009261402001495

DOI: 10.1016/s0009-2614(02)00149-5

527.

Electron Ionization Dissociation of Singly and Multiply Charged Peptides

YMEva Fung, Christopher M Adams, Roman A Zubarev

Journal of the American Chemical Society (2009-07-01) https://doi.org/d62f44

DOI: 10.1021/ja8087407 · PMID: 19621955

528.

Implementation of Activated Ion Electron Transfer Dissociation on a Quadrupole-Orbitrap-Linear Ion Trap Hybrid Mass Spectrometer

Nicholas M Riley, Michael S Westphall, Alexander S Hebert, Joshua J Coon

Analytical Chemistry (2017-04-17) https://doi.org/f93cx8

DOI: 10.1021/acs.analchem.7b00213 · PMID: 28383247 · PMCID: PMC5560271

529.

Ion Activation Methods for Peptides and Proteins

Luis A Macias, Inês C Santos, Jennifer S Brodbelt

Analytical Chemistry (2019-10-30) https://doi.org/gp6ppg

DOI: 10.1021/acs.analchem.9b04859 · PMID: 31665881 · PMCID: PMC6949381

530.

Photodissociation mass spectrometry: new tools for characterization of biological molecules

Jennifer S Brodbelt

Chem. Soc. Rev. (2014) https://doi.org/ghh6xb

DOI: 10.1039/c3cs60444f · PMID: 24481009 · PMCID: PMC3966968

531.

Ultraviolet Photodissociation Mass Spectrometry for Analysis of Biological Molecules

Jennifer S Brodbelt, Lindsay J Morrison, Inês Santos

Chemical Reviews (2019-12-18) https://doi.org/gmntb8

DOI: 10.1021/acs.chemrev.9b00440 · PMID: 31851501 · PMCID: PMC7145764

532.

Applications of Infrared Multiple Photon Dissociation (IRMPD) to the Detection of Posttranslational Modifications

Philippe Maitre, Debora Scuderi, Davide Corinti, Barbara Chiavarino, Maria Elisa Crestoni, Simonetta Fornarini

Chemical Reviews (2019-12-06) https://doi.org/gsr77w

DOI: 10.1021/acs.chemrev.9b00395 · PMID: 31809038

533.

Infrared multiphoton dissociation (IRMPD) and collisionally activated dissociationof peptides in a quadrupole ion trapwith selective IRMPD of phosphopeptides

Matthew C Crowe, Jennifer S Brodbelt

Journal of the American Society for Mass Spectrometry (2004-11-01) https://doi.org/d6qb5t

DOI: 10.1016/j.jasms.2004.07.016 · PMID: 15519225

534.

Fragmentation of Singly Charged Peptide Ions by Photodissociation at λ=157 nm

Matthew S Thompson, Weidong Cui, James P Reilly

Angewandte Chemie International Edition (2004-09-07) https://doi.org/ck67xt

DOI: 10.1002/anie.200460788 · PMID: 15366089

535.

Ultrafast Ultraviolet Photodissociation at 193 nm and its Applicability to Proteomic Workflows

James A Madsen, Daniel R Boutz, Jennifer S Brodbelt

Journal of Proteome Research (2010-07-15) https://doi.org/bqqprx

DOI: 10.1021/pr100515x · PMID: 20578723 · PMCID: PMC2917496

536.

Thorough Performance Evaluation of 213 nm Ultraviolet Photodissociation for Top-down Proteomics

Luca Fornelli, Kristina Srzentić, Timothy K Toby, Peter F Doubleday, Romain Huguet, Christopher Mullen, Rafael D Melani, Henrique dos Santos Seckler, Caroline J DeHart, Chad R Weisbrod, … Neil L Kelleher

Molecular & Cellular Proteomics (2020-02) https://doi.org/gsr773

DOI: 10.1074/mcp.tir119.001638 · PMID: 31888965 · PMCID: PMC7000117

537.

Rapid peptide fragmentation without electrons, collisions, infrared radiation, or native chromophores

Geoffrey K Yeh, Qingyu Sun, Claudia Meneses, Ryan R Julian

Journal of the American Society for Mass Spectrometry (2009-03-01) https://doi.org/fc6krk

DOI: 10.1016/j.jasms.2008.10.019 · PMID: 19036607

538.

Ultraviolet photodissociation at 266 nm of phosphorylated peptide cations

Soojin Park, Wha‐Keun Ahn, Sunyoung Lee, Sang Yun Han, Bum Ku Rhee, Han Bin Oh

Rapid Communications in Mass Spectrometry (2009-11-06) https://doi.org/dqr3cf

DOI: 10.1002/rcm.4184 · PMID: 19890956

539.

MS/MS Simplification by 355 nm Ultraviolet Photodissociation of Chromophore-Derivatized Peptides in a Quadrupole Ion Trap

Jeffrey J Wilson, Jennifer S Brodbelt

Analytical Chemistry (2007-09-11) https://doi.org/cbf8kj

DOI: 10.1021/ac071241t · PMID: 17845006

540.

Residue-Specific Radical-Directed Dissociation of Whole Proteins in the Gas Phase

Tony Ly, Ryan R Julian

Journal of the American Chemical Society (2007-12-14) https://doi.org/ddngs4

DOI: 10.1021/ja076535a · PMID: 18078340

541.

Ultraviolet Photodissociation: Developments towards Applications for Mass‐Spectrometry‐Based Proteomics

Tony Ly, Ryan R Julian

Angewandte Chemie International Edition (2009-09-09) https://doi.org/c5fncw

DOI: 10.1002/anie.200900613 · PMID: 19610000

542.

The Mechanism Behind Top-Down UVPD Experiments: Making Sense of Apparent Contradictions

Ryan R. Julian

Journal of the American Society for Mass Spectrometry (2017-07-12) https://doi.org/gbtc6z

DOI: 10.1007/s13361-017-1721-0 · PMID: 28702929 · PMCID: PMC5711567

543.

Deciphering combinatorial post-translational modifications by top-down mass spectrometry

Jennifer S Brodbelt

Current Opinion in Chemical Biology (2022-10) https://doi.org/gsr77r

DOI: 10.1016/j.cbpa.2022.102180 · PMID: 35779351 · PMCID: PMC9489649

544.

Complete Protein Characterization Using Top-Down Mass Spectrometry and Ultraviolet Photodissociation

Jared B Shaw, Wenzong Li, Dustin D Holden, Yan Zhang, Jens Griep-Raming, Ryan T Fellers, Bryan P Early, Paul M Thomas, Neil L Kelleher, Jennifer S Brodbelt

Journal of the American Chemical Society (2013-06-04) https://doi.org/f48shf

DOI: 10.1021/ja4029654 · PMID: 23697802 · PMCID: PMC3757099

545.

Ultraviolet Photodissociation of Tryptic Peptide Backbones at 213 nm

Lars Kolbowski, Adam Belsom, Juri Rappsilber

Journal of the American Society for Mass Spectrometry (2020-04-30) https://doi.org/gsr77z

DOI: 10.1021/jasms.0c00106 · PMID: 32352297 · PMCID: PMC7273743

546.

Comparison of Top-Down Protein Fragmentation Induced by 213 and 193 nm UVPD

Michael Lanzillotti, Jennifer S Brodbelt

Journal of the American Society for Mass Spectrometry (2023-01-03) https://doi.org/gsr772

DOI: 10.1021/jasms.2c00288 · PMID: 36594540

547.

Capillary Liquid Chromatography/Mass Spectrometry for Peptide and Protein Characterization

MT Davis, DC Stahl, KM Swiderek, TD Lee

Methods (1994-09) https://doi.org/fmtw5k

DOI: 10.1006/meth.1994.1031

548.

Method to Correlate Tandem Mass Spectra of Modified Peptides to Amino Acid Sequences in the Protein Database

John R Yates, Jimmy K Eng, Ashley L McCormack, David Schieltz

Analytical Chemistry (1995-04-15) https://doi.org/dtcrm9

DOI: 10.1021/ac00104a020 · PMID: 7741214

549.

Data-controlled automation of liquid chromatography/tandem mass spectrometry analysis of peptide mixtures.

DC Stahl, KM Swiderek, MT Davis, TD Lee

Journal of the American Society for Mass Spectrometry (1996-06) https://www.ncbi.nlm.nih.gov/pubmed/24203425

DOI: 10.1016/1044-0305(96)00057-8 · PMID: 24203425

550.

Accurate Proteome-wide Label-free Quantification by Delayed Normalization and Maximal Peptide Ratio Extraction, Termed MaxLFQ

Jürgen Cox, Marco Y Hein, Christian A Luber, Igor Paron, Nagarjuna Nagaraj, Matthias Mann

Molecular & Cellular Proteomics (2014-09) https://doi.org/f6hmm5

DOI: 10.1074/mcp.m113.031591 · PMID: 24942700 · PMCID: PMC4159666

551.

The MaxQuant computational platform for mass spectrometry-based shotgun proteomics

Stefka Tyanova, Tikira Temu, Juergen Cox

Nature Protocols (2016-10-27) https://doi.org/f89fwn

DOI: 10.1038/nprot.2016.136 · PMID: 27809316

552.

Advances in proteomics data analysis and display using an accurate mass and time tag approach

Jennifer SD Zimmer, Matthew E Monroe, Wei‐Jun Qian, Richard D Smith

Mass Spectrometry Reviews (2006-01-20) https://doi.org/bqv76w

DOI: 10.1002/mas.20071 · PMID: 16429408 · PMCID: PMC1829209

553.

A New Algorithm Using Cross-Assignment for Label-Free Quantitation with LC−LTQ-FT MS

Victor P Andreev, Lingyun Li, Lei Cao, Ye Gu, Tomas Rejtar, Shiaw-Lin Wu, Barry L Karger

Journal of Proteome Research (2007-04-19) https://doi.org/d3fshp

DOI: 10.1021/pr0606880 · PMID: 17441747 · PMCID: PMC2563808

554.

IDEAL-Q, an Automated Tool for Label-free Quantitation Analysis Using an Efficient Peptide Alignment Approach and Spectral Data Validation

Chih-Chiang Tsou, Chia-Feng Tsai, Ying-Hao Tsui, Putty-Reddy Sudhir, Yi-Ting Wang, Yu-Ju Chen, Jeou-Yuan Chen, Ting-Yi Sung, Wen-Lian Hsu

Molecular & Cellular Proteomics (2010-01) https://doi.org/d9gxpm

DOI: 10.1074/mcp.m900177-mcp200 · PMID: 19752006 · PMCID: PMC2808259

555.

 SuperHirn - a novel tool for high resolution LC-MS-based peptide/protein profiling

Lukas N Mueller, Oliver Rinner, Alexander Schmidt, Simon Letarte, Bernd Bodenmiller, Mi-Youn Brusniak, Olga Vitek, Ruedi Aebersold, Markus Müller

PROTEOMICS (2007-08-28) https://doi.org/c5zp29

DOI: 10.1002/pmic.200700057 · PMID: 17726677

556.

Evaluating False Transfer Rates from the Match-between-Runs Algorithm with a Two-Proteome Model

Matthew Y Lim, João A Paulo, Steven P Gygi

Journal of Proteome Research (2019-09-23) https://doi.org/ggd6nh

DOI: 10.1021/acs.jproteome.9b00492 · PMID: 31547658 · PMCID: PMC7346880

557.

IonQuant Enables Accurate and Sensitive Label-Free Quantification With FDR-Controlled Match-Between-Runs

Fengchao Yu, Sarah E Haynes, Alexey I Nesvizhskii

Molecular & Cellular Proteomics (2021) https://doi.org/gqfrh3

DOI: 10.1016/j.mcpro.2021.100077 · PMID: 33813065 · PMCID: PMC8131922

558.

Post Analysis Data Acquisition for the Iterative MS/MS Sampling of Proteomics Mixtures

Michael R Hoopmann, Gennifer E Merrihew, Priska D von Haller, Michael J MacCoss

Journal of Proteome Research (2009-03-03) https://doi.org/fgtwdr

DOI: 10.1021/pr800828p · PMID: 19256536 · PMCID: PMC2671646

559.

The Implications of Proteolytic Background for Shotgun Proteomics

Paola Picotti, Ruedi Aebersold, Bruno Domon

Molecular & Cellular Proteomics (2007-09) https://doi.org/ffrsx7

DOI: 10.1074/mcp.m700029-mcp200 · PMID: 17533221

560.

Evaluation of HCD- and CID-type Fragmentation Within Their Respective Detection Platforms For Murine Phosphoproteomics

Mark P Jedrychowski, Edward L Huttlin, Wilhelm Haas, Mathew E Sowa, Ramin Rad, Steven P Gygi

Molecular & Cellular Proteomics (2011-12) https://doi.org/fw5pzp

DOI: 10.1074/mcp.m111.009910 · PMID: 21917720 · PMCID: PMC3237076

561.

Feasibility of Large-Scale Phosphoproteomics with Higher Energy Collisional Dissociation Fragmentation

Nagarjuna Nagaraj, Rochelle CJ D’Souza, Juergen Cox, Jesper V Olsen, Matthias Mann

Journal of Proteome Research (2010-10-26) https://doi.org/d3xcz7

DOI: 10.1021/pr100637q · PMID: 20873877

562.

Phosphoproteomics with Activated Ion Electron Transfer Dissociation

Nicholas M Riley, Alexander S Hebert, Gerhard Dürnberger, Florian Stanek, Karl Mechtler, Michael S Westphall, Joshua J Coon

Analytical Chemistry (2017-04-17) https://doi.org/f9353n

DOI: 10.1021/acs.analchem.7b00212 · PMID: 28383256 · PMCID: PMC5555596

563.

Unambiguous Phosphosite Localization using Electron-Transfer/Higher-Energy Collision Dissociation (EThcD)

Christian K Frese, Houjiang Zhou, Thomas Taus, AFMaarten Altelaar, Karl Mechtler, Albert JR Heck, Shabaz Mohammed

Journal of Proteome Research (2013-02-07) https://doi.org/f3sk5m

DOI: 10.1021/pr301130k · PMID: 23347405 · PMCID: PMC3588588

564.

Evaluation of Gas-Phase Rearrangement and Competing Fragmentation Reactions on Protein Phosphorylation Site Assignment Using Collision Induced Dissociation-MS/MS and MS3

Amanda M Palumbo, Gavin E Reid

Analytical Chemistry (2008-11-14) https://doi.org/fh634h

DOI: 10.1021/ac801768s · PMID: 19012417

565.

Examining factors that influence erroneous phosphorylation site localization via competing fragmentation and rearrangement reactions during ion trap <scp>CID</scp>‐<scp>MS</scp>/<scp>MS</scp> and ‐<scp>MS</scp>3

Li Cui, Gavin E Reid

PROTEOMICS (2013-03) https://doi.org/f2d3hv

DOI: 10.1002/pmic.201200384 · PMID: 23335301

566.

Comparative Assessment of Site Assignments in CID and Electron Transfer Dissociation Spectra of Phosphopeptides Discloses Limited Relocation of Phosphate Groups

Nikolai Mischerikow, AFMaarten Altelaar, JDaniel Navarro, Shabaz Mohammed, Albert JR Heck

Molecular & Cellular Proteomics (2010-10) https://doi.org/bv4grk

DOI: 10.1074/mcp.m900619-mcp200 · PMID: 20233845 · PMCID: PMC2953911

567.

Pinpointing Phosphorylation Sites: Quantitative Filtering and a Novel Site-specific x-Ion Fragment

Christian D Kelstrup, Omid Hekmat, Chiara Francavilla, Jesper V Olsen

Journal of Proteome Research (2011-04-28) https://doi.org/bckqkr

DOI: 10.1021/pr200154t · PMID: 21526838

568.

Large-scale characterization of HeLa cell nuclear phosphoproteins

Sean A Beausoleil, Mark Jedrychowski, Daniel Schwartz, Joshua E Elias, Judit Villén, Jiaxu Li, Martin A Cohn, Lewis C Cantley, Steven P Gygi

Proceedings of the National Academy of Sciences (2004-08-09) https://doi.org/cjmg8h

DOI: 10.1073/pnas.0404720101 · PMID: 15302935 · PMCID: PMC514446

569.

Evaluation of the utility of neutral‐loss‐dependent MS3 strategies in large‐scale phosphorylation analysis

Judit Villén, Sean A Beausoleil, Steven P Gygi

PROTEOMICS (2008-10-29) https://doi.org/c52q48

DOI: 10.1002/pmic.200800283 · PMID: 18972524 · PMCID: PMC2745099

570.

Targeted phosphoproteomics of insulin signaling using data-independent acquisition mass spectrometry

Benjamin L Parker, Guang Yang, Sean J Humphrey, Rima Chaudhuri, Xiuquan Ma, Scott Peterman, David E James

Science Signaling (2015-06-09) https://doi.org/f7qzfx

DOI: 10.1126/scisignal.aaa3139 · PMID: 26060331

571.

Data Processing and Analysis for DIA-Based Phosphoproteomics Using Spectronaut

Ana Martinez-Val, Dorte Breinholdt Bekker-Jensen, Alexander Hogrebe, Jesper Velgaard Olsen

Methods in Molecular Biology (2021) https://doi.org/gss5jc

DOI: 10.1007/978-1-0716-1641-3_6 · PMID: 34236657

572.

Plug-and-play analysis of the human phosphoproteome by targeted high-resolution mass spectrometry

Robert T Lawrence, Brian C Searle, Ariadna Llovet, Judit Villén

Nature Methods (2016-03-28) https://doi.org/gss5jn

DOI: 10.1038/nmeth.3811 · PMID: 27018578 · PMCID: PMC5915315

573.

High-Density, Targeted Monitoring of Tyrosine Phosphorylation Reveals Activated Signaling Networks in Human Tumors

Lauren E Stopfer, Cameron T Flower, Aaron S Gajadhar, Bhavin Patel, Sebastien Gallien, Daniel Lopez-Ferrer, Forest M White

Cancer Research (2021-01-28) https://doi.org/gss5js

DOI: 10.1158/0008-5472.can-20-3804 · PMID: 33509940 · PMCID: PMC8137532

574.

Benchmarking common quantification strategies for large-scale phosphoproteomics

Alexander Hogrebe, Louise von Stechow, Dorte B Bekker-Jensen, Brian T Weinert, Christian D Kelstrup, Jesper V Olsen

Nature Communications (2018-03-13) https://doi.org/gc8gfs

DOI: 10.1038/s41467-018-03309-6 · PMID: 29535314 · PMCID: PMC5849679

575.

Widespread bacterial protein histidine phosphorylation revealed by mass spectrometry-based proteomics

Clement M Potel, Miao-Hsia Lin, Albert JR Heck, Simone Lemeer

Nature Methods (2018-01-29) https://doi.org/gcwt3t

DOI: 10.1038/nmeth.4580 · PMID: 29377012

576.

Analysis of Histidine Phosphorylation Using Tandem MS and Ion−Electron Reactions

Anne J Kleinnijenhuis, Frank Kjeldsen, Birgitte Kallipolitis, Kim F Haselmann, Ole N Jensen

Analytical Chemistry (2007-09-07) https://doi.org/cpm6vt

DOI: 10.1021/ac0707838 · PMID: 17822303

577.

Histidine phosphorylation in human cells; a needle or phantom in the haystack?

Niels M Leijten, Albert JR Heck, Simone Lemeer

Nature Methods (2022-06-20) https://doi.org/gss5jq

DOI: 10.1038/s41592-022-01524-0 · PMID: 35726056

578.

Studying the fragmentation behavior of peptides with arginine phosphorylation and its influence on phospho‐site localization

Andreas Schmidt, Gustav Ammerer, Karl Mechtler

PROTEOMICS (2013-02-18) https://doi.org/f2d3h9

DOI: 10.1002/pmic.201200240 · PMID: 23172725

579.

Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry

Arthur R Salomon, Scott B Ficarro, Laurence M Brill, Achim Brinker, Qui T Phung, Christer Ericson, Karsten Sauer, Ansgar Brock, David M Horn, Peter G Schultz, Eric C Peters

Proceedings of the National Academy of Sciences (2003-01-09) https://doi.org/b559nw

DOI: 10.1073/pnas.2436191100 · PMID: 12522270 · PMCID: PMC141014

580.

Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks

Jesper V Olsen, Blagoy Blagoev, Florian Gnad, Boris Macek, Chanchal Kumar, Peter Mortensen, Matthias Mann

Cell (2006-11) https://doi.org/fk9n7v

DOI: 10.1016/j.cell.2006.09.026 · PMID: 17081983

581.

Higher Energy Collision Dissociation (HCD) Product Ion-Triggered Electron Transfer Dissociation (ETD) Mass Spectrometry for the Analysis of N-Linked Glycoproteins

Charandeep Singh, Cleidiane G Zampronio, Andrew J Creese, Helen J Cooper

Journal of Proteome Research (2012-08-06) https://doi.org/f36tfq

DOI: 10.1021/pr300257c · PMID: 22800195

582.

Clinical applications of quantitative proteomics using targeted and untargeted data-independent acquisition techniques

Jesse G Meyer, Birgit Schilling

Expert Review of Proteomics (2017-05-04) https://doi.org/gk6gdn

DOI: 10.1080/14789450.2017.1322904 · PMID: 28436239 · PMCID: PMC5671767

583.

Review of software tools for design and analysis of large scale MRM proteomic datasets

Christopher M Colangelo, Lisa Chung, Can Bruce, Kei-Hoi Cheung

Methods (2013-06) https://doi.org/f449z8

DOI: 10.1016/j.ymeth.2013.05.004 · PMID: 23702368 · PMCID: PMC3775261

584.

Quantification of C‐reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C‐labeled peptide standards

Eric Kuhn, Jiang Wu, Johann Karl, Hua Liao, Werner Zolg, Brad Guild

PROTEOMICS (2004-03-23) https://doi.org/cxn7fw

DOI: 10.1002/pmic.200300670 · PMID: 15048997

585.

Mass Spectrometric Quantitation of Peptides and Proteins Using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA)

NLeigh Anderson, Norman G Anderson, Lee R Haines, Darryl B Hardie, Robert W Olafson, Terry W Pearson

Journal of Proteome Research (2004-02-06) https://doi.org/c494px

DOI: 10.1021/pr034086h · PMID: 15113099

586.

A review on mass spectrometry-based quantitative proteomics: Targeted and data independent acquisition

Veronika Vidova, Zdenek Spacil

Analytica Chimica Acta (2017-04) https://doi.org/f93hpx

DOI: 10.1016/j.aca.2017.01.059 · PMID: 28351641

587.

The current status of clinical proteomics and the use of MRM and MRM3for biomarker validation

Jérôme Lemoine, Tanguy Fortin, Arnaud Salvador, Aurore Jaffuel, Jean-Philippe Charrier, Geneviève Choquet-Kastylevsky

Expert Review of Molecular Diagnostics (2012-05) https://doi.org/f337q3

DOI: 10.1586/erm.12.32 · PMID: 22616699

588.

High Sensitivity Detection of Plasma Proteins by Multiple Reaction Monitoring of N-Glycosites

Jianru Stahl-Zeng, Vinzenz Lange, Reto Ossola, Katrin Eckhardt, Wilhelm Krek, Ruedi Aebersold, Bruno Domon

Molecular & Cellular Proteomics (2007-10) https://doi.org/bwgf39

DOI: 10.1074/mcp.m700132-mcp200 · PMID: 17644760

589.

A database of mass spectrometric assays for the yeast proteome

Paola Picotti, Henry Lam, David Campbell, Eric W Deutsch, Hamid Mirzaei, Jeff Ranish, Bruno Domon, Ruedi Aebersold

Nature Methods (2008-11) https://doi.org/dvs3c7

DOI: 10.1038/nmeth1108-913 · PMID: 18974732 · PMCID: PMC2770732

590.

Parallel Reaction Monitoring for High Resolution and High Mass Accuracy Quantitative, Targeted Proteomics

Amelia C Peterson, Jason D Russell, Derek J Bailey, Michael S Westphall, Joshua J Coon

Molecular & Cellular Proteomics (2012-11) https://doi.org/f4gzw2

DOI: 10.1074/mcp.o112.020131 · PMID: 22865924 · PMCID: PMC3494192

591.

Parallel reaction monitoring (PRM) and selected reaction monitoring (SRM) exhibit comparable linearity, dynamic range and precision for targeted quantitative HDL proteomics

Graziella E Ronsein, Nathalie Pamir, Priska D von Haller, Daniel S Kim, Michael N Oda, Gail P Jarvik, Tomas Vaisar, Jay W Heinecke

Journal of Proteomics (2015-01) https://doi.org/f6wq8n

DOI: 10.1016/j.jprot.2014.10.017 · PMID: 25449833 · PMCID: PMC4259393

592.

Shotgun collision‐induced dissociation of peptides using a time of flight mass analyzer

Samuel Purvine, Jason‐Thomas Eppel*, Eugene C Yi, David R Goodlett

PROTEOMICS (2003-06) https://doi.org/c37bqm

DOI: 10.1002/pmic.200300362 · PMID: 12833507

593.

Automated approach for quantitative analysis of complex peptide mixtures from tandem mass spectra

John D Venable, Meng-Qiu Dong, James Wohlschlegel, Andrew Dillin, John R Yates III

Nature Methods (2004-09-29) https://doi.org/dm8rm4

DOI: 10.1038/nmeth705 · PMID: 15782151

594.

UPLC/MSE; a new approach for generating molecular fragment information for biomarker structure elucidation

Robert S Plumb, Kelly A Johnson, Paul Rainville, Brian W Smith, Ian D Wilson, Jose M Castro‐Perez, Jeremy K Nicholson

Rapid Communications in Mass Spectrometry (2006-06-06) https://doi.org/c8gx39

DOI: 10.1002/rcm.2550 · PMID: 16755610

595.

Precursor Acquisition Independent From Ion Count: How to Dive Deeper into the Proteomics Ocean

Alexandre Panchaud, Alexander Scherl, Scott A Shaffer, Priska D von Haller, Hemantha D Kulasekara, Samuel I Miller, David R Goodlett

Analytical Chemistry (2009-07-02) https://doi.org/dwbrjn

DOI: 10.1021/ac900888s · PMID: 19572557 · PMCID: PMC3086478

596.

Proteomics on an Orbitrap Benchtop Mass Spectrometer Using All-ion Fragmentation

Tamar Geiger, Juergen Cox, Matthias Mann

Molecular & Cellular Proteomics (2010-10) https://doi.org/fqrb3c

DOI: 10.1074/mcp.m110.001537 · PMID: 20610777 · PMCID: PMC2953918

597.

XDIA: improving on the label-free data-independent analysis

Paulo C Carvalho, Xuemei Han, Tao Xu, Daniel Cociorva, Maria da Gloria Carvalho, Valmir C Barbosa, John R Yates III

Bioinformatics (2010-01-26) https://doi.org/cn8x3r

DOI: 10.1093/bioinformatics/btq031 · PMID: 20106817 · PMCID: PMC2832823

598.

ETISEQ – an algorithm for automated elution time ion sequencing of concurrently fragmented peptides for mass spectrometry-based proteomics

Jason WH Wong, Alexander B Schwahn, Kevin M Downard

BMC Bioinformatics (2009-08-10) https://doi.org/c3rshm

DOI: 10.1186/1471-2105-10-244 · PMID: 19664259 · PMCID: PMC2731054

599.

Targeted Data Extraction of the MS/MS Spectra Generated by Data-independent Acquisition: A New Concept for Consistent and Accurate Proteome Analysis

Ludovic C Gillet, Pedro Navarro, Stephen Tate, Hannes Röst, Nathalie Selevsek, Lukas Reiter, Ron Bonner, Ruedi Aebersold

Molecular & Cellular Proteomics (2012-06) https://doi.org/fzqdc5

DOI: 10.1074/mcp.o111.016717 · PMID: 22261725 · PMCID: PMC3433915

600.

Multiplexed MS/MS for improved data-independent acquisition

Jarrett D Egertson, Andreas Kuehn, Gennifer E Merrihew, Nicholas W Bateman, Brendan X MacLean, Ying S Ting, Jesse D Canterbury, Donald M Marsh, Markus Kellmann, Vlad Zabrouskov, … Michael J MacCoss

Nature Methods (2013-06-23) https://doi.org/gjqdct

DOI: 10.1038/nmeth.2528 · PMID: 23793237 · PMCID: PMC3881977

601.

Optimization of Experimental Parameters in Data-Independent Mass Spectrometry Significantly Increases Depth and Reproducibility of Results

Roland Bruderer, Oliver M Bernhardt, Tejas Gandhi, Yue Xuan, Julia Sondermann, Manuela Schmidt, David Gomez-Varela, Lukas Reiter

Molecular & Cellular Proteomics (2017-12) https://doi.org/gcqvm4

DOI: 10.1074/mcp.ra117.000314 · PMID: 29070702 · PMCID: PMC5724188

602.

diaPASEF: parallel accumulation–serial fragmentation combined with data-independent acquisition

Florian Meier, Andreas-David Brunner, Max Frank, Annie Ha, Isabell Bludau, Eugenia Voytik, Stephanie Kaspar-Schoenefeld, Markus Lubeck, Oliver Raether, Nicolai Bache, … Matthias Mann

Nature Methods (2020-11-30) https://doi.org/gmhqdm

DOI: 10.1038/s41592-020-00998-0 · PMID: 33257825

603.

Interpretation of shotgun proteomic data: the protein inference problem.

Alexey I Nesvizhskii, Ruedi Aebersold

Molecular & cellular proteomics : MCP (2005-07-11) https://www.ncbi.nlm.nih.gov/pubmed/16009968

DOI: 10.1074/mcp.r500012-mcp200 · PMID: 16009968

604.

In-depth analysis of protein inference algorithms using multiple search engines and well-defined metrics

Enrique Audain, Julian Uszkoreit, Timo Sachsenberg, Julianus Pfeuffer, Xiao Liang, Henning Hermjakob, Aniel Sanchez, Martin Eisenacher, Knut Reinert, David L Tabb, … Yasset Perez-Riverol

Journal of Proteomics (2017-01) https://doi.org/f9r8r6

DOI: 10.1016/j.jprot.2016.08.002 · PMID: 27498275

605.

MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification

Jürgen Cox, Matthias Mann

Nature Biotechnology (2008-11-30) https://doi.org/crn24x

DOI: 10.1038/nbt.1511 · PMID: 19029910

606.

MSFragger: ultrafast and comprehensive peptide identification in mass spectrometry–based proteomics

Andy T Kong, Felipe V Leprevost, Dmitry M Avtonomov, Dattatreya Mellacheruvu, Alexey I Nesvizhskii

Nature Methods (2017-04-10) https://doi.org/f9z6p7

DOI: 10.1038/nmeth.4256 · PMID: 28394336 · PMCID: PMC5409104

607.

Probability-based protein identification by searching sequence databases using mass spectrometry data.

DN Perkins, DJ Pappin, DM Creasy, JS Cottrell

Electrophoresis (1999-12) https://www.ncbi.nlm.nih.gov/pubmed/10612281

DOI: 10.1002/(sici)1522-2683(19991201)20:18<3551::aid-elps3551>3.0.co;2-2 · PMID: 10612281

608.

MS-GF+ makes progress towards a universal database search tool for proteomics

Sangtae Kim, Pavel A Pevzner

Nature Communications (2014-10-31) https://doi.org/ggkdq8

DOI: 10.1038/ncomms6277 · PMID: 25358478 · PMCID: PMC5036525

609.

A method for reducing the time required to match protein sequences with tandem mass spectra

Robertson Craig, Ronald C Beavis

Rapid Communications in Mass Spectrometry (2003-09-19) https://doi.org/b7bgb9

DOI: 10.1002/rcm.1198 · PMID: 14558131

610.

TANDEM: matching proteins with tandem mass spectra

Robertson Craig, Ronald C Beavis

Bioinformatics (2004-02-19) https://doi.org/cthw6n

DOI: 10.1093/bioinformatics/bth092 · PMID: 14976030

611.

Comet: An open‐source <scp>MS</scp>/<scp>MS</scp> sequence database search tool

Jimmy K Eng, Tahmina A Jahan, Michael R Hoopmann

PROTEOMICS (2012-12-04) https://doi.org/f2d3cp

DOI: 10.1002/pmic.201200439 · PMID: 23148064

612.

Skyline: an open source document editor for creating and analyzing targeted proteomics experiments

Brendan MacLean, Daniela M Tomazela, Nicholas Shulman, Matthew Chambers, Gregory L Finney, Barbara Frewen, Randall Kern, David L Tabb, Daniel C Liebler, Michael J MacCoss

Bioinformatics (2010-02-09) https://doi.org/bqx9rq

DOI: 10.1093/bioinformatics/btq054 · PMID: 20147306 · PMCID: PMC2844992

613.

DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput

Vadim Demichev, Christoph B Messner, Spyros I Vernardis, Kathryn S Lilley, Markus Ralser

Nature Methods (2019-11-25) https://doi.org/gj9xgj

DOI: 10.1038/s41592-019-0638-x · PMID: 31768060 · PMCID: PMC6949130

614.

Chromatogram libraries improve peptide detection and quantification by data independent acquisition mass spectrometry

Brian C Searle, Lindsay K Pino, Jarrett D Egertson, Ying S Ting, Robert T Lawrence, Brendan X MacLean, Judit Villén, Michael J MacCoss

Nature Communications (2018-12-03) https://doi.org/gsthnx

DOI: 10.1038/s41467-018-07454-w · PMID: 30510204 · PMCID: PMC6277451

615.

Deep learning enables de novo peptide sequencing from data-independent-acquisition mass spectrometry

Ngoc Hieu Tran, Rui Qiao, Lei Xin, Xin Chen, Chuyi Liu, Xianglilan Zhang, Baozhen Shan, Ali Ghodsi, Ming Li

Nature Methods (2018-12-20) https://doi.org/gftvmn

DOI: 10.1038/s41592-018-0260-3 · PMID: 30573815

616.

Extending the Limits of Quantitative Proteome Profiling with Data-Independent Acquisition and Application to Acetaminophen-Treated Three-Dimensional Liver Microtissues

Roland Bruderer, Oliver M Bernhardt, Tejas Gandhi, Saša M Miladinović, Lin-Yang Cheng, Simon Messner, Tobias Ehrenberger, Vito Zanotelli, Yulia Butscheid, Claudia Escher, … Lukas Reiter

Molecular & Cellular Proteomics (2015-05) https://doi.org/f7b76h

DOI: 10.1074/mcp.m114.044305 · PMID: 25724911 · PMCID: PMC4424408

617.

PeptideShaker enables reanalysis of MS-derived proteomics data sets

Marc Vaudel, Julia M Burkhart, René P Zahedi, Eystein Oveland, Frode S Berven, Albert Sickmann, Lennart Martens, Harald Barsnes

Nature Biotechnology (2015-01) https://doi.org/ggkds8

DOI: 10.1038/nbt.3109 · PMID: 25574629

618.

PeptideShaker Online: A User-Friendly Web-Based Framework for the Identification of Mass Spectrometry-Based Proteomics Data

Yehia Mokhtar Farag, Carlos Horro, Marc Vaudel, Harald Barsnes

Journal of Proteome Research (2021-10-28) https://doi.org/gpdd85

DOI: 10.1021/acs.jproteome.1c00678 · PMID: 34709836 · PMCID: PMC8650087

619.

mzML—a Community Standard for Mass Spectrometry Data

Lennart Martens, Matthew Chambers, Marc Sturm, Darren Kessner, Fredrik Levander, Jim Shofstahl, Wilfred H Tang, Andreas Römpp, Steffen Neumann, Angel D Pizarro, … Eric W Deutsch

Molecular & Cellular Proteomics (2011-01) https://doi.org/dxkg99

DOI: 10.1074/mcp.r110.000133 · PMID: 20716697 · PMCID: PMC3013463

620.

Mass spectrometer output file format mzML.

Eric W Deutsch

Methods in molecular biology (Clifton, N.J.) (2010) https://www.ncbi.nlm.nih.gov/pubmed/20013381

DOI: 10.1007/978-1-60761-444-9_22 · PMID: 20013381 · PMCID: PMC3073315

621.

File Formats Commonly Used in Mass Spectrometry Proteomics

Eric W Deutsch

Molecular & Cellular Proteomics (2012-12) https://doi.org/ggkdvv

DOI: 10.1074/mcp.r112.019695 · PMID: 22956731 · PMCID: PMC3518119

622.

Anatomy and evolution of database search engines—a central component of mass spectrometry based proteomic workflows

Kenneth Verheggen, Helge Ræder, Frode S Berven, Lennart Martens, Harald Barsnes, Marc Vaudel

Mass Spectrometry Reviews (2017-09-13) https://doi.org/gbwkmf

DOI: 10.1002/mas.21543 · PMID: 28902424

623.

Assigning Significance to Peptides Identified by Tandem Mass Spectrometry Using Decoy Databases

Lukas Käll, John D Storey, Michael J MacCoss, William Stafford Noble

Journal of Proteome Research (2007-12-08) https://doi.org/fbxhxp

DOI: 10.1021/pr700600n · PMID: 18067246

624.

Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry.

Joshua E Elias, Steven P Gygi

Nature methods (2007-03) https://www.ncbi.nlm.nih.gov/pubmed/17327847

DOI: 10.1038/nmeth1019 · PMID: 17327847

625.

False Discovery Rate Estimation in Proteomics

Suruchi Aggarwal, Amit Kumar Yadav

Methods in Molecular Biology (2016) https://doi.org/f79mzp

DOI: 10.1007/978-1-4939-3106-4_7 · PMID: 26519173

626.

Unbiased False Discovery Rate Estimation for Shotgun Proteomics Based on the Target-Decoy Approach

Lev I Levitsky, Mark V Ivanov, Anna A Lobas, Mikhail V Gorshkov

Journal of Proteome Research (2016-12-13) https://doi.org/gqtfbj

DOI: 10.1021/acs.jproteome.6b00144 · PMID: 27959540

627.

A uniform proteomics MS/MS analysis platform utilizing open XML file formats.

Andrew Keller, Jimmy Eng, Ning Zhang, Xiao-jun Li, Ruedi Aebersold

Molecular systems biology (2005-08-02) https://www.ncbi.nlm.nih.gov/pubmed/16729052

DOI: 10.1038/msb4100024 · PMID: 16729052 · PMCID: PMC1681455

628.

Trans-proteomic pipeline: a pipeline for proteomic analysis.

Patrick GA Pedrioli

Methods in molecular biology (Clifton, N.J.) (2010) https://www.ncbi.nlm.nih.gov/pubmed/20013374

DOI: 10.1007/978-1-60761-444-9_15 · PMID: 20013374

629.

Software pipeline and data analysis for MS/MS proteomics: the trans-proteomic pipeline.

Andrew Keller, David Shteynberg

Methods in molecular biology (Clifton, N.J.) (2011) https://www.ncbi.nlm.nih.gov/pubmed/21082435

DOI: 10.1007/978-1-60761-977-2_12 · PMID: 21082435

630.

iProphet: multi-level integrative analysis of shotgun proteomic data improves peptide and protein identification rates and error estimates.

David Shteynberg, Eric W Deutsch, Henry Lam, Jimmy K Eng, Zhi Sun, Natalie Tasman, Luis Mendoza, Robert L Moritz, Ruedi Aebersold, Alexey I Nesvizhskii

Molecular & cellular proteomics : MCP (2011-08-29) https://www.ncbi.nlm.nih.gov/pubmed/21876204

DOI: 10.1074/mcp.m111.007690 · PMID: 21876204 · PMCID: PMC3237071

631.

Processing shotgun proteomics data on the Amazon cloud with the trans-proteomic pipeline.

Joseph Slagel, Luis Mendoza, David Shteynberg, Eric W Deutsch, Robert L Moritz

Molecular & cellular proteomics : MCP (2014-11-23) https://www.ncbi.nlm.nih.gov/pubmed/25418363

DOI: 10.1074/mcp.o114.043380 · PMID: 25418363 · PMCID: PMC4350034

632.

Trans-Proteomic Pipeline, a standardized data processing pipeline for large-scale reproducible proteomics informatics.

Eric W Deutsch, Luis Mendoza, David Shteynberg, Joseph Slagel, Zhi Sun, Robert L Moritz

Proteomics. Clinical applications (2015-04-02) https://www.ncbi.nlm.nih.gov/pubmed/25631240

DOI: 10.1002/prca.201400164 · PMID: 25631240 · PMCID: PMC4506239

633.

reSpect: software for identification of high and low abundance ion species in chimeric tandem mass spectra.

David Shteynberg, Luis Mendoza, Michael R Hoopmann, Zhi Sun, Frank Schmidt, Eric W Deutsch, Robert L Moritz

Journal of the American Society for Mass Spectrometry (2015-09-29) https://www.ncbi.nlm.nih.gov/pubmed/26419769

DOI: 10.1007/s13361-015-1252-5 · PMID: 26419769 · PMCID: PMC4750398

634.

StPeter: Seamless Label-Free Quantification with the Trans-Proteomic Pipeline.

Michael R Hoopmann, Jason M Winget, Luis Mendoza, Robert L Moritz

Journal of proteome research (2018-02-14) https://www.ncbi.nlm.nih.gov/pubmed/29400476

DOI: 10.1021/acs.jproteome.7b00786 · PMID: 29400476 · PMCID: PMC5891225

635.

PTMProphet: Fast and Accurate Mass Modification Localization for the Trans-Proteomic Pipeline.

David D Shteynberg, Eric W Deutsch, David S Campbell, Michael R Hoopmann, Ulrike Kusebauch, Dave Lee, Luis Mendoza, Mukul K Midha, Zhi Sun, Anthony D Whetton, Robert L Moritz

Journal of proteome research (2019-07-22) https://www.ncbi.nlm.nih.gov/pubmed/31290668

DOI: 10.1021/acs.jproteome.9b00205 · PMID: 31290668 · PMCID: PMC6898736

636.

Trans-Proteomic Pipeline: Robust Mass Spectrometry-Based Proteomics Data Analysis Suite.

Eric W Deutsch, Luis Mendoza, David D Shteynberg, Michael R Hoopmann, Zhi Sun, Jimmy K Eng, Robert L Moritz

Journal of proteome research (2023-01-17) https://www.ncbi.nlm.nih.gov/pubmed/36648445

DOI: 10.1021/acs.jproteome.2c00624 · PMID: 36648445 · PMCID: PMC10166710

637.

Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.

Andrew Keller, Alexey I Nesvizhskii, Eugene Kolker, Ruedi Aebersold

Analytical chemistry (2002-10-15) https://www.ncbi.nlm.nih.gov/pubmed/12403597

DOI: 10.1021/ac025747h · PMID: 12403597

638.

A statistical model for identifying proteins by tandem mass spectrometry.

Alexey I Nesvizhskii, Andrew Keller, Eugene Kolker, Ruedi Aebersold

Analytical chemistry (2003-09-01) https://www.ncbi.nlm.nih.gov/pubmed/14632076

DOI: 10.1021/ac0341261 · PMID: 14632076

639.

CLIPPER: an add-on to the Trans-Proteomic Pipeline for the automated analysis of TAILS N-terminomics data.

Ulrich auf dem Keller, Christopher M Overall

Biological chemistry (2012-12) https://www.ncbi.nlm.nih.gov/pubmed/23667905

DOI: 10.1515/hsz-2012-0269 · PMID: 23667905

640.

PyQuant: A Versatile Framework for Analysis of Quantitative Mass Spectrometry Data.

Christopher J Mitchell, Min-Sik Kim, Chan Hyun Na, Akhilesh Pandey

Molecular & cellular proteomics : MCP (2016-05-26) https://www.ncbi.nlm.nih.gov/pubmed/27231314

DOI: 10.1074/mcp.o115.056879 · PMID: 27231314 · PMCID: PMC4974355

641.

SimPhospho: a software tool enabling confident phosphosite assignment.

Veronika Suni, Tomi Suomi, Tomoya Tsubosaka, Susumu Y Imanishi, Laura L Elo, Garry L Corthals

Bioinformatics (Oxford, England) (2018-08-01) https://www.ncbi.nlm.nih.gov/pubmed/29596608

DOI: 10.1093/bioinformatics/bty151 · PMID: 29596608 · PMCID: PMC6061695

642.

WinProphet: A User-Friendly Pipeline Management System for Proteomics Data Analysis Based on Trans-Proteomic Pipeline.

Ching-Tai Chen, Chu-Ling Ko, Wai-Kok Choong, Jen-Hung Wang, Wen-Lian Hsu, Ting-Yi Sung

Analytical chemistry (2019-07-29) https://www.ncbi.nlm.nih.gov/pubmed/31305071

DOI: 10.1021/acs.analchem.9b01556 · PMID: 31305071

643.

ProtyQuant: Comparing label-free shotgun proteomics datasets using accumulated peptide probabilities.

Robert Winkler

Journal of proteomics (2020-09-19) https://www.ncbi.nlm.nih.gov/pubmed/32956841

DOI: 10.1016/j.jprot.2020.103985 · PMID: 32956841

644.

Metaproteomic Analysis of an Oral Squamous Cell Carcinoma Dataset Suggests Diagnostic Potential of the Mycobiome.

Steven He, Rajdeep Chakraborty, Shoba Ranganathan

International journal of molecular sciences (2023-01-05) https://www.ncbi.nlm.nih.gov/pubmed/36674563

DOI: 10.3390/ijms24021050 · PMID: 36674563 · PMCID: PMC9865486

645.

Building consensus spectral libraries for peptide identification in proteomics.

Henry Lam, Eric W Deutsch, James S Eddes, Jimmy K Eng, Stephen E Stein, Ruedi Aebersold

Nature methods (2008-09-21) https://www.ncbi.nlm.nih.gov/pubmed/18806791

DOI: 10.1038/nmeth.1254 · PMID: 18806791 · PMCID: PMC2637392

646.

mzSpecLib | HUPO Proteomics Standards Initiative https://psidev.info/mzSpecLib

647.

Novor: real-time peptide de novo sequencing software.

Bin Ma

Journal of the American Society for Mass Spectrometry (2015-06-30) https://www.ncbi.nlm.nih.gov/pubmed/26122521

DOI: 10.1007/s13361-015-1204-0 · PMID: 26122521 · PMCID: PMC4604512

648.

De novo mass spectrometry peptide sequencing with a transformer model

Melih Yilmaz, William E Fondrie, Wout Bittremieux, Sewoong Oh, William Stafford Noble

Cold Spring Harbor Laboratory (2022-02-09) https://doi.org/gsthnz

DOI: 10.1101/2022.02.07.479481

649.

Discovery and Visualization of Uncharacterized Drug-Protein Adducts Using Mass Spectrometry.

Michael Riffle, Michael R Hoopmann, Daniel Jaschob, Guo Zhong, Robert L Moritz, Michael J MacCoss, Trisha N Davis, Nina Isoherranen, Alex Zelter

Analytical chemistry (2022-02-20) https://www.ncbi.nlm.nih.gov/pubmed/35184559

DOI: 10.1021/acs.analchem.1c04101 · PMID: 35184559 · PMCID: PMC8892443

650.

Prosit: proteome-wide prediction of peptide tandem mass spectra by deep learning

Siegfried Gessulat, Tobias Schmidt, Daniel Paul Zolg, Patroklos Samaras, Karsten Schnatbaum, Johannes Zerweck, Tobias Knaute, Julia Rechenberger, Bernard Delanghe, Andreas Huhmer, … Mathias Wilhelm

Nature Methods (2019-05-27) https://doi.org/gjqdvt

DOI: 10.1038/s41592-019-0426-7 · PMID: 31133760

651.

Assembling the Community-Scale Discoverable Human Proteome.

Mingxun Wang, Jian Wang, Jeremy Carver, Benjamin S Pullman, Seong Won Cha, Nuno Bandeira

Cell systems (2018-08-29) https://www.ncbi.nlm.nih.gov/pubmed/30172843

DOI: 10.1016/j.cels.2018.08.004 · PMID: 30172843 · PMCID: PMC6279426

652.

OpenSWATH enables automated, targeted analysis of data-independent acquisition MS data

Hannes L Röst, George Rosenberger, Pedro Navarro, Ludovic Gillet, Saša M Miladinović, Olga T Schubert, Witold Wolski, Ben C Collins, Johan Malmström, Lars Malmström, Ruedi Aebersold

Nature Biotechnology (2014-03) https://doi.org/f2z4c3

DOI: 10.1038/nbt.2841 · PMID: 24727770

653.

CsoDIAq Software for Direct Infusion Shotgun Proteome Analysis

Caleb W Cranney, Jesse G Meyer

Analytical Chemistry (2021-09-01) https://doi.org/gs4qk3

DOI: 10.1021/acs.analchem.1c02021 · PMID: 34469131

654.

DIA-Umpire: comprehensive computational framework for data-independent acquisition proteomics

Chih-Chiang Tsou, Dmitry Avtonomov, Brett Larsen, Monika Tucholska, Hyungwon Choi, Anne-Claude Gingras, Alexey I Nesvizhskii

Nature Methods (2015-01-19) https://doi.org/f64sqj

DOI: 10.1038/nmeth.3255 · PMID: 25599550 · PMCID: PMC4399776

655.

PECAN: library-free peptide detection for data-independent acquisition tandem mass spectrometry data

Ying S Ting, Jarrett D Egertson, James G Bollinger, Brian C Searle, Samuel H Payne, William Stafford Noble, Michael J MacCoss

Nature Methods (2017-08-07) https://doi.org/gbqx8j

DOI: 10.1038/nmeth.4390 · PMID: 28783153 · PMCID: PMC5578911

656.

Quality Control in Proteomics

PROTEOMICS

(2011-03) https://doi.org/bzmh75

DOI: 10.1002/pmic.201190020 · PMID: 21374817

657.

Quality control in LC‐MS/MS

Thomas Köcher, Peter Pichler, Remco Swart, Karl Mechtler

PROTEOMICS (2011-02-07) https://doi.org/c54ck5

DOI: 10.1002/pmic.201000578 · PMID: 21360669

658.

Quality control in mass spectrometry‐based proteomics

Wout Bittremieux, David L Tabb, Francis Impens, An Staes, Evy Timmerman, Lennart Martens, Kris Laukens

Mass Spectrometry Reviews (2017-09-07) https://doi.org/gbs3vs

DOI: 10.1002/mas.21544 · PMID: 28802010

659.

AlphaPept, a modern and open framework for MS-based proteomics

Maximilian T Strauss, Isabell Bludau, Wen-Feng Zeng, Eugenia Voytik, Constantin Ammar, Julia Schessner, Rajesh Ilango, Michelle Gill, Florian Meier, Sander Willems, Matthias Mann

Cold Spring Harbor Laboratory (2021-07-26) https://doi.org/gqmt2q

DOI: 10.1101/2021.07.23.453379

660.

rawDiag: An R Package Supporting Rational LC–MS Method Optimization for Bottom-up Proteomics

Christian Trachsel, Christian Panse, Tobias Kockmann, Witold E Wolski, Jonas Grossmann, Ralph Schlapbach

Journal of Proteome Research (2018-07-06) https://doi.org/gd39tz

DOI: 10.1021/acs.jproteome.8b00173 · PMID: 29978702

661.

The rawrr R Package: Direct Access to Orbitrap Data and Beyond

Tobias Kockmann, Christian Panse

Journal of Proteome Research (2021-03-09) https://doi.org/gjgdxj

DOI: 10.1021/acs.jproteome.0c00866 · PMID: 33686856

662.

RawBeans: A Simple, Vendor-Independent, Raw-Data Quality-Control Tool

David Morgenstern, Rotem Barzilay, Yishai Levin

Journal of Proteome Research (2021-03-04) https://doi.org/gmwh5f

DOI: 10.1021/acs.jproteome.0c00956 · PMID: 33657803 · PMCID: PMC8041395

663.

SIMPATIQCO: A Server-Based Software Suite Which Facilitates Monitoring the Time Course of LC–MS Performance Metrics on Orbitrap Instruments

Peter Pichler, Michael Mazanek, Frederico Dusberger, Lisa Weilnböck, Christian G Huber, Christoph Stingl, Theo M Luider, Werner L Straube, Thomas Köcher, Karl Mechtler

Journal of Proteome Research (2012-10-22) https://doi.org/f3sk5j

DOI: 10.1021/pr300163u · PMID: 23088386 · PMCID: PMC3558011

664.

Quality Control Analysis in Real-time (QC-ART): A Tool for Real-time Quality Control Assessment of Mass Spectrometry-based Proteomics Data

Bryan A Stanfill, Ernesto S Nakayasu, Lisa M Bramer, Allison M Thompson, Charles K Ansong, Therese R Clauss, Marina A Gritsenko, Matthew E Monroe, Ronald J Moore, Daniel J Orton, … Thomas O Metz

Molecular & Cellular Proteomics (2018-09) https://doi.org/gd7n2k

DOI: 10.1074/mcp.ra118.000648 · PMID: 29666158 · PMCID: PMC6126382

665.

SprayQc: A Real-Time LC–MS/MS Quality Monitoring System To Maximize Uptime Using Off the Shelf Components

Richard A Scheltema, Matthias Mann

Journal of Proteome Research (2012-05-11) https://doi.org/gqmt2m

DOI: 10.1021/pr201219e · PMID: 22515319

666.

Metriculator: quality assessment for mass spectrometry-based proteomics

Ryan M Taylor, Jamison Dance, Russ J Taylor, John T Prince

Bioinformatics (2013-09-02) https://doi.org/f5gpzz

DOI: 10.1093/bioinformatics/btt510 · PMID: 24002108

667.

OpenMS: a flexible open-source software platform for mass spectrometry data analysis

Hannes L Röst, Timo Sachsenberg, Stephan Aiche, Chris Bielow, Hendrik Weisser, Fabian Aicheler, Sandro Andreotti, Hans-Christian Ehrlich, Petra Gutenbrunner, Erhan Kenar, … Oliver Kohlbacher

Nature Methods (2016-08-30) https://doi.org/f82r32

DOI: 10.1038/nmeth.3959 · PMID: 27575624

668.

MSstats: an R package for statistical analysis of quantitative mass spectrometry-based proteomic experiments

Meena Choi, Ching-Yun Chang, Timothy Clough, Daniel Broudy, Trevor Killeen, Brendan MacLean, Olga Vitek

Bioinformatics (2014-05-02) https://doi.org/f6j737

DOI: 10.1093/bioinformatics/btu305 · PMID: 24794931

669.

MSstatsQC: Longitudinal System Suitability Monitoring and Quality Control for Targeted Proteomic Experiments

Eralp Dogu, Sara Mohammad-Taheri, Susan E Abbatiello, Michael S Bereman, Brendan MacLean, Birgit Schilling, Olga Vitek

Molecular & Cellular Proteomics (2017-07) https://doi.org/gbmgrh

DOI: 10.1074/mcp.m116.064774 · PMID: 28483925 · PMCID: PMC5500765

670.

Proteomics Quality Control: Quality Control Software for MaxQuant Results

Chris Bielow, Guido Mastrobuoni, Stefan Kempa

Journal of Proteome Research (2015-12-28) https://doi.org/f8c54w

DOI: 10.1021/acs.jproteome.5b00780 · PMID: 26653327

671.

protti: an R package for comprehensive data analysis of peptide- and protein-centric bottom-up proteomics data

Jan-Philipp Quast, Dina Schuster, Paola Picotti

Bioinformatics Advances (2021-12-10) https://doi.org/gqmt2n

DOI: 10.1093/bioadv/vbab041 · PMID: 36699412 · PMCID: PMC9710675

672.

Statistical analysis of proteomics data: A review on feature selection

Marta Lualdi, Mauro Fasano

Journal of Proteomics (2019-04) https://doi.org/gjgg7j

DOI: 10.1016/j.jprot.2018.12.004 · PMID: 30529743

673.

Assessing normalization methods in mass spectrometry-based proteome profiling of clinical samples

Etienne Dubois, Antonio Núñez Galindo, Loïc Dayon, Ornella Cominetti

Biosystems (2022-06) https://doi.org/gszcbw

DOI: 10.1016/j.biosystems.2022.104661 · PMID: 35247480

674.

Normalization Approaches for Removing Systematic Biases Associated with Mass Spectrometry and Label-Free Proteomics

Stephen J Callister, Richard C Barry, Joshua N Adkins, Ethan T Johnson, Wei-jun Qian, Bobbie-Jo M Webb-Robertson, Richard D Smith, Mary S Lipton

Journal of Proteome Research (2006-01-17) https://doi.org/dt8xh9

DOI: 10.1021/pr050300l · PMID: 16457593 · PMCID: PMC1992440

675.

A systematic evaluation of normalization methods in quantitative label-free proteomics

Tommi Välikangas, Tomi Suomi, Laura L Elo

Briefings in Bioinformatics (2016-10-02) https://doi.org/gdjxsg

DOI: 10.1093/bib/bbw095 · PMID: 27694351 · PMCID: PMC5862339

676.

Normalization and missing value imputation for label-free LC-MS analysis

Yuliya V Karpievitch, Alan R Dabney, Richard D Smith

BMC Bioinformatics (2012-11) https://doi.org/gb8vpb

DOI: 10.1186/1471-2105-13-s16-s5 · PMID: 23176322 · PMCID: PMC3489534

677.

Normalyzer: A Tool for Rapid Evaluation of Normalization Methods for Omics Data Sets

Aakash Chawade, Erik Alexandersson, Fredrik Levander

Journal of Proteome Research (2014-05-02) https://doi.org/f23c6c

DOI: 10.1021/pr401264n · PMID: 24766612 · PMCID: PMC4053077

678.

Removing unwanted variation from large-scale RNA sequencing data with PRPS

Ramyar Molania, Momeneh Foroutan, Johann A Gagnon-Bartsch, Luke C Gandolfo, Aryan Jain, Abhishek Sinha, Gavriel Olshansky, Alexander Dobrovic, Anthony T Papenfuss, Terence P Speed

Nature Biotechnology (2022-09-15) https://doi.org/gqtm24

DOI: 10.1038/s41587-022-01440-w · PMID: 36109686 · PMCID: PMC9849124

679.

Diagnostics and correction of batch effects in large‐scale proteomic studies: a tutorial

Jelena Čuklina, Chloe H Lee, Evan G Williams, Tatjana Sajic, Ben C Collins, María Rodríguez Martínez, Varun S Sharma, Fabian Wendt, Sandra Goetze, Gregory R Keele, … Patrick GA Pedrioli

Molecular Systems Biology (2021-08) https://doi.org/gszcdk

DOI: 10.15252/msb.202110240 · PMID: 34432947 · PMCID: PMC8447595

680.

Selecting between-sample RNA-Seq normalization methods from the perspective of their assumptions

Ciaran Evans, Johanna Hardin, Daniel M Stoebel

Briefings in Bioinformatics (2017-02-27) https://doi.org/gfcf9w

DOI: 10.1093/bib/bbx008 · PMID: 28334202 · PMCID: PMC6171491

681.

A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

BM Bolstad, RA Irizarry, M Åstrand, TP Speed

Bioinformatics (2003-01-22) https://doi.org/ftnbxq

DOI: 10.1093/bioinformatics/19.2.185 · PMID: 12538238

682.

Normalization of RNA-seq data using factor analysis of control genes or samples

Davide Risso, John Ngai, Terence P Speed, Sandrine Dudoit

Nature Biotechnology (2014-08-24) https://doi.org/f6j2ph

DOI: 10.1038/nbt.2931 · PMID: 25150836 · PMCID: PMC4404308

683.

RobNorm: model-based robust normalization method for labeled quantitative mass spectrometry proteomics data

Meng Wang, Lihua Jiang, Ruiqi Jian, Joanne Y Chan, Qing Liu, Michael P Snyder, Hua Tang

Bioinformatics (2020-10-24) https://doi.org/gszcdg

DOI: 10.1093/bioinformatics/btaa904 · PMID: 33098413 · PMCID: PMC8098025

684.

Normalization of peak intensities in bottom-up MS-based proteomics using singular value decomposition

Yuliya V Karpievitch, Thomas Taverner, Joshua N Adkins, Stephen J Callister, Gordon A Anderson, Richard D Smith, Alan R Dabney

Bioinformatics (2009-07-14) https://doi.org/fb5jtv

DOI: 10.1093/bioinformatics/btp426 · PMID: 19602524 · PMCID: PMC2752608

685.

Systematic Error Removal Using Random Forest for Normalizing Large-Scale Untargeted Lipidomics Data

Sili Fan, Tobias Kind, Tomas Cajka, Stanley L Hazen, WHWilson Tang, Rima Kaddurah-Daouk, Marguerite R Irvin, Donna K Arnett, Dinesh K Barupal, Oliver Fiehn

Analytical Chemistry (2019-02-13) https://doi.org/gh5nfz

DOI: 10.1021/acs.analchem.8b05592 · PMID: 30758187 · PMCID: PMC9652764

686.

Development and Evaluation of Normalization Methods for Label-free Relative Quantification of Endogenous Peptides

Kim Kultima, Anna Nilsson, Birger Scholz, Uwe L Rossbach, Maria Fälth, Per E Andrén

Molecular & Cellular Proteomics (2009-10) https://doi.org/d6qz54

DOI: 10.1074/mcp.m800514-mcp200 · PMID: 19596695 · PMCID: PMC2758756

687.

NormalyzerDE: Online Tool for Improved Normalization of Omics Expression Data and High-Sensitivity Differential Expression Analysis

Jakob Willforss, Aakash Chawade, Fredrik Levander

Journal of Proteome Research (2018-10-02) https://doi.org/ggkdqg

DOI: 10.1021/acs.jproteome.8b00523 · PMID: 30277078

688.

AlphaPeptStats: an open-source Python package for automated and scalable statistical analysis of mass spectrometry-based proteomics

Elena Krismer, Isabell Bludau, Maximilian T Strauss, Matthias Mann

Bioinformatics (2023-08-01) https://doi.org/gszcdh

DOI: 10.1093/bioinformatics/btad461 · PMID: 37527012 · PMCID: PMC10415174

689.

A statistical framework for protein quantitation in bottom-up MS-based proteomics

Yuliya Karpievitch, Jeff Stanley, Thomas Taverner, Jianhua Huang, Joshua N Adkins, Charles Ansong, Fred Heffron, Thomas O Metz, Wei-Jun Qian, Hyunjin Yoon, … Alan R Dabney

Bioinformatics (2009-06-17) https://doi.org/cgpz63

DOI: 10.1093/bioinformatics/btp362 · PMID: 19535538 · PMCID: PMC2723007

690.

Bayesian Analysis of iTRAQ Data with Nonrandom Missingness: Identification of Differentially Expressed Proteins

Ruiyan Luo, Christopher M Colangelo, William C Sessa, Hongyu Zhao

Statistics in Biosciences (2009-10-08) https://doi.org/bn5gsg

DOI: 10.1007/s12561-009-9013-2 · PMID: 21927625 · PMCID: PMC3172970

691.

MissForest—non-parametric missing value imputation for mixed-type data

Daniel J Stekhoven, Peter Bühlmann

Bioinformatics (2011-10-28) https://doi.org/dhxth8

DOI: 10.1093/bioinformatics/btr597 · PMID: 22039212

692.

Missing value estimation methods for DNA microarrays

Olga Troyanskaya, Michael Cantor, Gavin Sherlock, Pat Brown, Trevor Hastie, Robert Tibshirani, David Botstein, Russ B Altman

Bioinformatics (2001-06-01) https://doi.org/bz5w38

DOI: 10.1093/bioinformatics/17.6.520 · PMID: 11395428

693.

pcaMethods—a bioconductor package providing PCA methods for incomplete data

Wolfram Stacklies, Henning Redestig, Matthias Scholz, Dirk Walther, Joachim Selbig

Bioinformatics (2007-03-07) https://doi.org/fvfh9c

DOI: 10.1093/bioinformatics/btm069 · PMID: 17344241

694.

Missing Value Imputation Approach for Mass Spectrometry-based Metabolomics Data

Runmin Wei, Jingye Wang, Mingming Su, Erik Jia, Shaoqiu Chen, Tianlu Chen, Yan Ni

Scientific Reports (2018-01-12) https://doi.org/gcw5nb

DOI: 10.1038/s41598-017-19120-0 · PMID: 29330539 · PMCID: PMC5766532

695.

Random forest-based imputation outperforms other methods for imputing LC-MS metabolomics data: a comparative study

Marietta Kokla, Jyrki Virtanen, Marjukka Kolehmainen, Jussi Paananen, Kati Hanhineva

BMC Bioinformatics (2019-10-11) https://doi.org/ght9dn

DOI: 10.1186/s12859-019-3110-0 · PMID: 31601178 · PMCID: PMC6788053

696.

A comparative study of evaluating missing value imputation methods in label-free proteomics

Liang Jin, Yingtao Bi, Chenqi Hu, Jun Qu, Shichen Shen, Xue Wang, Yu Tian

Scientific Reports (2021-01-19) https://doi.org/gk5cdj

DOI: 10.1038/s41598-021-81279-4 · PMID: 33469060 · PMCID: PMC7815892

697.

Why Batch Effects Matter in Omics Data, and How to Avoid Them

Wilson Wen Bin Goh, Wei Wang, Limsoon Wong

Trends in Biotechnology (2017-06) https://doi.org/f98dbg

DOI: 10.1016/j.tibtech.2017.02.012 · PMID: 28351613

698.

Tackling the widespread and critical impact of batch effects in high-throughput data

Jeffrey T Leek, Robert B Scharpf, Héctor Corrada Bravo, David Simcha, Benjamin Langmead, WEvan Johnson, Donald Geman, Keith Baggerly, Rafael A Irizarry

Nature Reviews Genetics (2010-09-14) https://doi.org/cfr324

DOI: 10.1038/nrg2825 · PMID: 20838408 · PMCID: PMC3880143

699.

The importance of experimental design in proteomic mass spectrometry experiments: Some cautionary tales

J Hu

Briefings in Functional Genomics and Proteomics (2005-01-01) https://doi.org/bjqshb

DOI: 10.1093/bfgp/3.4.322 · PMID: 15814023

700.

Adjusting batch effects in microarray expression data using empirical Bayes methods

WEvan Johnson, Cheng Li, Ariel Rabinovic

Biostatistics (2006-04-21) https://doi.org/dsf386

DOI: 10.1093/biostatistics/kxj037 · PMID: 16632515

701.

Removing Batch Effects in Analysis of Expression Microarray Data: An Evaluation of Six Batch Adjustment Methods

Chao Chen, Kay Grennan, Judith Badner, Dandan Zhang, Elliot Gershon, Li Jin, Chunyu Liu

PLoS ONE (2011-02-28) https://doi.org/dd7jxs

DOI: 10.1371/journal.pone.0017238 · PMID: 21386892 · PMCID: PMC3046121

702.

Using control genes to correct for unwanted variation in microarray data

JA Gagnon-Bartsch, TP Speed

Biostatistics (2011-11-17) https://doi.org/c7rjg9

DOI: 10.1093/biostatistics/kxr034 · PMID: 22101192 · PMCID: PMC3577104

703.

Batch effects in single-cell RNA-sequencing data are corrected by matching mutual nearest neighbors

Laleh Haghverdi, Aaron TL Lun, Michael D Morgan, John C Marioni

Nature Biotechnology (2018-04-02) https://doi.org/gc8754

DOI: 10.1038/nbt.4091 · PMID: 29608177 · PMCID: PMC6152897

704.

Efficient integration of heterogeneous single-cell transcriptomes using Scanorama

Brian Hie, Bryan Bryson, Bonnie Berger

Nature Biotechnology (2019-05-06) https://doi.org/gf9psf

DOI: 10.1038/s41587-019-0113-3 · PMID: 31061482 · PMCID: PMC6551256

705.

A practical guide to interpreting and generating bottom‐up proteomics data visualizations

Julia Patricia Schessner, Eugenia Voytik, Isabell Bludau

PROTEOMICS (2022-02-15) https://doi.org/gszcbn

DOI: 10.1002/pmic.202100103 · PMID: 35107884

706.

Artificial intelligence for proteomics and biomarker discovery

Matthias Mann, Chanchal Kumar, Wen-Feng Zeng, Maximilian T Strauss

Cell Systems (2021-08) https://doi.org/gprrzm

DOI: 10.1016/j.cels.2021.06.006 · PMID: 34411543

707.

Application of Machine Learning to Proteomics Data: Classification and Biomarker Identification in Postgenomics Biology

Anna Louise Swan, Ali Mobasheri, David Allaway, Susan Liddell, Jaume Bacardit

OMICS: A Journal of Integrative Biology (2013-12) https://doi.org/f5ph9d

DOI: 10.1089/omi.2013.0017 · PMID: 24116388 · PMCID: PMC3837439

708.

Bayesian methods for proteomic biomarker development

Belinda Hernández, Stephen R Pennington, Andrew C Parnell

EuPA Open Proteomics (2015-12) https://doi.org/gszcb6

DOI: 10.1016/j.euprot.2015.08.001

709.

A Bayesian network approach to feature selection in mass spectrometry data

Karl W Kuschner, Dariya I Malyarenko, William E Cooke, Lisa H Cazares, OJ Semmes, Eugene R Tracy

BMC Bioinformatics (2010-04-08) https://doi.org/bf9785

DOI: 10.1186/1471-2105-11-177 · PMID: 20377906 · PMCID: PMC3098056

710.

Advances, obstacles, and opportunities for machine learning in proteomics

Heather Desaire, Eden P Go, David Hua

Cell Reports Physical Science (2022-10) https://doi.org/gr32dw

DOI: 10.1016/j.xcrp.2022.101069 · PMID: 36381226 · PMCID: PMC9648337

711.

On evaluation metrics for medical applications of artificial intelligence

Steven A Hicks, Inga Strümke, Vajira Thambawita, Malek Hammou, Michael A Riegler, Pål Halvorsen, Sravanthi Parasa

Scientific Reports (2022-04-08) https://doi.org/gszcc9

DOI: 10.1038/s41598-022-09954-8 · PMID: 35395867 · PMCID: PMC8993826

712.

Why Inclusion Matters for Alzheimer’s Disease Biomarker Discovery in Plasma

Mostafa J Khan, Heather Desaire, Oscar L Lopez, MIlyas Kamboh, Renã AS Robinson

Journal of Alzheimer's Disease (2021-02-02) https://doi.org/gszcdm

DOI: 10.3233/jad-201318 · PMID: 33427747 · PMCID: PMC9126484

713.

How (Not) to Generate a Highly Predictive Biomarker Panel Using Machine Learning

Heather Desaire

Journal of Proteome Research (2022-08-25) https://doi.org/gszccq

DOI: 10.1021/acs.jproteome.2c00117 · PMID: 36004690 · PMCID: PMC9680826

714.

Rules of evidence for cancer molecular-marker discovery and validation

David F Ransohoff

Nature Reviews Cancer (2004-04) https://doi.org/cm2qb5

DOI: 10.1038/nrc1322 · PMID: 15057290

715.

An empirical evaluation of sampling methods for the classification of imbalanced data

Misuk Kim, Kyu-Baek Hwang

PLOS ONE (2022-07-28) https://doi.org/gszcdj

DOI: 10.1371/journal.pone.0271260 · PMID: 35901023 · PMCID: PMC9333262

716.

The harm of class imbalance corrections for risk prediction models: illustration and simulation using logistic regression

Ruben van den Goorbergh, Maarten van Smeden, Dirk Timmerman, Ben Van Calster

Journal of the American Medical Informatics Association (2022-06-10) https://doi.org/gswpkb

DOI: 10.1093/jamia/ocac093 · PMID: 35686364 · PMCID: PMC9382395

717.

Limitation of ROC in Evaluation of Classifiers for Imbalanced Data

F Movahedi, JF Antaki

The Journal of Heart and Lung Transplantation (2021-04) https://doi.org/gszcb8

DOI: 10.1016/j.healun.2021.01.1160

718.

The Precision-Recall Plot Is More Informative than the ROC Plot When Evaluating Binary Classifiers on Imbalanced Datasets

Takaya Saito, Marc Rehmsmeier

PLOS ONE (2015-03-04) https://doi.org/f69237

DOI: 10.1371/journal.pone.0118432 · PMID: 25738806 · PMCID: PMC4349800

719.

MAKER2: an annotation pipeline and genome-database management tool for second-generation genome projects.

Carson Holt, Mark Yandell

BMC bioinformatics (2011-12-22) https://www.ncbi.nlm.nih.gov/pubmed/22192575

DOI: 10.1186/1471-2105-12-491 · PMID: 22192575 · PMCID: PMC3280279

720.

The NCBI Eukaryotic Genome Annotation Pipeline https://www.ncbi.nlm.nih.gov/genome/annotation_euk/process/

721.

UniProt https://www.uniprot.org/help/biocuration

722.

https://www.psidev.info/sites/default/files/2018-03/MIAPE_MSI_1.1.pdf

723.

Guidelines for reporting quantitative mass spectrometry based experiments in proteomics.

Salvador Martínez-Bartolomé, Eric W Deutsch, Pierre-Alain Binz, Andrew R Jones, Martin Eisenacher, Gerhard Mayer, Alex Campos, Francesc Canals, Joan-Josep Bech-Serra, Montserrat Carrascal, … Juan P Albar

Journal of proteomics (2013-03-14) https://www.ncbi.nlm.nih.gov/pubmed/23500130

DOI: 10.1016/j.jprot.2013.02.026 · PMID: 23500130

724.

UniProt: the Universal Protein knowledgebase.

Rolf Apweiler, Amos Bairoch, Cathy H Wu, Winona C Barker, Brigitte Boeckmann, Serenella Ferro, Elisabeth Gasteiger, Hongzhan Huang, Rodrigo Lopez, Michele Magrane, … Lai-Su L Yeh

Nucleic acids research (2004-01-01) https://www.ncbi.nlm.nih.gov/pubmed/14681372

DOI: 10.1093/nar/gkh131 · PMID: 14681372 · PMCID: PMC308865

725.

UniProt https://www.uniprot.org/help/sequence_origin

726.

UniProt https://www.uniprot.org/help/manual_curation

727.

fasta_utilities

Phillip Wilmarth

(2023-08-01) https://github.com/pwilmart/fasta_utilities

728.

Global Identification of Protein Post-translational Modifications in a Single-Pass Database Search.

Michael R Shortreed, Craig D Wenger, Brian L Frey, Gloria M Sheynkman, Mark Scalf, Mark P Keller, Alan D Attie, Lloyd M Smith

Journal of proteome research (2015-09-29) https://www.ncbi.nlm.nih.gov/pubmed/26418581

DOI: 10.1021/acs.jproteome.5b00599 · PMID: 26418581 · PMCID: PMC4642219

729.

Datasets

NCBI

https://www.ncbi.nlm.nih.gov/datasets

730.

Eukaryotic genomes annotated at NCBI https://www.ncbi.nlm.nih.gov/genome/annotation_euk/all/

731.

Prokaryotic RefSeq Genomes https://www.ncbi.nlm.nih.gov/refseq/about/prokaryotes/

732.

Eukaryotic RefSeq Genome Annotation Status https://www.ncbi.nlm.nih.gov/genome/annotation_euk/status/

733.

Training & Tutorials - Site Guide - NCBI https://www.ncbi.nlm.nih.gov/guide/training-tutorials/

734.

Proteomics in Non-model Organisms: A New Analytical Frontier.

Michelle Heck, Benjamin A Neely

Journal of proteome research (2020-08-20) https://www.ncbi.nlm.nih.gov/pubmed/32786681

DOI: 10.1021/acs.jproteome.0c00448 · PMID: 32786681 · PMCID: PMC7874939

735.

Ensembl genome browser 110 https://useast.ensembl.org/index.html

736.

Ensembl Genomes http://ensemblgenomes.org/

737.

Interferences and contaminants encountered in modern mass spectrometry.

Bernd O Keller, Jie Sui, Alex B Young, Randy M Whittal

Analytica chimica acta (2008-04-25) https://www.ncbi.nlm.nih.gov/pubmed/18790129

DOI: 10.1016/j.aca.2008.04.043 · PMID: 18790129

738.

cRAP protein sequences https://www.thegpm.org/crap/

739.

Philosopher: a versatile toolkit for shotgun proteomics data analysis.

Felipe da Veiga Leprevost, Sarah E Haynes, Dmitry M Avtonomov, Hui-Yin Chang, Avinash K Shanmugam, Dattatreya Mellacheruvu, Andy T Kong, Alexey I Nesvizhskii

Nature methods (2020-09) https://www.ncbi.nlm.nih.gov/pubmed/32669682

DOI: 10.1038/s41592-020-0912-y · PMID: 32669682 · PMCID: PMC7509848

740.

Protein Contaminants Matter: Building Universal Protein Contaminant Libraries for DDA and DIA Proteomics

Ashley M Frankenfield, Jiawei Ni, Mustafa Ahmed, Ling Hao

Cold Spring Harbor Laboratory (2022-04-28) https://doi.org/gp4xcp

DOI: 10.1101/2022.04.27.489766

741.

The minotaur proteome: avoiding cross-species identifications deriving from bovine serum in cell culture models.

Jakob Bunkenborg, Guadalupe Espadas García, Marcia Ivonne Peña Paz, Jens S Andersen, Henrik Molina

Proteomics (2010-08) https://www.ncbi.nlm.nih.gov/pubmed/20641139

DOI: 10.1002/pmic.201000103 · PMID: 20641139

742.

Foetal bovine serum influence on in vitro extracellular vesicle analyses.

Brandon M Lehrich, Yaxuan Liang, Massimo S Fiandaca

Journal of extracellular vesicles (2021-01-25) https://www.ncbi.nlm.nih.gov/pubmed/33532042

DOI: 10.1002/jev2.12061 · PMID: 33532042 · PMCID: PMC7830136

743.

The CRAPome: a contaminant repository for affinity purification-mass spectrometry data.

Dattatreya Mellacheruvu, Zachary Wright, Amber L Couzens, Jean-Philippe Lambert, Nicole A St-Denis, Tuo Li, Yana V Miteva, Simon Hauri, Mihaela E Sardiu, Teck Yew Low, … Alexey I Nesvizhskii

Nature methods (2013-07-07) https://www.ncbi.nlm.nih.gov/pubmed/23921808

DOI: 10.1038/nmeth.2557 · PMID: 23921808 · PMCID: PMC3773500

744.

Common Repository of FBS Proteins (cRFP) To Be Added to a Search Database for Mass Spectrometric Analysis of Cell Secretome.

Jihye Shin, Yumi Kwon, Seonjeong Lee, Seungjin Na, Eun Young Hong, Shinyeong Ju, Hyun-Gyo Jung, Prashant Kaushal, Sungho Shin, Ji Hyun Back, … Cheolju Lee

Journal of proteome research (2019-09-10) https://www.ncbi.nlm.nih.gov/pubmed/31475827

DOI: 10.1021/acs.jproteome.9b00475 · PMID: 31475827

745.

Accurately Assigning Peptides to Spectra When Only a Subset of Peptides Are Relevant.

Andy Lin, Deanna L Plubell, Uri Keich, William S Noble

Journal of proteome research (2021-07-08) https://www.ncbi.nlm.nih.gov/pubmed/34236864

DOI: 10.1021/acs.jproteome.1c00483 · PMID: 34236864 · PMCID: PMC8489664

746.

Averaging Strategy To Reduce Variability in Target-Decoy Estimates of False Discovery Rate.

Uri Keich, Kaipo Tamura, William Stafford Noble

Journal of proteome research (2019-01-03) https://www.ncbi.nlm.nih.gov/pubmed/30560673

DOI: 10.1021/acs.jproteome.8b00802 · PMID: 30560673 · PMCID: PMC6919216

747.

Mass spectrometrists should search only for peptides they care about.

William Stafford Noble

Nature methods (2015-07) https://www.ncbi.nlm.nih.gov/pubmed/26125591

DOI: 10.1038/nmeth.3450 · PMID: 26125591 · PMCID: PMC4711994

748.

Choosing an Optimal Database for Protein Identification from Tandem Mass Spectrometry Data.

Dhirendra Kumar, Amit Kumar Yadav, Debasis Dash

Methods in molecular biology (Clifton, N.J.) (2017) https://www.ncbi.nlm.nih.gov/pubmed/27975281

DOI: 10.1007/978-1-4939-6740-7_3 · PMID: 27975281

749.

Human Plasma PeptideAtlas.

Eric W Deutsch, Jimmy K Eng, Hui Zhang, Nichole L King, Alexey I Nesvizhskii, Biaoyang Lin, Hookeun Lee, Eugene C Yi, Reto Ossola, Ruedi Aebersold

Proteomics (2005-08) https://www.ncbi.nlm.nih.gov/pubmed/16052627

DOI: 10.1002/pmic.200500160 · PMID: 16052627

750.

The PeptideAtlas project.

Frank Desiere, Eric W Deutsch, Nichole L King, Alexey I Nesvizhskii, Parag Mallick, Jimmy Eng, Sharon Chen, James Eddes, Sandra N Loevenich, Ruedi Aebersold

Nucleic acids research (2006-01-01) https://www.ncbi.nlm.nih.gov/pubmed/16381952

DOI: 10.1093/nar/gkj040 · PMID: 16381952 · PMCID: PMC1347403

751.

PASSEL: the PeptideAtlas SRMexperiment library.

Terry Farrah, Eric W Deutsch, Richard Kreisberg, Zhi Sun, David S Campbell, Luis Mendoza, Ulrike Kusebauch, Mi-Youn Brusniak, Ruth Hüttenhain, Ralph Schiess, … Robert L Moritz

Proteomics (2012-04) https://www.ncbi.nlm.nih.gov/pubmed/22318887

DOI: 10.1002/pmic.201100515 · PMID: 22318887 · PMCID: PMC3832291

752.

Using PeptideAtlas, SRMAtlas, and PASSEL: Comprehensive Resources for Discovery and Targeted Proteomics.

Ulrike Kusebauch, Eric W Deutsch, David S Campbell, Zhi Sun, Terry Farrah, Robert L Moritz

Current protocols in bioinformatics (2014-06-17) https://www.ncbi.nlm.nih.gov/pubmed/24939129

DOI: 10.1002/0471250953.bi1325s46 · PMID: 24939129 · PMCID: PMC4331073

753.

Human SRMAtlas: A Resource of Targeted Assays to Quantify the Complete Human Proteome.

Ulrike Kusebauch, David S Campbell, Eric W Deutsch, Caroline S Chu, Douglas A Spicer, Mi-Youn Brusniak, Joseph Slagel, Zhi Sun, Jeffrey Stevens, Barbara Grimes, … Robert L Moritz

Cell (2016-07-21) https://www.ncbi.nlm.nih.gov/pubmed/27453469

DOI: 10.1016/j.cell.2016.06.041 · PMID: 27453469 · PMCID: PMC5245710

754.

PRIDE: a public repository of protein and peptide identifications for the proteomics community

P Jones

Nucleic Acids Research (2006-01-01) https://doi.org/bjbzqv

DOI: 10.1093/nar/gkj138 · PMID: 16381953 · PMCID: PMC1347500

755.

The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences

Yasset Perez-Riverol, Jingwen Bai, Chakradhar Bandla, David García-Seisdedos, Suresh Hewapathirana, Selvakumar Kamatchinathan, Deepti J Kundu, Ananth Prakash, Anika Frericks-Zipper, Martin Eisenacher, … Juan Antonio Vizcaíno

Nucleic Acids Research (2021-11-01) https://doi.org/gpwt5t

DOI: 10.1093/nar/gkab1038 · PMID: 34723319 · PMCID: PMC8728295

756.

Proteomics Standards Initiative: Fifteen Years of Progress and Future Work

Eric W Deutsch, Sandra Orchard, Pierre-Alain Binz, Wout Bittremieux, Martin Eisenacher, Henning Hermjakob, Shin Kawano, Henry Lam, Gerhard Mayer, Gerben Menschaert, … Andrew R Jones

Journal of Proteome Research (2017-09-15) https://doi.org/gbw99d

DOI: 10.1021/acs.jproteome.7b00370 · PMID: 28849660 · PMCID: PMC5715286

757.

Building ProteomeTools based on a complete synthetic human proteome

Daniel P Zolg, Mathias Wilhelm, Karsten Schnatbaum, Johannes Zerweck, Tobias Knaute, Bernard Delanghe, Derek J Bailey, Siegfried Gessulat, Hans-Christian Ehrlich, Maximilian Weininger, … Bernhard Kuster

Nature Methods (2017-01-30) https://doi.org/gqsqwb

DOI: 10.1038/nmeth.4153 · PMID: 28135259 · PMCID: PMC5868332

758.

Panorama: A Targeted Proteomics Knowledge Base

Vagisha Sharma, Josh Eckels, Greg K Taylor, Nicholas J Shulman, Andrew B Stergachis, Shannon A Joyner, Ping Yan, Jeffrey R Whiteaker, Goran N Halusa, Birgit Schilling, … Brendan MacLean

Journal of Proteome Research (2014-08-18) https://doi.org/f66h5k

DOI: 10.1021/pr5006636 · PMID: 25102069 · PMCID: PMC4156235

759.

Chorus - Home https://chorusproject.org/pages/index.html

760.

iProX: an integrated proteome resource

Jie Ma, Tao Chen, Songfeng Wu, Chunyuan Yang, Mingze Bai, Kunxian Shu, Kenli Li, Guoqing Zhang, Zhong Jin, Fuchu He, … Yunping Zhu

Nucleic Acids Research (2018-09-25) https://doi.org/ggngpb

DOI: 10.1093/nar/gky869 · PMID: 30252093 · PMCID: PMC6323926

761.

Recent progress in mass spectrometry-based strategies for elucidating protein-protein interactions.

Teck Yew Low, Saiful Effendi Syafruddin, MAiman Mohtar, Adaikkalam Vellaichamy, Nisa Syakila A Rahman, Yuh-Fen Pung, Chris Soon Heng Tan

Cellular and molecular life sciences : CMLS (2021-05-27) https://www.ncbi.nlm.nih.gov/pubmed/34046695

DOI: 10.1007/s00018-021-03856-0 · PMID: 34046695 · PMCID: PMC8159249

762.

The IntAct database: efficient access to fine-grained molecular interaction data.

Noemi Del Toro, Anjali Shrivastava, Eliot Ragueneau, Birgit Meldal, Colin Combe, Elisabet Barrera, Livia Perfetto, Karyn How, Prashansa Ratan, Gautam Shirodkar, … Henning Hermjakob

Nucleic acids research (2022-01-07) https://www.ncbi.nlm.nih.gov/pubmed/34761267

DOI: 10.1093/nar/gkab1006 · PMID: 34761267 · PMCID: PMC8728211

763.

Systematic computational prediction of protein interaction networks.

JG Lees, JK Heriche, I Morilla, JA Ranea, CA Orengo

Physical biology (2011-05-13) https://www.ncbi.nlm.nih.gov/pubmed/21572181

DOI: 10.1088/1478-3975/8/3/035008 · PMID: 21572181

764.

The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets.

Damian Szklarczyk, Annika L Gable, Katerina C Nastou, David Lyon, Rebecca Kirsch, Sampo Pyysalo, Nadezhda T Doncheva, Marc Legeay, Tao Fang, Peer Bork, … Christian von Mering

Nucleic acids research (2021-01-08) https://www.ncbi.nlm.nih.gov/pubmed/33237311

DOI: 10.1093/nar/gkaa1074 · PMID: 33237311 · PMCID: PMC7779004

765.

Evolution of Centrality Measurements for the Detection of Essential Proteins in Biological Networks.

Mahdi Jalili, Ali Salehzadeh-Yazdi, Shailendra Gupta, Olaf Wolkenhauer, Marjan Yaghmaie, Osbaldo Resendis-Antonio, Kamran Alimoghaddam

Frontiers in physiology (2016-08-26) https://www.ncbi.nlm.nih.gov/pubmed/27616995

DOI: 10.3389/fphys.2016.00375 · PMID: 27616995 · PMCID: PMC4999434

766.

A systematic survey of centrality measures for protein-protein interaction networks.

Minoo Ashtiani, Ali Salehzadeh-Yazdi, Zahra Razaghi-Moghadam, Holger Hennig, Olaf Wolkenhauer, Mehdi Mirzaie, Mohieddin Jafari

BMC systems biology (2018-07-31) https://www.ncbi.nlm.nih.gov/pubmed/30064421

DOI: 10.1186/s12918-018-0598-2 · PMID: 30064421 · PMCID: PMC6069823

767.

Why do hubs tend to be essential in protein networks?

Xionglei He, Jianzhi Zhang

PLoS genetics (2006-04-26) https://www.ncbi.nlm.nih.gov/pubmed/16751849

DOI: 10.1371/journal.pgen.0020088 · PMID: 16751849 · PMCID: PMC1473040

768.

Comparative genomics of centrality and essentiality in three eukaryotic protein-interaction networks.

Matthew W Hahn, Andrew D Kern

Molecular biology and evolution (2004-12-22) https://www.ncbi.nlm.nih.gov/pubmed/15616139

DOI: 10.1093/molbev/msi072 · PMID: 15616139

769.

Closeness centrality | Network analysis of protein interaction data

EMBL-EBI

https://www.ebi.ac.uk/training/online/courses/network-analysis-of-protein-interaction-data-an-introduction/building-and-analysing-ppins/topological-ppin-analysis/closeness-centrality/

770.

The importance of bottlenecks in protein networks: correlation with gene essentiality and expression dynamics.

Haiyuan Yu, Philip M Kim, Emmett Sprecher, Valery Trifonov, Mark Gerstein

PLoS computational biology (2007-02-14) https://www.ncbi.nlm.nih.gov/pubmed/17447836

DOI: 10.1371/journal.pcbi.0030059 · PMID: 17447836 · PMCID: PMC1853125

771.

Computational approaches for detecting protein complexes from protein interaction networks: a survey.

Xiaoli Li, Min Wu, Chee-Keong Kwoh, See-Kiong Ng

BMC genomics (2010-02-10) https://www.ncbi.nlm.nih.gov/pubmed/20158874

DOI: 10.1186/1471-2164-11-s1-s3 · PMID: 20158874 · PMCID: PMC2822531

772.

Evaluation of clustering algorithms for protein-protein interaction networks.

Sylvain Brohée, Jacques van Helden

BMC bioinformatics (2006-11-06) https://www.ncbi.nlm.nih.gov/pubmed/17087821

DOI: 10.1186/1471-2105-7-488 · PMID: 17087821 · PMCID: PMC1637120

773.

An automated method for finding molecular complexes in large protein interaction networks.

Gary D Bader, Christopher WV Hogue

BMC bioinformatics (2003-01-13) https://www.ncbi.nlm.nih.gov/pubmed/12525261

DOI: 10.1186/1471-2105-4-2 · PMID: 12525261 · PMCID: PMC149346

774.

Protein function prediction using guilty by association from interaction networks.

Damiano Piovesan, Manuel Giollo, Carlo Ferrari, Silvio CE Tosatto

Amino acids (2015-07-28) https://www.ncbi.nlm.nih.gov/pubmed/26215734

DOI: 10.1007/s00726-015-2049-3 · PMID: 26215734

775.

Cytoscape: a software environment for integrated models of biomolecular interaction networks.

Paul Shannon, Andrew Markiel, Owen Ozier, Nitin S Baliga, Jonathan T Wang, Daniel Ramage, Nada Amin, Benno Schwikowski, Trey Ideker

Genome research (2003-11) https://www.ncbi.nlm.nih.gov/pubmed/14597658

DOI: 10.1101/gr.1239303 · PMID: 14597658 · PMCID: PMC403769

776.

Cytoscape stringApp 2.0: Analysis and Visualization of Heterogeneous Biological Networks.

Nadezhda T Doncheva, John H Morris, Henrietta Holze, Rebecca Kirsch, Katerina C Nastou, Yesid Cuesta-Astroz, Thomas Rattei, Damian Szklarczyk, Christian von Mering, Lars J Jensen

Journal of proteome research (2022-12-13) https://www.ncbi.nlm.nih.gov/pubmed/36512705

DOI: 10.1021/acs.jproteome.2c00651 · PMID: 36512705 · PMCID: PMC9904289

777.

Protein Bioinformatics

Cathy H Wu, Cecilia N Arighi, Karen E Ross (editors)

Methods in Molecular Biology (2017) https://doi.org/grmckg

DOI: 10.1007/978-1-4939-6783-4

778.

Recent advances in mass-spectrometry based proteomics software, tools and databases

Ankit Halder, Ayushi Verma, Deeptarup Biswas, Sanjeeva Srivastava

Drug Discovery Today: Technologies (2021-12) https://doi.org/grmckh

DOI: 10.1016/j.ddtec.2021.06.007 · PMID: 34906327

779.

Data analysis and bioinformatics tools for tandem mass spectrometry in proteomics

Eric W Deutsch, Henry Lam, Ruedi Aebersold

Physiological Genomics (2008-03) https://doi.org/d8zpvp

DOI: 10.1152/physiolgenomics.00298.2007 · PMID: 18212004

780.

Gene ontology: tool for the unification of biology. The Gene Ontology Consortium.

M Ashburner, CA Ball, JA Blake, D Botstein, H Butler, JM Cherry, AP Davis, K Dolinski, SS Dwight, JT Eppig, … G Sherlock

Nature genetics (2000-05) https://www.ncbi.nlm.nih.gov/pubmed/10802651

DOI: 10.1038/75556 · PMID: 10802651 · PMCID: PMC3037419

781.

KEGG: kyoto encyclopedia of genes and genomes.

M Kanehisa, S Goto

Nucleic acids research (2000-01-01) https://www.ncbi.nlm.nih.gov/pubmed/10592173

DOI: 10.1093/nar/28.1.27 · PMID: 10592173 · PMCID: PMC102409

782.

15 years of PhosphoSitePlus®: integrating post-translationally modified sites, disease variants and isoforms.

Peter V Hornbeck, Jon M Kornhauser, Vaughan Latham, Beth Murray, Vidhisha Nandhikonda, Alex Nord, Elzbieta Skrzypek, Travis Wheeler, Bin Zhang, Florian Gnad

Nucleic acids research (2019-01-08) https://www.ncbi.nlm.nih.gov/pubmed/30445427

DOI: 10.1093/nar/gky1159 · PMID: 30445427 · PMCID: PMC6324072

783.

Network integration and modelling of dynamic drug responses at multi-omics levels.

Nathalie Selevsek, Florian Caiment, Ramona Nudischer, Hans Gmuender, Irina Agarkova, Francis L Atkinson, Ivo Bachmann, Vanessa Baier, Gal Barel, Chris Bauer, … Jos Kleinjans

Communications biology (2020-10-15) https://www.ncbi.nlm.nih.gov/pubmed/33060801

DOI: 10.1038/s42003-020-01302-8 · PMID: 33060801 · PMCID: PMC7567116

784.

The reactome pathway knowledgebase 2022.

Marc Gillespie, Bijay Jassal, Ralf Stephan, Marija Milacic, Karen Rothfels, Andrea Senff-Ribeiro, Johannes Griss, Cristoffer Sevilla, Lisa Matthews, Chuqiao Gong, … Peter D'Eustachio

Nucleic acids research (2022-01-07) https://www.ncbi.nlm.nih.gov/pubmed/34788843

DOI: 10.1093/nar/gkab1028 · PMID: 34788843 · PMCID: PMC8689983

785.

Bioinformatics approaches for the functional interpretation of protein lists: from ontology term enrichment to network analysis.

Kris Laukens, Stefan Naulaerts, Wim Vanden Berghe

Proteomics (2015-02-20) https://www.ncbi.nlm.nih.gov/pubmed/25430566

DOI: 10.1002/pmic.201400296 · PMID: 25430566

786.

The Gene Ontology resource: enriching a GOld mine. Nucleic acids research (2021-01-08) https://www.ncbi.nlm.nih.gov/pubmed/33290552

DOI: 10.1093/nar/gkaa1113 · PMID: 33290552 · PMCID: PMC7779012

787.

Urgent need for consistent standards in functional enrichment analysis

Kaumadi Wijesooriya, Sameer A Jadaan, Kaushalya L Perera, Tanuveer Kaur, Mark Ziemann

PLOS Computational Biology (2022-03-09) https://doi.org/gpm77p

DOI: 10.1371/journal.pcbi.1009935 · PMID: 35263338 · PMCID: PMC8936487

788.

Gene Set Analysis: Challenges, Opportunities, and Future Research.

Farhad Maleki, Katie Ovens, Daniel J Hogan, Anthony J Kusalik

Frontiers in genetics (2020-06-30) https://www.ncbi.nlm.nih.gov/pubmed/32695141

DOI: 10.3389/fgene.2020.00654 · PMID: 32695141 · PMCID: PMC7339292

789.

On the Interpretation of χ 2 from Contingency Tables, and the Calculation of P

RA Fisher

Journal of the Royal Statistical Society (1922-01) https://doi.org/frpswx

DOI: 10.2307/2340521

790.

Urgent need for consistent standards in functional enrichment analysis.

Kaumadi Wijesooriya, Sameer A Jadaan, Kaushalya L Perera, Tanuveer Kaur, Mark Ziemann

PLoS computational biology (2022-03-09) https://www.ncbi.nlm.nih.gov/pubmed/35263338

DOI: 10.1371/journal.pcbi.1009935 · PMID: 35263338 · PMCID: PMC8936487

791.

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Aravind Subramanian, Pablo Tamayo, Vamsi K Mootha, Sayan Mukherjee, Benjamin L Ebert, Michael A Gillette, Amanda Paulovich, Scott L Pomeroy, Todd R Golub, Eric S Lander, Jill P Mesirov

Proceedings of the National Academy of Sciences of the United States of America (2005-09-30) https://www.ncbi.nlm.nih.gov/pubmed/16199517

DOI: 10.1073/pnas.0506580102 · PMID: 16199517 · PMCID: PMC1239896

792.

Methods and approaches in the topology-based analysis of biological pathways.

Cristina Mitrea, Zeinab Taghavi, Behzad Bokanizad, Samer Hanoudi, Rebecca Tagett, Michele Donato, Călin Voichiţa, Sorin Drăghici

Frontiers in physiology (2013-10-10) https://www.ncbi.nlm.nih.gov/pubmed/24133454

DOI: 10.3389/fphys.2013.00278 · PMID: 24133454 · PMCID: PMC3794382

793.

Faculty Opinions recommendation of Gene co-expression analysis for functional classification and gene-disease predictions.

Naoki Masuda

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature (2021-11-13) https://doi.org/grmckm

DOI: 10.3410/f.727201931.793589848

794.

Robust gene coexpression networks using signed distance correlation

Javier Pardo-Diaz, Lyuba V Bozhilova, Mariano Beguerisse-Díaz, Philip S Poole, Charlotte M Deane, Gesine Reinert

Cold Spring Harbor Laboratory (2020-06-22) https://doi.org/grmckj

DOI: 10.1101/2020.06.21.163543

795.

Community detection in graphs

Santo Fortunato

Physics Reports (2010-02) https://doi.org/b48x7f

DOI: 10.1016/j.physrep.2009.11.002

796.

Fundamental differences

Peter W Gunning, Edna C Hardeman

eLife (2018-02-01) https://doi.org/10.7554/eLife.34477

DOI: 10.7554/elife.34477

797.

Systematic detection of functional proteoform groups from bottom-up proteomic datasets

Isabell Bludau, Max Frank, Christian Dörig, Yujia Cai, Moritz Heusel, George Rosenberger, Paola Picotti, Ben C Collins, Hannes Röst, Ruedi Aebersold

Cold Spring Harbor Laboratory (2020-12-22) https://doi.org/grmckk

DOI: 10.1101/2020.12.22.423928

798.

Peptide Correlation Analysis (PeCorA) Reveals Differential Proteoform Regulation.

Maria Dermit, Trenton M Peters-Clarke, Evgenia Shishkova, Jesse G Meyer

Journal of proteome research (2020-12-16) https://www.ncbi.nlm.nih.gov/pubmed/33325715

DOI: 10.1021/acs.jproteome.0c00602 · PMID: 33325715 · PMCID: PMC8592057

799.

Overview of protein structural and functional folds.

Peter D Sun, Christine E Foster, Jeffrey C Boyington

Current protocols in protein science (2004-05) https://www.ncbi.nlm.nih.gov/pubmed/18429251

DOI: 10.1002/0471140864.ps1701s35 · PMID: 18429251 · PMCID: PMC7162418

800.

Distance-based protein folding powered by deep learning

Jinbo Xu

Proceedings of the National Academy of Sciences (2019-08-09) https://doi.org/ggr3kr

DOI: 10.1073/pnas.1821309116 · PMID: 31399549 · PMCID: PMC6708335

801.

Highly accurate protein structure prediction with AlphaFold

John Jumper, Richard Evans, Alexander Pritzel, Tim Green, Michael Figurnov, Olaf Ronneberger, Kathryn Tunyasuvunakool, Russ Bates, Augustin Žídek, Anna Potapenko, … Demis Hassabis

Nature (2021-07-15) https://doi.org/gk7nfp

DOI: 10.1038/s41586-021-03819-2 · PMID: 34265844 · PMCID: PMC8371605

802.

Accurate prediction of protein structures and interactions using a three-track neural network.

Minkyung Baek, Frank DiMaio, Ivan Anishchenko, Justas Dauparas, Sergey Ovchinnikov, Gyu Rie Lee, Jue Wang, Qian Cong, Lisa N Kinch, RDustin Schaeffer, … David Baker

Science (New York, N.Y.) (2021-07-15) https://www.ncbi.nlm.nih.gov/pubmed/34282049

DOI: 10.1126/science.abj8754 · PMID: 34282049 · PMCID: PMC7612213

803.

D²P²: database of disordered protein predictions.

Matt E Oates, Pedro Romero, Takashi Ishida, Mohamed Ghalwash, Marcin J Mizianty, Bin Xue, Zsuzsanna Dosztányi, Vladimir N Uversky, Zoran Obradovic, Lukasz Kurgan, … Julian Gough

Nucleic acids research (2012-11-29) https://www.ncbi.nlm.nih.gov/pubmed/23203878

DOI: 10.1093/nar/gks1226 · PMID: 23203878 · PMCID: PMC3531159

804.

Molecular docking: a powerful approach for structure-based drug discovery.

Xuan-Yu Meng, Hong-Xing Zhang, Mihaly Mezei, Meng Cui

Current computer-aided drug design (2011-06) https://www.ncbi.nlm.nih.gov/pubmed/21534921

DOI: 10.2174/157340911795677602 · PMID: 21534921 · PMCID: PMC3151162

805.

Molecular dynamics simulations: advances and applications

Josep Gelpi, Adam Hospital, Ramón Goñi, Modesto Orozco

Advances and Applications in Bioinformatics and Chemistry (2015-11) https://doi.org/gb9wxp

DOI: 10.2147/aabc.s70333 · PMID: 26604800 · PMCID: PMC4655909

806.

Basic local alignment search tool.

SF Altschul, W Gish, W Miller, EW Myers, DJ Lipman

Journal of molecular biology (1990-10-05) https://www.ncbi.nlm.nih.gov/pubmed/2231712

DOI: 10.1016/s0022-2836(05)80360-2 · PMID: 2231712

807.

Learning functional properties of proteins with language models

Serbulent Unsal, Heval Atas, Muammer Albayrak, Kemal Turhan, Aybar C Acar, Tunca Doğan

Nature Machine Intelligence (2022-03-21) https://doi.org/grckz2

DOI: 10.1038/s42256-022-00457-9

808.

Learning the protein language: Evolution, structure, and function

Tristan Bepler, Bonnie Berger

Cell Systems (2021-06) https://doi.org/gqbqpp

DOI: 10.1016/j.cels.2021.05.017 · PMID: 34139171 · PMCID: PMC8238390

809.

Thermal proteome profiling for interrogating protein interactions.

André Mateus, Nils Kurzawa, Isabelle Becher, Sindhuja Sridharan, Dominic Helm, Frank Stein, Athanasios Typas, Mikhail M Savitski

Molecular systems biology (2020-03) https://www.ncbi.nlm.nih.gov/pubmed/32133759

DOI: 10.15252/msb.20199232 · PMID: 32133759 · PMCID: PMC7057112

810.

Computational prediction of protein–protein binding affinities

Till Siebenmorgen, Martin Zacharias

WIREs Computational Molecular Science (2019-10-29) https://doi.org/grmckf

DOI: 10.1002/wcms.1448

811.

DEG 10, an update of the database of essential genes that includes both protein-coding genes and noncoding genomic elements: Table 1.

Hao Luo, Yan Lin, Feng Gao, Chun-Ting Zhang, Ren Zhang

Nucleic Acids Research (2013-11-15) https://doi.org/f5shvv

DOI: 10.1093/nar/gkt1131 · PMID: 24243843 · PMCID: PMC3965060

812.

The phenotypic landscape of essential human genes

Luke Funk, Kuan-Chung Su, Jimmy Ly, David Feldman, Avtar Singh, Brittania Moodie, Paul C Blainey, Iain M Cheeseman

Cell (2022-11) https://doi.org/gq68c5

DOI: 10.1016/j.cell.2022.10.017 · PMID: 36347254 · PMCID: PMC10482496

813.

Transient and stable vector transfection: Pitfalls, off-target effects, artifacts

Aleksei A Stepanenko, Henry H Heng

Mutation Research/Reviews in Mutation Research (2017-07) https://doi.org/gb4hwj

DOI: 10.1016/j.mrrev.2017.05.002 · PMID: 28927539

814.

Choosing the Right Tool for the Job: RNAi, TALEN, or CRISPR

Michael Boettcher, Michael T McManus

Molecular Cell (2015-05) https://doi.org/f7dvmk

DOI: 10.1016/j.molcel.2015.04.028 · PMID: 26000843 · PMCID: PMC4441801

815.

A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity

Martin Jinek, Krzysztof Chylinski, Ines Fonfara, Michael Hauer, Jennifer A Doudna, Emmanuelle Charpentier

Science (2012-08-17) https://doi.org/f22dgd

DOI: 10.1126/science.1225829 · PMID: 22745249 · PMCID: PMC6286148

816.

A glance at genome editing with CRISPR–Cas9 technology

Antara Barman, Bornali Deb, Supriyo Chakraborty

Current Genetics (2019-11-05) https://doi.org/gjrcz5

DOI: 10.1007/s00294-019-01040-3 · PMID: 31691023

817.

From DNA break repair pathways to CRISPR/Cas-mediated gene knock-in methods

Mahere Rezazade Bazaz, Hesam Dehghani

Life Sciences (2022-04) https://doi.org/gr5j2p

DOI: 10.1016/j.lfs.2022.120409 · PMID: 35182556

818.

Gene editing and its applications in biomedicine

Guanglei Li, Xiangyang Li, Songkuan Zhuang, Liren Wang, Yifan Zhu, Yangcan Chen, Wen Sun, Zeguang Wu, Zhuo Zhou, Jia Chen, … Wensheng Wei

Science China Life Sciences (2022-02-18) https://doi.org/gp8msx

DOI: 10.1007/s11427-021-2057-0 · PMID: 35235150 · PMCID: PMC8889061

819.

A Review on Advanced CRISPR-Based Genome-Editing Tools: Base Editing and Prime Editing

Ali Saber Sichani, Maryam Ranjbar, Maryam Baneshi, Farid Torabi Zadeh, Jafar Fallahi

Molecular Biotechnology (2022-12-22) https://doi.org/gr5j2d

DOI: 10.1007/s12033-022-00639-1 · PMID: 36547823

820.

Recent Advances in Genome-Engineering Strategies

Michaela A Boti, Konstantina Athanasopoulou, Panagiotis G Adamopoulos, Diamantis C Sideris, Andreas Scorilas

Genes (2023-01-02) https://doi.org/gr5j2w

DOI: 10.3390/genes14010129 · PMID: 36672870 · PMCID: PMC9859587

821.

Latest Developed Strategies to Minimize the Off-Target Effects in CRISPR-Cas-Mediated Genome Editing

Muhammad Naeem, Saman Majeed, Mubasher Zahir Hoque, Irshad Ahmad

Cells (2020-07-02) https://doi.org/gmhjsc

DOI: 10.3390/cells9071608 · PMID: 32630835 · PMCID: PMC7407193

822.

Targeted Protein Degradation Tools: Overview and Future Perspectives

Yuri Prozzillo, Gaia Fattorini, Maria Virginia Santopietro, Luigi Suglia, Alessandra Ruggiero, Diego Ferreri, Giovanni Messina

Biology (2020-11-26) https://doi.org/gmfb42

DOI: 10.3390/biology9120421 · PMID: 33256092 · PMCID: PMC7761331

823.

Tet-On Systems For Doxycycline-inducible Gene Expression

Atze T. Das, Liliane Tenenbaum, Ben Berkhout

Current Gene Therapy (2016-06-16) https://doi.org/f8sfzz

DOI: 10.2174/1566523216666160524144041 · PMID: 27216914 · PMCID: PMC5070417

824.

How to Choose the Right Inducible Gene Expression System for Mammalian Studies?

Kallunki, Barisic, Jäättelä, Liu

Cells (2019-07-30) https://doi.org/gr5j2v

DOI: 10.3390/cells8080796 · PMID: 31366153 · PMCID: PMC6721553

825.

Rapid Creation of Stable Mammalian Cell Lines for Regulated Expression of Proteins Using the Gateway® Recombination Cloning Technology and Flp-In T-REx® Lines

Jessica Spitzer, Markus Landthaler, Thomas Tuschl

Methods in Enzymology (2013) https://doi.org/f5fkw5

DOI: 10.1016/b978-0-12-418687-3.00008-2 · PMID: 24011039

826.

Using the Flp-In™ T-Rex™ System to Regulate GPCR Expression

Richard J Ward, Elisa Alvarez-Curto, Graeme Milligan

Methods in Molecular Biology (2011) https://doi.org/dsvq7p

DOI: 10.1007/978-1-61779-126-0_2 · PMID: 21607850

827.

The Art of Validating Quantitative Proteomics Data

David C Handler, Dana Pascovici, Mehdi Mirzaei, Vivek Gupta, Ghasem Hosseini Salekdeh, Paul A Haynes

PROTEOMICS (2018-11-25) https://doi.org/gr5j2b

DOI: 10.1002/pmic.201800222 · PMID: 30352137

828.

Pulse‐Chase Analysis for Studying Protein Synthesis and Maturation

Susanne Fritzsche, Sebastian Springer

Current Protocols in Protein Science (2014-11) https://doi.org/gr5jz9

DOI: 10.1002/0471140864.ps3003s78 · PMID: 25367008

829.

Degradation Parameters from Pulse-Chase Experiments

Celine Sin, Davide Chiarugi, Angelo Valleriani

PLOS ONE (2016-05-16) https://doi.org/gbmt2f

DOI: 10.1371/journal.pone.0155028 · PMID: 27182698 · PMCID: PMC4868333

830.

Mass Spectrometry Methods for Measuring Protein Stability

Daniel D Vallejo, Carolina Rojas Ramírez, Kristine F Parson, Yilin Han, Varun V Gadkari, Brandon T Ruotolo

Chemical Reviews (2022-03-22) https://doi.org/gr5j2q

DOI: 10.1021/acs.chemrev.1c00857 · PMID: 35316030 · PMCID: PMC9197173

831.

New Developments in Quantitative Real-time Polymerase Chain Reaction Technology

Current Issues in Molecular Biology

(2014) https://doi.org/gr5j2t

DOI: 10.21775/cimb.016.001 · PMID: 23562919

832.

RNA-Seq: a revolutionary tool for transcriptomics

Zhong Wang, Mark Gerstein, Michael Snyder

Nature Reviews Genetics (2009-01) https://doi.org/crrz3v

DOI: 10.1038/nrg2484 · PMID: 19015660 · PMCID: PMC2949280

833.

Development and Applications of Superfolder and Split Fluorescent Protein Detection Systems in Biology

Jean-Denis Pedelacq, Stéphanie Cabantous

International Journal of Molecular Sciences (2019-07-15) https://doi.org/ggks55

DOI: 10.3390/ijms20143479 · PMID: 31311175 · PMCID: PMC6678664

834.

Analysis of protein-protein proximities using the split-ubiquitin system

N Lehming

Briefings in Functional Genomics and Proteomics (2002-01-01) https://doi.org/b9btsv

DOI: 10.1093/bfgp/1.3.230 · PMID: 15239890

835.

Split-luciferase complementary assay: applications, recent developments, and future perspectives

Taha Azad, Amin Tashakor, Saman Hosseinkhani

Analytical and Bioanalytical Chemistry (2014-07-08) https://doi.org/f6gkk9

DOI: 10.1007/s00216-014-7980-8 · PMID: 25002334

836.

Tobacco Etch Virus protease: A shortcut across biotechnologies

Francesca Cesaratto, Oscar R Burrone, Gianluca Petris

Journal of Biotechnology (2016-08) https://doi.org/gr5j2k

DOI: 10.1016/j.jbiotec.2016.06.012 · PMID: 27312702

837.

A split β-lactamase sensor for the detection of DNA modification by cisplatin and ruthenium-based chemotherapeutic drugs

Samuel R Hinton, Elizabeth LS Corpuz, Karen L McFarlane Holman, Scott C Meyer

Journal of Inorganic Biochemistry (2022-11) https://doi.org/gr5j2m

DOI: 10.1016/j.jinorgbio.2022.111986 · PMID: 36084568

838.

Detecting Protein-Protein Interaction Based on Protein Fragment Complementation Assay

Tianwen Wang, Ningning Yang, Chen Liang, Hongjv Xu, Yafei An, Sha Xiao, Mengyuan Zheng, Lu Liu, Gaozhan Wang, Lei Nie

Current Protein & Peptide Science (2020-08-21) https://doi.org/gr5j2s

DOI: 10.2174/1389203721666200213102829 · PMID: 32053071

839.

Technologies for the identification and validation of protein-protein interactions

Karoline Pichlerova, Jozef Hanes

General physiology and biophysics (2021) https://doi.org/gr5j2z

DOI: 10.4149/gpb_2021035 · PMID: 34897023

840.

A novel genetic system to detect protein–protein interactions

Stanley Fields, Ok-kyu Song

Nature (1989-07) https://doi.org/c3ntbc

DOI: 10.1038/340245a0 · PMID: 2547163

841.

Yeast Two-Hybrid, a Powerful Tool for Systems Biology

Anna Brückner, Cécile Polge, Nicolas Lentze, Daniel Auerbach, Uwe Schlattner

International Journal of Molecular Sciences (2009-06-18) https://doi.org/d45mqr

DOI: 10.3390/ijms10062763 · PMID: 19582228 · PMCID: PMC2705515

842.

The mammalian two-hybrid system as a powerful tool for high-throughput drug screening

Daniela Patrício, Margarida Fardilha

Drug Discovery Today (2020-04) https://doi.org/gr5j2j

DOI: 10.1016/j.drudis.2020.01.022 · PMID: 32032707

843.

Isolation of Endogenously Assembled RNA-Protein Complexes Using Affinity Purification Based on Streptavidin Aptamer S1

Yangchao Dong, Jing Yang, Wei Ye, Yuan Wang, Chuantao Ye, Daihui Weng, Huan Gao, Fanglin Zhang, Zhikai Xu, Yingfeng Lei

International Journal of Molecular Sciences (2015-09-16) https://doi.org/f7xz9m

DOI: 10.3390/ijms160922456 · PMID: 26389898 · PMCID: PMC4613318

844.

FRET as a biomolecular research tool — understanding its potential while avoiding pitfalls

WRuss Algar, Niko Hildebrandt, Steven S Vogel, Igor L Medintz

Nature Methods (2019-08-30) https://doi.org/ggdxxw

DOI: 10.1038/s41592-019-0530-8 · PMID: 31471616

845.

Split-protein systems: beyond binary protein–protein interactions

Sujan S Shekhawat, Indraneel Ghosh

Current Opinion in Chemical Biology (2011-12) https://doi.org/cpvhs8

DOI: 10.1016/j.cbpa.2011.10.014 · PMID: 22070901 · PMCID: PMC3237955

846.

Proximity ligation assay: an ultrasensitive method for protein quantification and its applications in pathogen detection

Pengzhi Wang, Yi Yang, Tianqi Hong, Guoqiang Zhu

Applied Microbiology and Biotechnology (2021-01-11) https://doi.org/gr5j2c

DOI: 10.1007/s00253-020-11049-1 · PMID: 33427935

847.

Understanding FRET as a Research Tool for Cellular Studies

Dilip Shrestha, Attila Jenei, Péter Nagy, György Vereb, János Szöllősi

International Journal of Molecular Sciences (2015-03-25) https://doi.org/f7cbff

DOI: 10.3390/ijms16046718 · PMID: 25815593 · PMCID: PMC4424985

848.

Illuminating insights into protein-protein interactions using bioluminescence resonance energy transfer (BRET)

Kevin DG Pfleger, Karin A Eidne

Nature Methods (2006-02-17) https://doi.org/fq5kjq

DOI: 10.1038/nmeth841 · PMID: 16489332

849.

Developments in FRET- and BRET-Based Biosensors

Yuexin Wu, Tianyu Jiang

Micromachines (2022-10-20) https://doi.org/gr5j2x

DOI: 10.3390/mi13101789 · PMID: 36296141 · PMCID: PMC9610962

850.

Fluorescence correlation spectroscopy as a tool for the study of the intracellular dynamics and biological fate of protein corona

Marta Martinez-Moro, Desiré Di Silvio, Sergio E Moya

Biophysical Chemistry (2019-10) https://doi.org/gr5j2f

DOI: 10.1016/j.bpc.2019.106218 · PMID: 31325709

851.

Proximity labeling methods for proteomic analysis of membrane proteins

Francisco Zafra, Dolores Piniella

Journal of Proteomics (2022-07) https://doi.org/gr5j2n

DOI: 10.1016/j.jprot.2022.104620 · PMID: 35598870

852.

Research Techniques Made Simple: Emerging Methods to Elucidate Protein Interactions through Spatial Proximity

Yonglu Che, Paul A Khavari

Journal of Investigative Dermatology (2017-12) https://doi.org/gcmmkp

DOI: 10.1016/j.jid.2017.09.028 · PMID: 29169465

853.

Analysis of Protein Interactions in situ by Proximity Ligation Assays

Björn Koos, Linda Andersson, Carl-Magnus Clausson, Karin Grannas, Axel Klaesson, Gaëlle Cane, Ola Söderberg

Current Topics in Microbiology and Immunology (2013) https://doi.org/f25nfj

DOI: 10.1007/82_2013_334 · PMID: 23921974

854.

Cross-linking and mass spectrometry as a tool for studying the structural biology of ribonucleoproteins

Chris P Sarnowski, Maria Bikaki, Alexander Leitner

Structure (2022-04) https://doi.org/gr5jz6

DOI: 10.1016/j.str.2022.03.003 · PMID: 35366400

855.

Protein–RNA interactions: from mass spectrometry to drug discovery

Benjamin Steinmetz, Izabela Smok, Maria Bikaki, Alexander Leitner

Essays in Biochemistry (2023-03) https://doi.org/gr5jz8

DOI: 10.1042/ebc20220177 · PMID: 36866608 · PMCID: PMC10070478

856.

Anatomy of a crosslinker

Adam Belsom, Juri Rappsilber

Current Opinion in Chemical Biology (2021-02) https://doi.org/gk6ddr

DOI: 10.1016/j.cbpa.2020.07.008 · PMID: 32829152

857.

Analysis of Protein Interactions by Surface Plasmon Resonance

Dennis G Drescher, Dakshnamurthy Selvakumar, Marian J Drescher

Protein-Protein Interactions in Human Disease, Part A (2018) https://doi.org/gr5jz7

DOI: 10.1016/bs.apcsb.2017.07.003 · PMID: 29412994

858.

Open collaborative writing with Manubot

Daniel S Himmelstein, Vincent Rubinetti, David R Slochower, Dongbo Hu, Venkat S Malladi, Casey S Greene, Anthony Gitter

PLOS Computational Biology (2019-06-24) https://doi.org/c7np

DOI: 10.1371/journal.pcbi.1007128 · PMID: 31233491 · PMCID: PMC6611653

Type	Acronym	Principle	Characteristics
Time-of-flight	TOF	Time dispersion of a pulsed ion beam; separation by the time it takes for ions to travel a fixed distance	High-speed analysis, large mass range and good sensitivity. Suited for fast data acquisition and high-throughput applications. Modern TOF systems usually can achieve mass resolution well over 10,000 (m/Δm) or even higher.
Linear quadrupole	Q	Continuous ion beam in linear radio frequency quadrupole field; separation due to instability of ion trajectories	High transmission efficiency, simple design, good sensitivity, and tunable mass range; relatively low mass resolution ranges from several hundreds to a thousand; often used in tandem mass spectrometry (MS/MS) experiments
Quadrupole ion trap	QIT	Traps ions by electromagnetic fields; separation in three-dimensional radio frequency quadrupole field by resonant excitation	Efficient for fragmenting ions and structural elucidation, higher sensitivity, and relatively compact which good for benchtop instruments. Relatively a low mass resolution around 1,000 - 3,000.
Fourier transform-ion cyclotron resonance	FT-ICR	Traps ions in a strong magnetic field by Lorentz force; separation by cyclotron frequency, image current detection and Fourier transformation of transient signal	Ultimate high mass resolution (up to 1,000,000), making it ideal for elemental and isotopic analysis. Large size, low speed, and expensive in terms of both initial purchase cost and ongoing operation and maintenance costs.
Orbitrap	Orbitrap	Axial oscillation in inhomogeneous electric field; detection of frequency after Fourier transformation of transient signal	Extremely high resolution and accuracy (up to 500,000), capable of resolving complex mixtures with high sensitivity. Relatively low speed, expensive in terms of both initial purchase cost and ongoing operation and maintenance costs. Need high vacuum.

Type	Principle	Characteristics
Electron Multiplier	Amplifies signals by utilizing a sequence of dynodes that emit secondary electrons when struck by an incident electron, creating a cascading effect. This results in an amplified output current at the final anode, proportional to the intensity of the initial signal.	Very good signal amplification to even one electron (may cause more noise dependent on gain), high sensitivity, need high vacuum and high voltage, expensive. Limited dynamic range, finite lifespan and need to be replaced periodically
Faraday Cup	Charged particles, such as ions or electrons, enter the cup and transfer their charge to it, causing a change in electric potential that can be measured over time to infer the number of particles.	Suitable for particles and charge state detection. Simplicity and robustness, Wide dynamic range, no need for high voltage and high vacuum. Lower sensitivity. Sensitive to Secondary Emission directional sensitivity (direction of incoming particles)
Microchannel Plate	Similar to electron multiplier, a two-dimensional matrix or “plate” of many tiny, parallel, hollow channels made from a type of glass that can generate secondary electron emissions upon incident particles striking the channel walls. These secondary emissions create an electron avalanche down the channels and amplifies the original signal.	Signal Amplification (Not as good as electron multiplier, but lower noise), Spatial Resolution ability, shorter life expectancy due to channel aging and depletion of the secondary emission material, smaller and cheaper than electron multiplier
Daly Detector	Directing ions onto a surface (Doorknob) to trigger the emission of electrons, which are then accelerated towards a phosphor screen to produce photons, that are subsequently detected and amplified by a photomultiplier tube, thereby converting the ion signal into a measurable electrical signal.	High gain, ruggedness, wide dynamic range, suitable for high mass and high energy ions. Limited mass resolution, larger size and need high voltage, finite lifespan.

Separation concept	Ion mobility techniques	Ion movement direction	Electric field direction	Drift Gas direction	Characteristics
Temporally Dispersive	drift tube IMS (DTIMS)	→	→	#	High mobility resolution (need long drift tube), direct measurement of CCS. Low speed, large size, low sensitivity,
Temporally Dispersive	traveling wave IMS (TWIMS)	→	→→→	#	High mobility resolution, faster than DTIMS. Low sensitivity, large size, low sensitivity, traveling electric field waves.
Spatially Dispersive	high-field asymmetric IMS (FAIMS)	→	↑↓	→	Good as mass filter, Fast. No CCS measurement (Compensation voltage instead), low mobility resolution.
Spatially Dispersive	transverse modulation IMS (TMIMS)	→	→ and ↑↓	#	Transverse Modulation, compact instrumentation, orthogonal Separation, fast and high resolution
Confinement and Selective Release	trapped ion mobility spectrometry (TIMS)	→	←	→	High mobility resolution, compact instrumentation, high sensitivity, high speed, high ion utilization rate
Confinement and Selective Release	multi-pass cyclic traveling wave IMS	→	→→→	#	High mobility resolution, improved Signal-to-Noise ratio and sensitivity, versatility (from small molecules to large biomolecules) and adjustability (number of passes can often be adjusted)

Name	Publication	Website
MaxDIA	Cox and Mann, 2008[605]	MaxQuant
Skyline	MacLean et al., 2010[612]	Skyline
DIA-NN	Demichev et al., 2019[613]	DIA-NN
EncyclopeDIA	Searle et al., 2018[614]	EncyclopeDIA

Name	Publication	Website
ProteomeDiscoverer		ProteomeDiscoverer
Mascot	Perkins et al., 1999[607]	Mascot
Spectromine		Spectromine
PEAKS	Tran et al., 2018[615]	PEAKS

Name	Publication	Website
Spectronaut	Bruderer et al., 2015[616]	Spectronaut
PEAKS	Tran et al., 2018[615]	PEAKS

Name	Supported instrument vendors	Website/Download	publication	Note
QuiC	Thermo Scientific, AB SCIEX, Agilent, Bruker, Waters	QuiC		requires Biognosys iRT peptides
AlphaPept	Thermo Scientific, Bruker	AlphaPept	[659]
RawMeat 2.1	Thermo Scientific	RawMeat
rawDiag	Thermo Scientific	rawDiag	[660]
rawrr	Thermo Scientific	rawrr	[661]
rawBeans	Thermo or mzML	rawBeans	[662]
SIMPATIQCO	Thermo Scientific	SIMPATIQCO	[663]
QC-ART		QC-ART	[664]
SprayQc	Thermo Scientific, AB SCIEX, extensible to other instrumentation	SprayQc	[665]
Metriculator		Metriculator	[666]
MassQC		MassQC
OpenMS		OpenMS	[667]

Name	Website/Download/publication	publication	Note
MSStats	MSStats	[668]	can use output from MaxQuant, Proteome Discoverer, Skyline, Progenesis, Spectronaut
MSStatsQC	MSStatsQC	[669]
PTXQC	PTXQC	[670]	requires MaxQuant search engine output
protti	protti	[671]

	Proteins with altered abundance	Proteins with unaltered abundance	Total
Proteins in TCA set	15	25	40
Proteins not in TCA set	185	1775	1960
Total	200	1800	2000